 EX-2.1  

Exhibit 2.1













EQUITY PURCHASE AGREEMENT

by and among:

Omnicell, Inc.,

a Delaware corporation;



PSGH, LLC,

a Texas limited liability company;



BW Apothecary Holdings, LLC,

a Delaware limited liability company;

The Sellers Set Forth on the Signature Pages Hereto;

and

Charles Miller,

as the Sellers' Representative





____________________________________________________________________________

Dated August 11, 2020

____________________________________________________________________________ Table of Contents

| | | | | | | | | | | 
---|---|---|---|---|---|---|---|---|---|---|--- 
| | | Page 
1.| Description of Transaction| | 2 
| 1.1| Sale and Purchase| 2 
| 1.2| Purchase Price| 2 
| 1.3| Purchase Price Adjustment| 3 
| 1.4| Closing| 5 
| 1.5| Escheat| 10 
| 1.6| Tax Withholding| 10 
| 1.7| Waiver of Notices| 11 
| 1.8| Tax Treatment; Allocation of Purchase Price| 11 
2.| Representations and Warranties of the Company| | 12 
| 2.1| Due Organization; Subsidiaries; Etc.| 12 
| 2.2| Charter Documents; Records| 13 
| 2.3| Capitalization| 14 
| 2.4| Financial Statements and Related Information| 16 
| 2.5| No Liabilities; Indebtedness| 19 
| 2.6| Absence of Changes| 19 
| 2.7| Title to Assets| 20 
| 2.8| Bank Accounts| 20 
| 2.9| Equipment; Real Property| 21 
| 2.10| Intellectual Property| 22 
| 2.11| Contracts| 33 
| 2.12| Compliance with Legal Requirements| 38 
| 2.13| Governmental Authorizations| 39 
| 2.14| Tax Matters| 40 
| 2.15| Employee and Labor Matters; Benefit Plans| 43 
| 2.16| Environmental Matters| 50 
| 2.17| Insurance| 50 
| 2.18| Transactions with Related Parties| 51 
| 2.19| Legal Proceedings; Orders| 51 
| 2.20| Authority; Binding Nature of Agreement; Inapplicability of Anti-
takeover Statutes| 52 
| 2.21| Non-Contravention; Consents| 52 
| 2.22| Compliance with Health Care Laws| 53 
| 2.23| Significant Business Relationships| 55 
| 2.24| Books and Records| 56 
| 2.25| Brokers| 56 
| 2.26| Full Disclosure| 56 
3.| Representations and Warranties of Each Seller| | 57 
| 3.1| Organization, Good Standing and Qualification| 57 

 | | | | | | | | | | | 
---|---|---|---|---|---|---|---|---|---|---|--- 
| 3.2| Ownership of Units| 57 
| 3.3| Capacity and Authority of Sellers| 58 
| 3.4| Execution, Delivery; Valid and Binding Agreements| 58 
| 3.5| No Legal Proceedings| 58 
| 3.6| Brokers| 59 
| 3.7| Non-Contravention; No Consents or Approvals| 59 
| 3.8| Rights to Intellectual Property| 59 
4.| Representations and Warranties of Blocker| | 60 
| 4.1| Organization, Good Standing and Qualification| 60 
| 4.2| Charter Documents; Records| 61 
| 4.3| Capitalization| 61 
| 4.4| No Liabilities; Indebtedness| 63 
| 4.5| Assets| 64 
| 4.6| Contracts| 64 
| 4.7| Compliance with Legal Requirements| 65 
| 4.8| Legal Proceedings; Orders| 65 
| 4.9| Governmental Authorizations| 65 
| 4.10| Authority; Binding Nature of Agreement; Inapplicability of Anti-
takeover Statutes| 66 
| 4.11| Non-Contravention; Consents| 67 
| 4.12| Books and Records| 68 
| 4.13| Brokers| 68 
| 4.14| No Prior Activities or Operations| 68 
| 4.15| Tax Matters| 68 
5.| Representations and Warranties of Purchaser| | 69 
| 5.1| Due Organization| 69 
| 5.2| Non-Contravention; Consents| 69 
| 5.3| Authority; Binding Nature of Agreement| 70 
| 5.4| Availability of Funds| 70 
6.| Certain Covenants of the Company and Blocker| | 70 
| 6.1| Access and Investigation| 70 
| 6.2| Operation of the Business of the Acquired Companies| 71 
| 6.3| Operation of the Business of Blocker Entities| 75 
| 6.4| Notification| 76 
| 6.5| No Negotiation| 76 
| 6.6| Data Room Information| 77 
| 6.7| Termination/Amendment of Agreements and Release of Encumbrances| 77 
| 6.8| Resignation of Officers, Managers and Directors| 77 
| 6.9| DandO Insurance| 77 
| 6.10| Payoff Letters and Invoices; Draft Closing Consideration Certificate
and Updated Pro Rata Portion Schedule| 78 

 | | | | | | | | | | | 
---|---|---|---|---|---|---|---|---|---|---|--- 
| 6.11| Employee Matters| 79 
| 6.12| Integration| 80 
| 6.13| Bank Accounts| 80 
| 6.14| Spin-Off| 81 
| 6.15| Financial Statements| 81 
| 6.16| Transfer of Purchased Securities| 82 
| 6.17| SpinCo Insurance| 82 
| 6.18| Sublease Agreement| 82 
7.| Certain Covenants of the Parties| | 82 
| 7.1| Filings and Consents| 82 
| 7.2| Reasonable Efforts| 84 
| 7.3| Communications with Employees| 84 
| 7.4| Books and Records| 84 
| 7.5| Purchaser Non-Solicitation| 85 
8.| Conditions Precedent to Obligations of Purchaser| | 86 
| 8.1| Accuracy of Representations| 86 
| 8.2| Performance of Covenants| 87 
| 8.3| Governmental and Other Consents| 87 
| 8.4| No Material Adverse Effect| 87 
| 8.5| Employees| 88 
| 8.6| Documents and Agreements| 88 
| 8.7| No Restraints| 88 
| 8.8| No Legal Proceedings| 88 
9.| Conditions Precedent to Obligations of the Sellers| | 89 
| 9.1| Accuracy of Representations| 89 
| 9.2| Performance of Covenants| 89 
| 9.3| HSR Approval; Other Governmental Consents| 89 
| 9.4| Documents and Agreements| 89 
| 9.5| No Restraints| 89 
10.| Termination| | 90 
| 10.1| Termination Events| 90 
| 10.2| Termination Procedures| 91 
| 10.3| Effect of Termination| 91 
11.| Indemnification, Etc.| | 91 
| 11.1| Survival of Representations, Etc| 91 
| 11.2| Indemnification| 93 
| 11.3| Limitations| 96 
| 11.4| No Contribution| 100 
| 11.5| Claim Procedures| 101 
| 11.6| Payment of Determined Amounts| 105 
| 11.7| Escrow Matters| 105 

 | | | | | | | | | | | 
---|---|---|---|---|---|---|---|---|---|---|--- 
| 11.8| Defense of Third Party Claims| 108 
| 11.9| RandW Policy| 109 
| 11.10| Exclusive Remedy| 110 
| 11.11| Exercise of Remedies Other Than by Purchaser| 111 
| 11.12| Provisions Relating to the Designated Tax Matter| 111 
12.| Miscellaneous Provisions| | 112 
| 12.1| Sellers' Representative| 112 
| 12.2| Further Assurances| 114 
| 12.3| Fees and Expenses| 114 
| 12.4| Taxes| 114 
| 12.5| Attorneys' Fees| 121 
| 12.6| Notices| 121 
| 12.7| Time of the Essence| 123 
| 12.8| Headings| 123 
| 12.9| Counterparts and Exchanges by Electronic Transmission| 123 
| 12.10| Governing Law; Dispute Resolution| 123 
| 12.11| Successors and Assigns| 124 
| 12.12| Remedies Cumulative; Specific Performance| 124 
| 12.13| Waiver| 125 
| 12.14| Waiver of Jury Trial| 125 
| 12.15| Amendments| 125 
| 12.16| Severability| 125 
| 12.17| Parties in Interest| 126 
| 12.18| Confidential Nature of Information| 126 
| 12.19| No Public Announcement| 126 
| 12.20| Legal Representation| 127 
| 12.21| Entire Agreement| 127 
| 12.22| Disclosure Schedule| 128 
| 12.23| Mutual Drafting| 128 
| 12.24| Construction| 128 

 





















 List of Exhibits and Schedules

| | | | | 
---|---|---|---|---|--- 
Exhibit A| Certain Definitions 
Exhibit B-1| Form of Noncompetition Agreement (Continuing Employee Seller) 
Exhibit B-2| Form of Noncompetition Agreement (Non-Continuing Employee Seller) 
Exhibit B-3| Form of Noncompetition Agreement (SpinCo) 
Exhibit C| Release 
Exhibit D| Form of Escrow Agreement 
Exhibit E-1| Persons Whose Knowledge Is Imputed to the Company 
Exhibit E-2| Persons Whose Knowledge Is Imputed to Blocker 
Exhibit F| Sample Net Working Capital 
Exhibit G-1| Form of Reorganization Agreement 
Exhibit G-2 | Form of Agreement and Plan of Merger (Divisional Merger) 
Exhibit G-3| Form of Indemnity Agreement 
Exhibit H-1| Form of 340B Transition Services Agreement 
Exhibit H-2| Form of PSG Transition Services Agreement 
Exhibit I| Form of Assignment 
Exhibit J| Closing Date Offer Letter 
Exhibit K| Change of Control Bonuses 
Exhibit L| Offered Employees 
Exhibit M| Sublease Term Sheet 
| 
Schedule 1.2| Sellers and Payment Information 
Schedule 1.4(b)(iii)| Persons to Execute a Noncompetition Agreement 
Schedule 1.4(b)(iv)| Persons to Execute a Release 
Schedule 1.4(b)(vi)| Persons Whose Created IP To Be Transferred to the Company 
Schedule 1.4(b)(vii)| Acquired Contracts 
Schedule 1.4(b)(xx)| Required Employees 
Schedule 1.4(b)(xxiv)| Required Consents 
Schedule 1.4(b)(xxv)| Required Notices 
Schedule 1.4(c)| Post-Closing Managers/Directors and Officers 
Schedule 1.8| Allocation Principles 
Schedule 6.2| Purchaser Authorized Persons 
Schedule 6.2(b)| Operation of the Business of the Acquired Companies 
Schedule 6.7(i)| Agreements to be Terminated 
Schedule 6.7(ii)| Agreements to be Amended 
Schedule 6.7(iii)| Encumbrances to be Released 
Schedule 6.11(c) | Accrued Employee Amounts 
Schedule 6.17| SpinCo Policies 
Schedule 11.2(a)(vi)| Special Indemnity Matters 
Schedule 11.3(c)(v)| Sources of Recovery 
Schedule 12.4(a)(ii)(B)| Straddle Period Flow-Through Tax Returns of the
Company 

 

Equity Purchase Agreement

This Equity Purchase Agreement ("Agreement") is made and entered into on
August 11, 2020 by and among: Omnicell, Inc., a Delaware corporation
("Purchaser"); PSGH, LLC, a Texas limited liability company (the "Company");
BW Apothecary Holdings, LLC, a Delaware limited liability company ("Blocker");
the Person set forth on the signature page hereto under the heading "Class A
Holder" (the "Class A Holder"); Blue Wolf Capital Fund II, L.P., a Delaware
limited partnership ("Blocker Seller"); the Persons set forth on the signature
pages hereto under the heading "Class C Holders" (collectively, the "Class C
Holders"); the Persons set forth on the signature pages hereto under the
heading "Class D Holders" (collectively, the "Class D Holders," and together
with Blocker Seller, the Class A Holder and the Class C Holders, the
"Sellers"); and Charles Miller as the Sellers' Representative (the "Sellers'
Representative"). Purchaser, the Company, Blocker, Blocker Seller, the Class A
Holder, the Class C Holders, the Class D Holders and the Sellers'
Representative are sometimes referred to individually as a "Party" and
collectively as the "Parties". Certain other capitalized terms used in this
Agreement are defined in Exhibit A.

Recitals

A. As of the date hereof, the Sellers collectively own directly or, in the
case of Blocker Seller, indirectly through its ownership of Blocker, (i) all
of the issued and outstanding limited liability company membership, profits
and other interests in the Company, which consists entirely of the Class A
Units, the Class B Units, the Class C Units and the Class D Units
(collectively, the "Units"), and (ii) all of the issued and outstanding
options to purchase Class C Units (the "Class C Options").

B. Upon the terms and subject to the conditions set forth in this Agreement,
Purchaser desires to acquire from the Sellers all of the Units (directly and
indirectly), including all of the Class C Units that will be issued by the
Company upon the exercise of the Class C Options prior to the Closing, and
Blocker Units, as applicable, and the Sellers desire to sell to Purchaser all
of the Units and Blocker Units, as applicable.

C. The Company, Blocker and the Sellers have made representations and
warranties to Purchaser in this Agreement with the intention that Purchaser
should rely upon such representations and warranties in entering into this
Agreement, and Purchaser has made representations and warranties to the
Sellers in this Agreement with the intention that the Sellers should rely upon
such representations and warranties.

D. As an inducement for Purchaser to enter into this Agreement and to
consummate the transactions contemplated hereby, at the Closing, each of the
Persons identified on Schedule 1.4(b)(iii) will enter into a Noncompetition
and Non-Solicitation Agreement in favor of the Company and Purchaser in one of
the forms of Exhibit B-1, Exhibit B-2 and Exhibit B-3 hereto (each, a
"Noncompetition Agreement").

E. As an inducement for Purchaser to enter into this Agreement and consummate
the transactions contemplated hereby, concurrently with the execution and
delivery hereof, each of 

the Persons set forth on Schedule 1.4(b)(xx) are entering into offer letters
(collectively, the "Signing Date Offer Letters"), which shall become effective
on the Closing Date.

Agreement

In consideration of the mutual covenants contained herein and other good and
valuable consideration, the receipt and sufficiency of which are hereby
acknowledged, the Parties, intending to be legally bound, agree as follows:

1. Description of Transaction

1.1 Sale and Purchase. At the Closing (as defined in Section 1.4(a)), upon the
terms and subject to the conditions set forth in this Agreement, each of the
Sellers shall sell, assign, transfer and convey to Purchaser, and Purchaser
shall purchase and acquire from each of the Sellers, the number and class of
equity securities of the Company and Blocker, as applicable, set forth
opposite such Seller's name in the column titled "Number and Class of Units
(or Blocker Units) Owned as of Immediately Prior to the Closing" (the
"Purchased Securities"), free and clear from all Encumbrances and with the
benefit of all rights of whatsoever nature attaching or accruing to such
Purchased Securities, in consideration for the payments described in Section
1.2.

1.2 Purchase Price.

(a) Purchase Price. Upon the terms and subject to the conditions set forth in
this Agreement, and subject to Sections 1.2(b) and 1.6, the aggregate
consideration payable by Purchaser (or an Affiliate of Purchaser) for the
Purchased Securities (the "Purchase Price") shall be: (i) the Estimated
Closing Purchase Price payable to the Sellers pursuant to Section 1.4(c)(i);
(ii) any payments to be made pursuant to Section 1.3(e)(ii); (iii) any
distributions to be made to the Sellers from the Escrow Funds pursuant to
Section 11.7 and the Escrow Agreement; and (iv) any distributions to be made
to the Sellers from the Sellers' Representative Fund pursuant to Section
12.1(f). The "Estimated Closing Purchase Price" shall mean: (a) $225,000,000,
plus (b) the Closing Cash Amount, if any (as set forth and represented in the
Closing Consideration Certificate delivered to Purchaser pursuant to Section
1.4(b)(xii)), minus (c) the Transaction Expenses (as set forth and represented
in the Closing Consideration Certificate delivered to Purchaser pursuant to
Section 1.4(b)(xii)), minus (d) the Closing Indebtedness Amount, if any (as
set forth and represented in the Closing Consideration Certificate delivered
to Purchaser pursuant to Section 1.4(b)(xii)), minus (e) the Net Working
Capital Shortfall Amount (as set forth and represented in the Closing
Consideration Certificate delivered to Purchaser pursuant to Section
1.4(b)(xii)), if any, plus (f) the Net Working Capital Surplus Amount (as set
forth and represented in the Closing Consideration Certificate delivered to
Purchaser pursuant to Section 1.4(b)(xii)), if any, minus (g) the Escrow
Amount, minus (h) the Sellers' Representative Amount. Set forth on Schedule
1.2 is an estimate, as of the date of this Agreement, of the portion of the
Purchase Price payable by Purchaser to each Seller for all of the Purchased
Securities held by such Seller. On the Business Day prior to the Closing, the
Sellers' Representative will deliver an updated Schedule 1.2 (the "Updated Pro
Rata Portion Schedule"), which Updated Pro Rata Portion Schedule will be
consistent with the Company's Charter Documents and which will



result in all Pro Rata Portions totaling 100% and all Special Pro Rata
Portions totaling 100% and the portion of the Purchase Price payable by
Purchaser to each Seller for all of the Purchased Securities held by such
Seller shall be based on such Seller's Pro Rata Portion or Special Pro Rata
Portion, as applicable, as set forth in the Updated Pro Rata Portion Schedule.
Each of the Sellers hereby agrees to the allocations of the Purchase Price
contemplated in this Agreement (including in Schedule 1.2, as updated by the
Updated Pro Rata Portion Schedule) and forever waives and relinquishes any and
all rights to have the Purchase Price allocated in any other manner, whether
pursuant to any provision of the Company's Charter Documents or the terms and
conditions of any other Contract with, or for the benefit of, such Seller.

(b) Escrow. At the Closing, the General Indemnity Escrow Amount shall be
deposited into the General Indemnity Escrow Account and the Special Indemnity
Escrow Amount shall be deposited into the Special Indemnity Escrow Account, in
each case to be held and distributed by Citizens Bank, N.A. (the "Escrow
Agent") in accordance with the terms of this Agreement and the Escrow
Agreement.

1.3 Purchase Price Adjustment.

(a) Within 60 days after the Closing Date, Purchaser shall prepare and deliver
to Sellers' Representative a statement (the "Statement") setting forth its
calculation of the Closing Cash Amount, the Transaction Expenses, the Closing
Indebtedness Amount, the Net Working Capital Amount, the Net Working Capital
Shortfall Amount, if any, and the Net Working Capital Surplus Amount, if any,
and its resulting calculation of the Closing Purchase Price. The "Closing
Purchase Price" shall mean: (a) $225,000,000, plus (b) the Closing Cash
Amount, if any, minus (c) the Transaction Expenses, minus (d) the Closing
Indebtedness Amount, if any, minus (e) the Net Working Capital Shortfall
Amount, if any, plus (f) the Net Working Capital Surplus Amount, if any, minus
(g) the Escrow Amount, minus (h) the Sellers' Representative Amount.

(b) During the 60-day period following the Sellers' Representative's receipt
of the Statement, the Sellers' Representative and its accountants shall have
reasonable access, during normal business hours, to the working papers of
Purchaser relating to the Statement. The Statement shall become final and
binding upon the Parties on the 60th day following delivery thereof, unless
the Sellers' Representative gives written notice of its disagreement with the
Statement (a "Notice of Disagreement") to Purchaser on or before such date.
Any Notice of Disagreement shall (i) specify in reasonable detail the nature
of any disagreement so asserted and (ii) only include disagreements based on
mathematical errors or based on the Closing Cash Amount, the Transaction
Expenses, the Closing Indebtedness Amount, the Net Working Capital Amount, the
Net Working Capital Shortfall Amount, the Net Working Capital Surplus Amount
or the resulting calculation of the Closing Purchase Price not being
calculated in accordance with this Agreement or a general objection if
Purchaser failed to provide reasonable access needed to make a specific
objection. If a Notice of Disagreement is received by Purchaser in a timely
manner, then the Statement (as revised in accordance with this sentence) shall
become final and binding upon the Sellers and Purchaser on the earlier of (A)
the date the Sellers' Representative and Purchaser resolve in writing any
differences they have with respect to the matters specified



in the Notice of Disagreement or (B) the date any disputed matters are finally
resolved in writing by the Accounting Firm. During the 60-day period following
the delivery of a Notice of Disagreement, the Sellers' Representative and
Purchaser shall use commercially reasonable efforts in good faith to resolve
in writing any differences that they may have with respect to the matters
specified in the Notice of Disagreement. During such period, Purchaser and its
accountants shall have reasonable access, during normal business hours, to the
working papers of the Sellers' Representative prepared in connection with the
Notice of Disagreement.

(c) At the end of such 60-day period, the Sellers' Representative and
Purchaser shall submit to an independent accounting firm (the "Accounting
Firm") for resolution any and all matters that remain in dispute and that were
properly included in the Notice of Disagreement. No later than 60 days after
Purchaser's receipt of the Notice of Disagreement, Purchaser may prepare and
deliver to the Sellers' Representative a reply setting forth alternative
positions with respect to the issues raised in the Statement or the Notice of
Disagreement (the "Reply"). The Accounting Firm shall not consider any issues
not raised in the Statement, the Notice of Disagreement or the Reply. The
Accounting Firm shall be Grant Thornton LLP or, if such firm is unable or
unwilling to act, such other nationally-recognized independent public
accounting firm as shall be agreed upon by Purchaser and the Sellers'
Representative. The Sellers' Representative and Purchaser shall jointly
request that the Accounting Firm render a decision resolving the matters
submitted to the Accounting Firm within 45 days after such submission. In
making its determination, the Accounting Firm shall: (i) not assign any value
to any item comprising the Closing Cash Amount, the Transaction Expenses, the
Closing Indebtedness Amount, the Net Working Capital Amount, the Net Working
Capital Shortfall Amount or the Net Working Capital Surplus Amount that is
less than the lowest amount attributed to such item by Purchaser or the
Sellers or greater than the highest amount attributed to such item by
Purchaser or the Sellers; (ii) not determine or question the Parties'
determination of any matter not properly included in the Notice of
Disagreement; and (iii) act as an expert only and not as an arbitrator or
moderator. The Accounting Firm shall set forth its determination of all such
issues in a written opinion, which opinion, absent manifest error, shall be
binding and conclusive on the Parties and not subject to appeal or further
review.

(d) The cost of engaging the Accounting Firm pursuant to this Section 1.3
shall be borne by Purchaser and the Sellers in inverse proportion as they may
prevail on matters resolved by the Accounting Firm, which proportionate
allocations shall also be determined by the Accounting Firm at the time its
determination is rendered on the merits of the matters submitted. All other
fees and expenses incurred by Purchaser or the Sellers in connection with the
preparation, review or certification of the Statement, the Notice of
Disagreement or the Reply shall be borne by the party incurring such fees and
expenses.

(e) Adjustment Payments.

(i) If the Estimated Closing Purchase Price exceeds the Closing Purchase Price
as determined in accordance with this Section 1.3, then, within ten Business
Days after the Statement becomes final and binding on the Parties, each Seller
shall, and the Sellers'



Representative shall cause each Seller to, pay its Special Pro Rata Portion of
such excess to Purchaser.

(ii) If the Closing Purchase Price as determined in accordance with this
Section 1.3 exceeds the Estimated Closing Purchase Price, then, within ten
Business Days after the Statement becomes final and binding on the Parties,
Purchaser shall pay the amount of such excess to, or shall deposit with the
Paying Agent for distribution to, the Sellers in accordance with their Special
Pro Rata Portions of such excess.

(f) Closing Consideration Certificate. No later than three Business Days after
the Statement has become final and binding, the Sellers' Representative shall
update the Closing Consideration Certificate to reflect any change to any
amounts set forth therein that were based on estimates when such Closing
Consideration Certificate was delivered at the Closing, which Closing
Consideration Certificate, as so updated, shall thereafter be deemed to be the
final Closing Consideration Certificate for all purposes of this Agreement. In
addition, to the extent any additional amounts are required to be paid to the
Sellers as a result of any changes made to the Closing Consideration
Certificate delivered at the Closing, the Sellers' Representative shall
include in such update a statement setting forth with respect to any such
Seller the amount so required to be paid (which statement shall form part of
the Closing Consideration Certificate for all purposes of this Agreement).
Notwithstanding anything to the contrary in Section 1.3(e), Purchaser shall
not be required to pay any amount unless and until such update to the Closing
Consideration Certificate is delivered to Purchaser.

1.4 Closing.

(a) Closing. The consummation of the transactions contemplated by this
Agreement (the "Closing") shall take place at the offices of Sidley Austin
LLP, 1001 Page Mill Rd., Building 1, Palo Alto, CA 94304, on a date to be
designated by Purchaser, which shall be no later than the third Business Day
after the satisfaction or waiver of the last to be satisfied or waived of the
conditions set forth in Sections 8 and 9 (other than those conditions that by
their nature are to be satisfied at the Closing, but subject to the
satisfaction or waiver of such conditions), or at such time and date as the
Parties may designate. The date on which the Closing actually takes place is
referred to in this Agreement as the "Closing Date."

(b) Agreements and Documents. At the Closing, Purchaser shall have received
the following agreements and documents, each of which shall be in full force
and effect:

(i) written assignments in the form attached hereto as Exhibit I (the "Form of
Assignment") duly executed by each Seller transferring and assigning all of
the Purchased Securities outstanding immediately prior to the Closing;

(ii) the Escrow Agreement, duly executed by the Sellers' Representative;

(iii) the Noncompetition Agreements, duly executed by the Persons identified
on Schedule 1.4(b)(iii);



(iv) a Release, substantially in the form of Exhibit C, duly executed by each
of the Persons identified on Schedule 1.4(b)(iv);

(v) agreements, in form and substance reasonably satisfactory to Purchaser,
terminating the agreements identified in Schedules 6.7(i), including the
termination of the Blocker Note in the manner described in Schedule 6.7 (i);

(vi) assignments and releases, in form and substance reasonably satisfactory
to Purchaser, duly executed by each current and former employee, consultant
and/or contractor of each Acquired Company or Spin-Off Entity listed on
Schedule 1.4(b)(vi) who was involved in the creation of Company IP;

(vii) an assignment, in form and substance reasonably satisfactory to
Purchaser, duly executed by PSGSS, transferring to 340B OpCo: (A) PSGSS's
entire right, title and interest in and to the Company IP, other than any
Company IP constituting DMS Intellectual Property (as defined in the
Divisional Merger Agreement); and (B) the Contracts set forth in Schedule
1.4(b)(vii);

(viii) an assignment, in form and substance reasonably satisfactory to
Purchaser, duly executed by each Spin-Off Entity, transferring to 340B OpCo
such Spin-Off Entity's entire right, title and interest in and to the Retained
Business IT Systems;

(ix) a certificate duly executed by the Company and containing the
representation and warranty of the Company that the conditions set forth in
Section 8.1, 8.2, 8.4, 8.5, 8.7 and 8.8, in each case (other than Sections 8.4
and 8.5) only insofar as such conditions relate to the Acquired Companies as
of the relevant times referred to therein, have been duly satisfied (the
"Company Closing Certificate");

(x) a certificate duly executed on behalf of each Seller and containing the
representation and warranty of such Seller that the conditions set forth in
Section 8.1, 8.2, 8.7 and 8.8, in each case insofar as such conditions relate
to such Seller, have been duly satisfied (each, an "Individual Seller Closing
Certificate");

(xi) a certificate duly executed by the Blocker and containing the
representation and warranty of the Blocker that the conditions set forth in
Section 8.1, 8.2, 8.7 and 8.8, in each case insofar as such conditions relate
to the Blocker Entities, have been duly satisfied (the "Blocker Closing
Certificate");

(xii) a certificate duly executed by the Company and the Sellers'
Representative (the "Closing Consideration Certificate," which Closing
Consideration Certificate may be updated pursuant to Section 1.3(f)),
containing the following information (which shall be set forth on an
accompanying spreadsheet) and the representation and warranty of the Company
and the Sellers' Representative, on behalf of the Sellers, that the Pro Rata
Portion and Special Pro Rata Portion (as provided in the Updated Pro Rata
Portion Schedule) of each of the Sellers is true and accurate as of the
Closing, that the Closing Indebtedness Amount and the Transaction Expenses are
true and correct as of the Closing and that the Closing Cash Amount and the
Net



Working Capital Amount are the Company's best good faith estimates of such
amounts, each as set forth in the Closing Consideration Certificate:

(1) (i) the Closing Indebtedness Amount, (ii) the Transaction Expenses and
(iii) the Company's best good faith estimate of (x) the Closing Cash Amount
and (y) the Net Working Capital Amount and the resulting calculation of (A)
the Net Working Capital Shortfall Amount, (B) the Net Working Capital Surplus
Amount and (C) the Estimated Closing Purchase Price; and

(2) with respect to each Seller: (i) the name and address of record of such
Seller, together with the bank account or accounts for payment to such Seller;
(ii) the number and class of Purchased Securities held by each such Seller as
of immediately prior to the Closing; (iii) such Seller's Pro Rata Portion and
Special Pro Rata Portion as provided in the Updated Pro Rata Portion Schedule;
(iv) each such Seller's Pro Rata Portion of the Estimated Closing Purchase
Price; (v) each such Seller's Special Pro Rata Portion of the General
Indemnity Escrow Funds, (vi) each such Seller's Special Pro Rata Portion of
the Special Indemnity Escrow Funds; (vii) each such Seller's Special Pro Rata
Portion of the Sellers' Representative Fund; and (viii) the total amount of
Taxes to be withheld from such Seller's Pro Rata Portion of the Estimated
Closing Purchase Price;

(xiii) documentation reasonably satisfactory to Purchaser, in support of the
calculation of the amounts set forth in the Closing Consideration Certificate;

(xiv) a certificate executed by the Chief Executive Officer of the Company
attaching and certifying the resolutions of the board of managers of the
Company approving this Agreement and the transactions contemplated hereby
(including the Spin-Off);

(xv) a certificate, duly executed by the Chief Executive Officer of the
Company, certifying that true and correct copies of all of its Charter
Documents are attached thereto and that such Charter Documents are in full
force and effect;

(xvi) a certificate, duly executed by the President of Blocker, certifying
that true and correct copies of all Charter Documents of the Blocker Entities
are attached thereto and that such Charter Documents are in full force and
effect;

(xvii) a certificate executed by the Chief Executive Officer (or another
equivalent officer) of Blocker attaching and certifying the resolutions of the
board of managers of Blocker approving this Agreement and the transactions
contemplated hereby (including the Spin-Off);

(xviii) written resignations of all officers and managers of the Company, 340B
OpCo and PHSS and all officers and directors or managers, as applicable, of
the Blocker Entities, effective as of the Closing, and the revocation of all
signatory rights of all officers and managers of the Company, 340B OpCo and
PHSS and all officers and directors or managers, as applicable, of the Blocker
Entities;



(xix) written acknowledgments in forms that are reasonably acceptable to
Purchaser pursuant to which each Acquired Company's, Spin-Off Entity's and
Blocker Entity's outside legal counsel and any financial advisor, accountant
or other Person who performed services for or on behalf of, or provided advice
to, the Acquired Companies, the Spin-Off Entities or the Blocker Entities, or
who is otherwise entitled to any compensation from any Acquired Company, Spin-
Off Entity or Blocker Entity, in each case, in connection with this Agreement,
any of the transactions contemplated by this Agreement or is otherwise owed
any amount which is part of the Transaction Expenses, acknowledges: (i) the
total amount of unpaid fees, costs and expenses of any nature that is payable
in connection with this Agreement, any of the transactions contemplated by
this Agreement or otherwise; and (ii) that, upon payment at the Closing of
such unpaid amount, such party will have been paid in full and is not (and
will not be) owed any other amount by any Acquired Company, any Spin-Off
Entity or any Blocker Entity with respect to this Agreement, any of the
transactions contemplated by this Agreement or otherwise;

(xx) the Signing Date Offer Letters, duly executed by each of the individuals
set forth on Schedule 1.4(b)(xx) (such individuals, the "Required Employees"),
each of which shall be in full force and effect;

(xxi) offer letters (together with any applicable exhibits thereto) in
substantially one of the forms attached hereto as Exhibit J (each, a "Closing
Date Offer Letter"), duly executed by at least 90% of the total number of
Offered Employees listed on Exhibit L, other than the Required Employees, each
of which shall be in full force and effect;

(xxii) the minute books and other statutory books, records and registers
(complete and written up to the Closing) and Charter Documents of the Company,
340B OpCo, PHSS and the Blocker Entities;

(xxiii) a duly-executed and completed IRS Form W-9 from each Seller;

(xxiv) all Consents identified on Schedule 1.4(b)(xxiv);

(xxv) evidence satisfactory to Purchaser that PSG or PHSS shall have sent the
notices set forth and described on Schedule 1.4(b)(xxv).

(xxvi) evidence satisfactory to Purchaser that all Insider Receivables owed to
the Company, 340B OpCo or PHSS and Insider Payables owed by the Company, 340B
OpCo or PHSS have been repaid in full;

(xxvii) the Spin-Off Agreements, duly executed by the Company, PSG, SpinCo,
340B OpCo, BWA Feeder, Blocker, Blocker Seller and Class A Holder, as
applicable and evidence reasonably satisfactory to Purchaser that the
transactions contemplated by the Spin-Off Agreements have been Completed;

(xxviii) the Transition Services Agreements, duly executed by SpinCo;



(xxix) the financial statements required pursuant to Section 6.15;

(xxx) evidence reasonably satisfactory to Purchaser that all receivables (A)
payable by PSG or any of its Subsidiaries (other than PHSS) to PHSS or (B) by
PHSS, 340B OpCo or the Company to PSG or any of its Subsidiaries (other than
PHSS) have been satisfied or terminated in full;

(xxxi) the Sublease Agreement, duly executed by SpinCo and 340B OpCo and
consented to by the Landlord; and

(xxxii) evidence reasonably satisfactory to Purchaser of the due exercise of
all of the outstanding Class C Options.

(c) Actions at the Closing. In connection with the Closing and in addition to
the delivery of the agreements and documents identified in Section 1.4(b), the
following shall take place:

(i) Transfer to Sellers. On the Closing Date, Purchaser shall pay or shall
deposit with the Paying Agent and cause to be paid to each Seller, in cash and
without interest, by wire transfer in accordance with the instructions set
forth opposite such Seller's name on Schedule 1.2, such Seller's Pro Rata
Portion of the Estimated Closing Purchase Price as set forth in the Closing
Consideration Certificate;

(ii) Payment of Indebtedness and Transaction Expenses. Purchaser shall pay, or
shall deposit with the Paying Agent and cause to be paid, on behalf of the
Company, (A) on the Closing Date, to such accounts designated in any payoff
letters or invoices delivered by the Company to Purchaser pursuant to Section
6.10, the amounts set forth in such payoff letters or invoices and (B) on the
Business Day following the Closing Date, to each Change of Control Bonus
Recipient who is a Continuing Employee or Required Employee (each, a
"Continuing Employee Change of Control Bonus Recipients"), the amount payable
to him or her in accordance with Exhibit K (provided that such Continuing
Employee Change of Control Bonus Recipient shall have provided Purchaser with
his or her latest W-4 and bank information for receipt of his or her Change of
Control Bonus at least five Business Days prior to the Closing Date), in each
case by wire transfer of immediately available funds; provided, that,
Purchaser shall cause an amount equal to the Change of Control Bonuses payable
to Bill Brewer and Chris Hoover in accordance with Exhibit K to be paid to
PSGSS on the Closing Date and the Class A Holder shall cause PSGSS to pay Bill
Brewer and Chris Hoover their Change of Control Bonuses in accordance with
Exhibit K through PSGSS's payroll on the first Business Day following the
Closing;

(iii) Transfer to Escrow Agent. On the Closing Date, Purchaser shall cause (A)
the General Indemnity Escrow Amount to be delivered to the Escrow Agent in
cash as a contribution to the General Indemnity Escrow Funds and (B) the
Special Indemnity Escrow Amount to be delivered to the Escrow Agent in cash as
a contribution to the Special Indemnity Escrow Funds;



(iv) Escrow Agreement. At the Closing, Purchaser shall cause to be delivered
to the Sellers' Representative the Escrow Agreement, duly executed by
Purchaser and the Escrow Agent;

(v) Transition Services Agreements. At the Closing, Purchaser shall deliver to
the Sellers' Representative the Transition Services Agreements, duly executed
by 340B OpCo;

(vi) Sellers' Representative Amount. On the Closing Date, Purchaser shall
deliver, or deposit with the Paying Agent and cause to be delivered, to the
Sellers' Representative the Sellers' Representative Amount; provided that
Sellers' Representative shall have provided Purchaser with its bank
information for receipt of the Sellers' Representative Fund no later than two
Business Days prior to the Closing Date; and

(vii) Change in Managers/Directors and Officers. At the Closing, each of the
Company, 340B OpCo, PHSS and the Blocker Entities shall, and the Sellers shall
cause each of the Company, 340B OpCo, PHSS and the Blocker Entities to, take
all necessary steps to implement the change in the managers or directors, as
applicable, and officers of the Company, 340B OpCo, PHSS and the Blocker
Entities, including any corporate approvals and filings with the relevant
authorities. The composition of the board of managers or directors, as
applicable, and officers of the Company, 340B OpCo, PHSS and the Blocker
Entities at the Closing shall be as set forth on Schedule 1.4(c).

(d) Simultaneous. All payments and other actions under this Section 1.4, and
all documents to be executed and delivered by the Parties pursuant to this
Section 1.4, shall be deemed to have been made, taken, executed and delivered
simultaneously.

1.5 Escheat. Notwithstanding anything in this Agreement to the contrary,
neither Purchaser nor any other Person shall be liable to any Seller for any
amount paid to a public official pursuant to applicable abandoned property
law, escheat law or similar Legal Requirement.

1.6 Tax Withholding. Each of Purchaser, the Paying Agent and the Company shall
be entitled to deduct and withhold from any consideration payable by
Purchaser, the Paying Agent or the Company pursuant to this Agreement
(including any amounts distributed from the Escrow Funds) such amounts as
Purchaser, the Paying Agent or the Company determines in good faith are
required to be deducted or withheld therefrom or in connection therewith under
the Code or any provision of state, local or foreign Legal Requirements
relating to Taxes or under any other applicable Legal Requirement. Prior to
making any such deduction or withholding (other than withholding of amounts
listed in the Closing Consideration Certificate), Purchaser shall notify the
Sellers of the obligation or entitlement to deduct and withhold and, if
applicable and to the extent practicable, provide such Sellers a reasonable
opportunity to provide forms or other evidence that would exempt such amounts
from such deduction and withholding (or reduce the amount of deduction and
withholding) under applicable Legal Requirements. Purchaser and the Company,
as applicable, shall reasonably cooperate with the Sellers to obtain such
information and tax forms that are available to reduce or eliminate any such
deduction or withholding. To the extent such amounts are so deducted or
withheld and subsequently paid to



the appropriate Governmental Body by Purchaser or the Company, Purchaser or
the Company, as the case may be, shall provide evidence that such deducted or
withheld amounts have been remitted to the applicable Governmental Body, and
such amounts shall be treated for all purposes under this Agreement as having
been paid to the Person to whom such amounts would otherwise have been paid.

1.7 Waiver of Notices. Each of the Sellers who is entitled to notice of the
transactions contemplated by this Agreement under any provision of the Charter
Documents of the Company or Blocker, any Contract with the Company, Blocker or
otherwise, hereby acknowledges and agrees that (i) it has either previously
received such notice or that if it has not received notice, this Agreement
constitutes sufficient notice of the transactions contemplated by this
Agreement under any such provision and (ii) to the extent that any such notice
would have been required to have been given within a certain period of time
prior to the Closing, such Seller hereby expressly waives any such requirement
and agrees and consents to the occurrence of the Closing when and as required
by this Agreement.

1.8 Tax Treatment; Allocation of Purchase Price. As soon as reasonably
practicable, but in no event later than 90 days after the Closing Date,
Purchaser shall prepare or cause to be prepared and submit to Sellers'
Representative, a balance sheet of the Company, as of the Closing Date, that
sets out the fair market value of the assets owned by the Company (as
determined for U.S. Tax purposes) on the Closing Date, which assets for the
avoidance of doubt shall not include the Spin-Off Assets, and the amounts of
the Liabilities of the Company (as determined for U.S. federal tax purposes)
on the Closing Date, which Liabilities for the avoidance of doubt shall not
include the Spin-Off Liabilities (collectively, the "Fair Market Value Balance
Sheet"). The Fair Market Value Balance Sheet shall allocate the fair market
value among the assets using the principles set forth in Schedule 1.8. As soon
as reasonably practicable, but in no event later than 90 days after the
Closing Date, the Sellers' Representative shall prepare or cause to be
prepared and submit to Purchaser, a balance sheet of the Company that sets out
the Tax basis of the assets owned by the Company (as determined for U.S.
federal Tax purposes) on the Closing Date, which assets for the avoidance of
doubt shall not include the Spin-Off Assets, and the amount of Liabilities of
the Company (as determined for U.S. federal Tax purposes) on the Closing Date,
which Liabilities for the avoidance of doubt shall not include the Spin-Off
Liabilities (collectively, the "Tax Basis Balance Sheet"). The Fair Market
Value Balance Sheet and the Tax Basis Balance Sheet shall each contain
sufficient detail to permit the Parties to make the computations and
adjustments required under Section 743(b), Section 751 and Section 755 of the
Code. If, within 30 days of the later of Purchaser's submission of the Fair
Market Value Balance Sheet to the Sellers' Representative or the Sellers'
Representative's submission of the Tax Basis Balance Sheet to Purchaser,
either the Sellers' Representative notifies Purchaser that the Sellers'
Representative objects to the Fair Market Value Balance Sheet or Purchaser
notifies the Sellers' Representative that Purchaser objects to the Tax Basis
Balance Sheet, then the Sellers' Representative and Purchaser will negotiate
in good faith to resolve such dispute within 30 days. If following the good
faith negotiation of such dispute, the Sellers' Representative and Purchaser
are unable to reach an agreement on either or both of the Fair Market Value
Balance Sheet and the Tax Basis Balance Sheet, then with respect to the Fair
Market Value Balance Sheet and Tax Basis Balance Sheet each Party may report
for U.S. federal



tax purposes according to that Party's own determination of the fair market
value and tax basis of the assets owned by the Company, provided that in all
cases the principles of Schedule 1.8 continue to apply.

2. Representations and Warranties of the Company

Except as set forth in the Disclosure Schedule prepared and delivered by the
Company to Purchaser prior to the execution of this Agreement in accordance
with Section 12.22, the Company represents and warrants to Purchaser, as of
the date of this Agreement, as of immediately prior to the PSG Distribution
and as of the Closing (in each case, except to the extent a representation or
warranty expressly states that such representation or warranty is as of an
earlier date, which representation or warranty is made as of such earlier
date) as follows:

2.1 Due Organization; Subsidiaries; Etc.

(a) Organization. Each Acquired Company has been duly organized, and is
validly existing and in good standing under the Legal Requirements of such
Acquired Company's state of formation. Each Acquired Company has full power
and authority: (i) to conduct its business in the manner in which its business
is currently being conducted and currently contemplated by the Acquired
Companies to be conducted; (ii) to own, lease and use all assets and
properties in the manner in which such assets and properties are currently
owned, leased and used and currently contemplated by the Acquired Companies to
be owned, leased and used; and (iii) to perform its obligations under all
Contracts to which it is a party or by which it is bound.

(b) Qualification. Each Acquired Company is duly qualified, licensed or
admitted to do business and is in good standing (or its equivalent) as a
foreign limited liability company in each jurisdiction in which the nature of
its business make such qualification, license or admission necessary to such
Acquired Company's business as currently conducted, except where the failure
to be licensed, qualified or admitted would not, individually or in the
aggregate, have or reasonably be expected to have a Material Adverse Effect.
Part 2.1(b) of the Disclosure Schedule accurately sets forth each jurisdiction
where each Acquired Company is qualified, licensed and admitted to do
business.

(c) Managers and Officers. Part 2.1(c) of the Disclosure Schedule accurately
sets forth: (i) the names of the members of the board of managers of each
Acquired Company; (ii) the names of the members of each committee of the board
of managers of each Acquired Company; and (iii) the names and titles of the
officers of each Acquired Company.

(d) Subsidiaries. Other than the Spin-Off Entities, PSG and PHSS, as of the
date of this Agreement and until the completion of the PSG Distribution, the
Company does not have and will not have any Subsidiaries; and other than PHSS
and 340B OpCo, as of the completion of PSG Distribution and until the Closing,
the Company does not and will not have any Subsidiaries. Each of the Spin-Off
Entities, PSG and PHSS, as of the date of this Agreement and until the
completion of the PSG Distribution, is and will be directly or indirectly
wholly owned by the Company; and each of PHSS and 340B OpCo, as of the
completion of the PSG



Distribution and until the Closing, is and will be directly or indirectly
wholly owned by the Company. Other than the Spin-Off Entities, PSG, PHSS and,
following the completion of the Divisional Merger, 340B OpCo, none of the
Acquired Companies has ever owned, beneficially or otherwise, any shares,
equity interests or other securities of, or any direct or indirect equity
interest in, or otherwise controlled, any Entity. None of the Acquired
Companies has ever agreed or is obligated to make any future investment in or
capital contribution to any Entity. No Acquired Company has guaranteed or is
responsible or liable for any obligation of any other Entity.

(e) Solvency. The Spin-Off Entities are and will, after giving effect to the
Spin-Off and the other transactions contemplated by this Agreement, be Solvent
at and immediately after the Closing. As used in this Section 2.1(e), the term
"Solvent" means, with respect to a particular date, that on such date, (a) (i)
the sum of the assets, at a fair valuation, of each Spin-Off Entity will
exceed the debts of such Spin-Off Entity and (ii) the sum of the assets, at a
fair valuation, of the Spin-Off Entities taken as a whole will exceed the
debts of the Spin-off Entities taken as a whole, (b) (i) each Spin-Off Entity
has not incurred and does not intend to incur debts beyond its ability to pay
such debts as such debts mature in the Ordinary Course of Business and (ii)
the Spin-Off Entities on a consolidated basis have not incurred and do not
intend to incur, and do not believe that they will incur, debts beyond their
ability to pay such debts as such debts mature in the Ordinary Course of
Business and (c) (i) each Spin-Off Entity has (and, after the Closing, will
have) sufficient capital and liquidity with which to conduct its business and
(ii) the Spin-Off Entities collectively have (and, after the Closing, will
have) sufficient capital and liquidity with which to conduct their businesses.
For purposes of this Section 2.1(e), "debt " means any liability on a claim,
and "claim" means any (y) right to payment, whether or not such a right is
reduced to judgment, liquidated, unliquidated, fixed, contingent, matured,
unmatured, disputed, undisputed, legal, equitable, secured or unsecured, and
(z) any right to an equitable remedy for breach of performance if such breach
gives rise to a payment, whether or not such right to an equitable remedy is
reduced to judgment, fixed, contingent, matured, unmatured, disputed,
undisputed, secured or unsecured.

(f) Business Name. No Acquired Company has conducted any business under or
otherwise used, for any purpose or in any jurisdiction, any fictitious name,
assumed name, business name or other name, other than its corporate name as
set forth in this Agreement and, in the case of PHSS, the name "340B Link".

(g) Predecessors. There are no Entities that have been merged into or that
otherwise are predecessors to any Acquired Company.

(h) Powers of Attorney. There are no outstanding powers of attorney executed
by or on behalf of any Acquired Company.

2.2 Charter Documents; Records. The Company has Made Available to Purchaser
accurate and complete copies of: (a) the Charter Documents of each Acquired
Company; (b) the minutes and other records of the meetings and other
proceedings (including any actions taken by written consent or otherwise
without a meeting) of the members, the board of managers (or other similar
body) and all committees of the board of managers (or other



similar body) of each Acquired Company, which minutes or other records contain
a complete and accurate summary of all such meetings, and all actions taken at
such meetings or by written consent; and (c) the statutory registers and
records of each Acquired Company. All actions taken and all transactions
entered into by each Acquired Company have been duly approved by all necessary
action of the board of managers (or other similar body or committee thereof)
and members of such Acquired Company (as the case may be). There has been no
violation of any of the provisions of the Charter Documents of any Acquired
Company and no Acquired Company has taken any action that is inconsistent in
any material respect with any resolution adopted by such Acquired Company's
members or board of managers (or similar body or committee thereof). The books
of account, membership records, minute books and other records of each
Acquired Company are accurate, up-to-date and complete in all material
respects, and have been maintained in accordance with all applicable Legal
Requirements.

2.3 Capitalization.

(a) Outstanding Securities. The authorized limited liability company interests
of the Company consist solely of the Class A Units, the Class B Units, the
Class C Units and the Class D Units, of which (i) 1,000,000 Class A Units are
issued and outstanding as of the date of this Agreement, (ii) 1,200,000 Class
B Units are issued and outstanding as of the date of this Agreement, (iii)
17,755 Class C Units are issued and outstanding as of the date of this
Agreement and (iv) 140,500 Class D Units are issued and outstanding as of the
date of this Agreement. As of the date of this Agreement, there are
outstanding options to purchase 10,000 Class C Units. Part 2.3(a) of the
Disclosure Schedule sets forth (A) the names of the Company's members, the
addresses of the Company's members and the number, class and issue date of all
Units owned of record by each of such members as of the date hereof and (B)
for each outstanding Class C Option, the name of the holder, the address of
record of such holder, the number and class of Units issuable upon the
exercise of such option, the date of grant, the exercise price. All of the
outstanding Units have been duly authorized and validly issued and none of
such Units is subject to any repurchase option, forfeiture provision or
restriction on transfer (other than restrictions on transfer imposed by virtue
of applicable federal and state securities laws or by the Charter Documents).
All of the issued and outstanding Class D Units are, and have at all times
been treated as, profits interests within the meaning of Internal Revenue
Service Revenue Procedures 93-27 and 2001-43. None of the Units are
represented by any certificate and the ownership or interest therein and title
thereto are solely documented in the form of entries made by the Company in
the books and records of the Company that have been Made Available to
Purchaser.

(b) No Other Securities. No Acquired Company has ever adopted, sponsored or
maintained or promised to adopt, sponsor or maintain any profits interests
plan or any other plan or agreement providing for equity-related compensation
to any person (whether payable in limited liability company interests, cash or
otherwise). Other than the Class C Options, there are no and there have never
been and no Acquired Company has ever promised any options, warrants, calls,
rights, convertible securities, commitments or agreements of any character,
written or oral, to which any Acquired Company is a party or by which any
Acquired Company is bound, obligating any Acquired Company to issue, deliver,
sell, repurchase or redeem, or



cause to be issued, delivered, sold, repurchased or redeemed, any Units, any
interests in any Units or other securities of any Acquired Company or
obligating any Acquired Company to grant, extend, accelerate the vesting of,
change the price of, otherwise amend or enter into any such options, warrants,
calls, rights, convertible securities, commitments or agreements. There are no
outstanding, authorized or promised unit appreciation, phantom unit, profit
participation or other similar rights with respect to which any Acquired
Company is obligated. There is no condition or circumstance that may give rise
to or provide a basis for the assertion of a claim by any Person to the effect
that such Person is entitled to acquire or receive any Units or interests in
Units or other securities of any Acquired Company. There are no voting trusts,
proxies or other agreements or understandings with respect to the voting
rights attached to the Units, and other than the Charter Documents of the
Company, there are no agreements to which any Acquired Company is a party
relating to the registration, sale or transfer (including agreements relating
to rights of first refusal, co-sale rights or "drag-along" rights) of any
Units. As a result of the transactions contemplated by this Agreement, as of
the Closing, Purchaser will be the sole record and beneficial holder of all
issued and outstanding Units and all rights to acquire or receive any Units,
whether or not such Units are outstanding (except that Purchaser will hold the
Class B Units indirectly through its ownership of the Blocker Entities).

(c) Debt. Part 2.3(c) of the Disclosure Schedule sets forth an accurate and
complete list (including (i) the name of the lender, (ii) the principal amount
thereof and (iii) the interest rate and any accrued interest owed by any
Acquired Company thereon) of all bonds, debentures, notes or other
Indebtedness of any Acquired Company issued or outstanding as of the date of
this Agreement: (A) having the right to vote on any matters on which members
of any Acquired Company may vote (or which is convertible into, or
exchangeable for, securities having such right) or (B) the value of which is
in any way based upon or derived from capital or voting units of any Acquired
Company.

(d) Legal Issuance. All outstanding Units and all other securities that have
ever been issued or granted by any Acquired Company have been issued and
granted in compliance with: (i) all applicable securities laws and other
applicable Legal Requirements; and (ii) all requirements set forth in all
applicable Contracts. None of the outstanding Units were issued in violation
of any preemptive rights or other rights to subscribe for or purchase
securities of any Acquired Company. Part 2.3(d) of the Disclosure Schedule
accurately identifies each Company Contract relating to any Units or other
securities of any Acquired Company that contains any voting rights,
information rights, rights of first refusal, registration rights, financial
statement requirements or other terms that would survive the Closing.

(e) Repurchased Units. No Acquired Company has ever repurchased or redeemed
any units of its limited liability company interests.

(f) Manager and Officer Indemnification. No event has occurred, and no
circumstance or condition exists, that has resulted in, or that will or would
reasonably be expected to result in, any claim for indemnification,
reimbursement, contribution or the advancement of expenses by any Company
Service Provider (other than a claim for reimbursement by any Acquired
Company, in the Ordinary Course of Business, of travel



expenses or other out-of-pocket expenses of a routine nature incurred by such
Company Service Provider in the course of performing such Company Service
Provider's duties for the Acquired Companies) pursuant to: (i) the terms of
the Charter Documents of the Acquired Companies; (ii) any indemnification
agreement or other Contract between any Acquired Company and any such Company
Service Provider; or (iii) any applicable Legal Requirement.

(g) Dividends and Distributions. No Acquired Company has ever declared or paid
any dividends on or made any distributions to any Units.

(h) Claims by Securityholders. No event has occurred, and no circumstance or
condition exists, that has resulted in, or that will or would reasonably be
expected to result in, any Liability of any Acquired Company to any current,
former or alleged securityholder of any Acquired Company in such Person's
capacity (or alleged capacity) as a securityholder of such Acquired Company.

(i) Closing Consideration Certificate. The Closing Consideration Certificate
delivered at the Closing, with regard to the amounts specified in Sections
1.4(b)(xii)(2), will be true and correct in all respects as of the Closing
relative to payments owed to the Persons listed therein as a result of the
transactions contemplated hereby.

(j) Class C Options. All Class C Options are (i) fully vested, (ii) held by a
Company Service Provider, (iii) non-statutory options and (iv) not subject to
Section 409A of the Code. No Class C Option has been granted with an exercise
price less than the fair market value of a Class C Unit on the date on which
the grant of such Class C Option was by its terms to be effective (the "Grant
Date"). Each grant of a Class C Option was duly authorized no later than the
Grant Date by all necessary company action, including, as applicable, approval
by the Board of Managers of the Company (or a duly constituted and authorized
committee thereof) and any required member approval, in each case, by the
necessary number of votes or written consents, and the award agreement
governing such grant (if any) was duly executed and delivered by each party
thereto and is in full force and effect, each such grant was made in
accordance with the terms of the Equity Plan and all other applicable Legal
Requirements and each such grant was properly accounted for in accordance with
GAAP in the financial statements (including the related notes) of the Acquired
Companies. The exercise of the Class C Options by payment of cash or in a
cashless manner complied and will comply with the terms of the Equity Plan,
all Contracts applicable to such Class C Options and all Legal Requirements.
True and complete copies of all agreements, instruments and resolutions,
relating to or issued with regard to the Class C Options have been Made
Available and such agreements, instruments and resolutions have not been
amended, modified or supplemented, and there are no Contracts to amend, modify
or supplement such agreements, instruments or resolutions from the forms
thereof Made Available. As of the Closing, there will be no option to purchase
any equity securities of the Company outstanding.

2.4 Financial Statements and Related Information.

(a) Delivery of Financial Statements.



(i) Acquired Companies Financial Statements. Set forth in Part 2.4(a)(i) of
the Disclosure Schedule are the following financial statements (collectively,
the "Provided Company Financial Statements"): (A) the audited consolidated
balance sheets of the Acquired Companies (excluding the Company) as of
December 31, 2017, December 31, 2018 and December 31, 2019 and the related
audited consolidated statements of income, audited consolidated statements of
members' equity and audited consolidated statements of cash flows for the
fiscal years ended December 31, 2017, December 31, 2018 and December 31, 2019,
together with the notes thereto; and (B) the unaudited consolidated balance
sheet of the Acquired Companies as of June 30, 2020 (such unaudited
consolidated balance sheet of the Acquired Companies as of June 30, 2020 being
hereinafter referred to as the "Balance Sheet") and the related unaudited
consolidated statement of income, unaudited consolidated statement of members'
equity and unaudited consolidated statement of cash flows for the six-month
period ended June 30, 2020.

(ii) 340B Link Financial Statements. Set forth in Part 2.4(a)(ii) of the
Disclosure Schedule are the following financial statements (collectively, the
"Provided 340B Link Financial Statements"): (A) the audited consolidated
balance sheet of PSG and PHSS as of December 31, 2019 and the related audited
consolidated statement of income, audited consolidated statement of members'
equity and audited consolidated statement of cash flows for the fiscal year
ended December 31, 2019, together with the notes thereto; and (B) the
unaudited consolidated balance sheet of PSG and PHSS as of June 30, 2020 and
the related unaudited consolidated statement of income, unaudited consolidated
statement of members' equity and unaudited consolidated statement of cash
flows for the six-month period ended June 30, 2020, in each case of the
foregoing clauses "(A)" and "(B)" as related to the Retained Business.
Information included in the Provided 340B Link Financial Statements regarding
PSG and PHSS is consistent with information regarding PSG and PHSS included in
the Provided Company Financial Statements.

(b) Fair Presentation. The Company Financial Statements are true and complete
in all material respects and present fairly, in all material respects, the
financial position of the Acquired Companies as of the respective dates
thereof and the results of operations and cash flows of the Acquired Companies
for the periods covered thereby. The Company Financial Statements have been,
as of the date delivered to Purchaser pursuant to this Agreement, prepared in
accordance with GAAP applied on a consistent basis throughout the periods
covered, except that the financial statements referred to in Section
2.4(a)(i)(B) and Section 6.15(a)(i) do not contain notes. The 340B Link
Financial Statements are true and complete in all material respects and
present fairly, in all material respects, the financial position of the
Retained Business as of the respective dates thereof and the results of
operations and cash flows of the Retained Business for the periods covered
thereby. The 340B Link Financial Statements have been, as of date delivered to
Purchaser pursuant to this Agreement, prepared in accordance with GAAP applied
on a consistent basis throughout the periods covered, except that the
financial statements referred to in Section 2.4(a)(ii)(B), Section 6.15(a)(ii)
and Section 6.15(b) do not contain notes.

(c) Internal Controls. The books, records and accounts of the Acquired
Companies accurately and fairly reflect, in reasonable detail, the
transactions in and dispositions



of the assets of the Acquired Companies. The systems of internal accounting
controls maintained by each Acquired Company are sufficient to provide
reasonable assurance that: (i) transactions are executed in accordance with
management's general or specific authorization; (ii) transactions are recorded
as necessary to permit preparation of financial statements in conformity with
GAAP and to maintain accountability for assets; (iii) access to assets is
permitted only in accordance with management's general or specific
authorization; and (iv) the recorded accountability for assets is compared
with the existing assets at reasonable intervals and appropriate action is
taken with respect to any differences. No Acquired Company has identified or
been made aware of: (i) any deficiency or material weakness in the system of
internal accounting controls utilized by such Acquired Company; (ii) any
fraud, whether or not material, that involves such Acquired Company's
management or other Company Service Providers who have a role in the
preparation of financial statements or the internal accounting controls
utilized by such Acquired Company; or (iii) any claim or allegation regarding
any of the foregoing. Part 2.4(c) of the Disclosure Schedule lists, and the
Company has Made Available to Purchaser copies of, all written descriptions
of, and all policies, manuals and other documents promulgating, such internal
accounting controls.

(d) Accounts Receivable. Part 2.4(d) of the Disclosure Schedule provides an
accurate reconciliation of all accounts receivable, notes receivable and other
receivables of the Retained Business as of the Balance Sheet Date. All
existing accounts receivable of the Retained Business (including those
accounts receivable of the Retained Business reflected on the Company
Financial Statements that have not yet been collected and those accounts
receivable of the Retained Business that have arisen since the Balance Sheet
Date and have not yet been collected) represent valid obligations arising from
bona fide transactions entered into in the Ordinary Course of Business and not
in violation of applicable Legal Requirements. All existing accounts
receivable of the Retained Business are and will be fully collectible within
180 days. There is no Encumbrance (except for Permitted Encumbrances) on any
of such accounts receivable, and no request or agreement for deduction or
discount has been made with respect to any of such accounts receivable, except
as fully and adequately reflected in reserves for doubtful accounts set forth
in the Company Financial Statements. None of the accounts receivable of the
Retained Business have been assigned or pledged to any other Person, and no
further goods are required to be provided and no further services are required
to be rendered in order to complete the sales and fully render the services so
as to entitle PSG, 340B OpCo or PHSS, as applicable, to collect the accounts
receivable in full.

(e) Insider Receivables and Insider Payables. Part 2.4(e) of the Disclosure
Schedule provides an accurate and complete breakdown of: (i) all amounts
(including any Indebtedness) owed to any Acquired Company by any member of the
Company ("Insider Receivables") as of the date of this Agreement; and (ii) all
amounts owed by any Acquired Company to any member of the Company ("Insider
Payables"). There will be no outstanding Insider Receivables or Insider
Payables as of the Closing.



2.5 No Liabilities; Indebtedness.

(a) Absence of Liabilities. No Acquired Company has any Liabilities of any
nature, whether accrued, absolute, contingent, matured, unmatured or otherwise
(whether or not required to be reflected in financial statements prepared in
accordance with GAAP, and whether due or to become due), other than: (i)
Liabilities identified as such in the "liabilities" column of the Balance
Sheet; (ii) accounts payable or accrued salaries and other employee
compensation that have been incurred by the Acquired Companies since the
Balance Sheet Date in the Ordinary Course of Business; and (iii) the
Liabilities identified in Part 2.5(a) of the Disclosure Schedule.

(b) Accounts Payable. Part 2.5(b) of the Disclosure Schedule provides an
accurate and complete breakdown and aging of: (i) all accounts payable of each
Acquired Company as of the date of this Agreement; and (ii) all notes payable
of each Acquired Company as of the date of this Agreement.

(c) Indebtedness. Part 2.5(c) of the Disclosure Schedule sets forth a complete
and correct list of each item of Indebtedness of each Acquired Company as of
the date of this Agreement, identifying the creditor to which such
Indebtedness is owed, the address of such creditor, the title of the
instrument (including all amendments and supplements thereto) under which such
Indebtedness is owed, the outstanding balance, the maturity date and the
collateral, if any, securing such Indebtedness. No Indebtedness contains any
restriction upon (i) the prepayment of any of such Indebtedness, (ii) the
incurrence of any other Indebtedness by any Acquired Company or (iii) the
ability of any Acquired Company to grant any Encumbrance on any of its assets.
With respect to each item of Indebtedness, no Acquired Company is in default
and no payments are past due. No Acquired Company has received any written or,
to the Knowledge of the Company, oral notice of a default, alleged failure to
perform or any offset or counterclaim (in each case, that has not been waived
or remains pending as of the date of this Agreement) with respect to any item
of Indebtedness. Neither the consummation of any of the transactions
contemplated by this Agreement nor the execution, delivery or performance of
this Agreement or any of the other agreements, documents or instruments
referred to in this Agreement will result in a default or breach of the terms
of, or accelerate the maturity of or performance under, any conditions,
covenants or other terms of any such Indebtedness. No Acquired Company has
guaranteed or is responsible for any Indebtedness of any other Person, and no
Acquired Company has guaranteed any other obligation of any other Person.

(d) No "Off-Balance Sheet" Arrangements. No Acquired Company has ever effected
or has ever otherwise been involved in any "off-balance sheet arrangements"
(as defined in Item 303(a)(4)(ii) of Regulation S-K under the Securities
Exchange Act of 1934, as amended).

2.6 Absence of Changes. Since the Balance Sheet Date:

(a) each Acquired Company has conducted its business only in the Ordinary
Course of Business, other than remote working arrangements and travel
limitations undertaken with respect to the COVID-19 outbreak;

(b) there has not been any Material Adverse Effect;



(c) there has not been any material loss, damage or destruction to, or any
material interruption in the use of, any of any Acquired Company's material
assets (whether or not covered by insurance); and

(d) as of the date of this Agreement, no Acquired Company has taken any action
that would have been prohibited or otherwise restricted under Section 6.2
hereof, had such action been taken during the Pre-Closing Period.

2.7 Title to Assets.

(a) Good Title. Each Acquired Company owns, and has good and valid title to,
all material assets purported to be owned by it, including: (i) all assets
reflected on the Balance Sheet; and (ii) all other material assets reflected
in the books and records of such Acquired Company as being owned by such
Acquired Company. All of said assets are owned by each Acquired Company free
and clear of any Encumbrances, except for Permitted Encumbrances.

(b) Leased Assets. Part 2.7(b) of the Disclosure Schedule identifies all
material assets of each Acquired Company that are being leased to such
Acquired Company. Each Acquired Company has valid leasehold interests in such
leased assets, free and clear of any Encumbrances, except for Permitted
Encumbrances.

(c) Sufficiency of Assets. The assets owned, leased or licensed by the
Acquired Companies (excluding the Spin-Off Assets and rights to services to be
provided to the Acquired Companies under the Transition Services Agreement)
collectively constitute all of the properties, rights, interests and other
tangible and intangible assets used in or necessary to enable the Acquired
Companies to conduct, in all material respects, the Retained Business in the
manner in which such business is currently being conducted and in the manner
in which such business is currently proposed to be conducted immediately after
the Closing.

2.8 Bank Accounts.

(a) Part 2.8(a) of the Disclosure Schedule provides the following information
with respect to each account maintained by or for the benefit of each Acquired
Company at any bank or other financial institution (including the 340B
Accounts): (i) the name of the bank or other financial institution at which
such account is maintained; (ii) the account number; (iii) the type of
account; and (iv) the names of all Persons who are authorized to: (A) sign
checks or other documents with respect to such account or transfer amounts
from the relevant account; (B) access such account, view the account balance
and view the transactions with respect to such account, including all Persons
with online and remote access; and (C) input or release payments from such
account.

(b) No Acquired Company has any outstanding credit facility, overdraft, loan,
loan units, debenture, letter of credit, acceptance credit or other financial
facility. The aggregate balance of both 340B Accounts is sufficient to ensure
the Acquired Companies' full compliance



and performance of all distribution obligations of the Acquired Companies
under all of the Bank Model Contracts.

2.9 Equipment; Real Property.

(a) Equipment. All material items of equipment, fixtures and other tangible
assets owned by or leased to the Acquired Companies are adequate for the uses
to which they are being put, are in good condition and repair (ordinary wear
and tear excepted) and such equipment, fixtures and other tangible assets
(excluding the equipment, fixtures and other tangible assets that are Spin-Off
Assets) are adequate for the conduct of the Retained Business in the manner in
which such business is currently being conducted and in the manner in which
such business is currently proposed to be conducted immediately after the
Closing.

(b) Real Property. No Acquired Company owns any real property or has ever
owned any real property, and no Acquired Company is a party to any Contract to
purchase or sell any real property. Part 2.9(b) of the Disclosure Schedule
sets forth a list of all real property currently leased, subleased or licensed
by or from any Acquired Company or otherwise used or occupied by any Acquired
Company (each, a "Leased Real Property"). Part 2.9(b) of the Disclosure
Schedule sets forth a list of all leases, lease guaranties, licenses,
subleases or other Contracts for the leasing, use or occupancy of, or
otherwise granting a right in or relating to each Leased Real Property and all
amendments, terminations and modifications thereof (the "Lease Agreements").

(c) The Company has Made Available true, correct and complete copies of all
Lease Agreements. The execution and delivery of this Agreement by the Company
does not, and the consummation of the transactions contemplated hereby will
not, result in any breach of or constitute a default (or an event that with
notice or lapse of time or both would become a default) under, or materially
impair the rights of any Acquired Company or materially alter the rights or
obligations of the sublessor, lessor or licensor under, or give to others any
rights of termination, amendment, acceleration or cancellation of any Lease
Agreement, or otherwise materially and adversely affect the continued use and
possession of any Leased Real Property for the conduct of the business of the
Acquired Companies as presently conducted or as presently contemplated to be
conducted. The Acquired Companies currently occupy all of the Leased Real
Properties for the operation of their business. There are no other parties
occupying, or with a right to occupy, any Leased Real Property. No Acquired
Company has assigned, transferred or pledged any interest in any of the real
property leases pertaining to any Leased Real Property. No Acquired Company
owes brokerage commissions or finders' fees with respect to any such Leased
Real Property. Each Acquired Company has performed all of its obligations
under any termination agreements pursuant to which it has terminated any
leases, subleases, licenses or other occupancy agreements for real property
that are no longer in effect and has no continuing Liability with respect to
such termination agreements. Each Leased Real Property is in good operating
condition and repair, normal wear and tear excepted, and is structurally
sufficient and otherwise suitable for the conduct of the Acquired Companies'
business. Neither the operation of any Acquired Company on any Leased Real
Property nor, to the Company's Knowledge, any Leased Real Property, including
the improvements thereon, violates in any material respect any



applicable building code, zoning requirement or statute relating to such
property or operations thereon, and any such non-violation is not dependent on
so-called non-conforming use exceptions.

2.10 Intellectual Property.

(a) Registered IP. Part 2.10(a) of the Disclosure Schedule accurately sets
forth each item of Registered IP in which any Acquired Company has or purports
to have an ownership interest of any nature (whether exclusively, jointly with
another Person or otherwise) including:

(i) all Patents owned or filed by, or on behalf of, any Acquired Company or
used in the business or operations of any Acquired Company, or to which any
Acquired Company has exclusive rights, in any field or territory, including
the country of filing, owner, filing number, date of issue or filing,
expiration date and title;

(ii) all registered Trademarks and applications for registration of Trademarks
owned or filed by, or on behalf of, or used by any Acquired Company, including
country of filing, owner, description of goods or services (including class
numbers), registration or application number and date of issue;

(iii) all registered copyrights and applications for registration of
copyrights owned or filed by, or on behalf of, or used by any Acquired
Company, including description of the work, country of filing, owner, filing
number, date of issue and expiration date; and

(iv) all Domain Names and the like owned or registered by or on behalf of any
Acquired Company or used in the business or operations of any Acquired
Company, including the name and contact information of each registrant and
registrant organization.

Part 2.10(a) of the Disclosure Schedule also accurately lists any other Person
that has or purports to have an ownership interest in any item of Registered
IP set forth or required to be set forth therein and the nature of such
ownership interest. The Company has Made Available to Purchaser complete and
accurate copies of all unpublished applications, nonpublic correspondence with
any Governmental Body and other material nonpublic documents related to each
item of Registered IP identified in Part 2.10(a) of the Disclosure Schedule.

(b) Unregistered IP. Part 2.10(b) of the Disclosure Schedule accurately lists
(i) each unregistered Trademark, unregistered copyright and other Intellectual
Property Right other than Registered IP that is material to the business of
any Acquired Company in the manner in which such business is currently being
conducted or in the manner in which such business is currently planned by the
Acquired Companies to be conducted; and (ii) any other Person that has or
purports to have an ownership interest of any nature (whether exclusively,
jointly with another Person or otherwise) in such item of Company IP and the
nature of such ownership interest (collectively, "Unregistered IP"). The
Company has Made Available to Purchaser complete and accurate copies of all
material documents related to each such item of Company IP.



(c) Inbound Licenses. Part 2.10(c) of the Disclosure Schedule accurately sets
forth: (i) each Contract pursuant to which any Intellectual Property or
Intellectual Property Right is or has been licensed, granted, sold, assigned
or otherwise conveyed or provided to any Acquired Company (other than: (A) any
Company Service Provider Agreement that is in the Acquired Companies' standard
form thereof Made Available to Purchaser pursuant to Section 2.10(f); and (B)
non-exclusive licenses to "off-the-shelf" third party Computer Software that
is generally available on standard commercial terms for an aggregate license
fee for all of the Acquired Companies' internal users of less than $40,000
annually, provided that such Computer Software is not distributed by any
Acquired Company, is not incorporated into, or used in the development,
testing, distribution, delivery, maintenance or support of, any product or
service of any Acquired Company, and is not otherwise material to any Acquired
Company's business); and (ii) whether the licenses or rights granted to any
Acquired Company in each such Contract are exclusive or non-exclusive (such
Contracts, "Inbound Licenses"). For purposes of this Agreement, a covenant or
promise not to sue or not to assert claims regarding Intellectual Property
Rights infringement or misappropriation or similar releases shall be deemed to
be equivalent to a license.

(d) Outbound Licenses. Part 2.10(d) of the Disclosure Schedule accurately
lists each Contract pursuant to which any Person has been granted any license
under, or otherwise has received or acquired any right (whether or not
currently exercisable and including a right to receive a license) or interest
in, any Company IP or any Company Product (such Contracts, "Outbound
Licenses"). No Acquired Company is bound by, and no Company IP or Company
Product is subject to, any Contract containing any covenant or other provision
that in any way limits or restricts the ability of any Acquired Company to
use, exploit, make available, assert or enforce any Company IP or any Company
Product anywhere in the world.

(e) Royalty Obligations. Part 2.10(e) of the Disclosure Schedule contains a
complete and accurate list of each Contract pursuant to which any Acquired
Company is obligated to pay any royalties, fees, commissions and other amounts
to any other Person upon or for the use of any Company Product, Intellectual
Property Rights or Intellectual Property (other than sales commissions paid to
employees).

(f) Standard Form Company IP Contracts. The Company has Made Available to
Purchaser a complete and accurate copy of each standard form of Company IP
Contract, used by any Acquired Company at any time, which may include a
standard form of: (i) end user license agreement, developer agreement,
subscription agreement or terms of use or service; (ii) development agreement;
(iii) Company Service Provider Agreement containing any assignment or license
of a Company Product, Intellectual Property or Intellectual Property Rights or
any confidentiality provision; (iv) confidentiality or nondisclosure
agreement; (v) agreement to provide customer support or maintenance; (vi)
application programming interface (API) or data license agreement; (vii)
evaluation agreement; (viii) agreement for providing technology licensing,
distribution rights and/or managed services to customers; (ix) vendor
agreement; (x) credit agreement; (xi) sales agreement; (xii) partner
agreement; and (xiii) pre-production license and services customer agreement.
No Acquired Company has distributed or made available any Company Product
except pursuant to a valid and enforceable customer agreement, either in the



form Made Available to Purchaser pursuant to this Section 2.10(f) or as
otherwise set forth on Part 2.10(d) of the Disclosure Schedule. Each Acquired
Company has either ensured that each user of any Company Web Site is subject
to valid and enforceable web site terms of use in the form Made Available to
Purchaser pursuant to this Section 2.10(f), or, if it has not imposed such
terms, its failure to do so has not exposed any Acquired Company to any
Liability or violated any Legal Requirement. To the extent any customer or
licensee of any Acquired Company is authorized to distribute or make available
any Company Products to its customers or to permit access to any Company
Products via its web site, such customer or licensee is required by such
Acquired Company to ensure that such customers or licensees and their end
users are bound by intellectual property and confidentiality terms consistent
with those contained in its agreement with such Acquired Company and such
Acquired Company is a third-party beneficiary of any such terms of use in the
form Made Available to Purchaser pursuant to this Section 2.10(f) including
any indemnification provisions. Part 2.10(f) of the Disclosure Schedule
accurately identifies each Company IP Contract based on a standard form
agreement Made Available to Purchaser that (i) deviates in any material
respect from such standard form agreement, including any Company Service
Provider Agreement, in which the employee, consultant, independent contractor,
advisor, officer or manager expressly reserved or retained any Intellectual
Property or Intellectual Property Rights related to any Acquired Company's
business, research or development, (ii) deviates from any Acquired Company's
standard revenue share terms or (iii) deviates from any Acquired Company's
standard data privacy or security terms or limitation of liability terms.

(g) Ownership Free and Clear. The Acquired Companies are the sole and
exclusive owners of all right, title and interest to and in the Company IP
(other than Intellectual Property Rights exclusively licensed to any Acquired
Company, as identified in Part 2.10(c) of the Disclosure Schedule), free and
clear of any Encumbrances (other than Permitted Encumbrances and nonexclusive
licenses granted pursuant to the Contracts listed in Part 2.10(d) of the
Disclosure Schedule). To the Company's Knowledge, all modifications and
derivative works of any Company IP made by any Person are exclusively owned by
the Acquired Companies. Without limiting the generality of the foregoing:

(i) all documents and instruments necessary to establish, perfect and maintain
the rights of the Acquired Companies (or the rights any Acquired Company
wishes to acquire) in the Registered IP have been validly executed, delivered
and filed in a timely manner with the appropriate Governmental Body;

(ii) each Company Service Provider who is or was involved in the creation or
development of any Company Product or of any Intellectual Property or
Intellectual Property Rights for or on behalf of any Acquired Company has
signed a valid and enforceable agreement with such Acquired Company containing
(A) an obligation to assign all Intellectual Property Rights in any
Intellectual Property, including any procedures, systems, machines, methods,
processes, uses, apparatuses, compositions of matter, designs, configurations,
computer programs, copyrightable material, notes, records, drawings, trade and
service marks, trade dress and trade secrets of any kind, and any improvements
to any of the foregoing, that was conceived or developed by the Company
Service Provider during (i) his or her engagement with the



Acquired Company or (ii) a six-month period following the termination of the
Company Service Provider's engagement with the Acquired Company and that (a)
relates to or results from the actual or anticipated business, work, research,
investigations, products, or services of the Acquired Company, or (b) results,
to any extent, from use of any Acquired Company's premises or property, (B) an
automatic vesting in the Acquired Company of the copyright in any writings and
other works that may be copyrighted (including computer programs) that are (i)
related to the present, planned, or reasonably anticipated business of the
Acquired Company and (ii) prepared by the Company Service Provider during his
or her engagement with Acquired Company, to the extent such writings and other
works are deemed to be works for hire as permitted by law, (C) a waiver by the
Company Service Provider in any and all "moral rights" in any writings and
other works under Section 2.10(g)(ii)(B), to the extent such writings or other
works are not works for hire, and a present and irrevocable assignment of all
right, title, and interest, including copyright, to such writings and other
works considered not works for hire, (D) confidentiality provisions protecting
customer or prospective customer lists and information, customer or
prospective customer contact information, proposals, marketing and sales plans
and forecasts, financial and accounting information, accounts receivable
aging, customer payment histories and customer account activity reports,
costs, contracts, pricing information, employee information and compensation,
all designs, forms, manuals, policies, computer programs, computer codes
(including those designed or developed by the Company Service Provider during
his or her employment or engagement with the Acquired Company), data stored in
computer programs, spreadsheets, memorandum regarding the Acquired Company's
business and plans, analytics, electronically stored information of all such
information, and any other information that is not readily available to the
public and which the Acquired Company relies on to conduct its business and to
formulate its business plans and has reasonable expectations that such
information shall remain confidential, as well as any Trade Secrets as defined
by applicable laws. No such Company Service Provider has any obligation to any
other Person with respect to such Intellectual Property, Intellectual Property
Rights or Company Product;

(iii) each Company Service Provider who is or was involved in the creation or
development of any Company Product or of any Intellectual Property or
Intellectual Property Rights for or on behalf of any Acquired Company has
received any and all amounts payable to such Company Service Provider for such
Company Service Provider's services;

(iv) each Acquired Company has taken commercially reasonable steps to maintain
the confidentiality of and otherwise protect and enforce its rights in all
Trade Secrets and other proprietary or confidential information pertaining to
any Acquired Company, the Company IP, the Company Products or the business of
the Acquired Companies;

(v) the Acquired Companies own or otherwise have, and after the Closing
(including after the completion of the transactions contemplated by the Spin-
Off Agreements) will continue to have, sufficient rights in all Intellectual
Property and Intellectual Property Rights needed to conduct the Retained
Business as currently conducted and currently planned by the Acquired
Companies to be conducted;



(vi) no funding, facilities or personnel of any Governmental Body or any
university or educational or medical institution were ever sought, applied
for, received or used or took part, directly or indirectly, to develop,
research, create or exploit, in whole or in part, any Company IP or Company
Product;

(vii) no Company Service Provider who is or was involved in the creation or
development of any material portion of a Company Product or of any material
Intellectual Property or material Intellectual Property Rights for or on
behalf of any Acquired Company is subject, or was subject, at the time such
Company Service Provider was providing services to any Acquired Company, to
any Contract with any other Person or Legal Requirement which requires such
Company Service Provider to (A) notify or report any development of
Intellectual Property, (B) assign to any other Person any interest or other
Intellectual Property Right in any Company IP or (C) keep confidential any
Trade Secrets, proprietary data or other business or technical information
embodied in any Company IP;

(viii) to the Knowledge of the Company, during the period in which any Company
Service Provider was developing any Company Product or any Intellectual
Property or Intellectual Property Rights, no such Person was (i) employed by
any third party that has any rights in such Company Product, Intellectual
Property or Intellectual Property Rights or (ii) involved in any consulting
relationship with any third party that has any rights in such Company Product,
Intellectual Property or Intellectual Property Rights. To the Knowledge of the
Company, no part of any Company Product, Intellectual Property or Intellectual
Property Rights that was developed by any Company Service Provider was
developed during working hours for, or on any premises, equipment, computers,
electronic devices, machines or design tools of, any former or current Person
to which such Company Service Provider has provided services in any capacity;

(ix) no Acquired Company has performed, nor is any Acquired Company under any
obligation under any Contract to perform, any development services for any
Person where the deliverables or other results of such development services
would be owned by such Person, or exclusively licensed to such Person or where
any Acquired Company has otherwise granted any ownership interest of any
nature (whether exclusively, jointly with another Person or otherwise) to such
Person;

(x) (A) no Company Service Provider has any valid basis for claiming that any
Acquired Company has breached provisions of its Contracts with such Company
Service Provider that could reasonably be expected to result in the loss of
any Acquired Company's ownership rights in any Intellectual Property or
Intellectual Property Rights under such Contracts; and (B) no Intellectual
Property or Intellectual Property Rights owned by any such Company Service
Provider or any former employer of any such Company Service Provider has been
incorporated into or used in the development of any Company Products; and

(xi) no Acquired Company is now or has ever been a member or promoter of, or a
contributor to, any industry standards body or any similar organization that
requires or obligates any Acquired Company to grant or offer to any other
Person any license or right to any Company IP.



(h) Valid and Enforceable. All Company IP is valid, subsisting and
enforceable. Without limiting the generality of the foregoing:

(i) no Trademark owned, used or applied for by or on behalf of any Acquired
Company conflicts or interferes with, or is confusingly similar to, any
Trademark owned, used or applied for by any other Person, and each Acquired
Company has taken commercially reasonable steps to police the use of its
Trademarks;

(ii) Part 2.10(h)(ii) of the Disclosure Schedule accurately identifies and
describes each action, filing and payment that must be taken or made on or
before the date that is 180 days after the date of this Agreement in order to
maintain an item of Company IP in full force and effect;

(iii) no interference, opposition, cancellation, reissue, inter partes review,
post grant review, re-examination or other Legal Proceeding is or has been
pending or, to the Knowledge of the Company, threatened, in which the scope,
validity or enforceability of any Company IP is being, has been or would
reasonably be expected to be contested or challenged, and, to the Knowledge of
the Company, there is no valid basis for a claim that any Company IP is
invalid or unenforceable;

(iv) all necessary registration, maintenance and renewal fees in respect of
the Company IP owned by any Acquired Company that is Registered IP have been
paid and all necessary documents and certificates have been filed with the
relevant Governmental Body for the purpose of maintaining such Company IP; and

(v) no act has been done or omitted to be done by any Acquired Company, which
has had or would reasonably be expected to have the effect of materially and
adversely impairing or dedicating to the public, or entitling any Person to
cancel, forfeit, modify or consider abandoned, any Company IP.

(i) No Third Party Infringement of Company IP. To the Knowledge of the
Company, no Person has infringed, misappropriated or otherwise violated, and
no Person is currently infringing, misappropriating or otherwise violating,
any Company IP. Part 2.10(i) of the Disclosure Schedule accurately identifies
(and the Company has Made Available to Purchaser a complete and accurate copy
of) each letter or other written or electronic communication or correspondence
that has been sent by or to any Acquired Company or any Representative of any
Acquired Company regarding any actual, alleged or suspected infringement or
misappropriation of any Company IP, in each case, for Purchaser to fully
understand the history and analysis thereof (including any admission made by
any Acquired Company), and provides a brief description of the current status
of the matter referred to in such letter, communication or correspondence.

(j) Effects of This Transaction. Neither the execution, delivery nor
performance of this Agreement or any other agreements referred to in this
Agreement (including the Spin-Off Agreements and the Transition Services
Agreement) nor the consummation of any of the transactions contemplated by
this Agreement or any such other agreement entered into in



connection herewith or therewith (including the Spin-Off Agreements and the
Transition Services Agreement) will, with or without notice or lapse of time,
result in, or give any other Person the right or option to cause or declare:
(i) a loss of, or Encumbrance on, any Company IP or any Company Product; (ii)
a material breach of or default under, or right to terminate or suspend
performance of, any Company IP Contract; (iii) the release, disclosure or
delivery of any Company IP or Company Product by or to any escrow agent or
other Person; (iv) the grant, assignment or transfer to any other Person of
any license or other right or interest under, to or in any of the Company IP;
or (v) by the terms of any Company Contract, a reduction of any royalties,
revenue sharing or other payments any Acquired Company would otherwise be
entitled to with respect to any Company IP.

(k) No Infringement of Third Party IP Rights. Neither any Acquired Company nor
any of its employees, managers or officers (acting in such capacity) is
currently or has ever infringed (directly, secondarily, contributorily, by
inducement or otherwise), misappropriated or otherwise violated or made
unlawful use of any Intellectual Property or Intellectual Property Right of
any other Person. No Company Software, no Company Data and no Company Product
has ever or currently infringes, misappropriates, violates or makes unlawful
use of any Intellectual Property or Intellectual Property Right of, or
contains any Intellectual Property misappropriated from, any other Person.
Without limiting the generality of the foregoing:

(i) no infringement, misappropriation or similar claim or Legal Proceeding is
pending or, to the Knowledge of the Company, threatened against any Acquired
Company or against any other Person who is or may be entitled to be
indemnified, defended, held harmless or reimbursed by any Acquired Company
with respect to any such claim or Legal Proceeding, and no Acquired Company
has ever received any written notice or other written communication or, to the
Knowledge of the Company, any oral notice or other oral communication
requesting, claiming or demanding any of the foregoing with respect to any
such claim or Legal Proceeding;

(ii) no Acquired Company has ever received any written notice or other written
communication or, to the Knowledge of the Company, any oral notice or other
oral communication relating to any actual, alleged or suspected infringement,
misappropriation or violation by any Acquired Company, any Company Service
Provider or other Representative of any Acquired Company of any Intellectual
Property Rights of another Person, including any letter or other communication
in writing suggesting or offering that any Acquired Company obtain a license
to or a covenant not to sue with respect to any Intellectual Property Right of
another Person; and

(iii) no Acquired Company is bound by any Contract to indemnify, defend, hold
harmless or reimburse any other Person with respect to, or otherwise assumed
or agreed to discharge or otherwise take responsibility for, any existing or
potential Intellectual Property Rights infringement, misappropriation or
similar claim (other than indemnification provisions in the Acquired
Companies' standard forms of Company IP Contracts Made Available to Purchaser
pursuant to Section 2.10(f)).



Part 2.10(k) of the Disclosure Schedule accurately identifies (and the Company
has Made Available to Purchaser a complete and accurate copy of) each letter
or other written communication or correspondence that has been sent by or to
any Acquired Company or any Representative of any Acquired Company regarding
any third party allegations of any Acquired Company or Company Product
infringing or misappropriating any third party's Intellectual Property Rights,
in each case, for Purchaser to fully understand the history and analysis
thereof (including any admission made by any Acquired Company), and provides a
brief description of the current status of the matter referred to in such
letter, communication or correspondence.

(l) No Harmful Code. None of the Company Owned Software contains any "back
door," "drop dead device," "time bomb," "Trojan horse," "virus," or "worm" (as
such terms are commonly understood in the software industry) or any other code
designed or intended to have, or capable of performing, any of the following
functions: (i) disrupting, disabling, harming or otherwise impeding in any
manner the operation of, or providing unauthorized access to, a computer
system or network or other device on which such code is stored or installed;
or (ii) accessing, damaging or destroying any data or file without the user's
consent. None of the Company Software contains any "back doors" or other
undocumented access mechanism allowing unauthorized access to, viewing of,
manipulation of or modification or other changes to, any software or Company
IT Systems.

(m) Bugs. None of the Company Owned Software: (i) contains any material bug,
defect or error that adversely affects the use, functionality or performance
of such Company Software or any product or system containing or used in
conjunction with such Company Software; or (ii) fails to comply with any
applicable warranty or other contractual commitment relating to the use,
functionality or performance of such Company Software or any product or system
containing or used in conjunction with such Company Software. The Company has
Made Available to Purchaser a complete and accurate list of all known bugs,
defects and errors in each version of the Company Software.

(n) Source Code. No source code for any Company Software has been delivered,
licensed or made available to any escrow agent or other Person who is not an
employee of any Acquired Company. No Acquired Company has any duty or
obligation (whether present, contingent or otherwise) to deliver, license or
make available the source code for any Company Software to any escrow agent or
other Person. No event has occurred, and no circumstance or condition exists,
that (with or without notice or lapse of time) will, or would reasonably be
expected to, result in the delivery, license or disclosure of the source code
for any Company Software to any other Person. No Person has, or shall have, in
connection with or as a result of the transactions contemplated by this
Agreement, any right to lease, license, purchase or otherwise obtain any
source code for any Company Software or any Company IP.

(o) IT Systems. Part 2.10(o) of the Disclosure Schedule accurately sets forth
a list of all (i) computer hardware (including computer servers, computer
storage and computer networking devices), (ii) Computer Software licenses and
(iii) desktop, laptop or other computing devices assigned to Company Service
Providers, in each case that are owned (or purported to be owned) by an
Acquired Company and used in or necessary to the conduct of the



Retained Business (the "Retained Business IT Systems"). All Company IT Systems
are configured and perform in accordance with commercially reasonable security
standards, including all security standards to which any Acquired Company
claims compliance. The configuration and set-up of all Company IT Systems are
documented pursuant to generally-accepted standards within the information
technology industry and the industry in which any Acquired Company conducts
its business. Neither any Acquired Company's operation and maintenance of any
Company IT System nor the running and updating of the computer programs
developed by any Acquired Company are dependent on any individual employee or
third party and such operation and maintenance and running and updating can be
carried out by a skilled computer technician or expert. All Company IT Systems
(including all computer hardware and software, including rented, leased and
borrowed hardware and all programs available on and run by the computer
systems) are fully functional and no material errors or defects which have not
been fully remedied have been discovered therein. No Acquired Company is in
breach of any Contract related to any Company IT System nor is any Acquired
Company aware of any event that may constitute a material breach of any
Company Contract related to any User Data, Personal Data, Company Data or
Company IT Systems. The Company IT Systems that are not Spin-Off Assets
operate and perform as is necessary to conduct the Retained Business as
currently conducted and as currently contemplated by the Acquired Companies to
be conducted.

(p) Use of Open Source Code.

(i) Part 2.10(p)(i) of the Disclosure Schedule accurately sets forth a
description of: (A) each item of Open Source Code that is contained in,
distributed with or used in the development of the Company Owned Software or
from which any part of any Company Software is derived; (B) the version or
versions of each such item of Open Source Code; (C) the Company Owned Software
to which each such item of Open Source Code relates; (D) the applicable
license for each such item of Open Source Code; (E) whether each such item of
Open Source Code has been modified by or for any Acquired Company; and (F)
whether such modules or modifications have been distributed or made available
to any third party.

(ii) Except as set forth in Part 2.10(p)(i) of the Disclosure Schedule, no
Open Source Code (A) was or is used in connection with the development of any
Company Owned Software, (B) was or is incorporated (including as a programming
dependency) in whole or in part into or otherwise forms any part of any
Company Owned Software or (C) has been or is distributed by or for any
Acquired Company, or has been or is made available by any Acquired Company in
whole or in part, in conjunction with or for use with any Company Owned
Software.

(iii) No Acquired Company has used Open Source Code in such a way that (A)
creates or purports to create any obligations for any Acquired Company with
respect to any Company Owned Software or Company IP or (B) grants or purports
to grant to any third party any rights or immunities under any Company IP.
Each Acquired Company is in material compliance with all terms and conditions
of all relevant licenses for Open Source Code (including all requirements
relating to notices and making Open Source Code available to third parties).



(iv) Part 2.10(p)(iv) of the Disclosure Schedule sets forth a list of
Intellectual Property that any Acquired Company or any Company Service
Provider has contributed to an open source project or made available under an
open source license.

(q) Privacy Policies. Part 2.10(q) of the Disclosure Schedule identifies each
Company Privacy Notice in effect at any time and identifies with respect to
each Company Privacy Notice (i) the period of time during which such Company
Privacy Notice was or has been in effect; (ii) whether the terms of a later
Company Privacy Notice apply to the data or information collected under such
Company Privacy Notice; and (iii) if applicable, the mechanisms (such as opt
in, opt out or notice only) used to apply a later Company Privacy Notice to
data or information previously collected under such Company Privacy Notice.
Each Company Privacy Notice complies with applicable Privacy Requirements.

(r) Privacy Compliance. Each Acquired Company and all third parties acting on
behalf of any Acquired Company (i) have at all times complied in all material
respects with all of the Company Privacy Policies and with all applicable
Privacy Requirements and Company Contracts relating to privacy, security or
Personal Data; (ii) have not received any written or, to the Knowledge of the
Company, oral notice (including any enforcement notice), letter or complaint
from a Governmental Body or any Person alleging any noncompliance or potential
noncompliance with any applicable Privacy Requirements or Company Privacy
Policies, nor has it been subject to any Legal Proceeding relating to
compliance with Privacy Requirements or its Processing of Personal Data; and
(iii) no Acquired Company has been subject to any regulatory inquiries from
any Governmental Body regarding actual or potential noncompliance with
applicable Privacy Requirements.

(s) Execution, Delivery and Performance of the Agreement. Neither the
execution, delivery or performance of this Agreement or any of the other
agreements referred to in this Agreement (including the Spin-Off Agreements
and the Transition Services Agreement) nor the consummation of any of the
transactions contemplated by this Agreement or any such other agreements
(including the Spin-Off Agreements and the Transition Services Agreement), nor
the receipt, possession or use by Purchaser or any Affiliate of Purchaser of
the User Data or Personal Data of any Company Service Provider or any other
data or information in the Company Databases, nor the assignment and transfer
of any Company IP, will result directly or indirectly in (i) any material
violation of any Company Privacy Policy, Privacy Requirement, Company Contract
or any other applicable Legal Requirement or (ii) requirement to notify any
Person or Governmental Authority under Company Privacy Policies, Privacy
Requirements or Company Contracts relating to privacy, security or Personal
Data. Access to and collection of all Company Data, Personal Data and User
Data currently used in the Retained Business or necessary for the conduct of
the Retained Business as currently conducted or currently contemplated by the
Acquired Companies to be conducted will not be terminated or discontinued and
will continue immediately after the Closing Date for Processing by the
Company, 340B OpCo and PHSS following the consummation of the transactions
contemplated by this Agreement or any of the other agreements referred to in
this Agreement (including the Spin-Off Agreements and the Transition Services
Agreements) on substantially the same terms and conditions as existed
immediately before the consummation of the transactions contemplated by



this Agreement or any of the other agreements referred to in this Agreement
(including the Spin-Off Agreements and the Transition Services Agreements). No
Company Contract relating to privacy, security or Personal Data contains any
provision allowing a customer to terminate such Company Contract without cause
in a manner that would, or would reasonably be expected to, adversely impact
any Company Product, the operation of the Retained Business or any benefits
received by any Acquired Company under such Company Contract. The Acquired
Companies have not received any notice from any customer or other Person
indicating, suggesting or providing the Acquired Companies with reason to
believe that such Person intends to terminate any existing HIPAA business
associate agreement or other Company Contract with the Acquired Companies
relating to privacy, security or Personal Data.

(t) Processing of Personal Data. Part 2.10(t) of the Disclosure Schedule
identifies and describes each distinct electronic or other database containing
(in whole or in part) Personal Data Processed by or for any Acquired Company
at any time (each, a "Company Database"), the types of Personal Data in each
such database, the means by which the Personal Data was collected, the
security and retention policies that have been adopted and maintained with
respect to each such database, the geographical location(s) of each such
database and whether such database has been registered with any Governmental
Body. Each Company Database that is required to be registered under any
applicable Legal Requirement has been duly registered and maintained. Each
Acquired Company and each third party acting on behalf of any Acquired Company
has acquired, collected, transferred and used all Personal Data in accordance
with the terms of, valid and enforceable Contracts. No Acquired Company has
Processed any Personal Data or any data that is not publicly available in
material violation or breach of any Company Contract or applicable Privacy
Requirement. To the extent commercially reasonable for the nature and
sensitivity of the Personal Data being Processed, or required by applicable
Privacy Requirements or Company Privacy Policies, (i) Personal Data is stored
and transmitted by each Acquired Company in an encrypted manner and (ii)
Personal Data is not maintained by any Acquired Company for longer than is
required. There is no complaint or any audit, Legal Proceeding, investigation
or claim currently pending against any Acquired Company by any Person or
Governmental Body in respect of Personal Data or User Data.

(u) Government and University Rights. No facilities of any Governmental Body,
university, college, hospital, other medical or educational institution or
research center or funding from any Governmental Body or third parties was
used in the development of any Company IP. No current or former employee of
any Acquired Company, and to the Knowledge of the Company, no other Company
Service Provider who was involved in, or who contributed to, the creation or
development of, any Company IP, was employed by or has performed services for
any Governmental Body, university, college, hospital or other medical or
educational institution or research center during a period of time during
which such Company Service Provider was also involved in, or contributing to,
the creation or development of any Company IP or otherwise performing services
for any Acquired Company. No Governmental Body, university, college, hospital
or other medical or educational institution or research center has any rights
whatsoever in any Company IP.



(v) Information Security. Each Acquired Company has established and has
adhered to a written information security program (the "Information Security
Program") that complies in all material respects with applicable Privacy
Requirements and that: (i) includes administrative, technical and physical
safeguards that are commercially reasonable for the protection of Personal
Data (and, in particular, "electronic protected health information" ("ePHI")
as defined under Privacy Requirements) and which protect the security,
confidentiality and integrity of any Company Data, User Data or Personal Data
owned, controlled, maintained, held or Processed by any Acquired Company or
any third party operating on behalf of or at the direction of any Acquired
Company; (ii) includes policies and procedures regarding Personal Data and the
Processing thereof, as well as disaster recovery, business continuity,
incident response and security plans, procedures and facilities; (iii)
protects against Malicious Code, Data Breaches, denial-of-service attacks,
business interruptions and unauthorized access to and Processing of the
Company IT Systems, Personal Data, User Data and Company Data and the systems
of any third party service providers that have access to such data or Company
IT Systems; and (iv) uses reasonable encryption methods that comply with
Privacy Requirements and Company Privacy Policies for transmission of
information (and, in particular, ePHI) across wireless and wired networks and
storage of Personal Data according to its sensitivity and proportional to the
risk that the inappropriate use or disclosure of that information could cause
financial, physical or reputational harm to an individual. Each Acquired
Company has tested its Information Security Program on a no less than an
annual basis, remediated all critical, high and medium risks, and the
Information Security Program has proven sufficient and compliant with Privacy
Requirements in all material respects. No Acquired Company or, to the
Company's Knowledge, any third party operating on its behalf has ever suffered
a Data Breach, or has ever been actually or potentially liable for, or
required to notify any Person or Governmental Body of, any Data Breach, and no
Acquired Company has been materially and adversely affected by any denial-of-
service attacks, business interruption, Malicious Code or threats to
maintaining the security, confidentiality or integrity of Company Data, User
Data or Personal Data. No breach or violation of the Information Security
Program has occurred or, to the Company's Knowledge, is threatened. The
Company IT Systems that are not Spin-Off Assets do not contain any Malicious
Code.

(w) User Agreements. Part 2.10(w) of the Disclosure Schedule accurately and
completely identifies each form of Company User Agreement in effect at any
time and identifies, with respect to each Company User Agreement, the period
of time during which such Company User Agreement was or has been in effect.
Each Company User Agreement governing any Company Software or any Company
Product: (i) is (or was, if terminated) binding and enforceable, (ii) is fully
assignable by an Acquired Company and (iii) includes an indemnity from the
user for any content or data linked or provided by the user.

2.11 Contracts.

(a) List of Contracts. Part 2.11(a) of the Disclosure Schedule accurately sets
forth, as of the date of this Agreement:



(i) each Company Contract that is with a (A) Top Customer or (B) Top Supplier;

(ii) each Company Contract for the employment or retention of any individual
on a full-time, part-time, consulting or other basis, and each Company
Contract between any Acquired Company and any Company Service Provider or any
independent contractor that is a bonus, retention, severance, change in
control or similar agreement;

(iii) each Company Contract with any Company Service Provider pursuant to
which: (A) benefits would vest, amounts would become payable or the terms of
which would otherwise be altered by virtue of the consummation of the
transactions contemplated by this Agreement (whether alone or upon the
occurrence of any additional or subsequent events); (B) any Acquired Company
is or may become obligated to make any severance, termination, termination
indemnity or redundancy, retention, gross-up or similar payment to any Company
Service Provider; or (C) any Acquired Company is or may become obligated to
make any bonus, incentive compensation or similar payment (other than in
respect of salary) to any Company Service Provider;

(iv) each Company Contract with any labor union or association representing
any Company Service Provider;

(v) each Company Contract which provides for indemnification of any officer,
director, manager, employee or agent;

(vi) each Company Contract relating to any Disposition Transaction, any
acquisition of stock, membership interests or other equity, or all or
substantially all of the assets of, any other Person, and any merger,
consolidation, reorganization or any similar transaction involving or with
respect to any Acquired Company;

(vii) each Company Contract (including each Company IP Contract) relating to
the acquisition, transfer, development or sharing of any technology or
Intellectual Property (including any joint development agreement, technical
collaboration agreement or similar agreement entered into by any Acquired
Company);

(viii) each Inbound License and each Outbound License;

(ix) each Company Contract relating to the hosting of any Company Product;

(x) any Company Contract pursuant to which any Acquired Company is obligated
to pay any royalties, fees or other payments to any Person with respect to the
marketing, sale, distribution, manufacture, license or use of any Company
Products or Company IP;

(xi) each Company Contract relating to the acquisition, sale, spin-off or
outsourcing of any business unit or operation of any Acquired Company, for the
sale of any of the assets of any Acquired Company, other than in the Ordinary
Course of Business, or for the



grant to any Person of any preferential rights to purchase any of the assets
of any Acquired Company;

(xii) each Company Contract creating or relating to any partnership, joint
venture, strategic alliance or any sharing of revenues, profits, losses, costs
or liabilities or similar arrangement;

(xiii) each Company Contract imposing any restriction on the right or ability
of any Acquired Company (or that would purport to limit the freedom of
Purchaser or any of its Affiliates or Subsidiaries): (A) to engage in any
business practices or develop or distribute any Company Product; (B) to
compete with any other Person or to engage in any line of business, market or
geographic area, or to sell, license, manufacture or otherwise distribute any
Company Product to customers or potential customers or any class of customers,
in any geographic area, during any period of time or in any segment of the
market; (C) to solicit the employment of, or hire, any potential employees,
consultants or independent contractors; (D) to acquire any product, property
or other asset (tangible or intangible), or any services, from any other
Person, to sell any product or other asset to or perform any services for any
other Person or to transact business or deal in any other manner with any
other Person; or (E) to develop, distribute, license, grant rights to or share
any technology, Intellectual Property or Intellectual Property Rights
(including any joint development agreement, technical collaboration agreement
or similar agreement entered into by any Acquired Company);

(xiv) each Company Contract: (A) granting exclusive rights to license, market,
sell or deliver any Company Product; or (B) otherwise contemplating an
exclusive relationship between any Acquired Company and any other Person,
including with respect to advertising;

(xv) any Company Contract granting "most favored nation" status to any other
Person;

(xvi) each Company Contract with "requirements" or similar provisions
obligating any Acquired Company to sell and deliver all of another Person's
requirements of specified goods or services during the Contract term or under
which any Acquired Company is obligated to purchase all of its requirements of
specified goods or services from another Person during the Contract term;

(xvii) each Company Contract with "take-or-pay" or similar provisions
obligating any Acquired Company to purchase a specific quantity of goods or
services from another Person or to pay the equivalent cost if such goods or
services are not purchased;

(xviii) each Company Contract related to enrollment in or participation in
Federal Health Care Programs;

(xix) each Company Contract with physicians, physician groups, other sources
of referrals or recipients of referrals to or for Company Products;



(xx) each Company Contract with Integrated Delivery Networks (IDNs),
hospitals, health care systems and specialty pharmacies within IDNs,
hospitals, health care systems and any other provider who may meet the
definition of a 340B covered entity, as defined in 42 U.S.C.  256b(a)(4);

(xxi) each Company Contract: (A) with a pharmaceutical manufacturer, rebate
aggregator or similar rebate intermediary; (B) with a specialty pharmacy; (C)
with a payor group or pharmacy benefit manager; (D) with a pharmacy service
group or organization; or (E) with a retail pharmacy or a retail pharmacy
network;

(xxii) each Company Contract that is a business associate agreement or
nondisclosure agreement;

(xxiii) each Company Contract involving any loan, guaranty, pledge,
performance or completion bond or indemnity or surety arrangement or otherwise
relating to the incurrence, assumption or guarantee of any Indebtedness by any
Acquired Company or imposing an Encumbrance (except for a Permitted
Encumbrance) on any of the assets of any Acquired Company;

(xxiv) each Lease Agreement, lease guaranty or other Company Contract for the
leasing, use or occupancy of all Leased Real Property;

(xxv) each Company Contract relating to the purchase or sale of any asset by
or to, or the performance of any services by or for, any Related Party;

(xxvi) any Company Contract constituting or relating to any (A) prime
contract, contract, subcontract, letter contract, purchase order or delivery
order executed or submitted to or on behalf of any Governmental Body or any
prime contractor or higher-tier subcontractor of a Governmental Body, or under
which any Governmental Body or any such prime contractor or subcontractor
otherwise has or may acquire any right or interest or (B) quotation, bid or
proposal submitted to any Governmental Body or any proposed prime contractor
or higher-tier subcontractor of any Governmental Body;

(xxvii) each Company Contract relating to the voting and any other rights or
obligations of the members of any Acquired Company, other than any Contract
terminable in accordance with its terms in connection with the consummation of
the transactions contemplated hereby;

(xxviii) each Company Contract for the purchase, lease, license, subscription
(or similar grant of rights) or rental of equipment or assets in excess of
$50,000 on a one-time or annual basis;

(xxix) each Company Contract relating to capital expenditures or commitment on
any tangible plant, property or equipment and involving future payments in
excess of $10,000 individually or $25,000 in the aggregate;



(xxx) each Company Contract relating to the settlement of any Legal Proceeding
since January 1, 2014;

(xxxi) any Company Contract relating to any liquidation or dissolution of any
Acquired Company or any of its predecessors;

(xxxii) any Company Contract that is a hedging, futures, options or other
derivative Contract;

(xxxiii) any Company Contract that is with any investment banker, broker,
advisor or similar party, or accountant, legal counsel or other Person
retained by any Acquired Company, including in connection with this Agreement
and the transactions contemplated hereby;

(xxxiv) any Company Contract that contemplates or involves: (A) the payment or
delivery of cash or other consideration by any Acquired Company in an amount
or having a value in excess of $100,000 individually, or $300,000 in the
aggregate when taken together with all other Company Contracts involving such
Person or such Person's Affiliates; or (B) the performance of services by any
Acquired Company having a value in excess of $100,000 individually, or
$300,000 in the aggregate when taken together with all other Company Contracts
involving such Person or such Person's Affiliates;

(xxxv) each Company Service Provider Agreement; and

(xxxvi) any other Company Contract that was entered into outside the Ordinary
Course of Business of the Acquired Companies and that is otherwise material to
any Acquired Company.

Contracts in the respective categories described in clauses "(i)" through
"(xxxvi)" above (whether or not identified in Part 2.11(a) of the Disclosure
Schedule, including Contracts in such categories entered into after the date
of this Agreement and on and before the Closing Date) and all Contracts
identified, or required to be identified, in Parts 2.3(d), 2.10(c), 2.10(d)
and 2.10(e) of the Disclosure Schedule are referred to in this Agreement as
"Material Contracts."

(b) Delivery of Contracts. The Company has Made Available to Purchaser
accurate and complete copies of all written Material Contracts in existence as
of the date of this Agreement, including all amendments thereto. Part 2.11(b)
of the Disclosure Schedule provides an accurate and complete description of
the material terms of each Material Contract in existence as of the date of
this Agreement that is not in written form. Each Material Contract is valid
and in full force and effect, and is enforceable by the applicable Acquired
Company in accordance with its terms, subject to: (i) laws of general
application relating to bankruptcy, insolvency and the relief of debtors; and
(ii) rules of law governing specific performance, injunctive relief and other
equitable remedies. To the Knowledge of the Company, no Person has threatened
to terminate or refuse to perform its obligations under any Material Contract
(regardless of whether such Person has the right to do so under such
Contract). The Material Contracts that are not Spin-Off Assets constitute all
of the Contracts necessary to enable the Company, 340B OpCo and PHSS to
conduct, in all material respects, the Retained Business in the manner in
which such business is



currently being conducted and currently contemplated to be conducted
immediately after the Closing Date.

(c) No Breach. No Acquired Company has, in any material respect, violated or
breached or committed any default under any Material Contract which remains
uncured, and, to the Knowledge of the Company, no other Person has, in any
material respect, violated or breached or committed any default under any
Material Contract which remains uncured. No event has occurred, and no
circumstance or condition exists, that (with or without notice or lapse of
time) will or would reasonably be expected to: (i) result in a material
violation or breach of any of the provisions of any Material Contract; (ii)
give any Person the right to declare a default or exercise any remedy under
any Material Contract; (iii) give any Person the right to accelerate the
maturity or performance of any Material Contract; or (iv) give any Person the
right to cancel, terminate or modify any Material Contract. No Acquired
Company has received any written notice or other written communication or, to
the Knowledge of the Company, any oral notice or other oral communication
regarding any actual or possible violation or breach of, or default under, any
Material Contract. No Acquired Company has waived any of its respective
material rights under any Material Contract.

(d) No Renegotiation. No Person is actively renegotiating, or has a
contractual right pursuant to the terms of any Material Contract to
unilaterally renegotiate, any amount paid or payable to any Acquired Company
under any Material Contract relating to the Retained Business or any other
material term or provision of any Material Contract relating to the Retained
Business.

2.12 Compliance with Legal Requirements.

(a) Compliance. Each Acquired Company is, and has at all times been, in
compliance in all material respects with each Legal Requirement that is
applicable to it or to the conduct of its business or the ownership of its
assets, including Legal Requirements relating to consumer protection,
competition, trade practices, privacy, data security, health care, pharmacy
regulatory, state business and professional licensing and registration, money
laundering, bribery, banking, foreign exchange, import/export and employment
matters or to the distribution or making available of Company Software or
Company Products. No event has occurred, and to the Knowledge of the Company,
no condition or circumstance exists, that will or would reasonably be expected
to (with or without notice or lapse of time) constitute or result in a
violation by any Acquired Company of, or a failure on the part of any Acquired
Company to comply with, any applicable Legal Requirement in any material
respect. No Acquired Company has received any written notice or other written
communication or, to the Knowledge of the Company, any oral notice or other
oral communication from any Person (i) regarding any actual or possible
violation of, or failure to comply with, any applicable Legal Requirement,
(ii) requiring or threatening to require that any Acquired Company enter into
an Order with a Governmental Body relating to the operations of any Acquired
Company or (iii) advising any Acquired Company that a Governmental Body is
contemplating issuing or requesting such Order.

(b) Payments, Etc. Without limiting the generality of Section 2.12(a), none of
any Acquired Company or any of any Acquired Company's Representatives or other
Person



associated with or acting on behalf of any Acquired Company has at any time,
directly or indirectly, taken any action that would result in a violation by
any Acquired Company (including any of its Representatives or other Persons
associated with or acting on its behalf) of any Anti-Corruption and Anti-
Bribery Laws. Without limiting the generality of this representation, each
Acquired Company, its Representatives and other Persons associated with such
Acquired Company or acting on its behalf have not, directly or indirectly: (a)
used any company funds for unlawful contributions, loans, donations, gifts,
entertainment or other unlawful expenses relating to political activity; (b)
authorized, offered, promised or made any unlawful payment to foreign or
domestic Government Officials or to foreign or domestic political parties or
campaigns; (c) made, promised or taken any action in furtherance of any
unlawful bribe, rebate, payoff, influence payment, kickback or other similar
unlawful payment; (d) or otherwise taken any action which would reasonably be
expected to cause it to be in violation of any Anti-Corruption and Anti-
Bribery Laws. There have not been at any time and currently there are no
pending or, to the Company's Knowledge, threatened violations, settlements or
Legal Proceedings against any Acquired Company with respect to any Anti-
Corruption and Anti-Bribery Laws. To the Company's Knowledge, there are no
Legal Proceedings, conditions or circumstances pertaining to any Acquired
Company's (including any of its Representatives or other Person associated
with or acting on its behalf) activities that would reasonably be expected to
give rise to any future violations, settlements or Legal Proceedings under any
Anti-Corruption and Anti-Bribery Laws. No Acquired Company has ever received
an allegation or whistleblower complaint or conducted an investigation into
potential or actual violations of any Anti-Corruption and Anti-Bribery Laws.
Each Acquired Company has conducted its business in a prudent manner to
promote compliance with any Anti-Corruption and Anti-Bribery Laws.

(c) No Subsidies. No Acquired Company possesses (or has ever possessed) or has
any rights or interests with respect to (or has ever had any rights or
interests with respect to) any grants, incentives or subsidies from any
Governmental Body.

2.13 Governmental Authorizations. Part 2.13 of the Disclosure Schedule
identifies each Governmental Authorization held by each Acquired Company, and
the Company has Made Available to Purchaser accurate and complete copies of
all Governmental Authorizations identified in Part 2.13 of the Disclosure
Schedule. The Governmental Authorizations identified in Part 2.13 of the
Disclosure Schedule are valid and in full force and effect, and the
Governmental Authorizations identified in Part 2.13 of the Disclosure Schedule
that are not Spin-Off Assets collectively constitute all Governmental
Authorizations necessary to enable the Company, 340B OpCo and PHSS to conduct
the Retained Business in the manner in which such business is currently being
conducted and currently planned by the Acquired Companies to be conducted in
accordance with all applicable Legal Requirements. Each Acquired Company is,
and has at all times been, in compliance, in all material respects, with the
terms and requirements of the respective Governmental Authorizations
identified in Part 2.13 of the Disclosure Schedule. No event has occurred
that, with notice or lapse of time or both, would reasonably be expected to
constitute a material default or violation of any term, condition or provision
of any such Governmental Authorization. No Acquired Company has ever received
any written notice or other written communication or, to the Knowledge of the
Company, any oral notice or other oral communication from any Governmental
Body regarding (x) any actual



or possible violation of or failure to comply with any term or requirement of
any Governmental Authorization, (y) any actual or possible revocation,
withdrawal, suspension, cancellation, termination or modification of any
Governmental Authorization or (z) any failure to obtain or receive any
Governmental Authorization. None of the Company IP or any Company Product is
subject to import or export licensing requirements. Each Acquired Company has
filed all applications that are required to have been filed for the obtaining,
renewal or upkeep of any Governmental Authorization on a timely basis, or with
appropriate extensions, each with the appropriate Governmental Body and all
fees or other amounts required to be paid in connection therewith have been
paid to the appropriate Governmental Body. Each Acquired Company has filed
with the appropriate Governmental Bodies, all material reports, statements,
documents, registrations, waivers, filings or submissions required to be filed
by it. Each of such reports, statements, documents, registrations, waivers,
filings and submissions complied with applicable Legal Requirements, and no
deficiencies have been asserted by any Governmental Body with respect to such
reports, statements, documents, registrations, waivers, filings or submissions
that have not been cured.

2.14 Tax Matters.

(a) Tax Returns and Payments. All Tax Returns required to be filed by or with
respect to any Acquired Company with any Governmental Body have been timely
(taking into account applicable extensions) and properly filed, were prepared
in compliance with all applicable Legal Requirements and are true, accurate
and complete and disclose all Taxes required to be paid by or with respect to
any Acquired Company for the periods covered thereby. All Taxes of the
Acquired Companies that are due and payable (whether or not shown on any Tax
Return) have been timely and properly paid or properly accrued (or reserved
for), including all actual and contingent Tax liabilities, in accordance with
GAAP,. No extension of time within which to file any Tax Return is currently
in effect. The Company has Made Available to Purchaser accurate and complete
copies of all Tax Returns filed by the Acquired Companies for the tax years
ending on December 31, 2017, December 31, 2018 and December 31, 2019,
including examination reports and all statements of deficiencies assessed
against or agreed to by any Acquired Company, filed or received since their
inception. There are no jurisdictions in which any Acquired Company is
required to file a Tax Return other than the jurisdictions in which such
Acquired Company presently files Tax Returns. No unresolved written claim has
ever been made or, to the Knowledge of the Company, asserted by an authority
in a jurisdiction where any Acquired Company does not file Tax Returns that
such Acquired Company is, or may be, required to file a Tax Return in, or
subject to Taxation by that jurisdiction. The unpaid Taxes of the Acquired
Companies (A) did not, as of the Balance Sheet Date, exceed the reserve for
Tax liability (rather than any reserve for deferred Taxes established to
reflect timing differences between book and Tax income) set forth on the face
of the Balance Sheet (rather than in any notes thereto) and (B) do not exceed
that reserve as adjusted for the passage of time through the Closing Date in
accordance with the past custom and practice of the Acquired Companies in
filing their Tax Returns. Since the Balance Sheet Date, no Acquired Company
has incurred any liability for Taxes outside the Ordinary Course of Business.
Any related party transactions that have been carried out among related
parties as defined in accordance with applicable Legal Requirements have been
made at arm's length and in full compliance with any transfer pricing



Legal Requirements, and the Acquired Companies maintain true and complete
records evidencing such circumstances.

(b) Audits; Claims. No Tax Return of any Acquired Company has ever been
audited by any Governmental Body. No Acquired Company has received from any
Governmental Body any written or, to the Knowledge of the Company, oral: (i)
notice indicating an intent to open an audit or other review of a Tax matter;
(ii) request for information related to material Tax matters; or (iii) notice
of deficiency or proposed Tax adjustment. No extension or waiver of the
limitation period applicable to any income or franchise Tax Return or other
Tax Return has been granted by or requested from any Acquired Company with
respect to any currently open Tax period. No claim or Legal Proceeding is
pending or, to the Knowledge of the Company, threatened against any Acquired
Company in respect of any Tax. There are no Encumbrances for Taxes upon any of
the assets of any Acquired Company except for Permitted Encumbrances.

(c) Closing Agreements; Etc. No Acquired Company will be required to include
any item of income in, or exclude any item of deduction from, taxable income
for any taxable period (or portion thereof) ending after the date of this
Agreement as a result of any change in method of accounting, closing
agreement, intercompany transaction, installment sale, open transaction,
election under Section 108(i) of the Code or prepaid amount received for a
taxable period ending on or prior to the date of this Agreement. No Acquired
Company is a party to or is bound by any Tax allocation or sharing agreement
(other than agreements entered into in the Ordinary Course of Business that
are not primarily related to Taxes). No Acquired Company has ever been a
member of an Affiliated Group. No power of attorney has been granted with
respect to any matter related to Taxes of any Acquired Company that on the
Closing Date will be in effect.

(d) Tax Incentives. Part 2.14(d) of the Disclosure Schedule sets forth all Tax
exemptions, Tax holidays or other Tax reduction agreements or arrangements
applicable to any Acquired Company. The Company has Made Available to
Purchaser all documentation relating to any applicable Tax holidays or
incentives. Each Acquired Company is in material compliance with all
requirements and conditions for any applicable Tax holidays or incentives and
none of the Tax holidays or incentives will be jeopardized by the transactions
contemplated in this Agreement, except where failure to be in compliance would
not, either individually or in the aggregate, reasonably be expected to result
in a Material Adverse Effect. The consummation of the transactions
contemplated by this Agreement will not materially and adversely affect the
remaining duration or the extent of any such Tax holiday or incentive or
require any recapture of any previously-claimed incentive, and no Consent of
any Governmental Body is required prior to the consummation of such
transactions in order to preserve the entitlement of any Acquired Company to
any such incentive. To the Knowledge of Company, no failure by any Acquired
Company to satisfy one or more requirements of any such incentive will
adversely affect the remaining duration or the extent of any such incentive or
require any recapture of any such previously-claimed incentive.



(e) Tax Withholding. Each Acquired Company has (i) complied in all respects
with all applicable Legal Requirements relating to the payment, reporting and
withholding of (and payment on account of) Taxes, (ii) within the time and in
the manner prescribed by Legal Requirements, withheld from employee wages,
consulting compensation or consideration payable to any independent
contractor, supplier, member or other third party and timely paid over to the
proper Governmental Bodies (or is properly holding for such timely payment)
all amounts required to be so withheld and paid over under all applicable
Legal Requirements and (iii) timely filed all withholding Tax Returns, for all
periods.

(f) Tax Rulings; Closing Agreements. No Acquired Company has requested or
received a ruling from any Tax authority or signed a closing or other
agreement with any Tax authority.

(g) No Liability. No Acquired Company has any Liability for the Taxes of any
Person under U.S. Treasury Regulation Section 1.1502-6 (or any similar state,
local or non-U.S. Legal Requirement), as a transferee or successor, by
Contract (other than a Contract not primarily related to Taxes entered into in
the Ordinary Course of Business) or otherwise.

(h) Tax-Free Reorganization Restrictions. No Acquired Company has ever been a
distributing or controlled corporation in a transaction treated by the parties
as qualifying in whole or in part under Sections 355 or 361 of the Code.

(i) Reportable Transactions. No Acquired Company (i) is or has ever been party
to a "reportable transaction" as defined in Section 6706A(c)(1) of the Code or
U.S. Treasury Regulation Section 1.6011-4(b) or the Legal Requirements in
existence in any tax jurisdiction (including state and local tax
jurisdictions) in which any Acquired Company does business or (ii) has ever
engaged in any "listed transactions" within the meaning of Treasury Regulation
Section 1.6011-4(b)(2) or the Legal Requirements in existence in any tax
jurisdiction (including state and local tax jurisdictions) in which any
Acquired Company does business.

(j) Foreign Taxes. No Acquired Company has, or has ever had, a permanent
establishment in any country other than the United States. No Acquired Company
is subject to Tax in any country other than the United States.

(k) CFCs; PFICs; Etc. No Acquired Company is, or has ever been, a United
States shareholder (within the meaning of Section 951(b) of the Code) of a
controlled foreign corporation (within the meaning of Section 957 of the Code)
or a shareholder of a "passive foreign investment company" (within the meaning
of Section 1297 of the Code). No Acquired Company is, or has ever been, a
direct or indirect party to any joint venture, partnership or other
arrangement that could be treated as a partnership for Tax purposes.

(l) FIRPTA. No transaction contemplated by this Agreement is subject to
withholding under Section 1445 of the Code (related to "FIRPTA"), or any
similar state, local or non-U.S. Legal Requirement.



(m) Tax Classification. The Company is, and has always been since the time of
its formation, either classified as an entity disregarded from PSG or as a
partnership for all federal, state and local income Tax purposes. PSG is, and
has since the completion of the merger involving the Company and PSG been,
classified as an entity disregarded from the Company for all federal, state
and local income Tax purposes except in each case where such treatment is
inconsistent with relevant state or local Tax law and was, prior to the
completion of the merger involving the Company and PSG, classified as a
partnership for all federal, state and local income Tax purposes. PHSS is, and
has always been since the time of its formation, classified as an entity
disregarded from PSG for all federal, state and local income Tax purposes,
except in each case where such treatment is inconsistent with relevant state
or local Tax law. No Acquired Company has ever made an election to be treated
as a corporation for federal income or other Tax purposes.

(n) Tax Ownership of Property. No Acquired Company is treated as the owner of
any property for income Tax purposes that is owned by any other person for
non-income Tax purposes.

(o) Boycotts. No Acquired Company has participated in or cooperated with an
international boycott, within the meaning of Section 999 of the Code, or had
operations which are or may hereafter become reportable under Section 999 of
the Code.

(p) Exclusive Representations. No Acquired Company makes any representations
or warranties in respect of the existence, amount or usability of the Tax
attributes of the respective company for Tax periods (or portions thereof)
beginning on or after the Closing Date, including, without limitation, asset
bases, research and development credits and depreciation periods.

2.15 Employee and Labor Matters; Benefit Plans.

(a) Employee List. Part 2.15(a) of the Disclosure Schedule contains a list of
all current Company Service Providers that have performed services, or are
performing services as of the date of this Agreement, primarily for or related
to the Retained Business, and accurately reflects, as of the date of this
Agreement: (i) their dates of service; (ii) their job titles; (iii) work
location (including, for each Company Service Provider that works remotely,
the domicile of such Company Service Provider); (iv) employment
classifications (including whether each Company Services Provider is (A) full-
time or part-time, (B) hourly or salaried and (C) an employee, contractor or
intern); (v) classification as exempt or non-exempt under applicable overtime,
wage and hour regulation, if applicable; (vi) all compensation and benefits to
which each such person is entitled, including their hourly rate of
compensation, annualized salary, any other compensation payable to them,
whether in cash or otherwise (including housing allowances, cash compensation
payable pursuant to bonus, deferred compensation, travel allowances or
commission arrangements) and each Company Employee Plan in which they
participate or are eligible to participate; (vii) whether they are a party to
a Company Service Provider Agreement and an identification of each such
Company Service Provider Agreement; (viii) the number of hours and days of
sick time to which such persons are entitled and which have accrued and the
aggregate dollar amounts thereof; (ix) the vacation days to which such



persons are entitled, annual entitlement to vacation days and their accrued
and unpaid vacation (represented both in terms of the number of days as well
as the dollar value); (x) length of notice period required in order to
terminate their employment, if any; (xi) automobiles and other benefits in
kind; (xii) their most recent compensation increase including the date and the
amount thereof; (xiii) whether such persons are on leave or scheduled to be on
leave (and if so, the category of leave, the date on which such leave
commenced or will commence and the date of expected return to work); and (xiv)
visa status, if applicable. There are no written or unwritten policies or
customs that, by extension, could entitle any Company Service Providers to
benefits in addition to those to which they are entitled pursuant to
applicable Legal Requirements, other than those included in the Company
Employee Plans or the Company Service Provider Agreements. No Acquired Company
has made any promises or commitments to any Company Service Providers, whether
in writing or not, with respect to any future changes or additions to their
compensation or benefits, as listed in Part 2.15(a) of the Disclosure
Schedule.

(b) Employment and Termination. The employment of each of the current Company
Service Providers is terminable by an Acquired Company at will, subject only
to the terms of the applicable Company Service Provider Agreement and
applicable Legal Requirements. The Company has Made Available to Purchaser
accurate and complete copies of all material Company Service Provider
Agreements and employee manuals and handbooks. All Company Service Providers
that are employees are employees of PSG Support Services, LLC.

(c) Employee Departures/Restrictions. To the Knowledge of the Company, no
employee of any Acquired Company: (i) intends to terminate his employment with
such Acquired Company; (ii) has received an offer to join a business that may
be competitive with any Acquired Company's business; or (iii) is a party to or
is bound by any confidentiality agreement, noncompetition agreement or other
Contract (with any Person) that may have a material and adverse effect on: (A)
the performance by such employee of any of his duties or responsibilities as
an employee of any Acquired Company; or (B) any Acquired Company's business or
operations. Part 2.15(c) of the Disclosure Schedule contains an accurate and
complete list of each Company Contract (and each Company Service Provider who
has executed any Company Contract) containing provisions restricting any
Company Service Provider from competing with any Acquired Company, soliciting
or hiring employees of any Acquired Company or soliciting, contacting or
interfering with customers of any Acquired Company. Details of any Person who
has accepted an offer of employment made by any Acquired Company but whose
employment has not yet started and any Company Service Provider who was
provided with or who received a notice of termination of his or her employment
in the last 12 months prior to the date of this Agreement are contained in
Part 2.15(c) of the Disclosure Schedule. No Company Service Provider has been
involuntarily terminated in the last 12 months prior to the date of this
Agreement.

(d) Employee Plans and Agreements. Part 2.15(d) of the Disclosure Schedule
contains an accurate and complete list of each material Company Service
Provider Agreement and each Company Employee Plan. No Acquired Company intends
or has committed to establish or enter into any new Company Employee Plan or
Company Service Provider Agreement, or to modify any new or existing Company
Employee Plan or Company Service



Provider Agreement (except to conform any such Company Employee Plan or
Company Service Provider Agreement to the requirements of any applicable Legal
Requirements, in each case as previously disclosed to Purchaser in writing or
as required by this Agreement). No Acquired Company shall, following the Spin-
Off, and Purchaser shall not, following the Closing, have any Liability in
respect of any Company Benefit Plan or Company Service Provider Agreement.

(e) Foreign Plans. Part 2.15(e) of the Disclosure Schedule contains an
accurate and complete list of: (i) any Company Employee Plan that is subject
to any of the Legal Requirements of any jurisdiction outside of the United
States; or (ii) any Company Employee Plan that covers or has covered Company
Service Providers whose services are or have been performed primarily outside
of the United States. Each Company Employee Plan that is required to be
registered under the laws of a jurisdiction outside the United States has been
registered and has been maintained in good standing with the appropriate
regulatory authorities.

(f) Delivery of Documents. As applicable with respect to each Company Employee
Plan, the Company has Made Available to Purchaser: (i) correct and complete
copies of all documents setting forth the terms of each Company Employee Plan,
including all amendments thereto and all related trust documents, and a
written summary of the material terms of any unwritten Company Employee Plan;
(ii) the most recent summary plan description together with the summaries of
material modifications thereto, if any, with respect to each Company Employee
Plan; (iii) all material written Contracts relating to each Company Employee
Plan, including administrative service agreements and group insurance
contracts; (iv) all written materials provided to any Company Service Provider
relating to any Company Employee Plan or any proposed Company Employee Plan,
in each case, relating to any amendments, terminations, establishments,
increases or decreases in benefits, acceleration of payments or vesting
schedules or other events that would result in any Liability to any Acquired
Company; (v) all correspondence delivered to or received from any Governmental
Body relating to any Company Employee Plan; (vi) the annual reports (Form 5500
series) for the last three complete plan years; (vii) the most recent
determination or opinion letter from the Internal Revenue Service relating to
the tax-qualified status of each Company Employee Plan; and (viii) all
policies in the possession of any Acquired Company pertaining to fiduciary
liability insurance covering the fiduciaries for each Company Employee Plan.

(g) Absence of Certain Retiree Liabilities. No Company Employee Plan provides
retiree life insurance, retiree health benefits or other retiree employee
welfare benefits to any Person for any reason, except as may be required by
applicable Legal Requirements. Other than commitments made that involve no
future costs to any Acquired Company, no Acquired Company has ever
represented, promised or contracted (whether in oral or written form) to any
Company Service Provider (either individually or to Company Service Providers
as a group) or any other Person that such Company Service Provider(s) or other
Person would be provided with retiree life insurance, retiree health benefits
or other retiree employee welfare benefits, except to the extent required by
applicable Legal Requirements.

(h) No Defaults. Each of the Company Employee Plans has been operated, funded
and administered in all material respects in accordance with its terms and
applicable



Legal Requirements, including the applicable Tax qualification requirements
under the Code. All contributions to the Company Employee Plans for any period
ending on or before the Closing Date which are not yet due are reflected as an
accrued Liability on the Balance Sheet. With respect to each Company Employee
Plan intended to be "qualified" within the meaning of Section 401(a) of the
Code, each such Company Employee Plan has received a favorable IRS
determination letter or may rely on an opinion letter with respect to such
qualification and the Tax-exempt status of its related trust, and no
circumstances exist which could reasonably be expected to result in the loss
of such qualified status. No Company Employee Plan is intended to meet the
requirements of Section 501(c)(9) of the Code. Each Company Employee Plan can
be amended, terminated or otherwise discontinued after the date of this
Agreement, without Liability to any Acquired Company or Purchaser (other than
for ordinary administration expenses). There are no audits, inquiries or Legal
Proceedings pending or, to the Knowledge of the Company, threatened, by any
Person with respect to any Company Employee Plan.

(i) Claims Against Plans. There are no pending or, to the Knowledge of the
Company, threatened or reasonably anticipated claims or Legal Proceedings
against any of the Company Employee Plans, the assets of any of the Company
Employee Plans or any Acquired Company, or the Company Employee Plan
administrator or any fiduciary of the Company Employee Plans with respect to
the operation of such Company Employee Plans (other than routine, uncontested
benefit claims) or asserting any rights or claims to benefits under such
Company Employee Plans.

(j) Title IV of ERISA. Neither any Acquired Company, nor any ERISA Affiliate,
has ever maintained, been a participating employer, contributed to or has had
any Liability with respect to (i) any multiemployer plan as defined in Section
3(37) or Section 4001(a)(3) of ERISA or 414(f) of the Code; (ii) any multiple
employer plan within the meaning of Section 4063 or 4064 of ERISA or Section
413(c) of the Code; or (iii) any other employee benefit plan, fund, program,
contract or arrangement that is subject to Section 412 of the Code, Section
302 of ERISA or Title IV of ERISA.

(k) No Conflict. Neither the execution, delivery or performance of this
Agreement, nor the consummation of the transactions contemplated by this
Agreement, will or would reasonably be expected to (either alone or upon the
occurrence of any additional or subsequent events): (i) constitute an event
under any Company Service Provider Agreement, Company Employee Plan, trust or
loan that will or could reasonably be expected to result (either alone or in
connection with any other circumstance or event) in any payment (whether of
severance pay or otherwise), acceleration, forgiveness of indebtedness,
vesting, distribution, increase in benefits or obligation to fund benefits
(through a grantor trust or otherwise) with respect to any Company Service
Provider; or (ii) create or otherwise result in any Liability with respect to
any Company Service Provider Agreement or Company Employee Plan.

(l) Parachute Payments. No amount paid or payable in connection with the
transactions contemplated hereby (either solely as a result thereof or as a
result of such transactions in conjunction with any other event) could be an
"excess parachute payment" within the meaning of Section 280G of the Code (or
any corresponding provisions of state, local or



foreign Legal Requirements). No Acquired Company has any obligation to make
any "gross-up" or similar payment in respect of any Taxes that may become
payable under Section 4999 of the Code.

(m) Section 409A. No Company Employee Plan or Company Service Provider
Agreement and no grants, awards or benefits thereunder are subject to Section
409A(a) or 409A(b) of the Code or, if subject to Section 409A(a) of the Code,
have failed, in form or operation, to meet the requirements of Section
409A(a)(2), 409A(a)(3) or 409A(a)(4) of the Code. No Acquired Company has an
obligation to make any "gross-up" or similar payment in respect of any Taxes
that may become payable under Section 409A of the Code.

(n) Compliance. Each Acquired Company: (i) is and has at all times been in
compliance in all material respects with applicable Legal Requirements,
Contracts and Orders respecting employment hiring practices, employment
practices, terms and conditions of employment, wages, hours or other labor-
related matters and maintenance of registrations, licenses, records, registers
and periodic filings, including Legal Requirements and Orders relating to
discrimination, wages and hours, labor relations, leaves of absence, work
breaks, classification of employees, occupational health and safety, privacy,
harassment (including sexual harassment), retaliation, equal opportunity, fair
employment practices, immigration, work authorization or wrongful discharge,
including the Worker's Adjustment and Retraining Notification Act (and any
other applicable Legal Requirement); (ii) has withheld and reported all
amounts required by any applicable Legal Requirement or Contract to be
withheld and reported with respect to wages, salaries and other payments or
compensation to any Company Service Provider; (iii) has no Liability for any
arrears of wages or any Taxes, social security contributions or any penalty
for failure to comply with any of the foregoing; and (iv) has no Liability for
any payment to any trust or other fund governed by or maintained by or on
behalf of any Governmental Body with respect to unemployment compensation
benefits, social security or other benefits or obligations for any Company
Service Provider.

(o) No Breach of Employee Related Obligations. Each Acquired Company complies
and has at all times complied in all material respects with each obligation
imposed on it by applicable Legal Requirements, codes of conduct, collective
agreements, customs or practices in connection with: (i) all Company Service
Providers; and (ii) any relationship with a labor organization or other
employee representative body.

(p) No Misclassified Employees. Each Company Service Provider that has been
characterized as a contract laborer/worker, consultant or independent
contractor by an Acquired Company has been properly characterized as such. No
contract laborer/worker or independent contractor is eligible to participate
in any Company Employee Plan. No Acquired Company has any material Liability
to any individual who is not currently on any Acquired Company's payroll for
any claim, demand or entitlement based upon employment status. No Acquired
Company has promised any contract laborer/worker, consultant, independent
contractor or intern an employee position within any Acquired Company.

(q) No Unions, Etc. No Acquired Company is a party to or bound by, and no
Acquired Company has ever been a party to or bound by, any union contract,
works council or



collective bargaining agreement or similar Contract and there are no labor
organizations representing, purporting to represent or, to the Knowledge of
the Company, seeking to represent any employee of any Acquired Company. No
Acquired Company is or has ever been a member of any employers' organization
and there is no, and never has been, an employees' committee in any Acquired
Company.

(r) Labor Disputes, Etc. There has never been any slowdown, work stoppage,
labor dispute or union organizing activity, or any similar activity or
dispute, affecting any Acquired Company. No event has occurred and, to the
Knowledge of the Company, no condition or circumstance exists, that might
directly or indirectly give rise to or provide a basis for the commencement of
any such slowdown, work stoppage, labor dispute or union organizing activity
or any similar activity or dispute. No Acquired Company is engaged, or has
ever engaged, in any unfair labor practice of any nature. There are no
actions, suits, claims, labor disputes or grievances pending or, to the
Knowledge of the Company, threatened or reasonably anticipated relating to any
labor, safety or discrimination matters involving any Company Service
Provider, including charges of unfair labor practices or discrimination
complaints.

(s) Labor Relations and Labor-Related Claims. There is no Legal Proceeding,
claim, assessment, inspection, labor dispute or grievance pending or, to the
Knowledge of the Company, threatened or reasonably anticipated, relating to
any Company Service Provider Agreement, compensation, wages and hours, leave
of absence, office or plant closing notification, employment statute or
regulation, privacy right, labor dispute, workers' compensation policy, long-
term disability policy, safety, harassment (including sexual harassment),
retaliation, equal opportunity, fair employment practices, immigration, work
authorization or discrimination matter involving any Company Service Provider,
including charges of unfair labor practices or harassment complaints. To the
Knowledge of the Company, there are no facts indicating that the consummation
of the transactions contemplated by this Agreement will have a material
adverse effect on the labor relations of any Acquired Company. There are no
pending or, to the Knowledge of the Company, threatened or reasonably
anticipated claims or Legal Proceedings against any Acquired Company under any
workers' compensation policy or long-term disability policy or similar policy
subject to foreign Legal Requirements. No Acquired Company is a party to or is
bound by a settlement agreement with or relating to a current or former
Company Service Provider, officer, director, manager or executive of any
Acquired Company resolving or seeking to resolve allegations of sexual or
other harassment or misconduct by any Company Service Provider, officer,
director, manager or executive of any Acquired Company, nor has there been any
Legal Proceeding involving such conduct.

(t) Severance, Etc. (i) The employment of each current Company Service
Provider is subject to termination upon not more than 30 days prior written
notice under the termination notice provisions included in the applicable
Company Service Provider Agreement with such Company Service Provider
identified or required to be identified in Part 2.15(d) of the Disclosure
Schedule or under applicable Legal Requirements without the payment of
severance; and (ii) no current Company Service Provider's employment by any
Acquired Company requires any special license, permit or other Governmental
Authorization.



(u) Deductions from Compensation. All amounts that any Acquired Company is
legally or contractually required to either: (i) deduct from its employees'
salaries and any other compensation or benefit or to transfer to such
employees' plans or (ii) withhold from employees' salaries and any other
compensation or benefit and to pay to any Governmental Body as required by any
applicable Legal Requirement, have been duly deducted, transferred, withheld
and paid, in accordance with applicable Legal Requirements, and no Acquired
Company has any outstanding obligation to make any such deduction, transfer,
withholding or payment (other than routine payments, deductions or
withholdings to be timely made in the Ordinary Course of Business).

(v) Independent Contractors. Part 2.15(v) of the Disclosure Schedule
accurately sets forth, with respect to each Person who is an independent
contractor, as of the date of this Agreement, of any Acquired Company:

(i) the name of such independent contractor and the date as of which such
independent contractor was originally engaged by any Acquired Company;

(ii) a description of the position held and nature of work performed by such
independent contractor;

(iii) the location of such independent contractor;

(iv) all compensation to which each such Person is entitled, whether in cash
or otherwise (including commission arrangements);

(v) whether such Person is a party to a Company Service Provider Agreement and
an identification of each such Company Service Provider Agreement;

(vi) the notice period and termination payment required in order to terminate
the engagement with such Person;

(vii) such Person's most recent compensation increase including the date and
the amount thereof; and

(viii) the aggregate dollar amount of the compensation (including all payments
or benefits of any type) paid to such independent contractor by any Acquired
Company with respect to services performed in the fiscal year ending on
December 31, 2019 and a good faith estimate of the amount of such compensation
projected to be paid in the fiscal year ending on December 31, 2020.

All independent contractors can be terminated on notice of 30 days or less to
the independent contractor. All independent contractors are and all former
independent contractors were rightly classified as independent contractors and
would not reasonably be expected to be reclassified by any Governmental Body
as employees of any Acquired Company, for any purpose whatsoever. According to
the independent contractors' agreements with any of the Acquired Companies, no
independent contractor is entitled to any rights under the applicable



labor Legal Requirements. All current and former independent contractors have
received all of the rights to which they are and were entitled according to
any applicable Legal Requirements or Contracts with any of the Acquired
Companies. No Acquired Company engages temporary employees through third party
service providers.

2.16 Environmental Matters.

(a) Each Acquired Company has at all times been and is in compliance with all
applicable Environmental Laws, which compliance includes the possession by
such Acquired Company of all Environmental Licenses and other Governmental
Authorizations required under applicable Environmental Laws, and compliance
with the terms and conditions thereof. No Acquired Company has received any
written notice or other written communication or, to the Knowledge of the
Company, any oral notice or other oral communication, whether from a
Governmental Body, citizens group, current or former Company Service Provider
or otherwise, that alleges that any Acquired Company is not in compliance with
any Environmental Law, and, to the Knowledge of the Company, there are no
circumstances that may prevent or interfere with any Acquired Company's
compliance with any Environmental Law in the future.

(b) To the Knowledge of the Company, no current or prior owner of any property
leased or controlled by any Acquired Company has received any notice or other
communication, whether from a Governmental Body, citizens group, current or
former Company Service Provider or otherwise, that alleges that such current
or prior owner or any Acquired Company is not in compliance with any
Environmental Law. No Acquired Company has caused or contributed to any
Environmental Release and there are no circumstances which may give rise to
any Environmental Release by any Acquired Company. To the Knowledge of the
Company, no Contaminants are stored or contained on or under any of the Leased
Real Properties whether in storage tanks, landfills, pits, ponds, lagoons or
otherwise. No Acquired Company has entered into any agreement that may require
it to guarantee, reimburse, pledge, defend, hold harmless or indemnify any
other party with respect to Liabilities arising out of any Environmental Law.
All Governmental Authorizations currently held by the Acquired Companies
pursuant to Environmental Laws are identified in Part 2.16 of the Disclosure
Schedule. The Company has Made Available to Purchaser accurate and complete
copies of all internal and external environmental audits and studies in its
possession or control, if any, relating to the Acquired Companies or their
operations and all correspondence on substantial environmental matters
relating to the Acquired Companies or their operations.

2.17 Insurance. Part 2.17 of the Disclosure Schedule identifies each insurance
policy maintained by, at the expense of or for the benefit of each Acquired
Company as of the date of this Agreement (including the type of coverage, the
carrier, the amount of coverage, the term and the annual premiums of such
policies) and identifies any material claims made thereunder as of the date of
this Agreement (other than routine, uncontested benefit claims under Company
Employee Plans). The Company has Made Available to Purchaser accurate and
complete copies of the insurance policies identified in Part 2.17 of the
Disclosure Schedule. Each of the insurance policies identified in Part 2.17 of
the Disclosure Schedule is in full force and effect, and all premiums due
thereon have been paid in full. Each Acquired Company has



complied in all material respects with the provisions of such insurance
policies. No Acquired Company has received any written notice or other written
communication or, to the Knowledge of the Company, any oral notice or other
oral communication regarding any actual or possible: (i) cancellation or
invalidation of any insurance policy; (ii) refusal of any coverage or
rejection of any claim under any insurance policy; or (iii) material
adjustment in the amount of the premiums payable with respect to any insurance
policy. To the Company's Knowledge, there is no claim by any Acquired Company
pending under any of such policies as to which coverage has been questioned,
denied or disputed. In addition, to the Company's Knowledge, there is no
pending claim of which its total value (inclusive of defense expenses) would
reasonably be expected to exceed the policy limits. No Acquired Company has
ever maintained, established, sponsored, participated in or contributed to any
self-insurance plan. Neither: (A) the execution, delivery or performance of
this Agreement or any of the other agreements, documents or instruments
referred to in this Agreement; nor (B) the consummation of the transactions
contemplated by this Agreement or any such other agreement, document or
instrument, will (with or without notice or lapse of time): (1) result in the
cancellation, invalidation or termination, or give any Person the right to
cancel, invalidate or terminate, any of the insurance policies of any Acquired
Company; (2) result in the reduction of coverage, or give any Person the right
to reduce the coverage, under any such insurance policies; or (3) have any
impact on any Acquired Company's right or ability to make a claim under any
such insurance policies in respect of or relating to events or circumstances
that have occurred prior to the Closing. There are no claims currently pending
under such insurance policies and all prior claims under such insurance
policies have been filed in a timely fashion.

2.18 Transactions with Related Parties. No Related Party: (a) has, or has had,
any interest in any material asset used in or otherwise relating to the
business of any Acquired Company; (b) is, or has been, indebted to any
Acquired Company (other than for ordinary travel advances); (c) has entered
into, or has had any financial interest in, any Contract, transaction or
business dealing with or involving any Acquired Company, including the
provision of services of any kind to any Acquired Company; (d) to the
Knowledge of the Company, is competing, or has within the past 12 months
competed, with any Acquired Company; or (e) has or has had any valid claim or
right against any Acquired Company (other than rights to receive compensation
for services performed as a Company Service Provider). No member of the board
of managers (or other similar body) of any Acquired Company has ever had a
conflict of interest with respect to any Acquired Company, and each such
member has provided confirmation of the foregoing to each Acquired Company in
accordance with applicable Legal Requirements.

2.19 Legal Proceedings; Orders.

(a) Legal Proceedings. There is no pending Legal Proceeding and, to the
Knowledge of the Company, no Person has threatened to commence any Legal
Proceeding: (i) that involves any Acquired Company, any of its managers,
officers or employees (in their capacities as a manager, officer or employee
of an Acquired Company, respectively), the business of the Acquired Companies
or any of the assets owned by any Acquired Company; (ii) that challenges, or
that could reasonably be expected to prevent, make illegal or otherwise



materially and adversely interfere with, any of the transactions contemplated
by this Agreement; or (iii) that relates to the ownership of any equity
interests or other securities of any Acquired Company or any option or other
right to the equity interests or any other securities of any Acquired Company,
or the right to receive consideration as a result of this Agreement. To the
Knowledge of the Company, no event has occurred, and no claim, dispute or
other condition or circumstance exists, that (with or without notice or lapse
of time) will or could reasonably be expected to give rise to or serve as a
basis for the commencement of any such Legal Proceeding. No Legal Proceeding
has ever been commenced by, and no Legal Proceeding has ever been pending
against, any Acquired Company.

(b) Orders. There is no, and there has not been any, Order to which any
Acquired Company, or any of the assets owned or used by any Acquired Company,
is or was subject. To the Knowledge of the Company, no Representative of any
Acquired Company is, or has been, subject to any Order that prohibits such
Representative from engaging in or continuing any conduct, activity or
practice relating to any Acquired Company's business.

2.20 Authority; Binding Nature of Agreement; Inapplicability of Anti-takeover
Statutes.

(a) Authority; Binding Nature of Agreement. The Company has the absolute and
unrestricted right, power and authority to enter into and to perform its
obligations under this Agreement and under each other agreement, document or
instrument referred to in or contemplated by this Agreement, including the
Spin-Off Agreements (collectively, the "Ancillary Agreements," it being agreed
that such Ancillary Agreements shall not include any Material Contracts) to
which the Company is or will be a party; and the execution, delivery and
performance by the Company of this Agreement and of each such Ancillary
Agreement have been duly authorized by all necessary action on the part of the
Company and its board of managers, and no further action is required on the
part of the Company to authorize this Agreement and each Ancillary Agreement
to which the Company is or will be a party or to consummate the transactions
contemplated hereby and thereby. This Agreement and each Ancillary Agreement
to which the Company is a party has been duly executed and delivered and
constitutes the legal, valid and binding obligation of the Company,
enforceable against the Company in accordance with its terms, subject to: (i)
laws of general application relating to bankruptcy, insolvency and the relief
of debtors; and (ii) rules of law governing specific performance, injunctive
relief and other equitable remedies.

(b) No Takeover Statute. No state or foreign takeover statute or similar Legal
Requirement applies or purports to apply to this Agreement or any of the
transactions contemplated hereby.

2.21 Non-Contravention; Consents. Neither: (1) the execution, delivery or
performance of this Agreement or any of the other agreements, documents or
instruments referred to in this Agreement (including the Spin-Off Agreements);
nor (2) the consummation of any of the transactions contemplated by this
Agreement or any other agreement, document or instrument referred to in this
Agreement (including the Spin-Off Agreements), will (with or without notice or
lapse of time):



(a) contravene, conflict with or result in a violation of: (i) any of the
provisions of the Charter Documents of any Acquired Company; or (ii) any
resolution adopted by the members, board of managers or any committee of the
board of managers of any Acquired Company;

(b) contravene, conflict with or result in a violation of, or give any
Governmental Body or other Person the right to challenge any of the
transactions contemplated by this Agreement or to exercise any remedy or
obtain any relief under, any Legal Requirement or Order to which any Acquired
Company or any of the assets owned or used by any Acquired Company, is
subject;

(c) contravene, conflict with or result in a violation of any of the terms or
requirements of, or give any Governmental Body the right to revoke, withdraw,
suspend, cancel, terminate or modify, any Governmental Authorization that is
held by any Acquired Company or that otherwise relates to any Acquired
Company's business or to any of the assets owned or used by any Acquired
Company;

(d) (i) contravene, conflict with or result in a violation or breach of, or
result in a default under, any provision of any Material Contract or any
Company Contract where such contravention, conflict, violation, breach or
default would result in a material Liability of, or otherwise have a material
impact on, the Acquired Companies, or (ii) give any Person the right to: (A)
declare a default or exercise any remedy under any such Material Contract; (B)
accelerate the maturity or performance of any such Material Contract; or (C)
cancel, terminate or modify any such Material Contract;

(e) contravene any applicable Legal Requirement or Order currently in effect
or require any Acquired Company or any of its Affiliates to obtain any Consent
from any Governmental Body or other Person, with regard to any Company
Product, or to make any filing with any Governmental Body or to any other
Person, with regard to a Company Product; or

(f) result in the imposition or creation of any Encumbrance upon or with
respect to any asset owned or used by any Acquired Company (except for
Permitted Encumbrances).

Except for the expiration or early termination of waiting periods under the
HSR Act and the expiration of waiting periods or the receipt of approvals or
consents required under any other competition, merger control, antitrust or
similar Legal Requirements, if applicable, no Acquired Company is or will be
required to make any filing with or give any notice to, or to obtain any
Consent from, any Person in connection with: (x) the execution, delivery or
performance of this Agreement or any of the other agreements, documents or
instruments referred to in this Agreement; or (y) the consummation of any of
the transactions contemplated by this Agreement.

2.22 Compliance with Health Care Laws.

(a) Each Acquired Company is, and has at all times been, and its equity
holders, officers, managers, managing employees, Company Services Providers
and agents are,



and have at all times been, in compliance in all material respects with all
Health Care Laws. No event has occurred, and no condition or circumstance
exists, that will (with or without notice or lapse of time) constitute or
result in a violation by any Acquired Company of, or a failure on the part of
any Acquired Company or its equity holders, officers, managers, managing
employees, Company Services Providers or agents to comply with, any Health
Care Law. None of any Acquired Company or any of its equity holders, officers,
managers, managing employees, Company Services Providers or agents has
received any written notice or other written communication or, to the
Knowledge of the Company, any oral notice or other oral communication from any
Person, including from any Governmental Body, regarding any actual or possible
violation of, or failure to comply with, any Health Care Law. All reports,
documents, forms, applications, records, submissions, claims or notices and
supplements or amendments required to be filed, maintained or furnished to a
Governmental Body have been so filed, maintained or furnished in a timely and
proper manner and were complete and accurate on the date filed in accordance
with all applicable Health Care Laws.

(b) No Acquired Company has received any written communication or written
notice or, to the Knowledge of the Company, any oral notice or other oral
communication of any pending or threatened Legal Proceeding or other action
from the U.S. Department of Health and Human Services ("HHS"), the U.S. Food
and Drug Administration, the Centers for Medicare and Medicaid Services, the
HHS Office of Inspector General, the HHS Office for Civil Rights, the U.S.
Department of Justice, U.S. Attorney Offices, the Federal Bureau of
Investigation, Medicaid Fraud Control Units, State Attorneys General, State
Departments of Insurance, State Boards of Pharmacy, any State Medicaid Agency
or any other applicable Governmental Body, or any qui tam relator, alleging
that any operation, activity or product of any Acquired Company is in material
violation of any applicable Health Care Law, and, to the Company's Knowledge,
no such Legal Proceeding currently exists. No Acquired Company has received
any subpoenas, criminal information or civil investigative demands, has been a
party to a corporate integrity agreement or similar agreement or has had any
reporting obligation pursuant to a settlement agreement, plan of correction or
other remedial measure entered into with any Governmental Body.

(c) Neither any Acquired Company nor its equity holders, officers, directors,
managers, managing employees, Company Services Providers or agents: (i) has
been, or is currently, excluded, suspended or debarred by any Governmental
Body from participation in Federal Health Care Programs, as defined in 42
U.S.C.  1320-7b(f), state health care programs or any regulated activity or
been excluded, suspended or debarred by any other Governmental Body, nor are
any of the foregoing Persons aware of any pending or, to the Knowledge of the
Company, threatened investigation or government action that may lead to such
an exclusion, suspension or debarment; (ii) has been convicted of any criminal
offense under any Health Care Law, including with regard to the delivery of or
payment for any item or service under a Federal Health Care Program; (iii) has
been assessed a civil money penalty under applicable Health Care Laws; (iv)
has been listed on the General Services Administration's List of Parties
Excluded from Federal Programs; (v) has paid or been assessed a civil money
penalty under any Health Care Law; or (vi) is a party to or subject to any
proceeding concerning any of the matters described in clauses (i) through (v)
above.



(d) No Acquired Company has in the past or is currently: (i) paying a
physician or a physician's immediate family member any direct or indirect
remuneration or submitting claims for any items or services payable by a
Federal Health Care Program in violation of the federal Stark Law, 42 U.S.C.
1395nn, (ii) knowingly and willfully offering, paying, soliciting or
receiving any remuneration (including any kickback, bribe or rebate), directly
or indirectly, overtly or covertly, in cash or in kind in return for, or to
induce, the referral of or the purchase, lease or order, or the arranging for
or recommending of the purchase, lease or order, of any good, facility, item
or service for which payment may be made in whole or in part under any Federal
Health Care Program or (iii) engaging in any conduct that would promote
patients to switch medications currently prescribed to them or stay on
prescriptions prescribed against their prescriber's instructions.

(e) No Acquired Company participates in, is authorized to bill or has directly
claimed or received reimbursement from any Federal Health Care Program or from
any other third-party payor. No Acquired Company provides reimbursement,
coding or billing advice regarding any items or services payable by any payor,
including any Federal Health Care Programs. Each of the Acquired Companies and
their products and services is in compliance in all material respects with all
applicable Health Care Laws and all applicable third party payor requirements,
including requirements promulgated by commercial insurers, managed care
organizations, health maintenance organizations, employer or union-sponsored
health plans and any other plan or program that provides health care benefits,
whether directly, through insurance or otherwise, including Medicare Advantage
plans and managed Medicaid plans.

(f) No Acquired Company employs or contracts with any physicians, pharmacists
or other health care professionals to provide professional health care
services requiring a license or accreditation under any Health Care Law.
Neither any Acquired Company nor any of its managers, officers, agents or
employees, in their individual capacities, has directly or indirectly made or
offered to make any contribution, gift, bribe, rebate, payoff, influence
payment or kickback to any Person, regardless of form: (i) in violation of any
Health Care Law; or (ii) to obtain or maintain favorable treatment in securing
business in violation of any applicable Health Care Law.

(g) The Acquired Companies hold all Governmental Authorizations (excluding the
Spin-Off Assets) necessary to conduct their business, including all
Governmental Authorizations required to market and sell the Company Products.
All such Governmental Authorizations are valid and in good standing and there
is no proceeding pending or, to the Company's Knowledge, threatened which may
cause any such Governmental Authorizations to be withdrawn, cancelled,
suspended or not renewed.

2.23 Significant Business Relationships.

(a) Part 2.23(a) of the Disclosure Schedule contains a true and correct list
of the top 20 currently-active customers of the Retained Business by aggregate
dollar volume of sales to such customers on a consolidated basis for the
12-month period ending December 31, 2019 and the six-month period ended June
30, 2020 (each such customer, a "Top Customer"). No Acquired Company has
received any notice, nor does the Company have any Knowledge,



that any Top Customer has a material issue or has experienced a material
problem with any Company Product or intends to cancel or otherwise materially
and adversely modify its relationship with any Acquired Company (whether
related to payment, price or otherwise) on account of the transactions
contemplated by this Agreement or otherwise. No Acquired Company is currently
engaged in any material dispute with any Top Customer.

(b) Part 2.23(b) of the Disclosure Schedule contains a true and correct list
of the top ten currently-active suppliers (including vendors) of the Acquired
Companies by aggregate dollar volume of purchases by the Acquired Companies
from such suppliers (including vendors) on a consolidated basis for the
12-month period ending December 31, 2019 and the six-month period ended June
30, 2020 (each such supplier, a "Top Supplier") and for each such Top Supplier
what such Top Supplier is providing and which of the Acquired Companies'
businesses utilize what is being provided by such Top supplier. No Acquired
Company has received any notice, nor does the Company have Knowledge, that any
Top Supplier intends to cancel or otherwise materially and adversely modify
its relationship with any Acquired Company (whether related to payment, price
or otherwise) on account of the transactions contemplated by this Agreement or
otherwise. No Acquired Company is currently engaged in any material dispute
with any Top Supplier.

2.24 Books and Records. Each Acquired Company has made and kept business
records, financial books and records, personnel records, ledgers, sales
accounting records, Tax records and related work papers and other books and
records (collectively, the "Books and Records") that are true, correct and
complete in all material respects and accurately and fairly reflect, in all
material respects, the business activities of such Acquired Company. No
Acquired Company has engaged in any material transaction, maintained any bank
account or used any corporate funds except as reflected in its Books and
Records. At the Closing, all Books and Records (other than with respect to the
Spin-Off Assets) will be in the possession of the Acquired Companies.

2.25 Brokers. Part 2.25 of the Disclosure Schedule accurately sets forth: (a)
each broker, finder or investment banker that is entitled to any brokerage,
finder's or other similar fee or commission in connection with any of the
transactions contemplated by this Agreement based upon arrangements made by or
on behalf of any Acquired Company; and (b) each Person that is or may become
entitled to receive any fee or other amount from any Acquired Company for
professional services performed or to be performed in connection with any of
the transactions contemplated by this Agreement.

2.26 Full Disclosure. To the Knowledge of the Company, this Agreement
(including the Disclosure Schedule) does not, and the Closing Consideration
Certificate and the Company Closing Certificate will not: (a) contain any
representation, warranty or information that is false or misleading with
respect to any material fact; or (b) omit to state any material fact necessary
in order to make the representations, warranties and information contained and
to be contained herein and therein (in the light of the circumstances under
which such representations, warranties and information were or will be made or
provided) not false or misleading.



3. Representations and Warranties of Each Seller

Except as set forth in the Disclosure Schedule prepared and delivered by the
Sellers to Purchaser prior to the execution of this Agreement in accordance
with Section 12.22, each Seller, solely as to such Seller (and not jointly,
and with respect to representations and warranties regarding BWA Feeder, only
Blocker Seller), hereby represents and warrants to Purchaser, as of the date
of this Agreement and as of the Closing (in each case, except to the extent a
representation or warranty expressly states that such representation or
warranty is as of an earlier date, which representation or warranty is made as
of such earlier date) as follows:

3.1 Organization, Good Standing and Qualification. If such Seller is an
Entity, such Seller is duly organized, validly existing and in good standing
under the Legal Requirements of its jurisdiction of organization and has all
requisite power and authority to own and lease its properties and to carry on
its business as now being conducted.

3.2 Ownership of Units.

(a) Such Non-Blocker Seller is the record and beneficial owner of the number
and class of Units set forth as being owned by such Non-Blocker Seller in Part
2.3(a) of the Disclosure Schedule and in Schedule 1.2 opposite such Non-
Blocker Seller's name, and such Non-Blocker Seller has good, valid and
marketable title to such Units free and clear of all Encumbrances. All of the
Units owned by such Non-Blocker Seller have been duly and validly issued to
such Non-Blocker Seller. Such Non-Blocker Seller is not a party to any option,
warrant, purchase right or other Contract that could require such Non-Blocker
Seller to sell, transfer or otherwise dispose of any Units (other than
pursuant to this Agreement). Such Non-Blocker Seller is not a party to any
voting trust, proxy or other agreement or understanding with respect to the
voting of any such Units. Except for the number and class of Units set forth
in Schedule 1.2 as being owned by such Non-Blocker Seller, such Non-Blocker
Seller does not own any securities of the Company or any right to acquire any
securities of the Company. Upon payment of the portion of the Estimated
Closing Purchase Price payable to such Non-Blocker Seller pursuant to Section
1.2 and Schedule 1.2, such Non-Blocker Seller shall transfer to Purchaser
good, valid and marketable title to the number and class of Units held by such
Non-Blocker Seller, free and clear of all Encumbrances. In case of an
individual Non-Blocker Seller, no spousal community property rights (or
analogous rights) apply to the Units held by such Non-Blocker Seller or to the
transactions contemplated herein.

(b) BWA Feeder is the record and beneficial owner of the number and class of
Units set forth as being owned by BWA Feeder in Part 2.3(a) of the Disclosure
Schedule and BWA Feeder has good, valid and marketable title to such Units
free and clear of all Encumbrances. All of the Units owned by BWA Feeder have
been duly and validly issued to BWA Feeder. BWA Feeder is not a party to any
option, warrant, purchase right or other Contract that could require BWA
Feeder to sell, transfer or otherwise dispose of any Units (other than
pursuant to this Agreement). BWA Feeder is not a party to any voting trust,
proxy or other agreement or understanding with respect to the voting of any
such Units. Except for the number and class of Units set forth in Part 2.3(a)
of the Disclosure Schedule as being owed by BWA



Feeder, BWA Feeder does not own any securities of the Company or any right to
acquire any securities of the Company.

(c) Blocker Seller is the record and beneficial owner of the Blocker Units.
Blocker Seller has good, valid and marketable title to the Blocker Units, free
and clear of all Encumbrances. All of the Blocker Units have been duly and
validly issued to Blocker Seller. Blocker Seller is not a party to any option,
warrant, purchase right or other Contract that could require Blocker Seller to
sell, transfer or otherwise dispose of any Blocker Units (other than pursuant
to this Agreement). Blocker Seller is not a party to any voting trust, proxy
or other agreement or understanding with respect to the voting of any Blocker
Units. Except for the Blocker Units, Blocker Seller does not own any
securities of the Blocker or any right to acquire any securities of the
Blocker. Upon payment of the portion of the Estimated Closing Purchase Price
payable to Blocker Seller pursuant to Section 1.2 and Schedule 1.2, Blocker
Seller shall transfer to Purchaser good, valid and marketable title to the
Blocker Units, free and clear of all Encumbrances.

3.3 Capacity and Authority of Sellers. Such Seller has the absolute and
unrestricted right, power, capacity and authority to enter into, perform and
comply with such Seller's obligations under this Agreement and any other
agreement, document or instrument referred to in, or contemplated by, this
Agreement to which such Seller is or, pursuant to this Agreement, will be a
party; and the execution, delivery and performance by such Seller of this
Agreement and each such agreement, document and instrument (including all
right, power, capacity and authority to sell, transfer, convey and surrender
his Units as provided for by this Agreement, subject to restrictions under any
applicable Legal Requirement and the Charter Documents) have been duly
authorized by all necessary action on the part of such Seller.

3.4 Execution, Delivery; Valid and Binding Agreements. This Agreement and each
other agreement, document or instrument referred to in or contemplated by this
Agreement to be executed by such Seller has been duly executed and delivered
by such Seller, and assuming that this Agreement and any other agreement,
document or instrument referred to in or contemplated by this Agreement have
been duly executed and delivered by the other parties hereto and thereto,
constitute, or, when executed by the other parties hereto and thereto, will
constitute, valid and binding agreements of such Seller, enforceable against
such Seller in accordance with their terms, except to the extent that the
enforceability thereof may be limited by applicable bankruptcy, insolvency,
reorganization, moratorium, fraudulent conveyance or other laws from time to
time in effect relating to creditors' rights and remedies generally and
general principles of equity.

3.5 No Legal Proceedings. There is no pending Legal Proceeding and, to the
Knowledge of such Seller, no Person has threatened to commence any Legal
Proceeding: (i) that challenges, or that may have the effect of preventing,
delaying, making illegal or otherwise interfering with, the entry into,
performance of, compliance with and enforcement of any of the obligations of
such Seller under this Agreement; or (ii) that relates to the ownership of any
equity interests or other securities of the Company or any option or other
right to the equity interests or any other securities of the Company, or the
right to receive consideration as a result of this



Agreement. To the Knowledge of such Seller, no event has occurred, and no
claim, dispute or other condition or circumstance exists, that (with or
without notice or lapse of time) will or could reasonably be expected to give
rise to or serve as a basis for the legal commencement of any such Legal
Proceeding.

3.6 Brokers. Part 3.6 of the Disclosure Schedule accurately sets forth: (a)
each broker, finder or investment banker that is entitled to any brokerage,
finder's or other fee or commission in connection with any of the transactions
contemplated by this Agreement based upon arrangements made by or on behalf of
such Seller; and (b) each Person that is or may become entitled to receive any
fee or other amount from such Seller for professional services performed or to
be performed in connection with any of the transactions contemplated by this
Agreement.

3.7 Non-Contravention; No Consents or Approvals. Neither: (a) the execution,
delivery or performance of this Agreement or any of the other agreements,
documents or instruments referred to in this Agreement to which such Seller is
a party; nor (b) any of the transactions contemplated by this Agreement or any
such other agreement, document or instrument, will (with or without notice or
lapse of time):

(A) contravene, conflict with or result in a violation of, or give any
Governmental Body or other Person the right to challenge any of the
transactions contemplated by this Agreement, or to exercise any remedy or
obtain any relief under, any applicable Legal Requirement or any Order, writ,
injunction, judgment or decree to which such Seller is subject;

(B) contravene, conflict with or result in a violation or breach of, or result
in a default under, any provision of any Contract to which such Seller is a
party or by which such Seller is bound; or

(C) if such Seller is an Entity, contravene, conflict with or result in a
violation of: (i) any of the provisions of any of the organizational documents
of such Seller; or (ii) any resolution adopted by the shareholders, members,
directors or managers (or committees thereof), as applicable, of such Seller.

Except for the expiration or early termination of waiting periods under the
HSR Act and the expiration of waiting periods or the receipt of approvals or
consents required under any other competition, merger control, antitrust or
similar Legal Requirements, if applicable, such Seller is not (nor will such
Seller be) required to make any filing with or give any notice to, or to
obtain any Consent from, any Person in connection with: (a) the performance of
this Agreement or any of the other agreements, documents or instruments
referred to in this Agreement; or (b) any of the transactions contemplated by
this Agreement or by any of the other agreements, documents or instruments
referred to in this Agreement.

3.8 Rights to Intellectual Property. Such Seller owns no Intellectual Property
or Intellectual Property Rights used in the Retained Business as presently
conducted or as currently proposed to be conducted. Such Seller has not
transferred or conveyed all or any part



of its, his or her direct or indirect ownership or control of, or direct or
indirect interest in, any Intellectual Property or Intellectual Property
Rights used in the Retained Business as presently conducted or as currently
proposed to be conducted, to any Person (other than to any Acquired Company).

4. Representations and Warranties of Blocker

Except as set forth in the Disclosure Schedule prepared and delivered by
Blocker to Purchaser prior to the execution of this Agreement in accordance
with Section 12.22, Blocker hereby represents and warrants to Purchaser, as of
the date of this Agreement and as of the Closing (in each case, except to the
extent a representation or warranty expressly states that such representation
or warranty is as of an earlier date, which representation or warranty is made
as of such earlier date) as follows:



4.1 Organization, Good Standing and Qualification.

(a) Organization. Each Blocker Entity has been duly organized and is validly
existing and in good standing under the Legal Requirements of such Blocker
Entity's state of formation or incorporation. Each Blocker Entity has full
power and authority: (i) to conduct its business in the manner in which its
business is currently being conducted and currently contemplated by the
Blocker Entity to be conducted; (ii) to own, lease and use all assets and
properties in the manner in which such assets and properties are currently
owned, leased and used and currently contemplated by the Blocker Entity to be
owned, leased and used; and (iii) to perform its obligations under all
Contracts to which it is a party or by which it is bound.

(b) Qualification. Each Blocker Entity is duly qualified, licensed or admitted
to do business and is in good standing (or its equivalent) as a foreign
limited liability company in each jurisdiction in which the nature of its
business make such qualification, license or admission necessary to such
Blocker Entity's business as currently conducted, except where the failure to
be licensed, qualified or admitted would not, individually or in the
aggregate, have or reasonably be expected to have a Material Adverse Effect.
Part 4.1(b) of the Disclosure Schedule accurately sets forth each jurisdiction
where each Blocker Entity is qualified, licensed and admitted to do business.

(c) Managers and Officers. Part 4.1(c) of the Disclosure Schedule accurately
sets forth: (i) the names of the members of the board of managers or board of
directors, as applicable, of each Blocker Entity; (ii) the names of the
members of each committee of the board of managers or board of directors, as
applicable, of each Blocker Entity; and (iii) the names and titles of the
officers of each Blocker Entity.

(d) Subsidiaries. Each of the BWA Entities is directly or indirectly wholly
owned by Blocker. Other than the BWA Entities, Blocker does not have any
Subsidiaries. Other than the BWA Entities, the Spin-Off Entities and the
Acquired Companies, none of the Blocker Entities has ever owned, directly or
indirectly or beneficially or otherwise, any shares, equity interests or other
securities of, or any direct or indirect equity interest in, or otherwise
controlled, any Entity. None of the Blocker Entities has ever agreed or is
obligated to make any future



investment in or capital contribution to any Entity. No Blocker Entity has
guaranteed or is responsible or liable for any obligation of any other Entity.

(e) Business Name. No Blocker Entity has conducted any business under or
otherwise used, for any purpose or in any jurisdiction, any fictitious name,
assumed name, business name or other name, other than its corporate name as
set forth in this Agreement.

(f) Predecessors. There are no Entities that have been merged into or that
otherwise are predecessors to any Blocker Entity.

(g) Powers of Attorney. There are no outstanding powers of attorney executed
by or on behalf of any Blocker Entity.

4.2 Charter Documents; Records. Blocker has Made Available to Purchaser
accurate and complete copies of: (a) the Charter Documents of each Blocker
Entity; (b) the minutes and other records of the meetings and other
proceedings (including any actions taken by written consent or otherwise
without a meeting) of the members, the board of managers (or other similar
body) and all committees of the board of managers (or other similar body) of
each Blocker Entity, which minutes or other records contain a complete and
accurate summary of all such meetings, and all actions taken at such meetings
or by written consent; and (c) the statutory registers and records of each
Blocker Entity. All actions taken and all transactions entered into by each
Blocker Entity have been duly approved by all necessary action of the board of
managers (or other similar body or committee thereof) and members or
shareholders of such Blocker Entity (as the case may be). There has been no
violation of any of the provisions of the Charter Documents of any Blocker
Entity and no Blocker Entity has taken any action that is inconsistent in any
material respect with any resolution adopted by such Blocker Entity's members
or shareholders or board of managers (or similar body or committee thereof).
The books of account, membership records, minute books and other records of
each Blocker Entity are accurate, up-to-date and complete in all material
respects, and have been maintained in accordance with all applicable Legal
Requirements.

4.3 Capitalization.

(a) Outstanding Securities. The authorized limited liability company interests
of Blocker consist solely of the Blocker Units, all of which are issued and
outstanding and are owned of record and beneficially by Blocker Seller. All of
the Blocker Units have been duly authorized and validly issued and none of the
Blocker Units is subject to any repurchase option, forfeiture provision or
restriction on transfer (other than restrictions on transfer imposed by virtue
of applicable federal and state securities laws or by the Charter Documents).
None of the Blocker Units are represented by any certificate and the ownership
or interest therein and title thereto are solely documented in the form of
entries made by Blocker in the books and records of Blocker that have been
Made Available to Purchaser.

(b) No Other Securities. No Blocker Entity has ever adopted, sponsored or
maintained or promised to adopt, sponsor or maintain any profits interests
plan or any other plan or agreement providing for equity-related compensation
to any person (whether payable in



limited liability company interests, cash or otherwise). There are no and
there have never been and no Blocker Entity has ever promised any options,
warrants, calls, rights, convertible securities, commitments or agreements of
any character, written or oral, to which any Blocker Entity is a party or by
which any Blocker Entity is bound, obligating any Blocker Entity to issue,
deliver, sell, repurchase or redeem, or cause to be issued, delivered, sold,
repurchased or redeemed, any Blocker Units, any interests in any Blocker Units
or other securities of any Blocker Entity or obligating any Blocker Entity to
grant, extend, accelerate the vesting of, change the price of, otherwise amend
or enter into any such options, warrants, calls, rights, convertible
securities, commitments or agreements. There are no outstanding, authorized or
promised unit appreciation, phantom unit, profit participation or other
similar rights with respect to which any Blocker Entity is obligated. There is
no condition or circumstance that may give rise to or provide a basis for the
assertion of a claim by any Person to the effect that such Person is entitled
to acquire or receive any Blocker Units or interests in any Blocker Units or
other securities of any Blocker Entity. There are no voting trusts, proxies or
other agreements or understandings with respect to the voting rights attached
to the Blocker Units, and other than the Charter Documents of Blocker, there
are no agreements to which any Blocker Entity is a party relating to the
registration, sale or transfer (including agreements relating to rights of
first refusal, co-sale rights or "drag-along" rights) of any Blocker Units. As
a result of the transactions contemplated by this Agreement, as of the
Closing, Purchaser will be the sole record and beneficial holder of all issued
and outstanding Blocker Units and all rights to acquire or receive any Blocker
Units, whether or not such Blocker Units are outstanding.

(c) Debt. Part 4.3(c) of the Disclosure Schedule sets forth an accurate and
complete list (including (i) the name of the lender, (ii) the principal amount
thereof and (iii) the interest rate and any accrued interest owed by any
Blocker Entity thereon) of all bonds, debentures, notes or other Indebtedness
of any Blocker Entity issued or outstanding as of the date of this Agreement:
(A) having the right to vote on any matters on which members or shareholders
of any Blocker Entity may vote (or which is convertible into, or exchangeable
for, securities having such right) or (B) the value of which is in any way
based upon or derived from capital or voting units of any Blocker Entity.

(d) Legal Issuance. All outstanding Blocker Units and all other securities
that have ever been issued or granted by any Blocker Entity have been issued
and granted in compliance with: (i) all applicable securities laws and other
applicable Legal Requirements; and (ii) all requirements set forth in all
applicable Contracts. None of the outstanding Blocker Units were issued in
violation of any preemptive rights or other rights to subscribe for or
purchase securities of any Blocker Entity. Part 4.3(d) of the Disclosure
Schedule accurately identifies each Blocker Contract relating to any Blocker
Units or other securities of any Blocker Entity that contains any voting
rights, information rights, rights of first refusal, registration rights,
financial statement requirements or other terms that would survive the
Closing.

(e) Repurchased Units. No Blocker Entity has ever repurchased or redeemed any
of its securities.



(f) Manager and Officer Indemnification. No event has occurred, and no
circumstance or condition exists, that has resulted in, or that will or would
reasonably be expected to result in, any claim for indemnification,
reimbursement, contribution or the advancement of expenses by any current or
former officer, manager or director pursuant to: (i) the terms of the Charter
Documents of the Blocker Entities; (ii) any indemnification agreement or other
Contract between any Blocker Entity and any such current or former officer,
manager or director; or (iii) any applicable Legal Requirement.

(g) Dividends and Distributions. No Blocker Entity has ever declared or paid
any dividends on or made any distributions to any Blocker Units.

(h) Claims by Securityholders. No event has occurred, and no circumstance or
condition exists, that has resulted in, or that will or would reasonably be
expected to result in, any Liability of any Blocker Entity to any current,
former or alleged securityholder of any Blocker Entity in such Person's
capacity (or alleged capacity) as a securityholder of such Blocker Entity.

4.4 No Liabilities; Indebtedness.

(a) Absence of Liabilities. No Blocker Entity has any Liabilities of any
nature, whether accrued, absolute, contingent, matured, unmatured or otherwise
(whether or not required to be reflected in financial statements prepared in
accordance with GAAP, and whether due or to become due), other than the
Liabilities identified in Part 4.4(a) of the Disclosure Schedule.

(b) Indebtedness. Part 4.4(b) of the Disclosure Schedule sets forth a complete
and correct list of each item of Indebtedness of each Blocker Entity as of the
date of this Agreement, identifying the creditor to which such Indebtedness is
owed, the address of such creditor, the title of the instrument (including all
amendments and supplements thereto) under which such Indebtedness is owed, the
outstanding balance, the maturity date and the collateral, if any, securing
such Indebtedness. No Indebtedness contains any restriction upon (i) the
prepayment of any of such Indebtedness, (ii) the incurrence of any other
Indebtedness by any Blocker Entity or (iii) the ability of any Blocker Entity
to grant any Encumbrance on any of its assets. With respect to each item of
Indebtedness, no Blocker Entity is in default and no payments are past due. No
Blocker Entity has received any notice of a default, alleged failure to
perform or any offset or counterclaim (in each case, that has not been waived
or remains pending as of the date of this Agreement) with respect to any item
of Indebtedness. Neither the consummation of any of the transactions
contemplated by this Agreement nor the execution, delivery or performance of
this Agreement or any of the other agreements, documents or instruments
referred to in this Agreement will result in a default or breach of the terms
of, or accelerate the maturity of or performance under, any conditions,
covenants or other terms of any such Indebtedness. No Blocker Entity has
guaranteed or is responsible for any Indebtedness of any other Person, and no
Blocker Entity has guaranteed any other obligation of any other Person.



(c) No "Off-Balance Sheet" Arrangements. No Blocker Entity has ever effected
or has ever otherwise been involved in any "off-balance sheet arrangements"
(as defined in Item 303(a)(4)(ii) of Regulation S-K under the Securities
Exchange Act of 1934, as amended).

4.5 Assets. Part 4.5 of the Disclosure Schedule sets forth all of the assets
and properties (tangible or intangible) owned, leased or licensed by each
Blocker Entity and a description of whether such assets and properties are
owned, lease or licensed by such Blocker Entity and if lease or licensed the
applicable Blocker Contracts governing such arrangement, which assets and
properties collectively constitute all of the properties, rights, interests
and other tangible and intangible assets used in or necessary to enable each
of the Blocker Entities to conduct its business in the manner in which such
business is currently being conducted and in the manner in which such business
is currently proposed to be conducted immediately after the Closing. Each
Blocker Entity owns, and has good and valid title to, all assets purported to
be owned by it, including all assets reflected in the books and records of
such Blocker Entity as being owned by such Blocker Entity. All of said assets
are owned by each Blocker Entity free and clear of any Encumbrances. Each
Blocker Entity has valid leasehold interests in all assets purported to be
leased by it, free and clear of any Encumbrances.

4.6 Contracts.

(a) List of Contracts. Part 4.6(a) of the Disclosure Schedule accurately sets
forth, as of the date of this Agreement, each Blocker Contract.

(b) Delivery of Contracts. Blocker has Made Available to Purchaser accurate
and complete copies of all written Blocker Contracts, including all amendments
thereto. Part 4.6(b) of the Disclosure Schedule provides an accurate and
complete description of the material terms of each Blocker Contract that is
not in written form. Each Blocker Contract is valid and in full force and
effect, and is enforceable by the applicable Blocker Entity in accordance with
its terms, subject to: (i) laws of general application relating to bankruptcy,
insolvency and the relief of debtors; and (ii) rules of law governing specific
performance, injunctive relief and other equitable remedies. No Person has
threatened to terminate or refuse to perform its obligations under any Blocker
Contract (regardless of whether such Person has the right to do so under such
Contract).

(c) No Breach. No Blocker Entity has, in any material respect, violated or
breached or committed any default under any Blocker Contract which remains
uncured and no other Person has, in any material respect, violated or breached
or committed any default under any Blocker Contract which remains uncured. No
event has occurred, and no circumstance or condition exists, that (with or
without notice or lapse of time) will or would reasonably be expected to: (i)
result in a material violation or breach of any of the provisions of any
Blocker Contract; (ii) give any Person the right to declare a default or
exercise any remedy under any Blocker Contract; (iii) give any Person the
right to accelerate the maturity or performance of any Blocker Contract; or
(iv) give any Person the right to cancel, terminate or modify any Blocker
Contract. No Blocker Entity has received any notice or other communication
regarding any actual or possible violation or breach of, or default under, any
Blocker Contract. No Blocker Entity has waived any of its respective material
rights under any Blocker Contract.



(d) No Renegotiation. No Person is actively renegotiating, or has a
contractual right pursuant to the terms of any Blocker Contract to
unilaterally renegotiate, any amount paid or payable to any Blocker Entity
under any Blocker Contract or any other material term or provision of any
Blocker Contract.

4.7 Compliance with Legal Requirements. Each Blocker Entity is, and has at all
times been, in compliance in all material respects with each Legal Requirement
that is applicable to it or to the conduct of its business or the ownership of
its assets. No event has occurred, and to the Knowledge of Blocker, no
condition or circumstance exists, that will or would reasonably be expected to
(with or without notice or lapse of time) constitute or result in a violation
by any Blocker Entity of, or a failure on the part of any Blocker Entity to
comply with, any applicable Legal Requirement in any material respect. No
Blocker Entity has received any notice or other communication from any Person
(i) regarding any actual or possible violation of, or failure to comply with,
any applicable Legal Requirement, (ii) requiring or threatening to require
that any Blocker Entity enter into an Order with a Governmental Body relating
to the operations of any Blocker Entity or (iii) advising any Blocker Entity
that a Governmental Body is contemplating issuing or requesting such Order.

4.8 Legal Proceedings; Orders.

(a) Legal Proceedings. There is no pending Legal Proceeding and, to the
Knowledge of Blocker, no Person has threatened to commence any Legal
Proceeding: (i) that involves any Blocker Entity, any of its managers,
directors, officers or employees (in their capacities as a manager, director,
officer or employee of a Blocker Entity, respectively), the business of the
Blocker Entities or any of the assets owned by any Blocker Entity; (ii) that
challenges, or that could reasonably be expected to prevent, make illegal or
otherwise materially and adversely interfere with, any of the transactions
contemplated by this Agreement; or (iii) that relates to the ownership of any
equity interests or other securities of any Blocker Entity or any option or
other right to the equity interests or any other securities of any Blocker
Entity, or the right to receive consideration as a result of this Agreement.
To the Knowledge of Blocker, no event has occurred, and no claim, dispute or
other condition or circumstance exists, that (with or without notice or lapse
of time) will or could reasonably be expected to give rise to or serve as a
basis for the commencement of any such Legal Proceeding. No Legal Proceeding
has ever been commenced by, and no Legal Proceeding has ever been pending
against, any Blocker Entity.

(b) Orders. There is no, and there has not been any, Order to which any
Blocker Entity, or any of the assets owned or used by any Blocker Entity, is
or was subject. To the Knowledge of Blocker, no Representative of any Blocker
Entity is, or has been, subject to any Order that prohibits such
Representative from engaging in or continuing any conduct, activity or
practice relating to any Blocker Entity's business.

4.9 Governmental Authorizations. Part 4.9 of the Disclosure Schedule
identifies each Governmental Authorization held by each Blocker Entity, and
Blocker has Made Available to Purchaser accurate and complete copies of all
Governmental Authorizations identified in Part 4.9 of the Disclosure Schedule.
The Governmental Authorizations identified in Part 4.9 of the Disclosure
Schedule are valid and in full force and effect, and the Governmental



Authorizations identified in Part 4.9 of the Disclosure Schedule collectively
constitute all Governmental Authorizations necessary to enable the Blocker
Entities to conduct their business in the manner in which such business is
currently being conducted and currently planned by the Blocker Entities to be
conducted in accordance with all applicable Legal Requirements. Each Blocker
Entity is, and has at all times been, in compliance, in all material respects,
with the terms and requirements of the respective Governmental Authorizations
identified in Part 4.9 of the Disclosure Schedule. No event has occurred that,
with notice or lapse of time or both, would reasonably be expected to
constitute a material default or violation of any term, condition or provision
of any such Governmental Authorization. No Blocker Entity has ever received
any written notice or other written communication or, to the Knowledge of
Blocker, any oral notice or other oral communication from any Governmental
Body regarding (x) any actual or possible violation of or failure to comply
with any term or requirement of any Governmental Authorization, (y) any actual
or possible revocation, withdrawal, suspension, cancellation, termination or
modification of any Governmental Authorization or (z) any failure to obtain or
receive any Governmental Authorization. Each Blocker Entity has filed all
applications that are required to have been filed for the obtaining, renewal
or upkeep of any Governmental Authorization on a timely basis, or with
appropriate extensions, each with the appropriate Governmental Body and all
fees or other amounts required to be paid in connection therewith have been
paid to the appropriate Governmental Body. Each Blocker Entity has filed with
the appropriate Governmental Bodies, all material reports, statements,
documents, registrations, waivers, filings or submissions required to be filed
by it. Each of such reports, statements, documents, registrations, waivers,
filings and submissions complied with applicable Legal Requirements, and no
deficiencies have been asserted by any Governmental Body with respect to such
reports, statements, documents, registrations, waivers, filings or submissions
that have not been cured.

4.10 Authority; Binding Nature of Agreement; Inapplicability of Anti-takeover
Statutes.

(a) Authority; Binding Nature of Agreement. Blocker has the absolute and
unrestricted right, power and authority to enter into and to perform its
obligations under this Agreement and under each Ancillary Agreement to which
Blocker is or will be a party; and the execution, delivery and performance by
Blocker of this Agreement and of each such Ancillary Agreement have been duly
authorized by all necessary action on the part of Blocker and its board of
managers, and no further action is required on the part of Blocker to
authorize this Agreement and each Ancillary Agreement to which Blocker is or
will be a party or to consummate the transactions contemplated hereby and
thereby. This Agreement and each Ancillary Agreement to which Blocker is a
party has been duly executed and delivered and constitutes the legal, valid
and binding obligation of Blocker, enforceable against Blocker in accordance
with its terms, subject to: (i) laws of general application relating to
bankruptcy, insolvency and the relief of debtors; and (ii) rules of law
governing specific performance, injunctive relief and other equitable
remedies.



(b) No Takeover Statute. No state or foreign takeover statute or similar Legal
Requirement applies or purports to apply to this Agreement or any of the
transactions contemplated hereby.

4.11 Non-Contravention; Consents. Neither: (1) the execution, delivery or
performance of this Agreement or any of the other agreements, documents or
instruments referred to in this Agreement (including the Spin-Off Agreements);
nor (2) the consummation of any of the transactions contemplated by this
Agreement or any other agreement, document or instrument referred to in this
Agreement (including the Spin-Off Agreements), will (with or without notice or
lapse of time):

(a) contravene, conflict with or result in a violation of: (i) any of the
provisions of the Charter Documents of any Blocker Entity; or (ii) any
resolution adopted by the members or shareholders, board of managers or
directors or any committee of the board of managers or directors of any
Blocker Entity;

(b) contravene, conflict with or result in a violation of, or give any
Governmental Body or other Person the right to challenge any of the
transactions contemplated by this Agreement or to exercise any remedy or
obtain any relief under, any Legal Requirement or Order to which any Blocker
Entity or any of the assets owned or used by any Blocker Entity, is subject;

(c) contravene, conflict with or result in a violation of any of the terms or
requirements of, or give any Governmental Body the right to revoke, withdraw,
suspend, cancel, terminate or modify, any Governmental Authorization that is
held by any Blocker Entity or that otherwise relates to any Blocker Entity's
business or to any of the assets owned or used by any Blocker Entity;

(d) contravene, conflict with or result in a violation or breach of, or result
in a default under, any provision of any Blocker Contract, or give any Person
the right to: (i) declare a default or exercise any remedy under any Blocker
Contract; (ii) accelerate the maturity or performance of any Blocker Contract;
or (iii) cancel, terminate or modify any Blocker Contract; or

(e) result in the imposition or creation of any Encumbrance upon or with
respect to any asset owned or used by any Blocker Entity.

Except for the expiration or early termination of waiting periods under the
HSR Act and the expiration of waiting periods or the receipt of approvals or
consents required under any other competition, merger control, antitrust or
similar Legal Requirements, if applicable, no Blocker Entity is or will be
required to make any filing with or give any notice to, or to obtain any
Consent from, any Person in connection with: (x) the execution, delivery or
performance of this Agreement or any of the other agreements, documents or
instruments referred to in this Agreement; or (y) the consummation of any of
the transactions contemplated by this Agreement.



4.12 Books and Records. Each Blocker Entity has made and kept Books and
Records that are true, correct and complete in all material respects and
accurately and fairly reflect, in all material respects, the business
activities of such Blocker Entity. No Blocker Entity has engaged in any
transaction, maintained any bank account or used any corporate funds except as
reflected in its Books and Records. At the Closing, all Books and Records of
the Blocker Entities will be in the possession of the Blocker Entities.

4.13 Brokers. Part 4.13 of the Disclosure Schedule accurately sets forth: (i)
each broker, finder or investment banker that is entitled to any brokerage,
finder's or other similar fee or commission in connection with any of the
transactions contemplated by this Agreement based upon arrangements made by or
on behalf of any Blocker Entity; and (ii) each Person that is or may become
entitled to receive any fee or other amount from any Blocker Entity for
professional services performed or to be performed in connection with any of
the transactions contemplated by this Agreement.

4.14 No Prior Activities or Operations. Each Blocker Entity was formed or
incorporated, as applicable, under the Delaware Legal Requirements on August
17, 2011 as an investment vehicle for the sole purpose of facilitating Blocker
Seller's investment in and acquisition of the Class B Units. No Blocker Entity
has ever been, was or is engaged in any business activities or has ever
conducted or currently conducts any operations other than those solely arising
from or relating to its indirect ownership of the Class B Units. No Blocker
Entity has, or has ever had, any employee, worker, contract laborer/worker,
independent contractor, consultant or intern. No bank account is or was every
maintained by or for the benefit of any Blocker Entity at any bank or other
financial institution and no Blocker Entity has any outstanding credit
facility, overdraft, loan, loan units, debenture, letter of credit, acceptance
credit or other financial facility. The consummation of the transactions
contemplated by this Agreement (including the Spin-Off) will not have a
material adverse effect on any Blocker Entity.

4.15 Tax Matters. All Tax Returns required to be filed by or on behalf of any
Blocker Entity with any Governmental Body have been timely (taking into
account applicable extensions) and properly filed, were prepared in compliance
with all applicable Legal Requirements and are true, accurate and complete in
all respects and disclose all Taxes required to be paid by or on behalf of the
applicable Blocker Entity for the periods covered thereby. All Taxes of the
Blocker Entities that are due and payable (whether or not shown on any Tax
Return) have been timely and properly paid or properly accrued in accordance
with GAAP. All amounts required to be withheld (or paid on account of withheld
Taxes) by any Blocker Entity have been properly and timely withheld and
remitted or otherwise paid. No extension of time within which to file any Tax
Return of a Blocker Entity is currently in effect, other than extensions with
respect to filing the federal income and Texas franchise Tax Returns of BWA
Feeder, BWA Common Corp. and BWA Preferred Corp. for their taxable years ended
December 31, 2019, with respect to the federal income Tax Return, and for the
2020 privilege period with respect to the Texas franchise Tax Returns. Blocker
has Made Available to Purchaser accurate and complete copies of all Tax
Returns filed by the Blocker Entities for the tax years ending on December 31,
2017 and December 31, 2018, including examination reports and all statements
of deficiencies



assessed against or agreed to by any Blocker Entity, filed or received since
their inception. There are no jurisdictions in which any Blocker Entity is
required to file a Tax Return other than the jurisdictions in which such
Blocker Entity presently files Tax Returns. No claim has been made or asserted
in writing in the past three years by an authority in a jurisdiction where any
Blocker Entity does not file Tax Returns that such Blocker Entity is, or may
be, required to file a Tax Return in, or subject to Taxation by that
jurisdiction. No Blocker Entity has incurred any liability for Taxes outside
the Ordinary Course of Business (other than Taxes incurred solely with respect
to the activities of the Acquired Companies outside the Ordinary Course of
Business prior to the Balance Sheet Date that have been paid in full). No Tax
Return of any Blocker Entity has ever been audited by any Governmental Body.
No Blocker Entity has received from any Governmental Body any written or, to
the Knowledge of Blocker, oral: (i) notice indicating an intent to open an
audit or other review of a Tax matter; (ii) request for information related to
material Tax matters; or (iii) notice of deficiency or proposed Tax
adjustment. No claim or Legal Proceeding is pending or threatened in writing
by any Governmental Body against any Blocker Entity in respect of any Tax.
There are no Encumbrances for Taxes upon any of the assets of any Blocker
Entity except for Permitted Encumbrances. No Blocker Entity will be required
to include any item of income in, or exclude any item of deduction from,
taxable income for any taxable period (or portion thereof) ending after the
date of this Agreement as a result of any change in method of accounting,
closing agreement, intercompany transaction, installment sale, open
transaction, election under Section 108(i) of the Code or prepaid amount
received for a taxable period ending on or prior to the date of this
Agreement. Blocker is, and has always been since the time of its formation,
classified as an entity disregarded from Blocker Seller, and BWA Feeder is,
and has always been since the time of its formation, classified as a
partnership, for all federal, state and local income Tax purposes, except in
each case where such treatment is inconsistent with relevant state or local
Tax law. Each of BWA Common Corp. and BWA Preferred Corp. and any predecessor
of either has always been since the time of its formation a corporation for
federal income Tax purposes. Notwithstanding the foregoing, no Blocker Entity
makes any representations or warranties in respect of the existence, amount or
usability of the Tax attributes of the respective Blocker Entity for Tax
periods (or portions thereof) beginning on or after the Closing Date,
including, without limitation, net operating losses, capital loss carry
forwards, foreign tax credit carry forwards, asset bases, research and
development credits and depreciation periods.

5. Representations and Warranties of Purchaser

Purchaser represents and warrants to the Sellers as follows:

5.1 Due Organization. Purchaser has been duly organized, and is validly
existing under the Legal Requirements of the State of Delaware.

5.2 Non-Contravention; Consents. Neither (a) the execution, delivery or
performance of this Agreement or any of the other agreements, documents or
instruments referred to in this Agreement to which Purchaser is a party, nor
(b) the consummation of the transactions contemplated by this Agreement or
such other agreements, documents or instruments referred to in this Agreement
to which Purchaser is a party, will (with or without



notice or lapse of time) contravene, conflict with or result in a violation
of: (i) any of the provisions of the organizational documents of Purchaser;
(ii) any resolution adopted by the stockholders, the board of directors or any
committee of the board of directors of Purchaser; or (iii) any provision of
any material contract by which Purchaser is bound. Except as provided in this
Agreement and except for the expiration or early termination of waiting
periods under the HSR Act and the expiration of waiting periods or the receipt
of approvals or consents required under any other competition, merger control,
antitrust or similar Legal Requirements, if applicable, Purchaser will not be
required to make any filing with or give any notice to, or to obtain any
Consent from, any Person in connection with: (a) the execution, delivery or
performance of this Agreement or any of the other agreements, documents or
instruments referred to in this Agreement; or (b) the consummation of the
transactions contemplated by this Agreement.

5.3 Authority; Binding Nature of Agreement. Purchaser has the absolute and
unrestricted right, power and authority to enter into and perform its
obligations under this Agreement; and under each other agreement, document and
instrument referred to in this Agreement to which Purchaser is a party; and
the execution, delivery and performance by Purchaser of this Agreement and
each such other agreement, document and instrument have been duly authorized
by all necessary action on the part of Purchaser. No vote of Purchaser's
stockholders is needed to approve this Agreement or any of the other
agreements, documents and instruments referred to in this Agreement. This
Agreement constitutes the legal, valid and binding obligation of Purchaser,
enforceable against Purchaser in accordance with its terms, subject to: (a)
laws of general application relating to bankruptcy, insolvency and the relief
of debtors; and (b) rules of law governing specific performance, injunctive
relief and other equitable remedies.

5.4 Availability of Funds. Purchaser has, or will have at the Closing,
sufficient cash available to enable it to pay the full Purchase Price and to
make the other payments payable at the Closing hereunder, and to make all
other necessary payments by it in connection with the transactions
contemplated hereby.

6. Certain Covenants of the Company and Blocker 

6.1 Access and Investigation. During the period from the date of this
Agreement and continuing until and through the earlier of the termination of
this Agreement pursuant to Section 10 or the Closing Date (the "Pre-Closing
Period"), the Company and Blocker shall and shall cause their respective
Representatives to: (a) provide Purchaser and Purchaser's Representatives with
reasonable access during normal business hours to the Acquired Companies' and
Blocker Entities' Representatives, personnel and assets and to all existing
books, records, Tax Returns, work papers and other documents and information
relating to the Acquired Companies and Blocker Entities; and (b) provide
Purchaser and Purchaser's Representatives with copies of such existing books,
records, Tax Returns, work papers and other documents and information relating
to the Acquired Companies, the Blocker Entities or their respective
businesses, and with such additional financial, operating and other data and
information regarding the Acquired Companies, the Blocker Entities, or their
respective



businesses, as Purchaser may reasonably request. During the Pre-Closing
Period, Purchaser may, with the prior written approval of the Company or
Blocker, which approval shall not be unreasonably withheld, conditioned or
delayed, make inquiries of Persons having material business relationships with
the Acquired Companies (including suppliers, licensors, distributors and
customers) or Blocker Entities, and the Company and Blocker, as applicable,
shall help facilitate such inquiries to the extent such inquiries comply with
all applicable Legal Requirements (including any applicable antitrust or
competition laws or regulations).

6.2 Operation of the Business of the Acquired Companies.

(a) During the Pre-Closing Period, except (i) to the extent that Purchaser
shall otherwise consent in writing (such consent not to be unreasonably
withheld, conditioned or delayed), (ii) as expressly contemplated or permitted
herein (including with respect to the Spin-Off) or (iii) as set forth in Part
6.2(a) of the Disclosure Schedule, the Company shall, and shall cause each
Acquired Company to, conduct the business of each Acquired Company in the
Ordinary Course of Business in all material respects, pay all Taxes of each
Acquired Company when due and payable (including the timely withholding,
collecting, remitting and payment of all Taxes required under Legal
Requirements) (subject to Section 6.2(b)(xiii)), and use commercially
reasonable efforts to (1) pay or perform all other obligations of each
Acquired Company when due and payable and (2) to the extent consistent with
such business, preserve intact the present business organization of each
Acquired Company, keep available the services of the current Company Service
Providers of each Acquired Company, preserve the assets (including intangible
assets) and properties of each Acquired Company and preserve the relationships
of each Acquired Company with customers and suppliers, distributors,
licensors, licensees and others having business dealings with each Acquired
Company, all with the goal of preserving unimpaired the goodwill and ongoing
business of each Acquired Company at the Closing.

(b) During the Pre-Closing Period, except as (i) expressly contemplated or
permitted by this Agreement (including with respect to the Spin-Off), (ii)
expressly set forth in Schedule 6.2(b) or (iii) expressly set forth in Part
6.2(b) of the Disclosure Schedule, the Company shall not, and shall cause each
Acquired Company not to, without the prior written consent of Purchaser (which
consent shall not be unreasonably withheld, conditioned or delayed):

(i) cancel, amend (other than in connection with the addition of customers and
suppliers to such insurance policies from time to time in the Ordinary Course
of Business consistent with past practices) or fail to renew (on substantially
similar terms) any of its insurance policies identified in Part 2.17 of the
Disclosure Schedule or reduce the amount of any insurance coverage provided by
such insurance policies;

(ii) declare, set aside or pay any dividends on or pay or make any other
reimbursements or distributions (whether in cash, equity or property) in
respect of any Units, or split, combine or reclassify any Units or issue or
authorize the issuance of any other securities in respect of, in lieu of or in
substitution for any of the Units, or directly or indirectly repurchase,
redeem or otherwise acquire any Units;



(iii) issue, grant, deliver or sell or authorize or propose the issuance,
grant, delivery or sale of, or purchase or propose the purchase of, any units
of limited liability company interests or other securities (whether payable in
cash, equity or otherwise) or any securities convertible into, exercisable or
exchangeable for, or subscriptions, rights, warrants or options to acquire, or
other Contracts of any character obligating any Acquired Company to issue,
grant, deliver or sell any such units or other securities in any Acquired
Company;

(iv) amend or waive, or permit the acceleration of vesting under any
compensation obligation;

(v) amend, modify or change or permit the adoption of any amendment,
modification or changes to the Charter Documents, or effect or permit any
Acquired Company to become a party to any Disposition Transaction (other than
the transactions contemplated by this Agreement), a plan of complete or
partial liquidation, dissolution, restructuring, recapitalization,
reclassification of units, unit split, reverse unit split or similar
transaction;

(vi) form any Subsidiary or acquire any equity interest or other interest in
any other Entity or division thereof;

(vii) make or agree to make any capital expenditure or commitment on any
plant, property or equipment, except for capital expenditures or commitments
on any plant, property or equipment that, when added to all other capital
expenditures and commitments on any plant, property or equipment made on
behalf of any Acquired Company during the Pre-Closing Period, do not exceed
$50,000;

(viii) (A) enter into, or permit any of the assets owned or used by it to
become bound by, any Contract that would have been a Material Contract had
such Contract been entered into by any Acquired Company prior to the date of
this Agreement; or (B) amend or prematurely terminate, or waive any material
right or remedy under, any Material Contract;

(ix) (A) acquire, lease or license any right or other asset from any other
Person for an aggregate value in excess of $50,000; (B) outside of the
Ordinary Course of Business, sell or otherwise dispose of, or lease or license
(or grant any other right with respect to), any right or other asset to any
other Person, including the sale of any accounts receivable of any Acquired
Company or grant or otherwise create or consent to the creation of any
easement, covenant, restriction, assessment or charge affecting any leased
property or any part thereof; or (C) waive or relinquish any material right;

(x) (A) lend money to any Person (except that each Acquired Company may make
routine travel and business expense advances to current employees of such
Acquired Company in the Ordinary Course of Business); or (B) incur or
guarantee any Indebtedness (other than incurring item (j), (k) or (l) in the
definition of "Indebtedness" in the Ordinary Course of Business), issue or
sell any debt securities, create an Encumbrance (other than Permitted
Encumbrance) over any asset of any Acquired Company or amend the terms of any
outstanding Indebtedness of any Acquired Company;



(xi) (A) enter into any collective bargaining agreement; (B) establish, adopt,
amend, modify, permit the acceleration of vesting under or terminate any
Company Employee Plan or Company Service Provider Agreement; (C) make any
declaration, payment, commitment or obligation of any kind for the payment
(whether in cash, equity or otherwise) of any severance payment, change in
control payment, retention payment, termination payment, bonus, profit-sharing
payment, special remuneration or similar payment to any Company Service
Provider, except payments made pursuant to written agreements existing on the
date of this Agreement and disclosed in Part 6.2(b)(xi) of the Disclosure
Schedule; (D) increase, or make any commitment to increase, the amount of the
wages, salary, commissions, fringe benefits or other employee benefits or
compensation (including equity-based compensation or unit appreciation rights,
whether payable in cash or otherwise) or remuneration payable to any Company
Service Provider; (E) promote or change the title of any Company Service
Provider (retroactively or otherwise); (F) hire or make an offer to hire any
employee with a base salary in excess of $75,000; or (G) terminate (other than
for cause) any Company Service Provider;

(xii) adopt or change any of its methods of accounting or accounting practices
(including any change in depreciation or amortization policies or rates or any
change to practices that would impact the methodology for recognizing revenue)
other than as required by GAAP;

(xiii) make or change any Tax election, adopt or change a material accounting
method in respect of Taxes, prepare or file any Tax Return inconsistent with
past practice, except as required by applicable Legal Requirements, initiate
or enter into a Tax allocation agreement, Tax sharing agreement, Tax indemnity
agreement (other than a Contract entered into in the Ordinary Course of
Business not primarily related to Taxes), voluntary disclosure agreement or
closing agreement, amend a Tax Return of any Acquired Company, settle or
compromise any claim, notice, audit report or assessment in respect of Taxes,
consent to an extension or waiver of the statutory limitation period
applicable to a claim or assessment in respect of Taxes, surrender any right
to claim a Tax refund, offset or other reduction in Taxes, or apply for,
negotiate or receive a Tax ruling or pre-ruling on its own behalf or on behalf
of any of its members;

(xiv) commence or settle any Legal Proceeding or threat of any Legal
Proceeding by or against any Acquired Company or relating to any of any
Acquired Company's business (including the Retained Business), properties or
assets;

(xv) make any pledge of any of its assets or otherwise permit any of its
assets to become subject to any Encumbrance (other than Permitted
Encumbrances), except for pledges of immaterial assets made in the Ordinary
Course of Business;

(xvi) pay, discharge, release, waive or satisfy any claims, rights or
Liabilities, other than the payment, discharge or satisfaction in the Ordinary
Course of Business;

(xvii) accelerate or delay the collection of accounts receivable of any
Acquired Company, or the payment of accounts payable of any Acquired Company,
or otherwise alter the management of working capital or the components of the
Closing Cash Amount, in each case, outside the Ordinary Course of Business;



(xviii) except as required by applicable accounting or auditing standards
consistent with past practices, write off as uncollectible, or establish any
extraordinary reserve with respect to, any account receivable or other
Indebtedness in excess of $10,000 with respect to a single matter, or in
excess of $25,000 in the aggregate;

(xix) enter into any Contract to purchase or sell any interest in real
property or grant any security interest in any real property, enter into any
lease, sublease, license or other occupancy agreement with respect to any real
property or alter, amend, modify, violate or terminate any of the terms of any
Lease Agreements;

(xx) (A) sell, license exclusively or on a preferential basis (including, for
instance, in the form of a right of first refusal or first offer, or a right
to receive "most favored" terms, whether generally or with respect to any
Person) or assign to any Person or enter into any Contract to sell, license
exclusively or on a preferential basis (including, for instance, in the form
of a right of first refusal or first offer, or a right to receive "most
favored" terms, whether generally or with respect to any Person) or assign to
any Person any rights to any Company IP; (B) buy, license or otherwise acquire
rights in, to or under any material Intellectual Property Right of any third
party (except for licensing "off-the-shelf" third party Computer Software that
is generally available on standard commercial terms, is not distributed by any
Acquired Company, is not incorporated into, or used in the development,
testing, distribution, delivery, maintenance or support of, any Company
Product and is not otherwise material to the business of any Acquired
Company); (C) license or otherwise grant any rights in, to or under any
Company Products or Company IP to third parties other than in non-exclusive
agreements to provide the Company Products to customers entered into in the
Ordinary Course of Business consistent with past practice; (D) enter into any
distributor, reseller, sales representative, marketing or similar agreement,
other than entered into in the Ordinary Course of Business consistent with
past practice; (E) amend, modify or extend any Material Contract for the
license, sale or other distribution of Company Products or Company IP (other
than amendments, extensions or modifications to non-exclusive Material
Contracts to provide the Company Products to customers, which amendments,
extensions or modifications are entered into in the Ordinary Course of
Business consistent with past practice and that do not materially reduce
pricing under such agreements); (F) enter into any Contract with respect to
the development of any Intellectual Property on behalf of any Acquired Company
with a third party; (G) materially reduce pricing or royalties charged by any
Acquired Company to, or the compensation or other amounts payable to, any
Acquired Company's distributors, resellers, sales representatives, customers
or licensees, or materially reduce the pricing or royalties set or charged by
Persons who have licensed Intellectual Property to any Acquired Company; or
(H) amend the license applicable to any Company IP;

(xxi) withdraw any amount from any 340B Account other than for the purpose of
distributing such amount to a 340B covered entity customer of the Acquired
Companies pursuant to the applicable Bank Model Contract; or

(xxii) agree or commit to take any of the actions described in clauses "(i)"
through "(xxi)" above.



The Company may request consent from Purchaser to perform, engage in, or take
any actions pursuant to this Section 6.2 by sending to each of the Persons
listed on Schedule 6.2 (the "Purchaser Authorized Persons") an email
containing information reasonably necessary for the Purchaser Authorized
Persons to determine if a consent should be granted pursuant to this Section
6.2. In the event none of the Purchaser Authorized Persons provides a written
reply via email within five Business Days after their receipt of such written
email request with respect to matters described in Section 6.2(b)(vii) or
Section 6.2(b)(xi)(F) and, to the extent relating to the foregoing, Section
6.2(b)(xxii), the consent shall be considered granted. In the event none of
the Purchaser Authorized Persons provides a written reply via email within
three Business Days after their receipt of such written email request with
respect to matters described in Section 6.2(b)(viii)(A) and, to the extent
relating to the foregoing, Section 6.2(b)(xxii), the consent shall be
considered granted.

(c) During the Pre-Closing Period, the Company shall, and shall cause each
Acquired Company to, update, on a reasonably current basis, the Purchaser
Authorized Persons on any progress with any Governmental Body regarding the
matter described in Part 2.12 of the Disclosure Schedule. The Company shall
not, and shall cause each Acquired Company not to, take or commit to take any
action with respect to the matter described in Part 2.12 of the Disclosure
Schedule without the prior written consent of Purchaser, which consent may not
be unreasonably withheld, conditioned or delayed. Notwithstanding the
foregoing, if advised by outside counsel that notice to impacted customers is
required under applicable Company Contracts or applicable Legal Requirements,
the Company or another Acquired Company may provide such required notices to
customers impacted by the matter described in Part 2.12 of the Disclosure
Schedule; provided that at least two Business Days before providing any such
notices to the impacted customers, the Company shall, and shall cause each
Acquired Company to, send a draft of each such notice to Purchaser for its
review and consider in good faith any comments or feedback from Purchaser
regarding any such notices (including, but not limited to, the content and
structure of such notices and whether such notices are required pursuant to
any applicable Business Associate Agreement and applicable Legal Requirement).

6.3 Operation of the Business of Blocker Entities. During the Pre-Closing
Period, except (a) to the extent that Purchaser shall otherwise consent in
writing (not to be unreasonably withheld, conditioned or delayed), (b) as
expressly contemplated or permitted herein or (c) as set forth in Part 6.3 of
the Disclosure Schedule, (i) Blocker shall, and shall cause each BWA Entity
to, maintain and preserve the business and legal organization, assets and
properties of Blocker Entities as they are as of the date of this Agreement
and not engage in any business or legal activity other than filing tax returns
(subject to clause "(ii") of this sentence), conducting routine organizational
maintenance of each Blocker Entity, satisfying the Blocker Note pursuant to
the terms of this Agreement and distributing capital in accordance with the
organizational documents of each Blocker Entity as contemplated by the terms
of this Agreement or the Spin-Off Agreements; and (ii) Blocker shall not, and
shall cause each Blocker Entity not to, make or change any Tax election, adopt
or change a material accounting method in respect of Taxes, prepare or file
any Tax Return inconsistent with past practice, except as required by
applicable Legal Requirements, initiate or enter into a Tax allocation
agreement, Tax sharing agreement, Tax indemnity agreement, voluntary
disclosure agreement or closing agreement,



amend a Tax Return of any Blocker Entity, settle or compromise any claim,
notice, audit report or assessment in respect of Taxes, consent to an
extension or waiver of the statutory limitation period applicable to a claim
or assessment in respect of Taxes, surrender any right to claim a Tax refund,
offset or other reduction in Taxes, or apply for, negotiate or receive a Tax
ruling or pre-ruling on its own behalf or on behalf of any of its members or
shareholders.

6.4 Notification.

(a) During the Pre-Closing Period, the Company and Blocker shall promptly
notify Purchaser in writing of the Company or Blocker, as applicable,
obtaining Knowledge of any event, condition, fact or circumstance that would
make the timely satisfaction of any of the conditions set forth in Section 8
impossible or unlikely.

(b) During the Pre-Closing Period, each Seller shall promptly notify Purchaser
in writing of such Seller obtaining Knowledge of any event, condition, fact or
circumstance that would make the timely satisfaction of any of the conditions
set forth in Section 8 impossible or unlikely.

(c) No notification under this Section 6.4 shall be required with respect to
matters consented to in writing by Purchaser pursuant to Section 6.2 or the
actual taking of actions contemplated by Part 6.2(a) or Part 6.2(b) of the
Disclosure Schedule.

6.5 No Negotiation. During the Pre-Closing Period, the Sellers, the Company
and Blocker shall not, and shall not authorize or permit their respective
Representatives or Affiliates to: (i) solicit, or knowingly encourage or
knowingly facilitate the initiation or submission of, any expression of
interest, inquiry, proposal or offer from any Person (other than Purchaser)
relating to the purchase of all or any portion of any Blocker Entity's or any
Acquired Company's assets (other than immaterial sales of any Acquired
Company's assets in the Ordinary Course of Business and other than the Spin-
Off pursuant to the terms of this Agreement and the Spin-Off Agreements) or
ownership, economic or other equity interests in any Blocker Entity or any
Acquired Company, the license of any Intellectual Property of any Blocker
Entity or any Acquired Company (other than any license in the Ordinary Course
of Business) or the grant of any rights to distribute Company Products (other
than any grant of such rights in the Ordinary Course of Business) or any
merger, consolidation, business combination, share exchange, recapitalization
or similar transaction involving any Blocker Entity or any Acquired Company (a
"Disposition Transaction"), (ii) participate in any discussions or
negotiations or enter into any agreement with, or provide any nonpublic
information to, any Person (other than Purchaser) relating to or in connection
with a Disposition Transaction or (iii) accept, discuss or negotiate any
proposal or offer from any Person (other than Purchaser) relating to a
Disposition Transaction. In no event shall any Seller, the Company or Blocker
accept or enter into, or authorize or permit their respective Representatives
or Affiliates to accept or enter into, an agreement concerning a Disposition
Transaction (other than with Purchaser) during the Pre-Closing Period. Each
Seller, the Company and Blocker shall, and shall cause their respective
Representatives and Affiliates to, immediately discontinue any ongoing
discussions, agreements or negotiations (other than with Purchaser) relating
to a possible Disposition Transaction. Each Seller, the Company and Blocker
shall promptly (and in any event within 24 hours of receipt



thereof) notify Purchaser orally and in writing of any expression of interest,
inquiry, proposal, offer or request for non-public information with respect to
a proposed Disposition Transaction received by such Seller, the Company,
Blocker or any of their respective Representatives or Affiliates during the
Pre-Closing Period, which notice shall include: (i) the identity of the Person
making or submitting such inquiry, indication of interest, proposal, offer or
request, and the terms and conditions thereof; and (ii) an accurate and
complete copy of all written materials provided in connection with such
inquiry, indication of interest, proposal, offer or request.

6.6 Data Room Information. Within five Business Days after the date of this
Agreement, the Company shall deliver to Purchaser on one or more CD-ROMs an
electronic copy of the documents and information contained in the Smart Room
virtual online data room hosted on behalf of the Company or any other Acquired
Company by BMC Group in the online workspace captioned "Project Phoenix" as of
11:59 p.m., Pacific time on the date of this Agreement.

6.7 Termination/Amendment of Agreements and Release of Encumbrances. The
Company and Blocker, as the case may be, shall use commercially reasonable
efforts to: (a) cause the agreements identified in Schedule 6.7(i) to be
terminated effective as of the Closing (and with respect to the Blocker Note,
in the manner set forth in Paragraph 2 of Schedule 6.7(i)); (b) cause the
agreements identified in Schedule 6.7(ii) to be amended effective as of the
Closing in the manner set forth on Schedule 6.7(ii); and (c) take, or cause to
be taken, all actions reasonably necessary to secure the termination and
release of any and all Encumbrances (other than Permitted Encumbrances) upon
the assets or properties of the Company, 340B OpCo, PHSS or the Retained
Business (other than the Spin-Off Assets), including the Encumbrances set
forth in Schedule 6.7(iii); in each case, in form and substance reasonably
satisfactory to Purchaser and in a manner such that such terminated agreements
shall be of no further force and effect without any remaining Liability of the
Company, 340B OpCo, PHSS or any Blocker Entity and any of their respective
past, present and future Representatives, Affiliates, stockholders, members,
controlling persons, Subsidiaries, successors and assigns.

6.8 Resignation of Officers, Managers and Directors. The Company and Blocker
shall use commercially reasonable efforts to obtain and deliver to Purchaser,
at or prior to the Closing, the resignation of each officer, manager and
director of each of the Company, 340B OpCo, PHSS and the Blocker Entities
effective as of the later of the Closing Date and the date Purchaser desires
such manager, director or officer to be replaced, in form and substance
satisfactory to Purchaser (it being understood that such resignations shall
not constitute a termination of employment of such officer, manager or
director).

6.9 DandO Insurance.

(a) Prior to the Closing Date, the Company shall purchase directors' and
officers' liability insurance coverage (the "Company DandO Policy") for the
Company's, 340B OpCo's and PHSS's managers and officers, which shall provide
such managers and officers with coverage for at least six years following the
Closing Date with an amount of coverage and other terms consistent with
existing coverage in all material respects from the Company's existing
directors' and officers' liability insurance provider.



(b) Effective as of no later than the Closing Date, Blocker Seller shall, or
shall cause one of its Affiliates (other than any Blocker Entity) to, maintain
(or purchase a tail policy to) the directors' and officers' liability
insurance coverage (the "Blocker DandO Policy," and, together with the Company
DandO Policy, the "DandO Policies") for each Blocker Entity's managers or
directors, as applicable, and officers, which shall provide such managers or
directors, as applicable, and officers with coverage for at least six years
following the Closing Date with an amount of coverage and other terms
consistent with existing coverage in all material respects from the Blocker
Entities' existing directors' and officers' liability insurance provider.

6.10 Payoff Letters and Invoices; Draft Closing Consideration Certificate and
Updated Pro Rata Portion Schedule.

(a) At least five Business Days prior to the Closing Date, the Company shall
deliver to Purchaser an accurate and complete copy of: (a) one or more payoff
letters, each dated no more than five Business Days prior to the Closing Date,
with respect to all outstanding Indebtedness described in clauses "(a)(i)" and
"(m)" (to the extent as related to clause "(a)(i)") of the definition of
"Indebtedness" of the Acquired Companies, the Blocker Entities and the Spin-
Off Entities, to (i) satisfy such Indebtedness as of the Closing and (ii)
terminate and release any Encumbrances related thereto; and (b) an invoice
from each advisor or other service provider to the Acquired Companies, the
Blocker Entities and the Spin-Off Entities, dated no more than five Business
Days prior to the Closing Date, with respect to all Transaction Expenses
estimated to be due and payable to such advisor or other service provider, as
the case may be, as of the Closing Date. The Company shall use commercially
reasonable efforts to obtain payoff letters in forms reasonably satisfactory
to Purchaser with respect to all outstanding Indebtedness described in clauses
"(a)(ii)" and "(m)" (to the extent as related to clause "(a)(ii)") of the
definition of "Indebtedness".

(b) At least five Business Days prior to the anticipated Closing Date, the
Company shall prepare and deliver to Purchaser a draft of the Closing
Consideration Certificate and a draft of the Updated Pro Rata Portion Schedule
(which Updated Pro Rata Portion Schedule shall take into account any Special
Distribution made by the Company to BWA Feeder prior to the Company's delivery
of the draft of the Updated Pro Rata Portion Schedule pursuant to this Section
6.10(b) for purpose of satisfying the Blocker Note). Purchaser shall be
entitled to review the draft Closing Consideration Certificate and the draft
of the Updated Pro Rata Portion Schedule with any reasonable applicable
supporting detail and information that Purchaser has requested to verify the
amounts reflected therein, and the Company shall consider in good faith any
comments received from Purchaser on the draft Closing Consideration
Certificate or the draft Updated Pro Rata Portion Schedule. The Closing
Consideration Certificate delivered pursuant to Section 1.4(b)(xii) and the
Updated Pro Rata Portion Schedule delivered pursuant to Section 1.2(a) shall
be based upon the draft Closing Consideration Certificate and the draft
Updated Pro Rata Portion Schedule delivered pursuant to this Section 6.10(b)
after the Company's good faith consideration of the reasonable comments of
Purchaser thereon.



(c) At least five Business Days prior to the anticipated date of the
completion of the Divisional Merger, the Company shall prepare and deliver to
Purchaser a draft of any updated schedules and/or annexes to the Divisional
Merger Agreement that have been updated to account for activities and events
that occurred between the date of this Agreement and the date of the
completion of the Divisional Merger (the "Updated DMA Schedules/Annexes"),
which draft of Updated DMA Schedules/Annexes shall be prepared in accordance
with the allocation principle set forth in Footnote No.1 to the Divisional
Merger Agreement. Purchaser shall be entitled to review the draft Updated DMA
Schedules/Annexes with any reasonable applicable supporting detail and
information that Purchaser has requested to verify the allocation reflected
therein, and the Company shall consider in good faith any comments received
from Purchaser on the draft Updated DMA Schedules/Annexes. The schedules
and/or annexes included in the Divisional Merger Agreement to be executed by
PSG shall be based upon what are included in Exhibit G-2 and the draft Updated
DMA Schedules/Annexes delivered pursuant to this Section 6.10(c) after the
Company's good faith consideration of the reasonable comments of Purchaser
thereon.

(d) Nothing in this Section 6.10 shall limit any rights of any Indemnitee as
set forth in Section 11.

6.11 Employee Matters.

(a) Offer Letters. Prior to the date of this Agreement, Purchaser has
delivered the Signing Date Offer Letters to each of the Required Employees and
each Required Employee has executed such Signing Date Offer Letter and the
applicable exhibits thereto, including customary agreements relating to
confidentiality, invention assignment, non-solicitation and non-competition
obligations. The employment of the Required Employees shall be governed by the
terms and conditions of the Signing Date Offer Letters effective as of the
Closing Date. Within ten Business Days of the date of this Agreement,
Purchaser shall have delivered a Closing Date Offer Letter to each Offered
Employee listed on Exhibit L who is not a Required Employee. At any time
before the Closing, Purchaser may deliver a Closing Date Offer Letter to each
Offered Employee who is not listed on Exhibit L. Each such Offered Employee
who shall have executed a Closing Date Offer Letter is referred to herein as a
"Continuing Employee". Each Closing Date Offer Letter shall, with respect to
the Offered Employee receiving such Closing Date Offer Letter, provide for (i)
a salary or wage level and a target cash bonus opportunity (excluding any
sales compensation arrangements) that are, in the aggregate, at least equal to
such Offered Employee's current salary or wage level and target cash bonus
opportunity (excluding any sales compensation arrangements), (ii) a sales
compensation opportunity that is substantially comparable to Purchaser's
similarly-situated employees, (iii) a title that is substantially comparable
to Purchaser's similarly-situated employees and (iv) other than any benefits
and compensation referenced in (i), (ii) or (iii), benefits pursuant to
qualified and non-qualified retirement and savings plans, welfare plans and
programs, severance and paid time off plans, policies and arrangements and
equity-based plans that are, in the aggregate, substantially comparable to
such benefits provided to Purchaser's similarly-situated employees. Without
limiting the generality of Section 6.1, the Company shall provide Purchaser,
upon Purchaser's



reasonable advance notice to the Company, with reasonable access to each
Required Employee and Offered Employee during normal working hours following
the date of this Agreement.

(b) Certain Employee Benefit Plan Matters. Except to the extent required by
applicable Legal Requirements, effective as of the Closing, the Continuing
Employees and the Required Employees shall cease all active participation in
and accrual of benefits under the Company Employee Plans and Company Service
Provider Agreements, and the Acquired Companies shall cease all participation
under the Company Employee Plans.

(c) Payment of Accrued Employee Amounts. Prior to the Closing, the Company
shall pay out all vacation, sick time and paid time off that has been accrued
but unused as of the Closing Date by any Required Employee or Continuing
Employee, as well as all salaries, wages, bonuses, commissions, incentive
compensation, fees and other unpaid compensation and benefits, including
pursuant to any Company Employee Plan or Company Service Provider Agreement,
of, accrued for, owed to or payable to, any Required Employee or Continuing
Employee as of the Closing Date, including payment of a pro-rated portion of
the fiscal year 2020 bonuses listed on Schedule 6.11(c) that has been accrued
as of the Closing Date (collectively, the "Accrued Employee Amounts"), unless
otherwise required by Legal Requirements.

(d) No Modification; No Third Party Beneficiaries. The provisions of this
Section 6.11 are for the sole benefit of the Parties and nothing herein,
express or implied, is intended or shall be construed to (a) amend or modify
any Company Employee Plan or Purchaser employee benefit plan or other
compensation and benefits plans maintained for or provided to Company Service
Providers or any other Persons prior to or following the Closing or (b) confer
upon or give to any Person (including, for the avoidance of doubt, any Company
Service Providers), other than the Parties, any legal or equitable or other
rights or remedies with respect to the matters provided for in this Section
6.11 under or by reason of any provision of this Agreement. For the avoidance
of doubt, nothing contained in this Section 6.11(d) shall confer upon any
Continuing Employee or Required Employee any right to continued employment
with Purchaser or any Acquired Company, or any of their respective Affiliates
after the Closing Date or (ii) is intended to guarantee employment to any
Continuing Employee or Required Employee for any period of time.

6.12 Integration. To the maximum extent permitted by applicable Legal
Requirements, between the date hereof and the Closing, the Company, the
Sellers and Purchaser shall, and shall cause their respective Affiliates and
Representatives to, reasonably cooperate to achieve, and will discuss in good
faith, a plan for the integration of the Retained Business, including the
Company IT Systems that are not Spin-Off Assets, into the business and
operations of Purchaser following the Closing.

6.13 Bank Accounts. To the extent any individual at the Closing (other than a
Company Service Provider who remains employed by any Acquired Company
immediately following the Closing and actually performs services for the
Acquired Companies on or after the Closing Date, unless otherwise directed by
Purchaser) has authority to draw on or has access to the bank, savings,
deposit or custodial accounts and safe deposit boxes maintained by the



Company, 340B OpCo or PHSS, the Company shall use commercially reasonable
efforts to remove, effective as of the Closing, such individual's authority
unless otherwise directed in writing by Purchaser.

6.14 Spin-Off. (a) On a date that is no more than five Business Days prior to
the Closing Date, the Sellers and the Company shall cause PSG to enter into
and effect the transactions described in the Divisional Merger Agreement,
which transactions shall be the divisional merger of PSG into two surviving
entities, which will be PSG and, as of and after the completion of such
divisional merger, will be referred to as "SpinCo" in this Agreement and 340B
OpCo and (b) on the Closing Date and prior to the Closing, the Sellers shall
cause the Company and Blocker and their respective Affiliates to enter into
and effect the transactions described in the other Spin-Off Agreements, all of
which transactions described in the foregoing clauses "(a)" and "(b)" shall be
completed prior to the Closing. The intended federal income tax treatment of
the transactions comprising the Spin-Off is described in Section 8(d) of the
Reorganization Agreement in the form attached hereto as Exhibit G-1. Following
the completion of the transactions contemplated under the Spin-Off Agreements,
SpinCo will become wholly owned by the Class A Holder.

6.15 Financial Statements.

(a) During the Pre-Closing Period, within 30 days following the end of each
calendar month ending on or after the date of this Agreement, the Company
shall prepare (on a basis consistent with similar statements delivered by the
Company to Purchaser pursuant to Section 2.4(a)) and deliver to Purchaser: (i)
an unaudited consolidated balance sheet of the Acquired Companies as of the
last day of each such calendar month, and the related unaudited consolidated
statement of income, unaudited consolidated statement of members' equity and
unaudited consolidated statement of cash flows for such calendar month, as
well as an unaudited consolidated balance sheet of the Acquired Companies and
the related unaudited consolidated statement of income, unaudited consolidated
statement of members' equity and unaudited consolidated statement of cash
flows for the corresponding periods for the prior fiscal year (the "Required
Company Financial Statements") and (ii) an unaudited consolidated balance
sheet of the Company and PHSS as of the last day of each such calendar month,
and the related unaudited consolidated statement of income, unaudited
consolidated statement of members' equity and unaudited consolidated statement
of cash flows for such calendar month, in each case as related to the Retained
Business (collectively, the "Required 340B Link Interim Financial
Statements").

(b) Prior to Closing, the Company shall prepare (on a basis that is consistent
with the Provided 340B Link Financial Statements except that they need not
contain notes) and deliver to Purchaser unaudited statements of income
(including allocations of charges relating to corporate overhead) of PSG and
PHSS for the three months ended September 30, 2019, March 31, 2020 and June
30, 2020, the nine months ended September 30, 2019 and the twelve months ended
December 31, 2019, in each case as related to the Retained Business
(collectively, the "Required 340B Link Historical Financial Statements" and,
together with the Required 340B Link Interim Financial Statements, the
"Required 340B Link Financial Statements").



(c) If any of the Required Financial Statements are provided by the Company in
the good faith belief that such Required Financial Statements comply with
GAAP, Purchaser may not make a breach of covenant claim with respect to such
Required Financial Statements, but Purchaser shall not be precluded from
making a claim based on a breach of Section 2.4(b).

6.16 Transfer of Purchased Securities. Other than the sale to Purchaser as
contemplated hereunder, no Seller shall, directly or indirectly, transfer
(except as may be specifically required by court order or by operation of
law), grant an option or any right with respect to, sell, exchange, pledge,
convert or otherwise dispose of or encumber any Purchased Security or any
other security of the Company or Blocker, or make any offer or enter into any
agreement providing for any of the foregoing.

6.17 SpinCo Insurance. The Class A Holder shall cause SpinCo or one of its
Subsidiaries (which Subsidiaries shall, for the avoidance of doubt, not
include PHSS) to purchase, prior to the Closing Date, and maintain the
insurance coverages described in Schedule 6.17 (the "SpinCo Policies") and
name each of Purchaser, the Company, 340B OpCo and PHSS as an additional
insured, as applicable (collectively, the "Additionally Insured Entities").
Prior to the Closing, the Class A Holder shall use commercially reasonable
efforts to ensure that the SpinCo Policies provide the Additionally Insured
Entities the authority to make and manage any claims on behalf of the
Additionally Insured Entities under the SpinCo Policies and direct the payment
of any claims regarding the Additionally Insured Entities under the SpinCo
Policies; provided that if the Class A Holder is unable to do so, the Class A
Holder shall, and shall cause SpinCo and its Subsidiaries to, follow the
reasonable instructions of the Additionally Insured Entities regarding the
management of and payments of amounts under such SpinCo Policies with regard
to claims of the Additionally Insured Entities. The SpinCo Policies shall be
effective as of the Closing Date and shall continue for the period of time
described in Schedule 6.17, as applicable. The Class A Holder shall cause
SpinCo and its Subsidiaries to maintain the SpinCo Policies in full force and
effect for the term of such policies.

6.18 Sublease Agreement. Promptly following the date of this Agreement,
Purchaser and the Company shall, and shall cause their Affiliates to,
negotiate in good faith to reach agreement on a sublease agreement (the
"Sublease Agreement") by 340B OpCo, as the sublessor, to SpinCo, as the
sublessee, that contains substantially the terms set forth in the Sublease
Term Sheet attached hereto as Exhibit M. Promptly following Purchaser's and
the Company's reaching agreement on the Sublease Agreement, Purchaser shall,
and the Company shall cause PSG to, collectively with the other party,
approach the Landlord to obtain the Landlord's consent to the Sublease
Agreement.

7. Certain Covenants of the Parties 

7.1 Filings and Consents. All obligations of the Parties set forth in this
Section 7.1 are applicable to the Pre-Closing Period only.

(a) Filings. Each Party shall use commercially reasonable efforts during the
Pre-Closing Period to file, as soon as practicable after the date of this
Agreement, all notices, reports and other documents required to be filed by
such Party with any Governmental Body



with respect to any of the transactions contemplated by this Agreement, and to
submit promptly any additional information requested by any such Governmental
Body. Purchaser shall pay all filing and related fees in connection with any
such filings that must be made by any of the Parties under the HSR Act or any
similar Legal Requirements of any other jurisdiction. Without limiting the
generality or effect of the foregoing sentence, each of the Company, Blocker
and Purchaser shall, as soon as practicable but in any event within ten
Business Days of the execution of the Agreement, make any initial filings
required under the HSR Act in connection with the transactions contemplated by
this Agreement. Purchaser, the Company and Blocker shall respond as promptly
as practicable to any inquiries or requests received from any Governmental
Body in connection with such filings. Subject to the confidentiality
provisions of this Agreement, Purchaser, the Company and Blocker shall
promptly supply the other with any information which may be required in order
to effectuate any filings (including applications) pursuant to (and to
otherwise comply with its obligations set forth in) this Section 7.1(a).
Except where prohibited by applicable Legal Requirements or any Governmental
Body, and subject to the confidentiality provisions of this Agreement, the
Company and Blocker shall: (i) cooperate with Purchaser with respect to any
filings made by Purchaser in connection with the transactions contemplated by
this Agreement; (ii) permit Purchaser to review (and consider in good faith
the views of Purchaser in connection with) any documents before submitting
such documents to any Governmental Body in connection with the transactions
contemplated by this Agreement; and (iii) promptly provide Purchaser with
copies of all filings, notices and other documents (and a summary of any oral
presentations) made or submitted by the Company or Blocker with or to any
Governmental Body in connection with the transactions contemplated by this
Agreement. Purchaser shall, in consultation with the Company and Blocker,
determine strategy, lead all proceedings and coordinate all activities with
respect to seeking any actions, consents, approvals or waivers of any
Governmental Body as contemplated hereby, and the Sellers, the Company and
Blocker shall, and the Sellers shall cause the Company and Blocker to, take
such actions as reasonably requested by Purchaser in connection with obtaining
such consents, approvals or waivers. Subject to Section 6.2(c), nothing in
this Section 7.1(a) shall be deemed to require Sellers, the Company or any
Acquired Company to provide any notice to Purchaser or any Affiliate of
Purchaser regarding the matters set forth in Part 2.12 of the Disclosure
Schedule.

(b) Efforts. Subject to Section 7.1(c), Purchaser, the Company and Blocker
shall use commercially reasonable efforts to take, or cause to be taken, all
actions necessary to make effective the transactions contemplated by this
Agreement. Without limiting the generality of the foregoing, but subject to
Section 7.1(c), each Party: (i) shall make or cause to be made all filings (if
any) and give or cause to be given all notices (if any) required to be made or
given (pursuant to any applicable Legal Requirement or Contract, or otherwise,
including the Contracts set forth in Part 2.21(d) of the Disclosure Schedule)
by such Party or any Acquired Company, Spin-Off Entity or Blocker Entity in
connection with the transactions contemplated by this Agreement and the other
transactions contemplated by this Agreement; and (ii) shall use commercially
reasonable efforts to obtain or cause to be obtained each Consent (if any)
required to be obtained (pursuant to any applicable Legal Requirement or
Contract, or otherwise, including the Contracts set forth in Part 2.21(d) of
this Disclosure Schedule) by such Party or any Acquired Company, Spin-Off
Entity or Blocker Entity in connection with the transactions contemplated by
this Agreement.



(c) Limitations. Notwithstanding anything to the contrary contained in Section
7.1(b) or elsewhere in this Agreement, Purchaser shall not have any obligation
under this Agreement, and the Company and Blocker shall not agree or commit
(without the prior written consent of Purchaser), as applicable, other than
pursuant to Section 6.14, to divest or agree to divest (or cause any of its
Subsidiaries or Affiliates or the Acquired Companies to divest or agree to
divest) any of its respective businesses, product lines or assets, or to take
or agree to take (or cause any of its Subsidiaries or Affiliates or the
Acquired Companies to take or agree to take) any other action or to agree (or
cause any of its Subsidiaries or Affiliates or the Acquired Companies to
agree) to any limitation or restriction on any of its respective businesses,
product lines or assets. Purchaser shall not have any obligation to contest
any Legal Proceeding by any Governmental Body relating to the Closing or any
of the other transactions contemplated by this Agreement.

7.2 Reasonable Efforts. Prior to the Closing, as applicable: (a) the Sellers,
the Company and Blocker shall use commercially reasonable efforts to cause the
conditions set forth in Section 8 to be satisfied on a timely basis; and (b)
Purchaser shall use commercially reasonable efforts to cause the conditions
set forth in Section 9 to be satisfied on a timely basis.

7.3 Communications with Employees. Prior to the Closing Date, the Company
shall ensure that its and its Representatives' and Affiliates' communications
with Offered Employees regarding post-Closing employment matters with
Purchaser, any Subsidiary or Affiliate of Purchaser or any Acquired Company,
including post-Closing employee benefit plans and compensation, are consistent
in all material respects with a communications plan that has been approved by
Purchaser.

7.4 Books and Records.

(a) From and for seven years after the Closing, Purchaser shall, and shall
cause the Company to, (a) afford the Sellers and their representatives
reasonable access, during normal business hours, upon reasonable advance
written notice and under reasonable circumstances, to the books and records of
the Company, 340B OpCo, PHSS and the Blocker Entities, and permit the Sellers
and their representatives to examine and copy such books and records to the
extent reasonably requested by such Party, and (b) cause their representatives
to furnish all information regarding the Company, 340B OpCo, PHSS and the
Blocker Entities reasonably requested by the Sellers or their representatives,
in the case of clauses (a) and (b) to the extent required in connection with
financial reporting, third party litigation not involving Purchaser or any of
its Affiliates (including the Company, 340B OpCo, PHSS and the Blocker
Entities following the Closing), insurance claims or Tax audits; provided,
however, that nothing in this Section 7.4(a) shall require Purchaser or its
Affiliates (including the Company, 340B OpCo, PHSS and the Blocker Entities
following the Closing) to furnish to any Seller or any of its representatives
any materials that (i) are subject to an attorney-client or solicitor-client
privilege or an attorney or solicitor work-product privilege, (ii) which may
not be disclosed pursuant to applicable Legal Requirements, (iii) which may
not be disclosed without contravening any Contract of any Acquired Company or
(iv) to the extent relating to any dispute or potential dispute relating to
this Agreement or the transactions contemplated by this Agreement (though



Purchaser agrees that this clause "(iv)" shall not be interpreted to limit
document discovery to which any of the Sellers or their respective Affiliates
may be otherwise entitled in connection with any such dispute or potential
dispute). For the period as may be required by applicable Legal Requirements,
Purchaser shall, and shall cause its Affiliates (including the Company, PHSS
and Blocker following the Closing) to, maintain all such books and records and
shall not destroy, alter or otherwise dispose of any such books and records.

(b) From and for seven years after the Closing, the Class A Holder shall, and
shall cause the Spin-Off Entities to, (a) afford Purchaser and its
representatives reasonable access, during normal business hours, upon
reasonable advance written notice and under reasonable circumstances, to the
books and records of the Spin-Off Entities, and permit Purchaser and its
representatives to examine and copy such books and records to the extent
reasonably requested by such Party, and (b) cause their representatives to
furnish all information regarding the Spin-Off Entities reasonably requested
by Purchaser or its representatives, in the case of clauses (a) and (b) to the
extent required in connection with financial reporting, third-party litigation
not involving the Class A Holder or any of his Affiliates (including the Spin-
Off Entities following the Closing), insurance claims or Tax audits; provided,
however, that nothing in this Section 7.4(b) shall require the Class A Holder
or his Affiliates (including the Spin-Off Entities following the Closing) to
furnish to Purchaser or any of its representatives any materials that (i) are
subject to an attorney-client or solicitor-client privilege or an attorney or
solicitor work-product privilege, (ii) which may not be disclosed pursuant to
applicable Legal Requirements, (iii) which may not be disclosed without
contravening any Contract of any Spin-Off Entity or (iv) to the extent
relating to any dispute or potential dispute relating to this Agreement or the
transactions contemplated by this Agreement (though the Class A Holder agrees
that this clause "(iv)" shall not be interpreted to limit document discovery
to which any of Purchaser or its Affiliates may be otherwise entitled in
connection with any such dispute or potential dispute). For the period as may
be required by applicable Legal Requirements, the Class A Holder shall, and
shall cause his Affiliates (including the Spin-Off Entities following the
Closing) to, maintain all such books and records and shall not destroy, alter
or otherwise dispose of any such books and records.

7.5 Purchaser Non-Solicitation. For the period that begins on the Closing Date
and ends on the second anniversary of the Closing Date, Purchaser shall not,
and shall cause its Affiliates (including 340B OpCo) not to, directly or
indirectly solicit, for employment or the engagement of services, any employee
of SpinCo or any of the Spin-Off Entities that for the avoidance of doubt is
not a Required Employee or Continuing Employee (each, a "Spin-Off Employee"),
or induce or attempt to induce any Spinoff Employee to leave his or her
employment with SpinCo or any of the Spin-Off Entities, or in any way
knowingly and intentionally interfere with the employment relationship between
any Spinoff Employee and SpinCo or any of the Spin-Off Entities, in each case
for the purpose of employing or engaging the services of such Spinoff Employee
or soliciting such Spinoff Employee to become an employee or consultant of
Purchaser or any of its Affiliates or any other Person; provided, however,
that nothing in this Section 7.5 shall preclude Purchaser from soliciting any
Spinoff Employee (i) who independently responds to any public advertisement or
general solicitation (such as a newspaper advertisement or internet posting)
not specifically



targeting such Spinoff Employee or (ii) following the termination of such
Spinoff Employee's employment with SpinCo or any of the Spin-Off Entities for
any reason, provided, that Purchaser or an Affiliate of Purchaser has not
induced such Spin-Off Employee to terminate his or her employment in breach of
Purchaser's obligations under Section 7.5.

8. Conditions Precedent to Obligations of Purchaser

The obligations of Purchaser to cause the transactions contemplated by this
Agreement to be consummated are subject to the satisfaction (or waiver by
Purchaser), at or prior to the Closing, of each of the following conditions:

8.1 Accuracy of Representations.

(a) Accuracy at Signing.

(i) Each of the representations and warranties made by the Company in this
Agreement (other than the Fundamental Representations and the representations
and warranties set forth in the second sentence of Section 2.8(b)) shall have
been accurate in all respects as of the date of this Agreement (provided,
however, that for purposes of determining the accuracy of such representations
and warranties, all "material," "materially," "Material Adverse Effect" or
similar qualifications limiting the scope of such representations and
warranties shall be disregarded), except for such failures to be so accurate
that have not had and would not reasonably be expected to have, individually
or in the aggregate, a Material Adverse Effect.

(ii) (A) Each of the Fundamental Representations set forth in Sections 2.1(a),
2.1(b), 2.3(a), 2.3(b), 2.20, 2.25, 3 (other than Section 3.7 and Section 3.8)
and 4 (other than the Blocker Business Representations) and the
representations and warranties set forth in the second sentence of Section
2.8(b) shall have been accurate in all respects as of the date of this
Agreement and (B) each of Fundamental Representations (other than the
Fundamental Representations referenced in the foregoing clause "(A)" and
including the Fundamental Representations set forth in Section 3.7, Section
3.8 and the Blocker Business Representations) shall have been accurate in all
material respects as of the date of this Agreement (provided, however, that
for purposes of determining the accuracy of such representations and
warranties referred to in this clause "(B)", all "material," "materially" or
similar qualifications limiting the scope of such representations and
warranties shall be disregarded).

(b) Accuracy as of immediately prior to the PSG Distribution and at the
Closing.

(i) Each of the representations and warranties made by the Company in this
Agreement (other than the Fundamental Representations and the representations
and warranties set forth in the second sentence of Section 2.8(b)) shall be
accurate in all respects as of immediately prior to the PSG Distribution and
as of the Closing Date as if made as of immediately prior to the PSG
Distribution and on and as of the Closing Date other than representations and
warranties which by their terms are made as of a specific earlier date, which
shall have been accurate in all respects as of such earlier date, (provided,
however, that for



purposes of determining the accuracy of such representations and warranties,
all "material," "materially," "Material Adverse Effect" or similar
qualifications limiting the scope of such representations and warranties shall
be disregarded) except, in each case, for such failures to be so accurate that
have not had and would not reasonably be expected to have, individually or in
the aggregate, a Material Adverse Effect.

(ii) (A) Each of the Fundamental Representations set forth in Sections 2.1(a),
2.1(b), 2.3(a), 2.3(b), 2.20, 2.25, 3 (other than Section 3.7 and Section 3.8)
and 4 (other than the Blocker Business Representations) and the
representations and warranties set forth in the second sentence of Section
2.8(b) shall be accurate in all respects as of immediately prior to the PSG
Distribution and as of the Closing Date as if made as of immediately prior to
the PSG Distribution and on and as of the Closing Date other than such
Fundamental Representations which by their terms are made as of a specific
earlier date, which shall have been accurate in all respects as of such
earlier date, and (B) each of the Fundamental Representations (other than the
Fundamental Representations referenced in the foregoing clause "(A)"),
including the Fundamental Representations set forth in Section 3.7, Section
3.8 and the Blocker Business Representations, shall be accurate in all
material respects as of immediately prior to the PSG Distribution and as of
the Closing Date as if made as of immediately prior to the PSG Distribution
and on and as of the Closing Date other than such Fundamental Representations
which by their terms are made as of a specific earlier date, which shall have
been accurate in all material respects as of such earlier date (provided,
however, that for purposes of determining the accuracy of such representations
and warranties referred to in this clause "(B)", all "material," "materially"
or similar qualifications limiting the scope of such representations and
warranties shall be disregarded).

8.2 Performance of Covenants. Each of the covenants and obligations that the
Sellers, the Company or Blocker are required to comply with or to perform at
or prior to the Closing shall have been complied with and performed in all
material respects.

8.3 Governmental and Other Consents.

(a) HSR Approval; Other Governmental Consents. Any waiting period applicable
to the transactions contemplated by this Agreement under the HSR Act shall
have expired or been terminated early, and any approvals, consents or
clearances required in connection with the transactions under the HSR Act
shall have been obtained. All other filings with and other Consents of any
Governmental Body required to be made or obtained in connection with the
transactions contemplated by this Agreement shall have been made and obtained
and shall be in full force and effect and any other waiting period under any
applicable Legal Requirement shall have expired or been terminated.

(b) Other Consents. All Consents identified in Schedule 1.4(b)(xxiv) shall
have been obtained and shall be in full force and effect.

8.4 No Material Adverse Effect. Since the date of this Agreement, there shall
not have occurred any Material Adverse Effect, which Material Adverse Effect
has not been cured by the Closing Date.



8.5 Employees.

(a) None of the Required Employees shall have ceased to be employed (other
than due to death or disability of such Required Employee) by the Acquired
Companies or the Spin-Off Entities or shall have expressed a formal and
definitive intention to any Acquired Company or Spin-Off Entity or, to the
actual knowledge (without a duty of inquiry) of a Knowledge Person, an
informal and definitive intention, to terminate his or her employment with
Purchaser following the Closing Date.

(b) All Continuing Employees who (i) shall have executed a Closing Date Offer
Letter, (ii) shall have not ceased to be employed (other than due to death or
disability of such Continuing Employee) by the Acquired Companies or the Spin-
Off Entities and (iii) shall have not expressed a formal and definitive
intention to any Acquired Company or Spin-Off Entity or, to the actual
knowledge (without a duty of inquiry) of a Knowledge Person, an informal and
definitive intention, to terminate his or her employment with Purchaser
following the Closing Date, collectively continue to constitute no less than
90% of the Offered Employees listed on Exhibit L.

8.6 Documents and Agreements. Purchaser shall have received each of the
documents and agreements contemplated to be provided to Purchaser in Section
1.4(b).

8.7 No Restraints. No temporary restraining order, preliminary or permanent
injunction or other Order against a Party preventing or otherwise impeding the
consummation of the transactions contemplated by this Agreement shall have
been issued by any court of competent jurisdiction or other Governmental Body
and remain in effect, and there shall not be any Legal Requirement enacted or
deemed applicable to the transactions contemplated by this Agreement that
makes any Party's consummation of the transactions contemplated by this
Agreement illegal.

8.8 No Legal Proceedings. No Governmental Body and no other Person shall have
commenced or threatened in writing to commence any Legal Proceeding: (a)
challenging the Closing or any of the other transactions contemplated by this
Agreement or seeking the recovery of damages (which damages, in the case of
any Person other than a Governmental Body, are material) in connection with
the Closing or any of the other transactions contemplated by this Agreement;
(b) seeking to prohibit or limit the exercise by Purchaser of any material
right pertaining to its ownership of the Purchased Securities or other
securities of the Company or Blocker; (c) that is reasonably likely to have
the effect of preventing, materially delaying, making illegal or otherwise
materially interfering with the Closing or any of the other transactions
contemplated by this Agreement; (d) seeking to compel any of the Acquired
Companies, the Blocker Entities, Purchaser or any Affiliate of Purchaser to
dispose of or hold separate any material assets as a result of the Closing or
any of the other transactions contemplated by this Agreement; or (e) that may
result in the imposition of criminal liability on any Blocker Entity, any
Acquired Company, Purchaser or any Affiliate of Purchaser or any
Representative of any Blocker Entity, any Acquired Company, Purchaser or any
Affiliate of Purchaser or the imposition of regulatory fines on any Blocker
Entity, any Acquired Company,



Purchaser or any Affiliate of Purchaser or any Representative of any Blocker
Entity, any Acquired Company, Purchaser or any Affiliate of Purchaser.

9. Conditions Precedent to Obligations of the Sellers

The obligations of the Sellers to consummate the transactions contemplated by
this Agreement are subject to the satisfaction (or waiver by Sellers'
Representative on behalf of the Sellers), at or prior to the Closing, of the
following conditions:

9.1 Accuracy of Representations.

(a) Accuracy at Signing. Each of the representations and warranties made by
Purchaser in this Agreement shall have been accurate in all respects as of the
date of this Agreement, except where the failure of the representations and
warranties of Purchaser to be accurate in all respects would not reasonably be
expected to have a material adverse effect on the ability of Purchaser to
consummate the Closing.

(b) Accuracy at Closing. Each of the representations and warranties made by
Purchaser in this Agreement shall be accurate in all material respects as of
the Closing Date as if made on and as of the Closing Date, other than
representations and warranties which by their terms are made as of a specific
date, which shall have been accurate in all respects as of such date, except,
in each case, where the failure of the representations and warranties of
Purchaser to be accurate in all respects would not reasonably be expected to
have a material adverse effect on the ability of Purchaser to consummate the
Closing.

9.2 Performance of Covenants. Each of the covenants and obligations that
Purchaser is required to comply with or to perform at or prior to the Closing
shall have been complied with and performed in all material respects.

9.3 HSR Approval; Other Governmental Consents. Any waiting period applicable
to the transactions contemplated by this Agreement under the HSR Act shall
have expired or been terminated early, and any approvals, consents or
clearances required in connection with the transactions under the HSR Act
shall have been obtained. All other filings with and other Consents of any
Governmental Body required to be made or obtained in connection with the
transactions contemplated by this Agreement shall have been made and obtained
and shall be in full force and effect and any other waiting period under any
applicable Legal Requirement shall have expired or been terminated.

9.4 Documents and Agreements. The Sellers' Representative shall have received
each of the documents and agreements contemplated to be provided to the
Sellers' Representative in Section 1.4(c)(iv) and Section 1.4(c)(v).

9.5 No Restraints. No temporary restraining order, preliminary or permanent
injunction or other Order against a Party preventing or otherwise impeding the
consummation of the transactions contemplated by this Agreement shall have
been issued by any court of competent jurisdiction or other Governmental Body
and remain in effect, and there shall not be



any Legal Requirement enacted or deemed applicable to the transactions
contemplated by this Agreement by any Governmental Body that makes any Party's
consummation of the transactions contemplated by this Agreement illegal.

10. Termination

10.1 Termination Events. This Agreement may be terminated prior to the
Closing:

(a) by the mutual written consent of Purchaser and the Sellers'
Representative;

(b) by Purchaser if the Closing has not taken place on or before 5:00 p.m.
(Pacific time) on the date that is 150 days following the date of this
Agreement (the "Outside Date"), unless the failure to so close is the result
of the willful and intentional breach by Purchaser of this Agreement or any
other agreement or instrument delivered to the Sellers' Representative in
connection with the transactions contemplated by this Agreement;

(c) by the Sellers' Representative if the Closing has not taken place on or
before 5:00 p.m. (Pacific time) on the Outside Date, unless the failure to so
close is the result of the willful and intentional breach by a Seller, the
Company, Blocker or the Sellers' Representative of this Agreement or any other
agreement or instrument delivered to Purchaser in connection with the
transactions contemplated by this Agreement;

(d) by either Purchaser or the Sellers' Representative if: (i) a court of
competent jurisdiction or other Governmental Body shall have issued a final
and nonappealable Order, or shall have taken any other action, having the
effect of permanently restraining, enjoining or otherwise prohibiting the
transactions contemplated by this Agreement; or (ii) there shall be any
applicable Legal Requirement enacted, promulgated, issued or deemed applicable
to the transactions contemplated by this Agreement by any Governmental Body
that would make consummation of the transactions contemplated by this
Agreement illegal;

(e) by Purchaser if: (i) any of the representations and warranties of the
Sellers, Blocker or the Company contained in this Agreement shall be
inaccurate as of the date of this Agreement, or shall have become inaccurate
as of a date subsequent to the date of this Agreement, such that the condition
set forth in Section 8.1 would not be satisfied; (ii) any of the covenants of
the Sellers, the Company or Blocker contained in this Agreement shall have
been breached such that the condition set forth in Section 8.2 would not be
satisfied; or (iii) any Material Adverse Effect shall have occurred (solely to
the extent such Material Adverse Effect has not been cured prior to the
Outside Date); provided, however, that, in the case of clauses "(i)" and
"(ii)" only, if an inaccuracy in any of the representations and warranties of
the Sellers, the Company or Blocker as of a date subsequent to the date of
this Agreement or a breach of a covenant by the Sellers, the Company or
Blocker is curable by the Sellers, the Company or Blocker, as the case may be,
through the use of reasonable efforts within five Business Days after
Purchaser notifies the Sellers' Representative in writing of the existence of
such inaccuracy or breach (the "Sellers Cure Period"), then Purchaser may not
terminate this Agreement under



this Section 10.1(e) as a result of such inaccuracy or breach prior to the
expiration of the Sellers Cure Period, provided, that the Sellers, the Company
and Blocker, during the Sellers Cure Period, continue to exercise reasonable
efforts to cure such inaccuracy or breach (it being understood that Purchaser
may not terminate this Agreement pursuant to this Section 10.1(e) with respect
to such inaccuracy or breach if such inaccuracy or breach is cured prior to
the expiration of the Sellers Cure Period); or

(f) by the Sellers' Representative if: (i) any of Purchaser's representations
and warranties contained in this Agreement shall be inaccurate as of the date
of this Agreement, or shall have become inaccurate as of a date subsequent to
the date of this Agreement, such that the condition set forth in Section 9.1
would not be satisfied; or (ii) if any of Purchaser's covenants contained in
this Agreement shall have been breached such that the condition set forth in
Section 9.2 would not be satisfied; provided, however, that if an inaccuracy
in any of Purchaser's representations and warranties as of a date subsequent
to the date of this Agreement or a breach of a covenant by Purchaser is
curable by Purchaser through the use of reasonable efforts within five
Business Days after the Sellers' Representative notifies Purchaser in writing
of the existence of such inaccuracy or breach (the "Purchaser Cure Period"),
then the Sellers' Representative may not terminate this Agreement under this
Section 10.1(f) as a result of such inaccuracy or breach prior to the
expiration of the Purchaser Cure Period, provided, that Purchaser, during the
Purchaser Cure Period, continues to exercise reasonable efforts to cure such
inaccuracy or breach (it being understood that the Sellers' Representative may
not terminate this Agreement pursuant to this Section 10.1(f) with respect to
such inaccuracy or breach if such inaccuracy or breach is cured prior to the
expiration of the Purchaser Cure Period).

10.2 Termination Procedures. If Purchaser wishes to terminate this Agreement
pursuant to Section 10.1, Purchaser shall deliver to the Sellers'
Representative a written notice stating that Purchaser is terminating this
Agreement and setting forth the specific subsection(s) of Section 10.1
pursuant to which Purchaser is terminating this Agreement and a brief
description of the basis on which Purchaser is terminating this Agreement. If
the Sellers' Representative wishes to terminate this Agreement pursuant to
Section 10.1, the Sellers' Representative shall deliver to Purchaser a written
notice stating that the Sellers' Representative is terminating this Agreement
and setting forth the specific subsection(s) of Section 10.1 pursuant to which
the Sellers' Representative is terminating this Agreement and a brief
description of the basis on which the Sellers' Representative is terminating
this Agreement.

10.3 Effect of Termination. If this Agreement is terminated pursuant to
Section 10.1, all further obligations of the Parties under this Agreement
shall terminate; provided, however, that: (a) neither the Sellers nor
Purchaser shall be relieved of any obligation or Liability arising from any
willful breach by such Party of any provision contained in this Agreement; and
(b) the Parties shall, in all events, remain bound by and continue to be
subject to the provisions set forth in Section 12.

11. Indemnification, Etc.

11.1 Survival of Representations, Etc.



(a) General Survival. Subject to Sections 11.1(b) and 11.1(d), the
representations and warranties made by the Company in this Agreement and in
the Company Closing Certificate, other than the Fundamental Representations,
shall survive the Closing and shall expire at 11:59 p.m. (Pacific time) on the
date that is 12 months following the Closing Date (the "General Survival
Expiration Date"); provided, however, that if, at any time on or prior to the
General Survival Expiration Date, any Indemnitee delivers to the Sellers'
Representative a written notice alleging the existence of an inaccuracy in or
a breach of any of such representations and warranties and asserting a claim
for recovery under Section 11.2 based on such alleged inaccuracy or breach,
then the claim asserted in such notice shall survive the General Survival
Expiration Date until such time as such claim is fully and finally resolved.

(b) Fundamental Representations. Notwithstanding anything to the contrary
contained in Section 11.1(a), but subject to Section 11.1(d), the Fundamental
Representations shall survive the Closing and shall remain in full force and
effect until the date that is six years following the Closing Date; provided,
however, that if, at any time on or prior to the applicable expiration date
referred to in this sentence, any Indemnitee delivers to the Sellers'
Representative a written notice alleging the existence of an inaccuracy in or
a breach of any Fundamental Representation and asserting a claim for recovery
under Section 11.2 based on such alleged inaccuracy or breach, then the claim
asserted in such notice shall survive such date until such time as such claim
is fully and finally resolved.

(c) Purchaser Representations. The representations and warranties made by
Purchaser in this Agreement shall terminate and expire as of the Closing, and
any Liability of Purchaser with respect to such representations and warranties
shall thereupon cease.

(d) Fraud. Notwithstanding anything to the contrary contained in Section
11.1(a) or 11.1(b), the limitations set forth in Sections 11.1(a) and 11.1(b)
shall not apply in the case of claims based upon Fraud.

(e) Covenant Survival. For the avoidance of doubt, (i) the covenants,
agreements and obligations that Purchaser, the Sellers, the Company and
Blocker are required to comply with or to perform at or prior to the Closing
shall survive the Closing until the date that is 12 months after the Closing
Date and (ii) all other covenants and agreements shall survive until the date
that is 30 days following the date on which the performance of such covenant
is due; provided, that, if there is no specified term of performance, such
covenant shall survive until the date that is 30 days after the date that no
Person can bring a Legal Proceeding in accordance with applicable Legal
Requirements against Purchaser, the Company, Blocker or any of their
respective Affiliates.

(f) Representations Not Limited by Information. The Company, Blocker and the
Sellers agree that the Indemnitees' rights to indemnification, compensation
and reimbursement contained in this Section 11 relating to the
representations, warranties, covenants and obligations of the Company, Blocker
and the Sellers set forth in this Agreement and in the Closing Certificates
are part of the basis of the bargain contemplated by this Agreement; and such
representations, warranties, covenants and obligations set forth in this
Agreement and in the Closing Certificates, and the rights and remedies that
may be exercised by the Indemnitees with



respect thereto, shall not be waived, limited or otherwise affected by or as a
result of any knowledge on the part of any of the Indemnitees or any of their
Representatives (regardless of whether obtained through any investigation by
any Indemnitee or any Representative of any Indemnitee or through disclosure
(other than in the Disclosure Schedule) by the Company, Blocker, the Sellers
or any other Person, and regardless of whether such knowledge was obtained
before or after the execution and delivery of this Agreement) or by reason of
the fact that an Indemnitee or any of its Representatives knew or should have
known that any representation or warranty set forth in this Agreement or in
the Closing Certificates is or might be inaccurate or untrue.

(g) Disclosure Schedule. For purposes of this Agreement, each statement or
other item of information set forth in the Disclosure Schedule shall be deemed
to be a qualification of or supplement to the representation and warranty made
by the Company, Blocker and the Sellers contained in this Agreement.

11.2 Indemnification.

(a) Indemnification with Respect to Representations, Warranties, Covenants and
Agreements Made by the Company. From and after the Closing (but subject to
Section 11.1), each Seller, severally (and not jointly and severally), shall
hold harmless and indemnify each of the Indemnitees from and against, and
shall compensate and reimburse each of the Indemnitees for, such Seller's Pro
Rata Portion of any Damages (or, to the extent recovered from the General
Indemnity Escrow Funds, the Special Indemnity Escrow Funds or the Sellers'
Representative Fund, such Seller's Special Pro Rata Portion) that are suffered
or incurred by any of the Indemnitees or to which any of the Indemnitees may
otherwise become subject (regardless of whether or not such Damages relate to
any third party claim) and that arise from or as a result of, or to the extent
connected with:

(i) any inaccuracy in or breach of any representation or warranty made by the
Company in this Agreement as of the date of this Agreement (without giving
effect to any materiality, Material Adverse Effect or similar qualifications
limiting the scope of such representation or warranty or any notification
pursuant to Section 6.4; except, with respect to this Section 11.2(a)(i), use
of the word "material" in the defined terms "Material Adverse Effect" and
"Material Contract" shall not be disregarded);

(ii) any inaccuracy in or breach of any representation or warranty made by the
Company: (A) in this Agreement as if such representation or warranty was made
(x) on and as of immediately prior to the PSG Distribution and (y) on and as
of the Closing or (B) in the Company Closing Certificate (in each case,
without giving effect to any materiality, Material Adverse Effect or similar
qualifications limiting the scope of such representation or warranty or any
notification pursuant to Section 6.4; except, with respect to this Section
11.2(a)(ii), the use of the word "material" in the defined terms "Material
Adverse Effect" and "Material Contract" shall not be disregarded);

(iii) any breach of any covenant or obligation of the Company in this
Agreement required to be performed prior to or at the Closing or any breach by
the Sellers'



Representative of any covenant or obligation in this Agreement required to be
performed by the Sellers' Representative prior to, at or after the Closing;

(iv) any (A) Taxes payable by, relating to or imposed on any Acquired Company,
or for which any Acquired Company is liable (whether under any Legal
Requirement, under any Contract (other than a Contract entered into in the
Ordinary Course of Business not relating primarily to Taxes), as a transferee
or successor or otherwise) (1) as a result of being or having been (or ceasing
to be) a member of an Affiliated Group on or before the Closing Date or (2)
for any taxable period of any Acquired Company ending on or before the Closing
Date and, with respect to any Straddle Period, the portion of such Straddle
Period ending on and including the Closing Date (without giving effect to any
disclosures set forth in the Disclosure Schedule and without limiting any
rights or remedies of any Indemnitee in the event of any inaccuracy in or
breach of any representation or warranty); provided, that, except as may be
otherwise required by Treasury Regulation 1.1502-76(b), for purposes of this
Agreement, the determination of Taxes of any Acquired Company or Blocker
Entity for the portion of the Straddle Period ending on and including the
Closing Date shall be determined on a closing-of-the-books basis by assuming
that the Straddle Period consisted of two taxable years or periods, one of
which ended at the close of the Closing Date and the other of which began at
the beginning of the day following the Closing Date (with depreciation,
allowances, deductions or Taxes that are calculated on an annual basis, such
as property Taxes, apportioned on a daily basis) and by treating any other
Acquired Company or other Blocker Entity owned by such Acquired Company or
Blocker Entity as having a Straddle Period consisting of such two taxable
years or periods; (B) Transfer Taxes, if any, imposed on the transactions
contemplated by this Agreement; provided, that, the amount of franchise Tax
shown on the Texas 2020 Return shall be allocated (x) to the Pre-Closing Tax
Period based on a fraction, the numerator of which will be the number of days
in the taxable year prior to and including the Closing Date and the
denominator shall be 365, and (y) the remainder to the portion of the Straddle
Period that begins on the day after the Closing Date; and (C) social security,
Medicare, unemployment or other employment, withholding or payroll Taxes or
similar Taxes or amounts (together with any interest, penalty, addition to tax
or additional amount imposed by any Governmental Body with respect thereto)
owed by or imposed on Purchaser or any Acquired Company, or for which
Purchaser or any Acquired Company or any of their respective Affiliates may
otherwise be liable, in each case, triggered in connection with, as a result
of or attributable to any payments made under this Agreement and the
consummation of the transactions contemplated by this Agreement to, or on
behalf of, any Company Service Provider, including any amounts released from
the Escrow Funds or payable in connection with distributions from the Escrow
Funds (all Taxes described in clauses "(A)", "(B)" and "(C)" and any Taxes
referred to in Section 11.2(a)(v) are collectively referred to in this
Agreement as "Acquired Company Pre-Closing Taxes"), in each case, to the
extent not taken into account in calculating Transaction Expenses or
Indebtedness;

(v) (A) the Post-DM Spin-Off, including any Taxes (including any Transfer
Taxes) or other Liabilities incurred on account of, or with respect to, the
Post-DM Spin-Off and (B) any Taxes (including any Transfer Taxes) incurred on
account of, or with respect to, the Divisional Merger; or



(vi) any matter set forth in Schedule 11.2(a)(vi).

(b) Indemnification with Respect to Representations, Warranties, Covenants and
Agreements Made by the Sellers. From and after the Closing (but subject to
Section 11.1), each Seller, on behalf of himself, herself or itself, shall
hold harmless and indemnify each of the Indemnitees from and against, and
shall compensate and reimburse each of the Indemnitees for, all Damages that
are suffered or incurred by any of the Indemnitees or to which any of the
Indemnitees may otherwise become subject (regardless of whether or not such
Damages relate to any third party claim) and that arise from or as a result
of, or to the extent connected with:

(i) any inaccuracy in or breach of any representation or warranty made by such
Seller in this Agreement as of the date of this Agreement (without giving
effect to any materiality, Material Adverse Effect or similar qualifications
limiting the scope of such representation or warranty or any notification
pursuant to Section 6.4);

(ii) any inaccuracy in or breach of any representation or warranty made by
such Seller: (A) in this Agreement as if such representation or warranty was
made on and as of the Closing; or (B) in such Seller's Individual Seller
Closing Certificate (in each case, without giving effect to any materiality,
Material Adverse Effect or similar qualifications limiting the scope of such
representation or warranty or any notification pursuant to Section 6.4); or

(iii) any breach of any covenant or obligation of such Seller in this
Agreement required to be performed prior to, at or after the Closing.

(c) Indemnification with Respect to Representations, Warranties, Covenants and
Agreements Made by Blocker. From and after the Closing (but subject to Section
11.1), Blocker Seller shall hold harmless and indemnify each of the
Indemnitees from and against, and shall compensate and reimburse each of the
Indemnitees for, all Damages that are suffered or incurred by any of the
Indemnitees or to which any of the Indemnitees may otherwise become subject
(regardless of whether or not such Damages relate to any third party claim)
and that arise from or as a result of, or to the extent connected with:

(i) any inaccuracy in or breach of any representation or warranty made by
Blocker in this Agreement as of the date of this Agreement (in each case,
without giving effect to any materiality, Material Adverse Effect or similar
qualifications limiting the scope of such representation or warranty or any
notification pursuant to Section 6.4);

(ii) any inaccuracy in or breach of any representation or warranty made by
Blocker: (A) in this Agreement as if such representation or warranty was made
on and as of the Closing; or (B) in the Blocker Closing Certificate (in each
case, without giving effect to any materiality, Material Adverse Effect or
similar qualifications limiting the scope of such representation or warranty
or any notification pursuant to Section 6.4);

(iii) any breach of any covenant or obligation of the Blocker Entities in this
Agreement required to be performed prior to or at the Closing; or



(iv) any Taxes payable by, relating to or imposed on Blocker or any of the BWA
Entities, or for which Blocker or any of the BWA Entities is liable (whether
under any Legal Requirement, under any Contract (other than a Contract entered
into in the Ordinary Course of Business not relating primarily to Taxes), as a
transferee or successor or otherwise) (A) as a result of being or having been
(or ceasing to be) a member of an Affiliated Group on or before the Closing
Date or (B) subject to Treasury Regulation Section 1.1502-76(b), for any
taxable period of Blocker or any BWA Entity ending on or before the Closing
Date and, with respect to any Straddle Period, the portion of such Straddle
Period ending on and including the Closing Date (without giving effect to any
disclosures set forth in the Disclosure Schedule and without limiting any
rights or remedies of any Indemnitee in the event of any inaccuracy in or
breach of any representation or warranty and including any Damages arising out
of, in connection with or incident to the determination, assessment or
collection of any such Tax) (all Taxes described in clauses "(A)" and "(B)"
are collectively referred to herein as "Blocker Entity Pre-Closing Taxes").

(d) Damage to Purchaser. The Parties acknowledge and agree that if any Blocker
Entity, the Company, 340B OpCo or PHSS suffers, incurs or otherwise becomes
subject to any Damages as a result of, or to the extent in connection with,
any inaccuracy in or breach of any representation, warranty, covenant or
obligation, then (without limiting any of the rights of any Blocker Entity,
the Company, 340B OpCo or PHSS as an Indemnitee) Purchaser shall also be
deemed, by virtue of its ownership of the Purchased Securities, to have
incurred Damages as a result of and to the extent in connection with such
inaccuracy or breach.

11.3 Limitations.

(a) Deductible. Subject to Section 11.3(b), none of the Sellers shall be
required to make any indemnification payment pursuant to Section 11.2(a)(i) or
Section 11.2(a)(ii) until such time as the total amount of all Damages
(including the Damages arising from any inaccuracy in or breach of any
particular representation or warranty and all other Damages arising from any
inaccuracies in or breaches of any other representations or warranties) that
have been suffered or incurred by any one or more of the Indemnitees, or to
which any one or more of the Indemnitees has or have otherwise become subject,
exceeds $843,750 in the aggregate (the "Deductible"). If the total amount of
such Damages exceeds the Deductible, then the Indemnitees shall be entitled to
be indemnified against and compensated and reimbursed for the portion of such
Damages exceeding the Deductible.

(b) Applicability of Deductible. The limitations set forth in Section 11.3(a)
shall not apply: (i) in the event of Fraud (whether on the part of any Seller,
any Blocker Entity or any Acquired Company); (ii) to inaccuracies in or
breaches of any of the Fundamental Representations; or (iii) to any of the
matters referred to in Section 11.2(a)(iii) through Section 11.2(a)(vi),
inclusive, Section 11.2(b)(i) through Section 11.2(b)(iii), inclusive, and
Section 11.2(c)(i) through Section 11.2(c)(iv), inclusive.



(c) Sources of Recovery.

(i) Subject to Section 11.3(a), Section 11.3(c)(vi) and Section 11.3(d),
Damages that are suffered or incurred by any of the Indemnitees or to which
any of the Indemnitees may otherwise become subject (regardless of whether or
not such Damages relate to any third party claim) pursuant to Section
11.2(a)(i) or Section 11.2(a)(ii) for any inaccuracy in or breach of any
General Representation shall be recovered by the Indemnitees solely: (x)
first, from the General Indemnity Escrow Funds (to the extent remaining and
available) until the then current retention under the RandW Policy is reached or
until the General Indemnity Escrow Funds are exhausted; and (y) second, under
the RandW Policy; provided, however, that, for the avoidance of doubt, the
Indemnitees' sole and exclusive remedy under this Section 11.3(c)(i) shall be
limited to clauses "(x)" and "(y)" in the preceding sentence (except in the
case of Fraud pursuant to Section 11.3(c)(vi) and Section 11.3(d)).

(ii) Subject to Section 11.3(c)(vi) and Section 11.3(d), Damages that are
suffered or incurred by any of the Indemnitees or to which any of the
Indemnitees may otherwise become subject (regardless of whether or not such
Damages relate to any third party claim) pursuant to (x) Section 11.2(a)(i) or
Section 11.2(a)(ii) for any inaccuracy in or breach of any Fundamental
Representation (other than any Seller Representation, which shall be governed
by Section 11.3(c)(iii), or Blocker Representation, which shall be governed by
Section 11.3(c)(iv)) or (y) Section 11.2(a)(iv) shall, in each case, be
recovered by the Indemnitees solely: (A) first, from the General Indemnity
Escrow Funds (to the extent remaining and available) until the then current
retention under the RandW Policy is reached or until the General Indemnity
Escrow Funds are exhausted; (B) second, solely to the extent the then current
retention under the RandW Policy is not reached after the General Indemnity
Escrow Funds are exhausted, directly from the Sellers in accordance with their
Pro Rata Portions up to, in the aggregate, the Fundamental Cap (provided,
however, that the Sellers' Representative shall be permitted to make such
payments on behalf of any such Seller from the Sellers' Representative Fund in
accordance with such Seller's Special Pro Rata Portion); and (C) third, under
the RandW Policy; provided, however, that, for the avoidance of doubt, the
Indemnitees' sole and exclusive remedy under this Section 11.3(c)(ii) shall be
limited to clauses "(A)" through "(C)" in the preceding sentence (except in
the case of Fraud pursuant to Section 11.3(c)(vi) and Section 11.3(d)).

(iii) Subject to Section 11.3(c)(vi) and Section 11.3(d), Damages that are
suffered or incurred by any of the Indemnitees or to which any of the
Indemnitees may otherwise become subject (regardless of whether or not such
Damages relate to any third party claim) pursuant to Section 11.2(b)(i) or
Section 11.2(b)(ii) for any inaccuracy in or breach of any Seller
Representation shall be recovered by the Indemnitees solely: (x) first, from
the General Indemnity Escrow Funds (to the extent remaining and available)
until the then current retention under the RandW Policy is reached or until the
General Indemnity Escrow Funds are exhausted; (y) second, solely to the extent
the then current retention under the RandW Policy is not reached after the
General Indemnity Escrow Funds are exhausted, directly from the applicable
Seller who made the Seller Representation(s) referred to in clause (x) of this
sentence up to, in the aggregate, the Fundamental Cap (provided, however, that
the Sellers' Representative shall be permitted to make such payments on behalf
of any such Seller from the Sellers' Representative



Fund in accordance with such Seller's Special Pro Rata Portion); and (z)
third, under the RandW Policy; provided, however, that, for the avoidance of
doubt, the Indemnitees' sole and exclusive remedy under this Section
11.3(c)(iii) shall be limited to clauses "(x)" through "(z)" in the preceding
sentence (except in the case of Fraud pursuant to Section 11.3(c)(vi) and
Section 11.3(d)).

(iv) Subject to Section 11.3(c)(vi) and Section 11.3(d), Damages that are
suffered or incurred by any of the Indemnitees or to which any of the
Indemnitees may otherwise become subject (regardless of whether or not such
Damages relate to any third party claim) pursuant to (x) Section 11.2(c)(i) or
Section 11.2(c)(ii) for any inaccuracy in or breach of any Blocker
Representation or (y) Section 11.2(c)(iv) shall be recovered by the
Indemnitees solely: (A) first, from the General Indemnity Escrow Funds (to the
extent remaining and available) until the then current retention under the RandW
Policy is reached or until the General Indemnity Escrow Funds are exhausted;
(B) second, solely to the extent the then current retention under the RandW
Policy is not reached after the General Indemnity Escrow Funds are exhausted,
directly from Blocker Seller up to, in the aggregate, the Fundamental Cap
(provided, however, that the Sellers' Representative shall be permitted to
make such payments on behalf of Blocker Seller from the Sellers'
Representative Fund in accordance with such Seller's Special Pro Rata
Portion); and (C) third, under the RandW Policy; provided, however, that, for
the avoidance of doubt, the Indemnitees' sole and exclusive remedy under this
Section 11.3(c)(iv) shall be limited to clauses "(A)" through "(C)" in the
preceding sentence (except in the case of Fraud pursuant to Section
11.3(c)(vi) and Section 11.3(d)).

(v) Subject to Section 11.3(c)(vi), Section 11.3(c)(vii), Section 11.3(d),
Section 11.12(d) and Schedule 11.3(c)(v), (A) Damages that are suffered or
incurred by any of the Indemnitees or to which any of the Indemnitees may
otherwise become subject (regardless of whether or not such Damages relate to
any third party claim) with respect to the matters referred to in Section
11.2(a)(iii), Section 11.2(a)(v) and Section 11.2(a)(vi) shall be recovered by
the Indemnitees: (x) first, from the General Indemnity Escrow Funds (to the
extent remaining and available) until the General Indemnity Escrow Funds are
exhausted; and (y) second, directly from the Sellers in accordance with their
Pro Rata Portions; (B) Damages that are suffered or incurred by any of the
Indemnitees or to which any of the Indemnitees may otherwise become subject
(regardless of whether or not such Damages relate to any third party claim)
with respect to the matters referred to in Section 11.2(b)(iii) shall be
recovered by the Indemnitees: (x) first, from the General Indemnity Escrow
Funds (to the extent remaining and available) until the General Indemnity
Escrow Funds are exhausted; and (y) second, directly from the applicable
Seller who breached the covenant referred to in Section 11.2(b)(iii); and (C)
Damages that are suffered or incurred by any of the Indemnitees or to which
any of the Indemnitees may otherwise become subject (regardless of whether or
not such Damages relate to any third party claim) with respect to the matters
referred to in Section 11.2(c)(iii) shall be recovered by the Indemnitees: (x)
first, from the General Indemnity Escrow Funds (to the extent remaining and
available) until the General Indemnity Escrow Funds are exhausted; and (y)
second, directly from Blocker Seller.

(vi) Subject to Section 11.3(d), (A) Damages that are suffered or incurred by
any of the Indemnitees or to which any of the Indemnitees may otherwise become
subject



(regardless of whether or not such Damages relate to any third party claim)
due to Fraud on the part of any Acquired Company may be recovered by the
Indemnitees directly from the Sellers in accordance with their Pro Rata
Portions; (B) Damages that are suffered or incurred by any of the Indemnitees
or to which any of the Indemnitees may otherwise become subject (regardless of
whether or not such Damages relate to any third party claim) due to Fraud on
the part of any Seller may be recovered by the Indemnitees directly from the
applicable Seller who committed such Fraud; and (C) Damages that are suffered
or incurred by any of the Indemnitees or to which any of the Indemnitees may
otherwise become subject (regardless of whether or not such Damages relate to
any third party claim) due to Fraud on the part of any Blocker Entity may be
recovered by the Indemnitees directly from Blocker Seller.

(vii) Notwithstanding any other provision to the contrary, in the event that
any Damages suffered or incurred by any of the Indemnitees hereunder are
recoverable as either a Covered Claim or a breach of a covenant, then, to the
extent reasonably expected to be recoverable under the RandW Policy, Purchaser
shall pursue recovery of such Damages first as a Covered Claim rather than as
a breach of a covenant; provided, that, Purchaser shall be entitled to recover
such Damages as a breach of a covenant to the extent that such Damages are not
reasonably likely to be recovered as a Covered Claim. For the purposes of this
Agreement, the term "Covered Claim" means a claim for Damages (i) based upon a
breach of a representation and warranty, or (ii) under Section 11.2(a)(iv) or
Section 11.2(c)(iv).

(d) Cap.

(i) Except with respect to Fraud, no Seller shall have any Liability under
Section 11.2(a)(i) or Section 11.2(a)(ii) for breaches of or inaccuracies in
General Representations in excess of the General Indemnity Escrow Funds.

(ii) Except with respect to Fraud, the total amount of indemnification
payments that the Sellers may be required to make to the Indemnitees (x) under
Section 11.2(a)(i) or Section 11.2(a)(ii) for any breach of or inaccuracy in
any Fundamental Representation or under Section 11.2(a)(iv), (y) under Section
11.2(b)(i) and Section 11.2(b)(ii) for any breach of or inaccuracy in any
Seller Representation or (z) under Section 11.2(c)(i) or Section 11.2(c)(ii)
for any breach of or inaccuracy in any Blocker Representation or under Section
11.2(c)(iv), as applicable, shall be limited (in the aggregate) to $1,687,500
(the "Fundamental Cap").

(iii) Except with respect to Fraud committed by such Seller or a Blocker
Entity, the total amount of indemnification payments that any Seller may be
required to make to the Indemnitees pursuant to Section 11.2(a)(iii), Section
11.2(a)(v) through Section 11.2(a)(vi), Section 11.2(b)(iii), Section
11.2(c)(iii) and due to Fraud committed by an Acquired Company or Spin-Off
Entity shall be limited (in the aggregate, when combined with all other
Damages paid by or on behalf of such Seller) to the aggregate consideration
that such Seller was entitled to receive pursuant to Section 1.2 (prior to the
deduction of any Taxes).

(e) No Double Recovery; Mitigation. Nothing in this Agreement is intended to
confer to or impose upon any Party a duplicative right, entitlement,
obligation or recovery



with respect to any matter arising out of the same facts and circumstances
(including with respect to the rights, entitlements, obligations and
recoveries that may arise out of one or more of the Sections contained
hereunder). Any Damages for which any Indemnitee is entitled to
indemnification under this Section 11 shall be determined without duplication
of recovery by reason of the state of facts giving rise to such Damages
constituting a breach of more than one representation, warranty or covenant.
No Indemnitee shall be entitled to indemnification under this Agreement for
any portion of Damages arising from a breach of any representation, warranty
or covenant set forth herein (and the amount of such portion of Damages
incurred in respect of such breach shall not be included in the calculation of
any limitations on indemnification set forth herein) that was already included
in a line item of the Net Working Capital Amount, the Transaction Expenses or
Closing Indebtedness Amount.

(f) Insurance Proceeds. The amount of any Damages that any Indemnitee may be
entitled to recover shall be reduced by the amount of any third party
insurance proceeds actually recovered by such Indemnitee from any third party
insurance carrier (net of any increase in insurance premiums, costs of
collections, deductible, retroactive or other premium adjustment,
reimbursement obligation or other costs directly related to the insurance
claim (together, "Insurance Costs")); provided, however, that the foregoing in
no way obligates any Indemnitee to purchase or maintain any third party
insurance policy (other than the RandW Policy). If an Indemnitee actually
receives any insurance proceeds as a result of a matter giving rise to any
indemnification claim of such Indemnitee prior to the date upon which the
Sellers' Representative is given a Claim Notice, the indemnification
obligation of the Sellers with respect to such claim shall be reduced by the
amount of any such insurance proceeds (net of costs and expenses of such
recovery and Insurance Costs) actually received by the Indemnitee. If the
Indemnitee actually receives any insurance proceeds directly arising from any
Damages after any of the Sellers have provided indemnification for such
Damages to the Indemnitee, then any excess Damages amount actually collected
(net of costs and expenses of such recovery and Insurance Costs) shall be
repaid to the Escrow Funds, or after release of the Escrow Funds, such amount
shall be paid to the Sellers. In the event any Damages incurred by an
Indemnitee are actually covered under the RandW Policy, each Indemnitee agrees
to use commercially reasonable efforts to seek recovery under the RandW Policy.

(g) Adjustments. All payments made pursuant to this Section 11 shall be
treated as adjustments to the Purchase Price for Tax purposes unless otherwise
required by Legal Requirements, and such agreed treatment shall govern for
purposes of this Agreement.

(h) Calculation of Damages. For purposes of determining the amount of Damages
pursuant to Section 11.2, all qualifications and limitations as to
materiality, Material Adverse Effect and words of similar import set forth in
this Agreement shall be disregarded.

11.4 No Contribution. Each Seller waives, acknowledges and agrees that such
Seller shall not have and shall not exercise or assert (or attempt to exercise
or assert), any right of contribution, right of indemnity or advancement of
expenses or other right or remedy against any Blocker Entity, the Company,
340B OpCo or PHSS or their respective Representatives in connection with any
indemnification obligation or any other Liability to which such Seller may



become subject under or in connection with this Agreement or any other
agreement, document or instrument delivered to Purchaser in connection with
this Agreement.

11.5 Claim Procedures. Any claim for indemnification, compensation or
reimbursement pursuant to this Section 11 shall be brought and resolved
exclusively as follows:

(a) Notice of Claim. If any Indemnitee has or claims in good faith to have
incurred or suffered, or believes in good faith that it may incur or suffer,
Damages for which it is or may be entitled to indemnification, compensation or
reimbursement under this Section 11 or for which it is or may otherwise be
entitled to a monetary remedy relating to this Agreement or any of the
transactions contemplated hereby, such Indemnitee may deliver a claim notice
(a "Claim Notice") to the Sellers' Representative (or, (x) in the case of an
Individual Seller Indemnification Matter, the applicable Seller and (y) in the
case of a Blocker Indemnification Matter, Blocker Seller). Each Claim Notice
shall: (i) contain a brief description of the facts and circumstances
supporting the Indemnitee's claim; and (ii) if practicable, contain a non-
binding, preliminary, good faith estimate of the amount to which the
Indemnitee might be entitled (the aggregate amount of such estimate, as it may
be modified by the Indemnitee in good faith from time to time, being referred
to as the "Claimed Amount").

(b) Dispute Procedure. During the 20-day period commencing upon receipt by the
Sellers' Representative (or, (x) in the case of an Individual Seller
Indemnification Matter, the applicable Seller and (y) in the case of a Blocker
Indemnification Matter, Blocker Seller) of a Claim Notice from an Indemnitee
(the "Dispute Period"), the Sellers' Representative (or, (x) in the case of an
Individual Seller Indemnification Matter, the applicable Seller and (y) in the
case of a Blocker Indemnification Matter, Blocker Seller) may deliver to the
Indemnitee a written response (the "Response Notice") in which the Sellers'
Representative (or, (x) in the case of an Individual Seller Indemnification
Matter, the applicable Seller and (y) in the case of a Blocker Indemnification
Matter, Blocker Seller): (i) agrees that the full Claimed Amount is owed to
the Indemnitee; (ii) agrees that part, but not all, of the Claimed Amount is
owed to the Indemnitee; or (iii) indicates that no part of the Claimed Amount
is owed to the Indemnitee. If the Response Notice is delivered in accordance
with clause "(ii)" or clause "(iii)" of the preceding sentence, the Response
Notice shall also contain a brief description of the facts and circumstances
supporting the Sellers' Representative's (or applicable Seller's) claim that
only a portion or no part of the Claimed Amount is owed to the Indemnitee, as
the case may be. Any part of the Claimed Amount that is not agreed to be owed
to the Indemnitee pursuant to the Response Notice (or the entire Claimed
Amount, if it is asserted in the Response Notice that no part of the Claimed
Amount is owed to the Indemnitee) is referred to herein as the "Contested
Amount" (it being understood that the Contested Amount shall be modified from
time to time to reflect any good faith modifications by the Indemnitee to the
Claimed Amount).

(c) Deemed Agreement to Claimed Amount. If a Response Notice is not received
by the Indemnitee from the Sellers' Representative (or, (x) in the case of an
Individual Seller Indemnification Matter, the applicable Seller and (y) in the
case of a Blocker Indemnification Matter, Blocker Seller) prior to the
expiration of the Dispute Period, then the Sellers' Representative (or, in the
case of an Individual Seller Indemnification Matter, the



applicable Seller and in the case of a Blocker Indemnification Matter, Blocker
Seller) shall be conclusively deemed to have agreed that an amount equal to
the full Claimed Amount is owed to the Indemnitee and such amount shall be
deemed a "Determined Amount" as of the date of expiration of the Dispute
Period.

(d) Agreement to Full Claimed Amount. If the Sellers' Representative (or, (x)
in the case of an Individual Seller Indemnification Matter, the applicable
Seller and (y) in the case of a Blocker Indemnification Matter, Blocker
Seller) in the Response Notice agrees that the full Claimed Amount is owed to
the Indemnitee, then the full Claimed Amount shall be deemed a "Determined
Amount" as of the date of delivery of the Response Notice.

(e) Partial Agreement to Claimed Amount. If the Sellers' Representative (or,
(x) in the case of an Individual Seller Indemnification Matter, the applicable
Seller and (y) in the case of a Blocker Indemnification Matter, Blocker
Seller) delivers a Response Notice to the Indemnitee during the Dispute Period
agreeing that part, but not all, of the Claimed Amount is owed to the
Indemnitee (the "Agreed Amount"), then such Agreed Amount shall become a
"Determined Amount" hereunder as of the date of delivery of the Response
Notice.

(f) Resolution between the Parties. If the Sellers' Representative (or, (x) in
the case of an Individual Seller Indemnification Matter, the applicable Seller
and (y) in the case of a Blocker Indemnification Matter, Blocker Seller)
delivers a Response Notice to the Indemnitee during the Dispute Period
expressly stating that there is a Contested Amount, the Sellers'
Representative (or, (x) in the case of an Individual Seller Indemnification
Matter, the applicable Seller and (y) in the case of a Blocker Indemnification
Matter, Blocker Seller) and the Indemnitee shall attempt in good faith to
resolve the dispute related to the Contested Amount. If the Sellers'
Representative (or, (x) in the case of an Individual Seller Indemnification
Matter, the applicable Seller and (y) in the case of a Blocker Indemnification
Matter, Blocker Seller) and the Indemnitee resolve such dispute, such
resolution shall be binding on the Sellers' Representative (or, (x) in the
case of an Individual Seller Indemnification Matter, the applicable Seller and
(y) in the case of a Blocker Indemnification Matter, Blocker Seller) and such
Indemnitee, and a settlement agreement stipulating the amount owed to such
Indemnitee (the "Stipulated Amount") shall be signed by such Indemnitee, on
the one hand, and the Sellers' Representative (or, (x) in the case of an
Individual Seller Indemnification Matter, the applicable Seller and (y) in the
case of a Blocker Indemnification Matter, Blocker Seller) on the other hand,
and the Stipulated Amount shall become a "Determined Amount" hereunder as of
the date such settlement agreement is executed or as of such other date as may
be provided for in the settlement agreement.

(g) Arbitration. In the event that there is a dispute relating to any Claim
Notice or Contested Amount (whether it is a matter between the Indemnitee, on
the one hand, and the Sellers' Representative (or, (x) in the case of an
Individual Seller Indemnification Matter, the applicable Seller and (y) in the
case of a Blocker Indemnification Matter, Blocker Seller), on the other hand,
or it is a matter that is subject to a claim or Legal Proceeding asserted or
commenced by a third party brought against the Indemnitee, the Company, 340B
OpCo, PHSS or any Blocker Entity), such dispute (an "Arbitrable Dispute")
shall be settled by binding



arbitration. Notwithstanding the preceding sentence, nothing in this Section
11.5(g) shall prevent a Party from seeking preliminary injunctive relief from
a Chosen Court of competent jurisdiction to maintain the status quo pending
resolution of any Arbitrable Dispute.

(i) Except as herein specifically stated, any Arbitrable Dispute shall be
resolved by arbitration in the County of Santa Clara, State of California in
accordance with the JAMS' Comprehensive Arbitration Rules and Procedures then
in effect (the "Arbitration Law"). However, in all events, the provisions
contained herein shall govern over any conflicting rules which may now or
hereafter be contained in the Arbitration Law. Any judgment upon the award
rendered by the arbitrator shall be entered in any court having jurisdiction
over the subject matter thereof. The arbitrator shall have the authority to
grant any equitable and legal remedies that would be available if any judicial
proceeding were instituted to resolve an Arbitrable Dispute. The final
decision of the arbitrator will be furnished by the arbitrator to the Sellers'
Representative and the Indemnitee (and, in the case of an Individual Seller
Indemnification Matter, the applicable Seller and, in the case of a Blocker
Indemnification Matter, Blocker Seller) in writing and will constitute a
final, conclusive and non-appealable determination of the issue in question,
binding upon the Sellers' Representative, the Sellers (or, (x) in the case of
an Individual Seller Indemnification Matter, the applicable Seller and (y) in
the case of a Blocker Indemnification Matter, Blocker Seller) and the
Indemnitee, and an order with respect thereto may be entered in any court of
competent jurisdiction. Any such arbitration shall be kept confidential by the
Indemnitee, the Sellers' Representative and the Sellers (or, (x) in the case
of an Individual Seller Indemnification Matter, the applicable Seller and (y)
in the case of a Blocker Indemnification Matter, Blocker Seller).

(ii) Any such arbitration will be conducted before a single arbitrator who
will be compensated for his or her services at a rate to be determined by the
Indemnitee and the Sellers' Representative (or, (x) in the case of an
Individual Seller Indemnification Matter, the applicable Seller and (y) in the
case of a Blocker Indemnification Matter, Blocker Seller), but based upon
reasonable hourly or daily consulting rates for the arbitrator in the event
the parties are not able to agree upon his or her rate of compensation.

(iii) The arbitrator shall be mutually agreed upon by the Indemnitee and the
Sellers' Representative (or, (x) in the case of an Individual Seller
Indemnification Matter, the applicable Seller and (y) in the case of a Blocker
Indemnification Matter, Blocker Seller). In the event the Indemnitee and the
Sellers' Representative (or, (x) in the case of an Individual Seller
Indemnification Matter, the applicable Seller and (y) in the case of a Blocker
Indemnification Matter, Blocker Seller) are unable to agree on an arbitrator
within 20 days following submission of the dispute to arbitration by one of
the parties, JAMS will have the authority to select an arbitrator from a list
of arbitrators who satisfy the criteria set forth in clause "(iv)" hereof.

(iv) No arbitrator shall have any past or present family, business or other
relationship with the Indemnitee, Purchaser, any Acquired Company, any Spin-
Off Entity, any Blocker Entity, the Sellers' Representative, any of the
Sellers or any Affiliate, manager, director or officer of any of the
foregoing, unless following full disclosure of all such relationships, the
Indemnitee and the Sellers' Representative (or, (x) in the case of an
Individual Seller



Indemnification Matter, the applicable Seller and (y) in the case of a Blocker
Indemnification Matter, Blocker Seller) agree in writing to waive such
requirement with respect to an individual in connection with any dispute.

(v) The arbitrator shall be instructed to hold an up to eight hour, one day
hearing regarding the disputed matter within 60 days of his or her designation
and to render an award (without written opinion) no later than ten days after
the conclusion of such hearing, in each case unless otherwise mutually agreed
in writing by the Indemnitee and the Sellers' Representative (or, (x) in the
case of an Individual Seller Indemnification Matter, the applicable Seller and
(y) in the case of a Blocker Indemnification Matter, Blocker Seller). The
final decision of the arbitrator: (A) shall include the amount of the award to
the Indemnitee (the "Award Amount"), if any; (B) shall be furnished to the
Sellers' Representative (or, (x) in the case of an Individual Seller
Indemnification Matter, the applicable Seller and (y) in the case of a Blocker
Indemnification Matter, Blocker Seller) and the Indemnitee in writing; and (C)
shall constitute a conclusive determination of the issue(s) in question, shall
be binding upon the Sellers' Representative, the Sellers (or, (x) in the case
of an Individual Seller Indemnification Matter, the applicable Seller and (y)
in the case of a Blocker Indemnification Matter, Blocker Seller) and the
Indemnitee and shall not be contested by any of them, and an order with
respect thereto may be entered in any court of competent jurisdiction.

(vi) The Indemnitee and the Sellers' Representative (on behalf of the Sellers)
(or, (x) in the case of an Individual Seller Indemnification Matter, the
applicable Seller and (y) in the case of a Blocker Indemnification Matter,
Blocker Seller) will each pay 50% of the initial compensation to be paid to
the arbitrator in any such arbitration and 50% of the costs of transcripts and
other normal and regular expenses of the arbitration proceedings; provided,
however, that: (A) the prevailing party in any arbitration will be entitled to
an award of attorneys' fees and costs; and (B) all costs of arbitration,
including the 50% of initial compensation and expenses paid by the prevailing
party, will be paid by the losing party, and the arbitrator will be authorized
to determine the identity of the prevailing party and the losing party. The
losing party shall be determined solely by the arbitrator. If an Indemnitee is
found to be the prevailing party in any arbitration, the amount of the fees
and expenses of such Indemnitee payable by the Sellers (or, (x) in the case of
an Individual Seller Indemnification Matter, the applicable Seller and (y) in
the case of a Blocker Indemnification Matter, Blocker Seller) pursuant to this
clause "(vi)" shall be added to and become a part of the Award Amount.

(vii) The arbitrator chosen in accordance with these provisions will not have
the power to alter, amend or otherwise affect the terms of these arbitration
provisions or any other provisions contained in this Section 11.5(g) or
elsewhere in this Agreement.

(viii) The Award Amount shall become a "Determined Amount" hereunder on the
date of entry of the arbitrator's decision by a court of competent
jurisdiction (such entry, the "Determined Order").

(ix) Notwithstanding anything to the contrary set forth in this Section
11.5(g), any claims arising out of, relating to or resulting from any Fraud or
any breach of covenant by a Party shall instead be brought before, and
adjudicated by, a Chosen Court.



11.6 Payment of Determined Amounts. After the date any amount becomes a
Determined Amount (the "Determination Date") pursuant to Section 11.5(c),
Section 11.5(d), Section 11.5(e), Section 11.5(f) or Section 11.5(g)(viii):
(a) Purchaser and Sellers' Representative shall, within three Business Days
after the Determination Date, jointly execute and deliver to the Escrow Agent
a written notice instructing the Escrow Agent to pay the Determined Amount to
such Indemnitee from the General Indemnity Escrow Funds or the Special
Indemnity Escrow Funds, as applicable, provided, however, that if the Sellers'
Representative fails to execute and deliver such written notice within such
three Business Day period, Purchaser's unilateral execution and delivery of
such written notice (and, in the event of any amount becoming a Determined
Amount pursuant to Section 11.5(g)(viii), together with a copy of the
Determined Order) shall constitute binding instructions to the Escrow Agent by
Purchaser and the Sellers' Representative to release the Determined Amount to
the Indemnitee from the General Indemnity Escrow Funds or the Special
Indemnity Escrow Funds, as applicable, subject to the terms of the Escrow
Agreement; and (b) if the applicable Escrow Funds are insufficient to cover
the full Determined Amount, then, the Indemnitees shall recover such
deficiency under the RandW Policy, directly from the Sellers in accordance with
their Pro Rata Portions or directly from the applicable Sellers, as
applicable, in each case pursuant to Section 11.3(c); provided, that if any
Seller is responsible for such deficiency or any part of such deficiency
pursuant to Section 11.3(c), such Seller shall make such payment within ten
Business Days following the Determination Date.

11.7 Escrow Matters. Subject to the terms of the Escrow Agreement:

(a) First Recourse to Escrow Fund. Other than pursuant to Section 11.3(c)(vi),
so long as the portion of the amount in the applicable Escrow Funds exceeds
the aggregate amount of all Indemnification Matters recoverable from such
Escrow Funds that have been asserted but not resolved, the Indemnitees shall
seek to recover the amounts in respect of such claims from the applicable
Escrow Funds (to the extent of the applicable Escrow Funds) prior to seeking
to recover the amounts in respect of such claims under the RandW Policy or
directly from any Seller. For the avoidance of doubt, the Indemnitees shall
not recover (i) any Designated Matter Damages from the General Indemnity
Funds, and (ii) any Damages other than the Designated Matter Damages from the
Special Indemnity Escrow Funds.

(b) Release of General Indemnity Escrow Funds. Within ten Business Days of the
12-month anniversary of the Closing Date (the "General Indemnity Escrow
Release Date"), Purchaser shall notify the Sellers' Representative in writing
of the amount (the "Release Date General Indemnity Escrow Retained Amount")
that Purchaser determines in good faith to be necessary to satisfy all
Indemnification Matters (other than the Designated Special Indemnification
Matters) that have been properly asserted pursuant to Section 11 on or prior
to the General Indemnity Escrow Release Date, but not resolved, on or prior to
11:59 p.m. (Pacific time) on the General Indemnity Escrow Release Date, it
being agreed that such amount shall include the aggregate of all Determined
Amounts with respect to all Indemnification Matters (other than the Designated
Special Indemnification Matters) that have been resolved but have not been
paid to the Indemnitee in accordance with Section 11.6(a) (each unresolved
Indemnification Matter described in this sentence, an "Unresolved General
Indemnity Escrow Claim"). Within



ten Business Days following the General Indemnity Escrow Release Date,
Purchaser and the Sellers' Representative shall execute and deliver joint
written instructions to the Escrow Agent instructing the Escrow Agent to
release from the General Indemnity Escrow Funds to each Seller such Seller's
Special Pro Rata Portion of the amount (if any) by which (A) the General
Indemnity Escrow Funds as of the General Indemnity Escrow Release Date exceeds
(B) the Release Date General Indemnity Escrow Retained Amount.

(c) Release of Special Indemnity Escrow Funds.

(i) Within ten Business Days of the later of 12-month anniversary of the
Closing Date and October 31, 2021 (the "First Special Indemnity Escrow Release
Date"), Purchaser shall notify the Sellers' Representative in writing of the
amount (the "First Release Date Special Indemnity Escrow Retained Amount")
that Purchaser determines in good faith to be necessary to satisfy all
Designated Special Indemnification Matters that have been properly asserted
pursuant to Section 11 on or prior to the First Special Indemnity Escrow
Release Date, but not resolved, on or prior to 11:59 p.m. (Pacific time) on
the First Special Indemnity Escrow Release Date, it being agreed that such
amount shall include the aggregate of all Determined Amounts with respect to
all Designated Special Indemnification Matters that have been resolved but
have not been paid to the Indemnitee in accordance with Section 11.6(a) (each
unresolved Designated Special Indemnification Matter described in this
sentence, a "First Release Date Unresolved Special Indemnity Escrow Claim" and
all Determined Amounts with respect to all Designated Special Indemnification
Matters that have been resolved and paid in accordance with Section 11.6(a) on
or prior to the First Special Indemnity Escrow Release Date, the "First
Release Date Special Indemnity Escrow Distributed Amounts"). If the sum of (A)
First Release Date Special Indemnity Escrow Retained Amount and (B) the First
Release Date Special Indemnity Escrow Distributed Amounts is less than
$500,000 (such excess of $500,000 over the sum of clauses "(A)" and "(B)" of
this sentence, the "First Release Date Special Indemnity Escrow Distribution
Amount"), then within ten Business Days following the First Special Indemnity
Escrow Release Date, Purchaser and the Sellers' Representative shall execute
and deliver joint written instructions to the Escrow Agent instructing the
Escrow Agent to release from the Special Indemnity Escrow Funds to each Seller
such Seller's Special Pro Rata Portion of the First Release Date Special
Indemnity Escrow Distribution Amount. If, however, the sum of the amounts in
clauses "(A)" and "(B)" of the immediately foregoing sentence is more than
$500,000, no distribution from the Special Indemnity Escrow Funds shall be
made to any Seller following the First Special Indemnity Escrow Release Date.

(ii) Within ten Business Days of the 12-month anniversary of the First Special
Indemnity Escrow Release Date (the "Second Special Indemnity Escrow Release
Date"), Purchaser shall notify the Sellers' Representative in writing of the
amount (the "Second Release Date Special Indemnity Escrow Retained Amount")
that Purchaser determines in good faith to be necessary to satisfy all
Designated Special Indemnification Matters that have been properly asserted
pursuant to Section 11 on or prior to the Second Special Indemnity Escrow
Release Date, but not resolved, on or prior to 11:59 p.m. (Pacific time) on
the Second Special Indemnity Escrow Release Date, it being agreed that such
amount shall include the aggregate of all Determined Amounts with respect to
all Designated Special Indemnification Matters that have



been resolved but have not been paid to the Indemnitee in accordance with
Section 11.6(a) (each unresolved Designated Special Indemnification Matter
described in this sentence, a "Second Release Date Unresolved Special
Indemnity Escrow Claim" and all Determined Amounts with respect to all
Designated Special Indemnification Matters that have been resolved and paid in
accordance with Section 11.6(a) on or prior to the Second Special Indemnity
Escrow Release Date, the "Second Release Date Special Indemnity Escrow
Distributed Amounts"). If (A) the sum of (x) the Second Release Date Special
Indemnity Escrow Retained Amount and (y) the Second Release Date Special
Indemnity Escrow Distributed Amounts is less than $1,000,000 (such excess of
$1,000,000 over the sum of the amounts described in clauses "(A)(x)" and
"(A)(y)" of this sentence, the "Second Release Date Special Indemnity Escrow
Excess Amount") and (B) the Second Release Date Special Indemnity Escrow
Excess Amount is more than the First Release Date Special Indemnity Escrow
Distribution Amount (such excess of Second Release Date Special Indemnity
Escrow Excess Amount over the First Release Date Special Indemnity Escrow
Distribution Amount, the "Second Release Date Special Indemnity Escrow
Distribution Amount"), within ten Business Days following the Second Special
Indemnity Escrow Release Date, Purchaser and the Sellers' Representative shall
execute and deliver joint written instructions to the Escrow Agent instructing
the Escrow Agent to release from the Special Indemnity Escrow Funds to each
Seller such Seller's Special Pro Rata Portion of the Second Release Date
Special Indemnity Escrow Distribution Amount. If, however, either the sum of
the amounts in clauses "(A)(x)" and "(A)(y)" of the immediately foregoing
sentence is more than $1,000,000 or the Second Release Date Special Indemnity
Escrow Excess Amount is less than First Release Date Special Indemnity Escrow
Distribution Amount, no distribution from the Special Indemnity Escrow Funds
shall be made to any Seller following the Second Special Indemnity Escrow
Release Date.

(iii) Within ten Business Days of the 12-month anniversary of the Second
Special Indemnity Escrow Release Date (the "Final Special Indemnity Escrow
Release Date" and collectively with the General Indemnity Escrow Release Date,
the First Special Indemnity Escrow Release Date and the Second Special
Indemnity Escrow Release Date, the "Release Dates" and each, a "Release
Date"), Purchaser shall notify the Sellers' Representative in writing of the
amount (the "Final Release Date Special Indemnity Escrow Retained Amount")
that Purchaser determines in good faith to be necessary to satisfy all
Designated Special Indemnification Matters that have been properly asserted
pursuant to Section 11 on or prior to the Final Special Indemnity Escrow
Release Date, but not resolved, on or prior to 11:59 p.m. (Pacific time) on
the Final Special Indemnity Escrow Release Date, it being agreed that such
amount shall include the aggregate of all Determined Amounts with respect to
all Designated Special Indemnification Matters that have been resolved but
have not been paid to the Indemnitee in accordance with Section 11.6(a) (each
unresolved Designated Special Indemnification Matter described in this
sentence, a "Final Release Date Unresolved Special Indemnity Escrow Claim,"
and collectively with the Unresolved General Indemnity Escrow Claims, the
First Release Date Unresolved Special Indemnity Escrow Claims and the Second
Release Date Unresolved Special Indemnity Escrow Claims, the "Unresolved
Claims," and each, an "Unresolved Claim"). If the Final Release Date Special
Indemnity Escrow Retained Amount is less than the funds then available in the
Special Indemnity Escrow Funds (such excess of the funds then available in the
Special Indemnity Escrow Funds over the Final Release Date Special



Indemnity Escrow Retained Amount, the "Final Release Date Special Indemnity
Escrow Distribution Amount"), within ten Business Days following the Final
Special Indemnity Escrow Release Date, Purchaser and the Sellers'
Representative shall execute and deliver joint written instructions to the
Escrow Agent instructing the Escrow Agent to release from the Special
Indemnity Escrow Funds to each Seller such Seller's Special Pro Rata Portion
of the Final Release Date Special Indemnity Escrow Distribution Amount. If,
however, the Final Release Date Special Indemnity Escrow Retained Amount is
more than the funds then available in the Special Indemnity Escrow Funds, no
distribution shall be made from the Special Indemnity Escrow Funds to any
Seller following the Final Special Indemnity Escrow Release Date.

(d) Resolution of Unresolved Claims. If at any time after the applicable
Release Date, an Unresolved Claim is finally resolved, then Purchaser and the
Sellers' Representative shall jointly execute and deliver to the Escrow Agent,
within three Business Days after the final resolution of such Unresolved Claim
and the delivery to the Indemnitee of the Determined Amount in accordance with
Section 11.6, a written notice instructing the Escrow Agent to disburse from
the applicable Escrow Funds for distribution to each Seller such Seller's
Special Pro Rata Portion of the amount (if any) by which (A) the then
remaining funds in the applicable Escrow Funds that are no longer subject to
Section 11.7(b) or Section 11.7(c) exceeds (B) the aggregate amount of all
Claimed Amounts (which are not also Contested Amounts or Determined Amounts)
and Contested Amounts associated with all unresolved Indemnification Matters
recoverable from such Escrow Funds (it being agreed that such aggregate amount
shall include the aggregate of all Determined Amounts with respect to all
Indemnification Matters recoverable from such Escrow Funds that have been
resolved but have not been paid to the Indemnitee in accordance with Section
11.6).

(e) Tax Treatment. All payments to the Sellers from the Escrow Funds shall be
treated as eligible for the installment method pursuant to Section 453 of the
Code, except for the portion of such payments treated as imputed interest
pursuant to Section 483 of the Code.

11.8 Defense of Third Party Claims. In the event of the assertion or
commencement by any Person of any claim or Legal Proceeding (whether against
the Company, 340B OpCo, PHSS, any Blocker Entity, Purchaser or any other
Person) with respect to which any Seller may become obligated to hold
harmless, indemnify, compensate or reimburse any Indemnitee pursuant to this
Section 11, Purchaser shall have the right, at its election, to proceed with
the defense of such claim or Legal Proceeding on its own with counsel
reasonably satisfactory to the Sellers' Representative. If Purchaser so
proceeds with the defense of any such claim or Legal Proceeding:

(a) subject to the other provisions of this Section 11, Purchaser may seek
recovery of all reasonable expenses relating to the defense of such claim or
Legal Proceeding (and all amounts due pursuant to any settlement, adjustment
or compromise of such claim or Legal Proceeding) as Damages;

(b) each Seller shall, to the extent legally permitted to do so, make
available to Purchaser any documents and materials in such Seller's possession
or control that may be necessary to the defense of such claim or Legal
Proceeding; provided, however, that (i) unless



otherwise required to do so by applicable court, arbitration or other legal
proceeding procedures, no Seller shall, solely by reason of this Section
11.8(b), be required to produce any such documents or materials to the extent
related to a dispute between such Seller and any Indemnitee or Purchaser or
(ii) no Seller shall be required to produce any such documents or materials to
the extent that such Seller has been advised by a reputable law firm with
offices in the United States in writing that such provision would waive or
materially impair such Seller's ability to assert attorney-client or other
legal privilege with respect to such documents and materials even with a joint
defense or common interest agreement in place; and

(c) Purchaser shall have the right to settle, adjust or compromise such claim
or Legal Proceeding without the consent of the Sellers' Representative or any
Seller; provided, however, that if Purchaser settles, adjusts or compromises
any such claim or Legal Proceeding without the consent of the Sellers'
Representative, then such settlement, adjustment or compromise shall not be
conclusive evidence of the amount of Damages incurred by the Indemnitee in
connection with such claim or Legal Proceeding (it being understood that if
Purchaser requests that the Sellers' Representative or any Seller consent to a
settlement, adjustment or compromise, neither the Sellers' Representative nor
any Seller shall unreasonably withhold, delay or condition such consent).

(d) If Purchaser does not elect to proceed with the defense of any such claim
or Legal Proceeding, the Sellers' Representative may proceed with the defense
of such claim or Legal Proceeding with counsel reasonably satisfactory to
Purchaser; provided, however, that the Sellers' Representative may not settle,
adjust or compromise any such claim or Legal Proceeding without the prior
written consent of Purchaser (which consent may not be unreasonably withheld,
delayed or conditioned). Purchaser shall give the Sellers' Representative
prompt notice of the commencement of any such Legal Proceeding against
Purchaser, the Company, 340B OpCo, PHSS or any Blocker Entity; provided,
however, that any failure on the part of Purchaser to so notify the Sellers'
Representative shall not limit any of the obligations of the Sellers under
this Section 11 (except to the extent such failure materially prejudices the
defense of such Legal Proceeding).

11.9 RandW Policy. Purchaser shall purchase and maintain the RandW Policy, and
shall have received as of the date hereof an executed binder for the RandW
Policy evidencing that coverage under such policy will be in effect as of the
Closing. Purchaser shall not amend, restate, supplement, modify or alter the
RandW Policy in a manner adverse to the Sellers, including in any manner that
results or could reasonably be expected to result in any incremental liability
to any Seller or any of its shareholders, officers, directors and employees
without the prior written consent of Sellers' Representative, including
amending, modifying or changing the waiver of subrogation of the Sellers in
Section X.A. of the RandW Policy. Except for the portion of the premium of the
RandW Policy specifically attributable to the excess coverage pertaining to the
Fundamental Representations and the Pre-Closing Taxes, which shall be borne
50% by the Sellers, on the one hand, and 50% by Purchaser, on the other, all
other costs and expenses related



to obtaining and maintaining, and the exercise of rights under, the RandW Policy
shall be borne by Purchaser.

11.10 Exclusive Remedy.

(a) Except (i) in the event of Fraud, (ii) for equitable remedies expressly
set forth in or contemplated by this Agreement, (iii) for remedies against PSG
set forth in the Indemnity Agreement and (iv) with respect to the procedures
set forth in Section 1.3, from and after the Closing, the rights to
indemnification, compensation and reimbursement set forth in this Section 11
shall be the sole and exclusive remedy of the Indemnitees with respect to any
breach of this Agreement. Purchaser acknowledges and agrees that the
Indemnitees will not have any legal recourse, remedy or other claim, whether
arising under statute, common law or otherwise, based on or with respect to
any inaccuracy in or breach of any representations, warranties or statements,
whether express or implied, made by the Company, Blocker any Seller or any of
their respective Representatives that are not expressly set forth in this
Agreement (as modified or supplemented by the Disclosure Schedule), the
Company Closing Certificate, the applicable Individual Seller Closing
Certificate, the Blocker Closing Certificate or the exhibits or schedules
hereto or thereto, whether or not such representations, warranties or
statements were made in writing or orally, including any implied warranty or
representation as to condition, merchantability, suitability or fitness for a
particular purpose or trade as to any of the assets of any Acquired Company or
any Blocker Entity.

(b) Purchaser acknowledges and agrees, on behalf of itself and each of its
Affiliates, that it has conducted an independent investigation of the
financial condition, results of operations, assets, Liabilities and properties
of each Acquired Company and each of the Blocker Entities, and, in making its
determination to proceed with the transactions contemplated by this Agreement,
Purchaser has relied solely on the results of its own independent
investigation and the representations and warranties regarding the Acquired
Companies and Spin-Off Entities specifically set forth in Section 2, as
modified or supplemented by the Disclosure Schedule, and the Company Closing
Certificate, the representations and warranties regarding the Sellers
specifically set forth in Section 3, as modified or supplemented by the
Disclosure Schedule, and the Individual Seller Closing Certificates and the
representations and warranties regarding the Blocker Entities set forth in
Section 4, as modified or supplemented by the Disclosure Schedule, and the
Blocker Closing Certificates, and has not relied on the accuracy or
completeness of any other information provided to (or otherwise acquired by)
Purchaser or any of its Affiliates. The representations and warranties
regarding the Acquired Companies and the Spin-Off Entities specifically set
forth in Section 2, as modified or supplemented by the Disclosure Schedule,
and the Company Closing Certificate, the representations and warranties
regarding the Sellers specifically set forth in Section 3, as modified or
supplemented by the Disclosure Schedule, and the Individual Seller Closing
Certificates and the representations and warranties regarding the Blocker
Entities specifically set forth in Section 4, as modified or supplemented by
the Disclosure Schedule, and the Blocker Closing Certificate constitute the
sole and exclusive representations, warranties and statements (including by
omission) of any kind by the Company or any of its Representatives regarding
the Acquired Companies and Spin-Off Entities, by Blocker or any of its
Representatives regarding the Blocker Entities, by each Seller or any of its



Representatives regarding such Seller (and, in the case of Blocker Seller,
regarding the Blocker Entities), in each case in connection with the
transactions contemplated hereby, and all other representations, warranties
and statements (including by omission) of any kind or nature expressed or
implied in connection with the transactions contemplated hereby are
specifically disclaimed by the Acquired Companies, Blocker Entities, the
Sellers and each of their respective Representatives.

11.11 Exercise of Remedies Other Than by Purchaser. No Indemnitee (other than
Purchaser or any successor thereto or assign thereof) shall be permitted to
assert any indemnification claim or exercise any other remedy under this
Agreement unless Purchaser (or any successor thereto or assign thereof) shall
have consented to the assertion of such indemnification claim or the exercise
of such other remedy.

11.12 Provisions Relating to the Designated Tax Matter. Notwithstanding any
other provision in this Agreement:

(a) "Designated Matter Damages" shall mean (i) all Taxes, penalties and
interest that become due and owing to any taxing authority by any Indemnitee
as a result of the Designated Tax Matter, (ii) all out-of-pocket costs
associated with income tax advisory and preparation services to assist such
Indemnitee with filing amended Tax Returns and claiming any available Tax
refunds or Tax credits as a result of the Designated Tax Matter, and (iii) any
other out-of-pocket costs reasonably incurred by such Indemnitee as a result
of the Designated Tax Matter.

(b) In the event that the Designated Tax Matter results in any Taxes being
asserted against any Indemnitee, then Sellers' Representative shall establish
at its expense a program to provide information to each Indemnitee and his or
her advisor to assist such Indemnitee with filing any necessary amended Tax
Returns and claiming any available Tax refunds or Tax credits as a result of
the Designated Tax Matter.

(c) The amount of Designated Matter Damages incurred by an Indemnitee with
respect to the Designated Tax Matter shall be reduced by any Tax refunds or
Tax credits that such Indemnitee actually receives or is deemed to receive as
a result of the Designated Tax Matter, which, for the avoidance of doubt shall
include any Tax refunds received or deemed received by an Acquired Company
with respect to any Indemnitee. An Indemnitee will be deemed to receive a Tax
refund or Tax credit where there is no apparent reason why such refund would
not have been made or such credit would not have been allowed if such
Indemnitee had used commercially reasonable efforts to timely pursue such
refund or credit.

(d) Notwithstanding Section 11.3(c)(v), all Designated Matter Damages shall be
recovered by the Indemnitees from the Special Indemnity Escrow Funds;
provided, that for the avoidance of doubt, the Indemnitees may recover any
such Damages that are not fully recovered from the Special Indemnity Escrow
Funds directly from the Sellers in accordance with their Pro Rata Portions.



12. Miscellaneous Provisions

12.1 Sellers' Representative.

(a) Appointment. Each Seller hereby irrevocably nominates, constitutes and
appoints the Sellers' Representative as the agent and true and lawful
attorney-in-fact of such Seller, with full power of substitution, to act in
the name, place and stead of such Seller for purposes of executing any
documents and taking, or refraining from taking, any actions that the Sellers'
Representative may, in the Sellers' Representative's sole discretion,
determine to be necessary, desirable or appropriate in connection with this
Agreement and any other agreement, document or instrument referred to in or
contemplated by this Agreement and any transaction contemplated under this
Agreement or any such other agreement, document or instrument including with
respect to, any claim for indemnification, compensation or reimbursement under
Section 11 or the Escrow Agreement. Charles Miller hereby accepts his
appointment as the Sellers' Representative. Purchaser shall be entitled to
deal exclusively with the Sellers' Representative on all matters relating to
this Agreement and any other agreement, document or instrument referred to in
or contemplated by this Agreement and any transaction contemplated under this
Agreement or any such other agreement, document or instrument (including all
matters relating to any notice to, or any Consent to be given or action to be
taken by, any Seller) and Purchaser shall be entitled to rely conclusively
(without further evidence of any kind whatsoever) on any document executed or
purported to be executed on behalf of any Seller by the Sellers'
Representative, and on any other action taken or purported to be taken on
behalf of any Seller by the Sellers' Representative, as fully binding upon
such Seller.

(b) Authority. Each of the Sellers hereby grants to the Sellers'
Representative the absolute and unrestricted right, power and authority to
execute, deliver, acknowledge, certify and file on behalf of such Seller (in
the name of any or all of the Sellers or otherwise) any or all documents that
the Sellers' Representative may, in his sole discretion, determine to be
necessary, desirable or appropriate, in such forms and containing such
provisions as the Sellers' Representative may, in his sole discretion,
determine to be appropriate, in performing his duties as contemplated by
Section 12.1(a), including amending this Agreement pursuant to Section 12.15.
Without limiting the generality of the foregoing, each Seller hereby grants to
the Sellers' Representative full authority to:

(i) take all actions required by, and exercise all rights granted to, the
Sellers' Representative in this Agreement, the Escrow Agreement or any other
agreement or instrument delivered by any Seller or the Sellers' Representative
in connection with the transactions contemplated by this Agreement;

(ii) receive all notices or other documents given or to be given to such
Seller by Purchaser pursuant to this Agreement, the Escrow Agreement or any
other agreement or instrument delivered by any Seller or the Sellers'
Representative in connection with the transactions contemplated by this
Agreement;

(iii) negotiate, undertake, compromise, defend, resolve and settle any suit,
proceeding or dispute on behalf of such Seller under this Agreement, the
Escrow Agreement or



any other agreement or instrument delivered by any Seller or the Sellers'
Representative in connection with the transactions contemplated by this
Agreement, including any arbitration proceedings conducted in accordance with
the terms herein;

(iv) to retain $4,000,000 (the "Sellers' Representative Amount") of the
Purchase Price as a reserve against Liabilities incurred by the Sellers or
Sellers' Representative in his capacity as the Sellers' Representative (the
"Sellers' Representative Fund") in connection with this Agreement and the
transactions contemplated hereby and as otherwise set forth in Section
12.1(f);

(v) execute and deliver all agreements, certificates and documents required or
deemed appropriate by the Sellers' Representative in connection with any of
the transactions contemplated by this Agreement, the Escrow Agreement and any
other agreement or instrument delivered by any Seller or the Sellers'
Representative in connection with the transactions contemplated by this
Agreement; and

(vi) take such other action as the Sellers' Representative may deem necessary
or appropriate to carry out the intents and purposes of this Agreement, the
Escrow Agreement and any other agreement or instrument delivered by any Seller
or the Sellers' Representative in connection with the transactions
contemplated by this Agreement.

Notwithstanding anything to the contrary contained in this Agreement or in any
other agreement executed in connection with the transactions contemplated
hereby, each Indemnitee shall be entitled to deal exclusively with the
Sellers' Representative on all matters relating to any claim for
indemnification, compensation or reimbursement under Section 11 or under the
Escrow Agreement.

(c) Power of Attorney. The Sellers recognize and intend that the power of
attorney granted in Section 12.1(a): (i) is coupled with an interest and is
irrevocable; (ii) may be delegated by the Sellers' Representative; and (iii)
shall survive the death, incapacity, dissolution, liquidation or winding up of
each of the Sellers.

(d) Replacement. If the Sellers' Representative shall die, resign, become
disabled or otherwise be unable to fulfill his responsibilities hereunder, the
Sellers shall within ten days after such death, resignation or disability or
inability, appoint a successor to the Sellers' Representative (who shall be
reasonably satisfactory to Purchaser) and immediately thereafter notify
Purchaser of the identity of such successor. Any such successor shall succeed
the Sellers' Representative as Sellers' Representative hereunder. If for any
reason there is no Sellers' Representative at any time, all references herein
to the Sellers' Representative shall be deemed to refer to the Sellers.

(e) No Liability. Under no circumstances shall Sellers' Representative be
liable to any Seller in its capacity as Sellers' Representative other than in
the case of Fraud or willful misconduct.



(f) Sellers' Representative Fund. The Sellers' Representative Fund shall be
held by the Sellers' Representative as agent and for the benefit of the
Sellers and shall be used for the purposes of (i) paying directly or
reimbursing the Sellers' Representative for any fees or expenses incurred in
connection with this Agreement, the Escrow Agreement or any applicable
Sellers' Representative letter agreement, (ii) paying certain specified
Damages in accordance with Section 11 (at the discretion of the Sellers'
Representative), (iii) paying any other amounts provided for by agreement
among the Sellers, and (iv) otherwise satisfying certain Liabilities incurred
by the Sellers or the Sellers' Representative in connection with this
Agreement and the transactions contemplated hereby. As soon as reasonably
determined by the Sellers' Representative that the Sellers' Representative
Fund is no longer required to be withheld, the Sellers' Representative shall
distribute the then remaining amount of the Sellers' Representative Fund, if
any, to the Sellers based on their respective Special Pro Rata Portions.

12.2 Further Assurances. Each Party shall execute and cause to be delivered to
each other Party such instruments and other documents, and shall take and
cause to be taken such other actions, as such other Party may reasonably
request (at or after the Closing) for the purpose of carrying out or
evidencing any of the transactions contemplated by this Agreement.

12.3 Fees and Expenses. Subject to Section 1.3(d), Section 7.1(a), Section 11,
Section 12.4 and the Escrow Agreement, each Party shall bear and pay all fees,
costs and expenses that have been incurred or that are incurred in the future
by such Party in connection with the transactions contemplated by this
Agreement, including all fees, costs and expenses incurred by such Party in
connection with or by virtue of: (a) the negotiation, preparation and review
of this Agreement (including the Disclosure Schedule) and all agreements,
certificates, opinions and other instruments and documents delivered or to be
delivered in connection with the transactions contemplated by this Agreement;
(b) the preparation and submission of any filing or notice required to be made
or given in connection with any of the transactions contemplated by this
Agreement, and the obtaining of any Consent required to be obtained in
connection with any of such transactions; and (c) the consummation of the
transactions contemplated by this Agreement.

12.4 Taxes.

(a) Tax Returns.

(i) Tax Return Filings by Sellers.

(A) The Sellers shall file or cause to be filed when due (taking into account
all extensions properly obtained) all flow-through income Tax Returns of the
Acquired Companies for Tax periods ending on or prior to the Closing Date and
all Tax Returns of the Spin-Off Entities for any Tax period ending on or prior
to the Closing Date and any Straddle Period. The Sellers shall file when due
all other Tax Returns of the Acquired Companies that are due (taking into
account all extensions properly obtained) on or prior to the Closing Date.
Blocker Seller shall file or cause to be filed when due (taking into account
all extensions properly obtained) all income Tax Returns of Blocker and the
BWA Entities for tax periods ending on or before the Closing Date.



(B) In each case, the Sellers (or, in the case of Blocker or the BWA Entities,
Blocker Seller) shall remit or cause to be remitted any Taxes due in respect
of such Tax Returns, excluding the amounts of any Taxes included as a
liability in Net Working Capital or Indebtedness (but only to the extent that
such inclusion actually reduces the Closing Purchase Price). All Tax Returns
that Sellers and Blocker Seller are required to file or cause to be filed in
accordance with this Section 12.4(a)(i) shall be prepared and filed in a
manner consistent with past practice and, on such Tax Returns, no position
shall be taken, election made or method adopted that is inconsistent with
positions taken, elections made or methods used in preparing and filing
similar Tax Returns in prior periods (including positions, elections or
methods that would have the effect of deferring income to periods ending after
the Closing Date or accelerating deductions to periods ending on or before the
Closing Date, unless otherwise required by applicable Legal Requirements). The
Sellers' Representative or Blocker Seller, as applicable, shall submit a draft
copy of any Tax Return that Sellers or Blocker Seller are required to file or
cause to be filed in accordance with this Section 12.4(a)(i) to Purchaser, no
later than 30 Business Days in the case of any income Tax Return, or within a
reasonable amount of time (but in no event later than 15 Business Days in the
case of any other Tax Return), prior to the due date for filing such Tax
Return, for its review. Such Tax Returns shall not be filed without the
consent of Purchaser (such consent not to be unreasonably withheld,
conditioned or delayed). The Sellers' Representative or Blocker Seller, as
applicable, shall consider in good faith any comments of Purchaser regarding
such Tax Returns that are delivered in writing to the Sellers' Representative
or Blocker Seller, as applicable, no later than 15 Business Days in the case
of any income Tax Return, or no later than ten Business Days in the case of
any other Tax Return after receipt by Purchaser of the applicable Tax Return,
and in the event that Purchaser and the Sellers' Representative or Blocker
Seller, as applicable, cannot resolve any disputed item, Purchaser and the
Sellers' Representative or Blocker Seller, as applicable, shall cause the item
in question to be resolved by the Accounting Firm in accordance with the
procedures set forth in Section 1.3(c) (to the extent applicable), which
resolution shall be binding on the Parties.

(C) Notwithstanding any other provisions herein, the Texas franchise tax
return that will be filed in 2020 for the privilege of doing business in Texas
during 2020 (the "Texas 2020 Return") will be filed by Sellers' Representative
regardless of whether such Tax Return is filed on, before or after the Closing
Date. For the avoidance of doubt, such Tax Return shall be treated in this
Agreement as a Tax Return for a Straddle Period.

(ii) Tax Return Filings by Purchaser.

(A) Purchaser shall file or cause to be filed when due (taking into account
all extensions properly obtained) all Tax Returns that are required to be
filed by or with respect to the Acquired Companies, Blocker or the BWA
Entities, other than those described in Section 12.4(a)(i), including for the
avoidance of doubt the U.S. federal, state and local income Tax Returns of the
Acquired Companies and the Blocker Entities for a Straddle Period; provided,
however, that for purposes of the provisions of this Section 12.4 (other than
Section 12.4(a)(i)), the term "Acquired Companies" shall refer only to the
Company, 340B OpCo and PHSS and shall not refer to any of the Spin-Off
Entities for the period after the Spin-Off except where stated otherwise.



(B) Any Tax Return that Purchaser is required to file or cause to be filed in
accordance with this Section 12.4(a)(ii) for any Pre-Closing Tax Period
(including any Straddle Period) shall be prepared and filed in a manner
consistent with past practice and, on such Tax Returns, no position shall be
taken, election made or method adopted that is inconsistent with positions
taken, elections made or methods used in preparing and filing similar Tax
Returns in prior periods (including elections or methods that would have the
effect of accelerating income to periods ending before the Closing Date or
deferring deductions to periods ending on or after the Closing Date) except to
the extent that Purchaser determines is required by applicable Legal
Requirements; provided, that, notwithstanding any other provision in this
Agreement, the federal partnership income Tax Return of the Company for a
Straddle Period and any conforming state and local income Tax Returns for a
Straddle Period shall comply with the requirements set forth in Schedule
12.4(a)(ii)(B), to the extent applicable in the case of such state and local
income Tax Returns. Purchaser shall submit a draft copy of any such Tax Return
for a Straddle Period to the Sellers' Representative or, in the case of any
such Tax Return relating to Blocker or any BWA Entity, to Blocker Seller, no
later than 30 Business Days in the case of any income Tax Return, or within a
reasonable amount of time (but in no event later than 15 Business Days) in the
case of any other Tax Return, prior to the due date for filing such Tax
Return, for its review and consent prior to filing (such consent not to be
unreasonably withheld, conditioned or delayed). Purchaser's submission of the
draft Tax Return for the Straddle Period shall include a workpaper (and
necessary supporting data) that provides for the allocation of items of
income, gain, loss, deduction and credit between the portion of the Straddle
Period ending on the Closing Date and the portion ending after the Closing
Date as determined applying the principles set forth in Section 11.2(a)(iv);
Purchaser shall consider in good faith any comments of the Sellers'
Representative or Blocker Seller, as applicable, regarding such Tax Returns
that are delivered in writing to Purchaser no later than 15 Business Days in
the case of any income Tax Return, or no later than 10 Business Days in the
case of any other Tax Return, after receipt by the Sellers' Representative or
Blocker Seller, as applicable, of the applicable Tax Return, and in the event
that Purchaser and the Sellers' Representative or Blocker Seller, as
applicable, cannot resolve any disputed item, Purchaser and the Sellers'
Representative or Blocker Seller, as applicable, shall cause the item in
question to be resolved by the Accounting Firm in accordance with the
procedures set forth in Section 1.3(c) (to the extent applicable), which
resolution shall be binding on the Parties. The Sellers or Blocker Seller, as
applicable, shall remit or cause to be remitted the excess, if any, of (A) the
amount of Taxes on such Tax Returns relating to the portion of such Straddle
Period ending on the Closing Date (as determined, under Section 11.2(a)(iv)),
over (B) the amount of Taxes paid by the Acquired Companies (including the
Spin-Off Entities) on or before the Closing Date in respect of such Straddle
Period or otherwise included in the determination of the Closing Purchase
Price and, if the amount in clause (B) (determined by excluding any Taxes
attributable to the Spin-Off Entities) shall exceed the amount described in
clause (A) above, Purchaser shall promptly pay the amount of such excess to
the Sellers\' Representative for the benefit of the Sellers or Blocker Seller,
as applicable. For the purposes of the preceding sentence, in the case of
Blocker Seller, the amount of Taxes relating to the portion of the Straddle
Period ending on the Closing Date shall include the Tax liability that each of
BWA Common and BWA Preferred would have as determined pursuant to Treasury
Regulation Section 1.1502-76(b)(2)(vi). For the avoidance of doubt, neither
Purchaser, the Acquired



Companies nor the Blocker Entities shall be liable for any Taxes of the Spin-
Off Entities whether incurred before or after the Closing.

(iii) For the avoidance of doubt, the Transaction Tax Deductions shall be
claimed on the U.S. federal (and applicable state, local and non-U.S.) Tax
Returns of the Acquired Companies (including the Spin-Off Entities), Blocker
and the BWA Entities for the pre-Closing portion of any Straddle Period, as
applicable, except where to do so would be inconsistent with applicable Legal
Requirements.

(b) This Section 12.4(b) rather than Section 11.8 shall control with respect
to any Tax Proceeding. As used in this Agreement, the term "Tax Proceeding"
shall mean any pending or threatened audit, examination or other
administrative or judicial proceeding, contest, assessment, notice of
deficiency or other adjustment or proposed adjustment that relates to either
(i) any and all Taxes of the Company, an Acquired Company (including the Spin-
Off Entities), Blocker or any BWA Entity, or flow through income Tax Returns
with respect to a tax period ending on or before the Closing Date, as
applicable, or (ii) to the extent not referred to in clause "(i)" of this
sentence, the Designated Tax Matter. Purchaser shall promptly notify the
Sellers' Representative (or, in the case of a Tax Proceeding relating to
Blocker or a BWA Entity, Blocker Seller) in writing upon receipt by Purchaser,
the Company, an Acquired Company, Blocker or any BWA Entity of written notice
of any Tax Proceeding. The Sellers' Representative shall assume control and be
responsible for any Tax Proceeding relating solely to a Spin-Off Entity and
shall be responsible for any Taxes in accordance with, but subject to any
applicable limitations of, Section 11 arising from such Tax Proceeding. The
Sellers' Representative shall assume control and be responsible for any Tax
Proceeding relating solely to a Special Tax Indemnity Matter and shall be
responsible for any Taxes (and in the case of any Designated Tax Matter, any
Designated Matter Damages) in accordance with, but subject to any applicable
limitations of, Section 11, except to the extent otherwise provided in Section
11.12; provided, that, Purchaser shall have the right to participate in any
such Tax Proceeding at its expense through its own counsel. The Sellers'
Representative (or, in the case of a Tax Proceeding relating to Blocker or a
BWA Entity, Blocker Seller) shall have, in its discretion, the right to assume
control and defend at its expense any Tax Proceeding not relating to a Spin-
Off Entity or a Special Tax Indemnity Matter by providing written notice to
Purchaser within thirty (30) days after receipt of such notice from Purchaser;
provided, that, Purchaser shall have the right to participate in any such Tax
Proceeding at its expense through its own counsel. The Sellers' Representative
(or, in the case of a Tax Proceeding relating to Blocker or a BWA Entity,
Blocker Seller) may settle or compromise any such Tax Proceeding in its
discretion; provided, that, if any such settlement or compromise would
reasonably be expected to materially and adversely affect the Company, an
Acquired Company, Blocker or any BWA Entity, as the case may be, for a Tax
period ending after the Closing Date, the Sellers' Representative or Blocker
Seller, as applicable, shall not settle or compromise such Tax Proceeding
without the written consent of Purchaser, which consent shall not be
unreasonably conditioned, withheld or delayed. Purchaser shall take all
reasonable actions requested by the Sellers' Representative or Blocker Seller,
as applicable, to permit the Sellers or Blocker Seller, as applicable, to
control and defend such Tax Proceeding (including, at Purchaser's election,
either by providing a limited power of attorney or by participating in such
Tax Proceeding). Any Tax Proceeding relating to a Straddle Period of the



Acquired Companies or to any other Tax Returns of the Acquired Companies or
Blocker required to be filed by Purchaser shall be controlled by Purchaser;
provided, however, that the Sellers' Representative or Blocker Seller, as
applicable, shall have the right to participate in such Tax Proceeding,
including through separate counsel of its own choosing at its sole cost and
expense and Purchaser shall use commercially reasonable efforts to provide the
Sellers' Representative or Blocker Seller with such participation rights,
provided, that, Purchaser shall, after consultation with Sellers'
Representative (or Blocker Seller, as the case may be), have the right to
control such Tax Proceeding. For the avoidance of doubt, the Sellers'
Representative shall control any Tax Proceeding relating to the Texas 2020
Return and Purchaser shall have such participation rights. Where a party has
participation rights pursuant to this Section 12.4(b), such rights shall
include (i) the right to receive reasonable advance notice of any meetings,
hearings or proceedings, and (ii) the right to review in advance and comment
on any pleadings, briefs or other documents to be filed. Purchaser shall not
enter into any settlement or compromise for any such Tax Proceeding described
in the second and third preceding sentence without the Sellers'
Representative's or Blocker Seller, as applicable, consent (which consent
shall not be unreasonably withheld, conditioned or delayed). For the avoidance
of doubt, the exercise of participation rights by Purchaser through counsel at
Purchaser's expense shall not eliminate or modify any right of Purchaser or
any other Indemnitee to assert Damages consisting of attorneys' fees or other
expenses as the result of any Tax Proceeding for which Purchaser or such other
Indemnitee reasonably incurs expenses on account of being made a party to such
Tax Proceeding prior to Sellers' Representative's assumption of control with
respect to such Tax Proceeding.

(c) For purposes of this Agreement, the Parties agree (i) that 70% of success-
based fees paid by the Company in connection with the transactions
contemplated hereby shall be deductible under Rev. Proc. 2011-29 and (ii) all
Transaction Expenses shall be allocated to the Pre-Closing Tax Period (which
for the avoidance doubt shall include Change of Control Bonus of the
Continuing Employee Change of Control Bonus Recipient) for purposes of
preparing the Tax Returns of the Company, Blocker and the BWA Entities to the
maximum extent permitted by applicable Legal Requirements (provided, that, for
the avoidance of doubt, Purchaser's own expenses in connection with the
transactions contemplated herein shall be allocated to tax periods in
accordance with Purchaser's practices and requirements). Without the prior
written consent of the Sellers' Representative (or, in the case of any actions
described in this sentence relating to Blocker or the BWA Entities, Blocker
Seller), which consent shall not be unreasonably withheld, conditioned or
delayed (it being agreed that any refusal to consent to any actions described
below relating to any matter described in paragraph 1, 2 or 3 of Schedule
11.2(a)(vi) or to the Historic Treatment shall not be considered
unreasonable), Purchaser shall not, and shall not permit its Affiliates, an
Acquired Company, Blocker or any BWA Entities, to (1) file any Tax Return for
an Acquired Company, Blocker or any BWA Entity for a Pre-Closing Tax Period
other than in accordance with Section 12.4(a) and this Section 12.4(c), (2)
amend any Tax Return for an Acquired Company (or file an administrative
adjustment request with respect to the Company under Section 6227 of the Code
(and any comparable provision of state or local law, if applicable)), Blocker
or any BWA Entity for a Pre-Closing Tax Period, including the Company 2020
Federal Return as to any matter specified in Schedule 12.4(a)(ii)(B), (3) make
or change any Tax election that applies or is retroactive to a Pre-Closing Tax
Period or take any



other action after the Closing that could reasonably be expected to result in
any increased Tax Liability for any Seller, an Acquired Company, Blocker or
any BWA Entity with respect to a Pre-Closing Tax Period, (4) file any Tax
Return for an Acquired Company, Blocker or any BWA Entity for a Pre-Closing
Tax Period in any jurisdiction where, prior to the date hereof, the Acquired
Company, Blocker or such BWA Entity, as the case may be, has not filed such
type of Tax Return, (5) agree to extend the statute of limitations with
respect to: (A) any assessment of any Tax or deficiency related to a Pre-
Closing Tax Period for Blocker, any BWA Entity or any Acquired Company; or (B)
any Pre-Closing Tax Period that could result in an imputed underpayment (as
that term is defined in Section 6225 of the Code) for an Acquired Company or
BWA Feeder, (6) compromise or settle any Tax Liability for a Pre-Closing Tax
Period other than in accordance with this Section 12.4(c), or (7) initiate any
voluntary contact with a taxing authority regarding any Pre-Closing Tax
Period, including the Company 2020 Federal Return as to any matter specified
in Schedule 12.4(a)(ii)(B); provided, that, the written consent of Sellers'
Representative (or, in the case of any actions described in this sentence
relating to Blocker or the BWA Entities, Blocker Seller), shall not be
required with respect to any Straddle Period where the action taken would not
affect the portion of the Straddle Period ending on the Closing Date. For the
portion of the Closing Date after the time of Closing, other than transactions
expressly contemplated hereby, Purchaser shall cause the Acquired Companies,
Blocker and the BWA Entities to carry on their respective businesses only in
the Ordinary Course of Business.

(d) The Parties agree to cause the Company to make an election under Section
754 of the Code (and any similar provision of applicable state, local or
non-U.S. Tax laws) for the taxable year that includes the Closing Date.

(e) Notwithstanding any other provision herein to the contrary, the Parties
understand and agree that in the event of any audit of the Company after the
Closing Date resulting in an adjustment under Section 6225 of the Code where
the reviewed year (as defined in Section 6225(d) of the Code) is or includes a
Pre-Closing Tax Period, the Company's "partnership representative" (as defined
in Section 6223 of the Code) for such Tax period shall cause the Company to
elect under Section 6226 of the Code to push such adjustment out to the
members of the Company so that such members and not the Company are liable for
any Tax attributable to such adjustment.

(f) Any income Tax refunds of BWA Preferred Corp. or BWA Common Corp.
attributable to carrybacks of net operating losses arising in any tax period
ending on or before the Closing Date or overpayments of estimated taxes with
respect to 2019 that are received by Purchaser, an Acquired Company, Blocker
or any BWA Entity, and any amounts credited against Tax (in lieu of receiving
such a refund) to which Purchaser, an Acquired Company, Blocker or any BWA
Entity become entitled, shall be for the account of Blocker Seller. Purchaser
shall promptly pay, or cause to be paid, any such refund, or the amount of any
such credit, that is for the account of Blocker Seller in accordance with and
to the extent provided in the preceding sentence by wire transfer of
immediately available funds to the account(s) designated in writing by Blocker
Seller prior to such payment. Purchaser shall, and shall cause the Company,
Blocker and each BWA Entity, to cooperate with Blocker Seller (including by
filing amended Tax Returns and filing any claim for refund (including IRS Form



1139 or IRS Form 4466) or amended Tax Returns prepared by Blocker Seller and
approved by Purchaser (such approval not to be unreasonably withheld,
conditioned or delayed) to effect a carryback of any net operating loss of BWA
Common Corp. or BWA Preferred Corp. for the tax period ending on the Closing
Date to the fullest extent permitted by applicable Legal Requirements), to
obtain any refunds or credits that would result in a payment to Blocker Seller
under this Section 12.4(f); provided, that, Blocker Seller shall reimburse
Purchaser for its reasonable out-of-pocket expenses incurred in preparing and
filing such amended Tax Returns and claims for refund. Blocker Seller and
Purchaser shall jointly participate in any conferences or proceedings relating
to such amended Tax Returns and claims for refund. If there is any contest
relating to such refund claims, Blocker Seller shall determine the arguments
to be made in such contest after considering in good faith the views of
Purchaser, provided, that, if any such argument is objected to by Purchaser on
the ground that it would reasonably be expected to materially and adversely
affect the Company, an Acquired Company, Blocker or any BWA Entity, as the
case may be, for a Tax period ending after the Closing Date (other than by
reducing any net operating loss carryforward available in any such period),
then neither Blocker Seller nor its representative shall assert such argument.
Neither Purchaser, BWA Common Corp. or BWA Preferred Corp. nor any of their
Affiliates shall elect to waive any carryback of net operating losses under
Section 172(b)(3) of the Code (or any similar provision of state or local or
foreign Legal Requirements) on any Tax Return of BWA Common Corp. or BWA
Preferred Corp. for any Tax Period ending on or before the Closing Date. In
the event that Purchaser, the Company, an Acquired Company, Blocker or any BWA
Entity is required to pay to the applicable taxing authority any amount that
has been paid to Blocker Seller pursuant to this Section 12.4(f), then Blocker
Seller shall pay such amount to Purchaser immediately after receiving notice
from Purchaser.

(g) Blocker Seller and Purchaser shall, with respect to U.S. federal income
tax returns pursuant to Treasury Regulation Section 1.1502-76(b), and with
respect to all other Tax Returns, unless prohibited by applicable Legal
Requirements, close the taxable period of the Blocker and each BWA Entity
(other than BWA Feeder) as of the close of business on the Closing Date. If
applicable Legal Requirements do not permit the Blocker or any BWA Entity, as
the case may be, to close its respective taxable year on the Closing Date or
in any case in which a Tax is assessed with respect to a Straddle Period, the
Taxes, if any, attributable to a Straddle Period shall be allocated as
provided in Section 11.2(c)(iv).

(h) Purchaser, each Acquired Company, Blocker, each of the BWA Entities,
Blocker Seller and the Sellers' Representative shall cooperate fully, as and
to the extent reasonably requested by any other Party, in connection with the
filing of Tax Returns pursuant to this Section 12.4 and any Tax Proceeding.
Such cooperation shall include the retention and (upon the other Party's
request) the provision of records and information which are reasonably
relevant to any such audit, litigation, or other proceeding and making
employees available on a mutually convenient basis to provide additional
information and explanation of any material provided hereunder, including
Purchaser and Acquired Company providing records and information reasonably
necessary for Sellers' Representative to satisfy its obligations under Section
11.2. Each Acquired Company, each Spin-Off Entity, Blocker and each of the BWA
Entities shall (1) retain all books and records with respect to Tax matters
pertinent to such Acquired Company,



Spin-Off Entity, Blocker and such BWA Entity relating to any taxable period
beginning before the Closing Date until the expiration of the statute of
limitations (and, to the extent notified by Purchaser, the Sellers'
Representative, an Acquired Company, a Spin-Off Entity, Blocker or any BWA
Entity, any extensions thereof) of the respective taxable periods, and to
abide by all record retention agreements entered into with any taxing
authority, and (2) give the other Party reasonable written notice prior to
transferring, destroying, or discarding of any such books and records and, if
the other Party so requests, Purchaser, the Sellers' Representative, the
Acquired Company, Blocker, the BWA Entities or Blocker Seller, as the case may
be, shall allow the other Party to take possession of such books and records.

(i) Purchaser agrees to timely sign and deliver such certificates or forms as
may be necessary or appropriate to establish an exemption from (or otherwise
reduce), or file Tax Returns with respect to, Transfer Taxes imposed on the
transactions contemplated by this Agreement. Purchaser, Sellers'
Representative and the Sellers shall use commercially reasonable efforts to
cooperate with each other to reduce any Transfer Taxes payable in connection
with the transactions contemplated by this Agreement. In the event that
Purchaser is required to make any payment to Sellers' Representative or
Blocker Seller pursuant to this Section 12.4, then Purchaser may, at its
option, make such payment to the Paying Agent for disbursement to Sellers'
Representative and/or Blocker Seller, as the case may be.

(j) Purchaser, Blocker, Blocker Seller and the Company agree to waive the
ratable allocation election in Treasury Regulation Section
1.1502-76-(b)(2)(ii)(D).

12.5 Attorneys' Fees. If any Legal Proceeding relating to this Agreement or
the enforcement of any provision of this Agreement is brought against any
Party, the prevailing Party shall be entitled to recover reasonable attorneys'
fees, costs and disbursements (in addition to any other relief to which the
prevailing Party may be entitled) from the other Party.

12.6 Notices. All notices, requests, demands and other communications under
this Agreement shall be in writing and shall be deemed to have been duly given
or made as follows: (a) if sent by registered or certified mail in the United
States, return receipt requested, upon receipt; (b) if sent designated for
overnight delivery by internationally recognized overnight air courier (such
as DHL or Federal Express), three Business Days after delivery to such
courier; or (c) if actually personally delivered, when delivered; provided,
that such notices, requests, demands and other communications are delivered to
the addresses set forth below, or to such other addresses as any Party shall
provide by like notice to the other Parties, accompanied by a simultaneous
delivery of such notices, requests, demands and other communications via
e-mail to the e-mail addresses set forth below:

If to Purchaser:

Omnicell, Inc.

590 E. Middlefield Road

Mountain View, CA 94043

Attention: General Counsel

Email: GeneralCounsel@omnicell.com





and with a copy (which shall not constitute notice) to:

Sidley Austin LLP

1001 Page Mill Rd, Building 1

Palo Alto, CA 94304

Attention: Jen Fitchen

Email: jfitchen@sidley.com



If to the Sellers, the Company (prior to Closing) or the Sellers'
Representative:

c/o Blue Wolf Capital Partners

One Liberty Plaza, 52nd Floor

New York, NY 10006

Facsimile: (917) 677-8233

E-mail: compliance@bluewolfcapital.com

Attention: Chief Compliance Officer and

Charles Miller, Sellers' Representative



with a copy (which shall not constitute notice) to:

Norton Rose Fulbright US LLP

2200 Ross Avenue, Suite 3600

Dallas, TX 75201

Attention: Bryn A. Sappington

Email: bryn.sappington@nortonrosefulbright.com



and



with a copy (which shall not constitute notice) to:

Holland and Knight LLP

1650 Tysons Blvd

Suite 1700

Tysons, VA 22102

Attention: Eric Wechselblatt

Email: Eric.Wechselblatt@hklaw.com



If to Blocker (prior to Closing):

BW Apothecary Holdings, LLC

c/o Blue Wolf Capital Partners

One Liberty Plaza, 52nd Floor

New York, NY 10006

Facsimile: (917) 677-8233

E-mail: compliance@bluewolfcapital.com

Attention: Chief Compliance Officer





with a copy (which shall not constitute notice) to:

Holland and Knight LLP

1650 Tysons Blvd

Suite 1700

Tysons, VA 22102

Attention: Eric Wechselblatt

Email: Eric.Wechselblatt@hklaw.com



12.7 Time of the Essence. For the purposes of this Agreement and the
transactions contemplated by this Agreement, time is of the essence with
respect to all dates and time periods.

12.8 Headings. The bold-faced headings and the underlined headings contained
in this Agreement are for convenience of reference only, shall not be deemed
to be a part of this Agreement and shall not be referred to in connection with
the construction or interpretation of this Agreement.

12.9 Counterparts and Exchanges by Electronic Transmission. This Agreement may
be executed in several counterparts (including by means of electronic
transmission in portable document format (pdf)), each of which shall
constitute an original and all of which, when taken together, shall constitute
one agreement. This Agreement and any signed agreement or instrument entered
into in connection with this Agreement, and any amendments hereto or thereto,
to the extent delivered by means of e-mail (any such delivery, an "Electronic
Delivery"), will be treated in all manner and respects as an original
agreement or instrument and will be considered to have the same binding legal
effect as if it were the original signed version thereof delivered in person.
At the reasonable request of any Party or to any such agreement or instrument,
each other Party will re-execute original forms thereof and deliver them to
all other Parties. No Party or to any such agreement or instrument will raise
the use of Electronic Delivery to deliver a signature or the fact that any
signature or agreement or instrument was transmitted or communicated through
the use of Electronic Delivery as a defense to the formation of a contract,
and each such Party waives any such defense, except to the extent such defense
related to lack of authenticity.

12.10 Governing Law; Dispute Resolution.

(a) Governing Law. This Agreement and all claims or causes of action (whether
in contract or tort) that may be based upon, arise out of or relate to this
Agreement or the negotiation, execution or performance of this Agreement
(including any claim or cause of action based upon, arising out of or related
to any representation or warranty made in or in connection with this
Agreement) shall be construed in accordance with, and governed in all respects
by, the laws of Delaware, without regard to the conflict of laws principles
thereof.

(b) Venue. Except as otherwise provided in the Escrow Agreement or in Section
12.10(c), any Legal Proceeding relating to this Agreement or the enforcement
of any



provision of this Agreement (including a Legal Proceeding based upon Fraud or
breach of a covenant or obligation set forth in this Agreement) shall be
brought or otherwise commenced exclusively in the Court of Chancery of the
State of Delaware, or, if (and only if) such court finds it lacks subject
matter jurisdiction, the Superior Court of the State of Delaware (Complex
Commercial Division) or, if subject matter jurisdiction over the matter that
is the subject of the Legal Proceeding is vested exclusively in the federal
courts of the United States of America, the federal court of the United States
of America sitting in the District of Delaware (collectively, the "Chosen
Courts"). Each Party: (i) expressly and irrevocably consents and submits to
the jurisdiction of the Chosen Courts in connection with any such Legal
Proceeding; (ii) agrees that each Chosen Courts shall be deemed to be a
convenient forum; and (iii) agrees not to assert (by way of motion, as a
defense or otherwise), in any such Legal Proceeding commenced in any Chosen
Court, any claim that such Party is not subject personally to the jurisdiction
of such court, that such Legal Proceeding has been brought in an inconvenient
forum, that the venue of such proceeding is improper or that this Agreement or
the subject matter of this Agreement may not be enforced in or by such court.

(c) Indemnification Claims. Any claim for indemnification, compensation or
reimbursement pursuant to Section 11 shall be brought and resolved exclusively
in accordance with Section 11.5 (it being understood that, for the avoidance
of doubt and without limiting any portion of Section 12.10(b); (i) any claim
or Legal Proceeding based upon Fraud or for breach of a covenant or obligation
set forth in this Agreement may only and exclusively be brought and resolved
in a Chosen Court rather than in accordance with Section 11.5; and (ii)
nothing in this Section 12.10(c) shall prevent any Indemnitee from seeking
preliminary injunctive relief or any other equitable remedy from a Chosen
Court).

12.11 Successors and Assigns. This Agreement shall be binding upon each of the
Parties and each of their respective heirs, estates, executors and personal
representatives and successors and permitted assigns, if any. This Agreement
shall inure to the benefit of: the Sellers, Purchaser, the other Indemnitees
and the respective heirs, estates, executors and personal representatives and
successors and permitted assigns (if any) of the foregoing. Purchaser may
freely assign any or all of its rights under this Agreement (including its
indemnification rights under Section 11), in whole or in part, to any other
Person without obtaining the consent or approval of any other Party or of any
other Person. No Seller shall be permitted to assign any of such Seller's
rights or delegate any of such Seller's obligations under this Agreement
without Purchaser's prior written consent. Any attempted assignment or
delegation by any Seller in violation of this Section 12.11 shall be null and
void.

12.12 Remedies Cumulative; Specific Performance. Except as expressly set forth
in this Agreement and without limiting the terms of Section 11, the rights and
remedies of the Parties shall be cumulative (and not alternative). The Parties
acknowledge and agree that the failure of any Party to perform its agreements
and covenants hereunder, including such Party's failure to take all actions as
are necessary on such Party's part in accordance with the terms and conditions
of this Agreement to consummate the transactions contemplated hereby, will
cause irreparable injury to the other Parties, for which Damages, even if
available, will not be an adequate remedy. Accordingly, each Party hereby
consents to the issuance of injunctive relief by



any court of competent jurisdiction to compel performance of such Party's
obligations and to the granting by any court of the remedy of specific
performance of such Party's obligations hereunder.

12.13 Waiver. No failure on the part of any Person to exercise any power,
right, privilege or remedy under this Agreement, and no delay on the part of
any Person in exercising any power, right, privilege or remedy under this
Agreement, shall operate as a waiver of such power, right, privilege or
remedy; and no single or partial exercise of any such power, right, privilege
or remedy shall preclude any other or further exercise thereof or of any other
power, right, privilege or remedy. No Person shall be deemed to have waived
any claim arising out of this Agreement, or any power, right, privilege or
remedy under this Agreement, unless the waiver of such claim, power, right,
privilege or remedy is expressly set forth in a written instrument duly
executed and delivered on behalf of such Person; and any such waiver shall not
be applicable or have any effect except in the specific instance in which it
is given.

12.14 Waiver of Jury Trial. EACH PARTY HEREBY ACKNOWLEDGES AND AGREES THAT ANY
CONTROVERSY WHICH MAY ARISE UNDER THIS AGREEMENT IS LIKELY TO INVOLVE
COMPLICATED AND DIFFICULT ISSUES, AND THEREFORE EACH SUCH PARTY HEREBY
IRREVOCABLY AND UNCONDITIONALLY WAIVES ANY RIGHT SUCH PARTY MAY HAVE TO A
TRIAL BY JURY IN RESPECT OF ANY LITIGATION DIRECTLY OR INDIRECTLY ARISING OUT
OF OR RELATING TO THIS AGREEMENT OR THE TRANSACTIONS CONTEMPLATED BY THIS
AGREEMENT. EACH PARTY CERTIFIES AND ACKNOWLEDGES THAT (I) NO REPRESENTATIVE,
AGENT OR ATTORNEY OF ANY OTHER PARTY HAS REPRESENTED, EXPRESSLY OR OTHERWISE,
THAT SUCH OTHER PARTY WOULD NOT, IN THE EVENT OF LITIGATION, SEEK TO ENFORCE
THE FOREGOING WAIVER, (II) EACH SUCH PARTY UNDERSTANDS AND HAS CONSIDERED THE
IMPLICATIONS OF THIS WAIVER, (III) EACH SUCH PARTY MAKES THIS WAIVER
VOLUNTARILY AND (IV) EACH SUCH PARTY HAS BEEN INDUCED TO ENTER INTO THIS
AGREEMENT BY, AMONG OTHER THINGS, THE MUTUAL WAIVERS AND CERTIFICATIONS IN
THIS SECTION 12.14.

12.15 Amendments. This Agreement may not be amended, modified, altered or
supplemented other than by means of a written instrument duly executed and
delivered on behalf of Purchaser and the Sellers' Representative (acting
exclusively for and on behalf of all of the Sellers).

12.16 Severability. In the event that any provision of this Agreement, or the
application of any such provision to any Person or set of circumstances, shall
be determined by a court of competent jurisdiction to be invalid, unlawful,
void or unenforceable to any extent, the remainder of this Agreement, and the
application of such provision to Persons or circumstances other than those as
to which it is determined to be invalid, unlawful, void or unenforceable,
shall not be impaired or otherwise affected and shall continue to be valid and
enforceable to the fullest extent permitted by law.



12.17 Parties in Interest. Except for the provisions of Section 11, none of
the provisions of this Agreement is intended to provide any rights or remedies
to any Person other than the Parties, the Indemnitees and their respective
successors and assigns (if any).

12.18 Confidential Nature of Information. Each Seller agrees that he, she or
it will, and will cause his, her or its Affiliates and employees, agents and
other Representatives to, treat in confidence (i) all documents, materials and
other written or oral information which he, she or it shall have obtained at
any time regarding Purchaser or its Affiliates, (ii) all documents, materials
and other written or oral information which he, she or it shall have obtained
at any time regarding the Company, 340B OpCo, PHSS, any Blocker Entity or the
Retained Business and (iii) all documents, materials and other written or oral
information which he, she or it shall have obtained at any time regarding the
transactions contemplated by this Agreement (including the existence and terms
of this Agreement and all the other agreements referred to in this Agreement),
and not use any such documents, materials and other written or oral
information for any purpose other than as specified in this Agreement;
provided, however, the obligation of each Seller to treat such documents,
materials and other written or oral information in confidence and not to use
any such documents, materials and other written or oral information for any
purpose other than as specified in this Agreement shall not apply to any
information which (a) is or becomes available to the public other than as a
result of any act or failure to act by such Seller or any of his, her or its
Affiliates or their employees, agents and other Representatives or (b) is
required to be disclosed under applicable law or judicial process, but only
that portion of such information which it is advised by counsel in writing is
legally required to be disclosed; provided, that such Seller shall promptly
notify Purchaser in writing of such requirement and shall use commercially
reasonable efforts to obtain an appropriate protective order or other
reasonable assurance that confidential treatment will be accorded such
information. Notwithstanding the foregoing, nothing in this Section 12.18
shall prevent a Seller from disclosing any relevant information, documents or
materials to the extent reasonably required in any dispute with Purchaser or
any of its Affiliates or any Indemnitee; provided that reasonable efforts are
made to maintain the confidentiality of such information, documents or
materials.

12.19 No Public Announcement. Prior to the Closing, neither Purchaser, any
Seller, Sellers' Representative, Blocker nor the Company (nor any of their
respective Affiliates or Representatives) shall, without the approval of each
other Party, make any press release or other public announcement concerning
this Agreement (including the terms and the existence of this Agreement) or
the transactions contemplated by this Agreement, except as and to the extent
that any Party shall be so obligated by law, in which case such Party shall
first advise each other Party thereof and the Parties shall use commercially
reasonable efforts to cause a mutually agreeable release or announcement to be
issued; provided, however, that the foregoing shall not preclude
communications or disclosures necessary to implement the provisions of this
Agreement; and provided, further, that Purchaser may issue a press release
announcing the transactions contemplated hereby in connection with the
execution of this Agreement. Following the Closing, none of the Sellers, nor
the Sellers' Representative nor any of their Affiliates or Representatives
shall make any press release or other public announcement concerning this
Agreement (including the terms and the existence of this Agreement) or the
transactions contemplated by this Agreement, except as and to the extent that
such Party shall be so obligated



by law, in which case such Party shall advise Purchaser thereof and the
Parties shall use commercially reasonable efforts to cause a mutually
agreeable release or announcement to be issued.

12.20 Legal Representation. Each of the Parties acknowledges that Norton Rose
Fulbright US LLP ("Norton Rose Fulbright") currently serves as counsel to each
of (i) the Company, (ii) Blocker and (iii) the Class A Holder, including in
connection with the negotiation, preparation, execution and delivery of this
Agreement and the consummation of the transactions contemplated hereby. There
may come a time, including after the Closing, when the interests of the Class
A Holder, the Company and Blocker may no longer be aligned or when, for any
reason, the Class A Holder, Norton Rose Fulbright, the Company or Blocker
believe that Norton Rose Fulbright cannot or should no longer represent each
of the Class A Holder, the Company and Blocker. The Parties understand and
specifically agree that Norton Rose Fulbright may withdraw from representing
the Company and/or Blocker, as the case may be, and continue to represent the
Class A Holder, even if the interests of the Class A Holder, and the interests
of the Company and/or Blocker, as the case may be, are or may be adverse,
including in connection with any dispute arising out of or relating to this
Agreement or the transactions contemplated hereby, and even though Norton Rose
Fulbright may have represented the Company or Blocker in a matter
substantially related to such dispute or may be handling ongoing matters for
the Company, Blocker or any of their respective Affiliates, and Purchaser, the
Company and Blocker hereby consent thereto and waive any conflict of interest
arising therefrom. Each of the Parties agrees that, as to all communications
among Norton Rose Fulbright, the Class A Holder and Holland and Knight LLP, as
counsel to Blocker Seller ("Holland and Knight"), related to the transactions
contemplated by this Agreement and not involving the Company or any of its
Subsidiaries or any of the Blocker Entities, the attorney-client privilege,
the expectation of client confidence and all other rights to any evidentiary
privilege belong to the Sellers' Representative, on behalf of the Sellers, and
shall not pass to or be claimed by the Company, any Acquired Company or any
Blocker Entity. As to any communications between Norton Rose Fulbright, the
Company and its Subsidiaries, the Blocker Entities and Holland and Knight prior
to the Closing (collectively, the "Privileged Communications"), Purchaser, the
Company and Blocker, together with any of their respective Affiliates,
successors or assigns, agree that no such Person may use or rely on any of the
Privileged Communications in any action or claim against or involving any of
the Sellers after the Closing. Notwithstanding anything herein to the
contrary, any communications between Holland and Knight and Blocker Seller or
any of its Affiliates shall be attorney-client confidences that belong solely
to the Blocker Seller. Recognizing that Holland and Knight has acted as legal
counsel to Blocker Seller and the Blocker Entities prior to the Closing, and
that Holland and Knight intends to act as legal counsel to Blocker Seller and
certain of their Affiliates after the Closing, Purchaser hereby waives, on its
own behalf and agrees to cause its Affiliates to waive, any conflicts that may
arise in connection with Holland and Knight's representing Blocker Seller and/or
their Affiliates after the Closing as such representation may relate to
Purchaser or the transactions contemplated herein (including in respect of
litigation).

12.21 Entire Agreement. This Agreement and the other agreements referred to
herein (including the Disclosure Schedule) set forth the entire understanding
of the Parties relating to the subject matter hereof and thereof and supersede
all prior agreements and



understandings among or between any of the Parties relating to the subject
matter hereof and thereof. The Parties acknowledge and agree that, effective
as of the Closing, the Confidentiality Agreement dated February 14, 2020
between PSG and Purchaser shall be terminated and shall be null and void and
of no force or effect.

12.22 Disclosure Schedule. The Disclosure Schedule shall be arranged in
separate parts corresponding to the numbered and lettered sections and
subsections contained in this Agreement, and the information disclosed in any
numbered or lettered part shall be deemed to relate to and to qualify only the
particular representation or warranty of the Company, the Sellers or Blocker,
as applicable, set forth in the corresponding numbered or lettered section or
subsection of this Agreement, except to the extent that (a) such information
is explicitly cross-referenced in another part of the Disclosure Schedule or
(b) it is reasonably apparent on the face of the disclosure (without reference
to any document referred to therein) that such information qualifies another
representation and warranty of the Company, the Sellers or Blocker, as
applicable, in this Agreement. The Disclosure Schedule may not be amended or
modified after the execution of this Agreement.

12.23 Mutual Drafting. The Parties are sophisticated and have been represented
by attorneys throughout the transactions contemplated hereby who have
carefully negotiated the provisions hereof. As a consequence, the Parties do
not intend that the presumptions of laws or rules relating to the
interpretation of contracts against the drafter of any particular clause
should be applied to this Agreement or any agreement or instrument executed in
connection herewith, and therefore waive their effects.

12.24 Construction.

(a) Gender; Etc. For purposes of this Agreement, whenever the context
requires: the singular number shall include the plural, and vice versa; the
masculine gender shall include the feminine and neuter genders; the feminine
gender shall include the masculine and neuter genders; and the neuter gender
shall include the masculine and feminine genders.

(b) Interpretation. As used in this Agreement: (i) the words "include" and
"including," and variations thereof, shall not be deemed to be terms of
limitation, but rather shall be deemed to be followed by the words "without
limitation"; (ii) the use of the word "or" shall not be exclusive; (iii) the
phrase "substantially in the form attached hereto" and any variations thereof
shall be deemed to mean in such form attached hereto subject to immaterial
changes; and (iv) the words "written" and "in writing" include communications
delivered electronically.

(c) References. Except as otherwise indicated, all references in this
Agreement to "Sections," "Schedules" and "Exhibits" are intended to refer to
Sections of this Agreement and Schedules and Exhibits to this Agreement.

(d) Currency. All references in this Agreement to "dollars" or "$"shall mean
United States Dollars.

[Remainder of page intentionally left blank]



The Parties have caused this Agreement to be executed and delivered as of the
date first written above.

OMNICELL, INC.,

a Delaware corporation

By: /s/ Peter J. Kuipers



Name: Peter J. Kuipers



Title: Executive Vice President and Chief Financial Officer





[Signature Page to Equity Purchase Agreement] 

The Parties have caused this Agreement to be executed and delivered as of the
date first written above.



PSGH, LLC,

a Texas limited liability company

By: /s/ David Borden



Name: David Borden



Title: President



[Signature Page to Equity Purchase Agreement] 

The Parties have caused this Agreement to be executed and delivered as of the
date first written above.

SELLERS' REPRESENTATIVE





/s/ Charles Miller

Charles Miller









[Signature Page to Equity Purchase Agreement] 



The Parties have caused this Agreement to be executed and delivered as of the
date first written above.

BW APOTHECARY HOLDINGS, LLC,

a Delaware limited liability company



By: /s/Charles P. Miller



Name: Charles P. Miller



Title: Secretary















[Signature Page to Equity Purchase Agreement] 

The Parties have caused this Agreement to be executed and delivered as of the
date first written above.

"CLASS A HOLDER":



By: /s/ David Borden



Name: David Borden





[Signature Page to Equity Purchase Agreement] 

The Parties have caused this Agreement to be executed and delivered as of the
date first written above.

BLUE WOLF CAPITAL FUND II, L.P.,

a Delaware limited partnership

By: Blue Wolf Capital Advisors, L.P., its General Partner

By: Blue Wolf Capital Advisors, LLC., its General Partner





By: /s/ Charles P. Miller



Name: Charles P. Miller



Title: Manager







[Signature Page to Equity Purchase Agreement] 

The Parties have caused this Agreement to be executed and delivered as of the
date first written above.

"CLASS C HOLDERS":





By: /s/ Jeff Legg



Name: Jeff Legg









[Signature Page to Equity Purchase Agreement] 

The Parties have caused this Agreement to be executed and delivered as of the
date first written above.

"CLASS C HOLDERS":





By: /s/ Molly Breimhorst



Name: Molly Breimhorst







[Signature Page to Equity Purchase Agreement] 

The Parties have caused this Agreement to be executed and delivered as of the
date first written above.

"CLASS C HOLDERS":





By: /s/ Michael Lonergan



Name: Michael Lonergan





[Signature Page to Equity Purchase Agreement] 

The Parties have caused this Agreement to be executed and delivered as of the
date first written above.

"CLASS C HOLDERS":





By: /s/ Diana Fox



Name: Diana Fox





[Signature Page to Equity Purchase Agreement] 

The Parties have caused this Agreement to be executed and delivered as of the
date first written above.

"CLASS C HOLDERS":





By: /s/ Rebekah Gregg



Name: Rebekah Gregg







[Signature Page to Equity Purchase Agreement] 

The Parties have caused this Agreement to be executed and delivered as of the
date first written above.

"CLASS D HOLDERS":



By: /s/ Bill Brewer



Name: Bill Brewer







[Signature Page to Equity Purchase Agreement] 

The Parties have caused this Agreement to be executed and delivered as of the
date first written above.

"CLASS D HOLDERS":



By: /s/ Karen Atkinson



Name: Karen Atkinson





[Signature Page to Equity Purchase Agreement] 

The Parties have caused this Agreement to be executed and delivered as of the
date first written above.

"CLASS D HOLDERS":



By: /s/ Michael Lonergan



Name: Michael Lonergan





[Signature Page to Equity Purchase Agreement] 

The Parties have caused this Agreement to be executed and delivered as of the
date first written above.

"CLASS D HOLDERS":



By: /s/ Dee Jones



Name: Dee Jones





[Signature Page to Equity Purchase Agreement] 

The Parties have caused this Agreement to be executed and delivered as of the
date first written above.

"CLASS D HOLDERS":



By: /s/ Kevin O\'Connor



Name: Kevin O\'Connor





[Signature Page to Equity Purchase Agreement] 

The Parties have caused this Agreement to be executed and delivered as of the
date first written above.

"CLASS D HOLDERS":



By: /s/ Mike Medel



Name: Mike Medel





[Signature Page to Equity Purchase Agreement] 

The Parties have caused this Agreement to be executed and delivered as of the
date first written above.

"CLASS D HOLDERS":



By: /s/ Tracy Spencer



Name: Tracy Spencer





[Signature Page to Equity Purchase Agreement] 

The Parties have caused this Agreement to be executed and delivered as of the
date first written above.

"CLASS D HOLDERS":



By: /s/ Charlie Hirner



Name: Charlie Hirner





[Signature Page to Equity Purchase Agreement] 

The Parties have caused this Agreement to be executed and delivered as of the
date first written above.

"CLASS D HOLDERS":



By: /s/ John Hines



Name: John Hines





[Signature Page to Equity Purchase Agreement] 

The Parties have caused this Agreement to be executed and delivered as of the
date first written above.

"CLASS D HOLDERS":



By: /s/ Chris Hoover



Name: Chris Hoover





[Signature Page to Equity Purchase Agreement] 

The Parties have caused this Agreement to be executed and delivered as of the
date first written above.

"CLASS D HOLDERS":



By: /s/ Jeff Spencer



Name: Jeff Spencer





[Signature Page to Equity Purchase Agreement] 

The Parties have caused this Agreement to be executed and delivered as of the
date first written above.

"CLASS D HOLDERS":



By: /s/ Libby Johnson



Name: Libby Johnson





[Signature Page to Equity Purchase Agreement] 

The Parties have caused this Agreement to be executed and delivered as of the
date first written above.

"CLASS D HOLDERS":



By: /s/ Diana Fox



Name: Diana Fox





[Signature Page to Equity Purchase Agreement] 

The Parties have caused this Agreement to be executed and delivered as of the
date first written above.

"CLASS D HOLDERS":



By: /s/ Rebekah Gregg



Name: Rebekah Gregg





[Signature Page to Equity Purchase Agreement] 

The Parties have caused this Agreement to be executed and delivered as of the
date first written above.

"CLASS D HOLDERS":



By: /s/ Gary Golebiewski



Name: Gary Golebiewski



[Signature Page to Equity Purchase Agreement] 

EXHIBIT A

CERTAIN DEFINITIONS

For purposes of the Agreement (including this Exhibit A):

"340B Accounts" means the second and the fourth bank accounts set forth in
Part 2.8(a) of the Disclosure Schedule that are maintained by and for the
benefit of PHSS with Silicon Valley Bank for purposes of collecting payments
payable by contract pharmacies to 340B covered entity customers of the
Acquired Companies on such customers' behalf and distributing the collected
payments to the applicable 340B covered entity customers.

"340B Link Financial Statements" means, collectively, the Provided 340B Link
Financial Statements and the Required 340B Link Financial Statements.

"340B OpCo" means the new entity that will be created from the Divisional
Merger and will be wholly owned by the Company following the completion of the
Divisional Merger.

"340B Transition Services Agreement" means the Transition Services Agreement,
dated as of the Closing Date, by and between 340B OpCo and SpinCo
substantially in the form of Exhibit H-1 to the Agreement.

"Accounting Firm" has the meaning set forth in Section 1.3(c) of the
Agreement.

"Accrued Employee Amounts" has the meaning set forth in Section 6.11(c) of the
Agreement.

"Acquired Companies" means the Company and all of its Subsidiaries, which
Entities, following the completion of the PSG Distribution, shall be the
Company, 340B OpCo and PHSS.

"Acquired Company Pre-Closing Taxes" has the meaning set forth in Section
11.2(a)(iv) of the Agreement.

"Affiliate" means, with respect to any Person, any other Person controlling,
controlled by or under common control with such Person. For purposes of this
definition and the Agreement, the term "control" (and correlative terms) means
the possession, directly or indirectly, of the power to direct the management
and policies of a Person whether through the ownership of voting securities,
Contract or otherwise.

"Affiliated Group" means any group of corporations or other entities that, at
any time on or before the Closing Date, includes or has included any Acquired
Company or any direct or indirect predecessor of any Acquired Company, that
files or has filed Tax Returns on a combined, consolidated, unitary or similar
basis with any Acquired Company or any direct or indirect predecessor of any
Acquired Company, including any "affiliated group" as defined in Section
1504(a) of the Code without regard to the limitations contained in Section
1504(b) of the Code. 

"Agreed Amount" has the meaning set forth in Section 11.5(e) of the Agreement.

"Agreement" means the Equity Purchase Agreement to which this Exhibit A is
attached (including the Disclosure Schedule), as it may be amended from time
to time.

"Ancillary Agreements" has the meaning set forth in Section 2.20(a) of the
Agreement.

"Anti-Corruption and Anti-Bribery Laws" means the United States' Foreign
Corrupt Practices Act of 1977, as amended, and the rules and regulations
thereunder, and any other applicable anti-corruption or anti-bribery Legal
Requirements or any similar applicable Legal Requirements of any other
jurisdiction where any Acquired Company operates or does business.

"Arbitrable Dispute" has the meaning set forth in Section 11.5(g) of the
Agreement.

"Arbitration Law" has the meaning set forth in Section 11.5(g)(i) of the
Agreement.

"Award Amount" has the meaning set forth in Section 11.5(g)(v) of the
Agreement.

"Balance Sheet" has the meaning set forth in Section 2.4(a)(i) of the
Agreement.

"Balance Sheet Date" means June 30, 2020.

"Bank Model Contracts" means each Company Contract pursuant to which any
Acquired Company agrees to collect payments payable by pharmacies to the
Acquired Companies' 340B covered entity customers.

"Blocker" has the meaning ascribed to such term in the preamble to the
Agreement.

"Blocker Business Representations" means Sections 4.1(c), 4.1(e), 4.1(g), 4.2,
4.3(c), 4.3(f), 4.3(g), 4.4, 4.5, 4.6, 4.7, 4.8, 4.9, 4.11, 4.12, 4.13(ii) and
4.15.

"Blocker Closing Certificate" has the meaning set forth in Section 1.4(b)(xi)
of the Agreement.

"Blocker Contract" means any Contract: (a) to which any Blocker Entity is a
party; (b) by which any Blocker Entity or any of its assets is or may become
bound or under which any Blocker Entity has, or may become subject to, any
obligation; or (c) under which any Blocker Entity has or may acquire any right
or interest.

"Blocker DandO Policy" has the meaning set forth in Section 6.9(b) of the
Agreement.

"Blocker Entities" means, collectively, the BWA Entities and Blocker.

"Blocker Entity Pre-Closing Taxes" has the meaning set forth in Section
11.2(c)(iv) of the Agreement.

"Blocker Indemnification Matter" means any claim for indemnification,
compensation or reimbursement under Section 11.2(c) of the Agreement. 

"Blocker Note" has the meaning set forth in Schedule 6.7(i) to the Agreement.

"Blocker Representations" means (a) the representations and warranties made by
Blocker set forth in Section 4 (Representations and Warranties of Blocker) of
the Agreement and (b) the representations, warranties, certifications and
other statements and information set forth in the Blocker Closing Certificate
with respect to such Section specified in the foregoing clause "(a)".

"Blocker Seller" has the meaning ascribed to such term in the preamble to the
Agreement.

"Blocker Units" mean all of the issued and outstanding equity, represented by
1,000 units, of Blocker.

"Books and Records" has the meaning set forth in Section 2.24 of the
Agreement.

"Business Day" means any day other than: (a) a Saturday, Sunday or federal
holiday; or (b) a day on which commercial banks in San Francisco, California
are authorized or required to be closed.

"BW Management Agreement" means the Management Agreement, dated as of
September 6, 2011, by and between Blue Wolf Capital Partners LLC and PSG, as
amended by the First Amendment, dated as of December 17, 2012, and the Second
Amendment, dated January 1, 2014.

"BWA Common Corp." means BW Apothecary Common Corp., a Delaware corporation.

"BWA Entities" means, collectively, BWA Common Corp., BWA Preferred Corp., and
BWA Feeder.

"BWA Feeder" means BW Apothecary Feeder, LLC, a Delaware limited liability
company.

"BWA Preferred Corp." means BW Apothecary Preferred Corp., a Delaware
corporation.

"Change of Control Bonuses" means the amounts set forth in the column titled
"Change of Control Bonus" payable to the Change of Control Bonus Recipients
set forth in Exhibit K to the Agreement.

"Change of Control Bonus Recipients" means, collectively, those individuals
set forth in Exhibit K to the Agreement that are entitled to be paid the
amount of Change of Control Bonus set forth opposite their names on Exhibit K
to the Agreement.

"Charter Documents" means the articles of organization or certificate of
formation and the limited liability company agreement (or comparable governing
documents) of a limited liability company, the certificate of incorporation or
articles of incorporation and bylaws (or comparable governing documents) of a
corporation and comparable or equivalent governing documents of other forms of
legal entities. 

"Chosen Courts" has the meaning set forth in Section 12.10(b) of the
Agreement.

"Claim Notice" has the meaning set forth in Section 11.5(a) the Agreement.

"Claimed Amount" has the meaning set forth in Section 11.5(a) of the
Agreement.

"Class A Unit" has the meaning and the rights and obligations specified with
respect thereto in the Company Operating Agreement.

"Class A Holder" has the meaning ascribed to such term in the preamble to the
Agreement.

"Class B Unit" has the meaning and the rights and obligations specified with
respect thereto in the Company Operating Agreement. All Class B Units are
beneficially owned and held of record in their entirety by BWA Feeder.

"Class C Holders" has the meaning ascribed to such term in the preamble to the
Agreement.

"Class C Options" has the meaning ascribed to such term in the recitals to the
Agreement.

"Class C Unit" has the meaning and the rights and obligations specified with
respect thereto in the Company Operating Agreement. All Class C Units are
beneficially owned and held of record in their entirety by the Class C
Holders.

"Class D Holders" has the meaning ascribed to such term in the preamble to the
Agreement.

"Class D Unit" has the meaning and the rights and obligations specified with
respect thereto in the Company Operating Agreement. All Class D Unit are
beneficially owned and held of record in their entirety by the Class D
Holders.

"Closing" has the meaning set forth in Section 1.4(a) of the Agreement.

"Closing Cash Amount" means the amount of cash and cash equivalents (other
than Restricted Cash) as reflected on the Company's, 340B OpCo's and PHSS's
bank statements or reported on the Company's, 340B OpCo's and PHSS's banking
websites as of immediately prior to the Closing, as adjusted for any deposits
in transit, any outstanding checks and any other proper reconciling items, as
valued in accordance with GAAP; provided that, for the avoidance of doubt, the
Closing Cash Amount shall not include any amount in any 340B Account.

"Closing Certificates" means the Company Closing Certificate, the Individual
Selling Closing Certificates and the Blocker Closing Certificate,
collectively.

"Closing Consideration Certificate" has the meaning set forth in Section
1.4(b)(xii) of the Agreement. 

"Closing Date" has the meaning set forth in Section 1.4(a) of the Agreement.

"Closing Date Offer Letter" has the meaning set forth in Section 1.4(b)(xxi)
of the Agreement.

"Closing Indebtedness Amount" means the aggregate amount of outstanding
Indebtedness of the Acquired Companies and the Blocker Entities as of the
Closing and the aggregate amount of outstanding Indebtedness described in
clauses "(a)" and "(m)" (to the extent as related to clause "(a)") of the
definition of "Indebtedness" of the Spin-Off Entities as of the Closing, in
each case determined in accordance with GAAP and on a basis consistent with
the Provided Company Financial Statements, the Provided 340B Link Financial
Statements and the Acquired Companies', the Blocker Entities' and the Spin-Off
Entities' respective historical practices.

"Closing Purchase Price" has the meaning set forth in Section 1.3(a) of the
Agreement.

"Code" means the Internal Revenue Code of 1986, as amended. All references to
the Code, U.S. Treasury regulations or other governmental pronouncements shall
be deemed to include references to any applicable successor regulations or
amending pronouncement.

"Company" has the meaning set forth in the introductory paragraph of the
Agreement.

"Company 2020 Federal Return" has the meaning set forth in Schedule
12.4(a)(ii)(B) to the Agreement.

"Company Closing Certificate" has the meaning set forth in Section 1.4(b)(ix)
of the Agreement.

"Company Contract" means any Contract: (a) to which any Acquired Company is a
party; (b) by which any Acquired Company or any of its assets is or may become
bound or under which any Acquired Company has, or may become subject to, any
obligation; or (c) under which any Acquired Company has or may acquire any
right or interest.

"Company DandO Policy" has the meaning set forth in Section 6.9(a) of the
Agreement.

"Company Data" means all right, title and interest in and with respect to the
data contained in the Company IT Systems or any databases of any Acquired
Company (including any and all Trade Secrets and User Data) and all other
information and data compilations used by, or necessary to the business of,
the Acquired Companies.

"Company Database" has the meaning set forth in Section 2.10(t) of the
Agreement.

"Company Employee Plan" means any plan, program, policy, practice, Contract or
other arrangement providing for independent consulting, compensation,
severance, termination pay, deferred compensation, bonus, incentive
compensation, commission, performance awards, equity or equity-related awards,
fringe benefits, social security benefits, change in control pay, provident
fund, employee state insurance, gratuity, pension, retirement, paid time off,
vacation, 

loan, health, welfare, disability pay, life insurance, educational assistance
or other employee benefits or remuneration of any kind, whether written,
unwritten or otherwise, funded or unfunded, formal or informal, that is or has
been maintained, contributed to or required to be contributed to, by any
Acquired Company for the benefit of any Company Service Provider, or with
respect to which any Acquired Company has or may have any Liability or
obligation, except such definition shall not include any Company Service
Provider Agreement.

"Company Financial Statements" means, collectively, the Provided Company
Financial Statements and the Required Company Financial Statements.

"Company IP" means all (a) registered and unregistered Intellectual Property
Rights and Intellectual Property in which any Acquired Company has (or
purports to have) an ownership interest of any nature (whether exclusively,
jointly with another Person or otherwise) or an exclusive license or similar
exclusive right in any field or territory, (b) all Registered IP and
Unregistered IP and (c) all Intellectual Property and Intellectual Property
Rights created or developed by each Company Service Provider during his or her
engagement with an Acquired Company and that (i) relates to or results from
the actual or anticipated business, work, research, investigations, products,
or services of the Acquired Company or (ii) results, to any extent, from use
of any Acquired Company's premises or property.

"Company IP Contract" means any Company Contract that contains any assignment
or license of, or any covenant not to assert or enforce, any Intellectual
Property Right or that otherwise relates to any Company IP or any Intellectual
Property developed by, with or for any Acquired Company or Spin-Off Entity (it
being understood that licenses to Open Source Code to which any Acquired
Company is or was a party or by which any Acquired Company is or was bound
shall constitute Company IP Contracts) and each Inbound License and Outbound
License.

"Company IT Systems" means all Computer Software, hardware, firmware,
middleware, equipment, electronics, platforms, servers, workstations, routers,
hubs, switches, interfaces, data, databases, data communication lines, network
and telecommunications equipment, websites and Internet-related information
technology infrastructure, wide area network and other data communications or
information technology equipment relating to the transmission, storage,
maintenance, organization, presentation, generation, Processing or analysis of
data and information whether or not in electronic format, used in or necessary
to the conduct of the business of the Acquired Companies.

"Company Privacy Notice" means all written privacy notices, disclosure
statements, or representations required by Privacy Requirements or made
available by an Acquired Company (i) to the public, or (ii) to any natural
Person for the purpose of describing, explaining, or characterizing the
Processing of Personal Data about such Person.

"Company Privacy Policy" means each external or internal, past or present
privacy policy, representation, obligation or promise of any Acquired Company
or any third party service provider of any Acquired Company, relating to: (a)
the privacy of any Person in connection with any Company Web Site, Company
Software or Company Product; (b) the Processing of any User Data or Personal
Data; and (c) any employee information. 

"Company Product" means each of the programs, products, services, databases
(or other Company Data offerings), systems, technology and Computer Software
that have been or are currently being developed, marketed, distributed,
licensed, sold, offered, made available or provided by or on behalf of any
Acquired Company, together with each Company Web Site.

"Company Service Provider" means any current or former employee, worker,
contract laborer/worker, independent contractor, consultant, advisor, officer,
manager or director of any Acquired Company.

"Company Service Provider Agreement" means each management, employment,
consulting, contractor, relocation, repatriation or expatriation agreement or
other Contract between an Acquired Company and a Company Service Provider.

"Company Operating Agreement" means that certain Amended and Restated Limited
Liability Company Agreement of the Company, dated as of August 3, 2020.

"Company Owned Software" means all Company Software that is owned, or
purported to be owned, by any Acquired Company.

"Company Software" means Computer Software owned, developed (or currently
being developed), used, marketed, distributed, licensed or sold by any
Acquired Company (excluding any "off-the-shelf" third party Computer Software
that is generally available on standard commercial terms, is not distributed
by any Acquired Company, is not incorporated into, or used in the development,
testing, distribution, delivery, maintenance or support of, any product or
service of any Acquired Company, and is not otherwise material to the business
of any Acquired Company).

"Company User Agreement" means each Company Contract that constitutes a user
agreement, terms of use, terms of service, developer agreement or end user
license agreement that governs (or is intended to govern) each user's or
developer's access to and use of any Company Web Site, any Company Software or
any Company Product.

"Company Web Site" means any public or private web site owned, maintained or
operated at any time by or on behalf of any Acquired Company, including the
web site located at https://www.psgconsults.com/.

"Computer Software" means computer software (including websites, HTML code,
firmware and other software embedded in hardware devices), data files, source
and object codes, APIs, tools, user interfaces, manuals and other
specifications and documentation and all know-how relating thereto.

"Consent" means any approval, consent, ratification, permission, waiver, order
or authorization (including any Governmental Authorization).

"Contaminant" includes any material, substance, chemical, gas, liquid, waste,
effluent, pollutant or contaminant which, whether on its own or admixed with
another, is identified or 

defined in or regulated by or pursuant to any Environmental Laws or which upon
release into the Environment presents a danger to the Environment or to the
health or safety or welfare of any Person.

"Contested Amount" has the meaning set forth in Section 11.5(b) of the
Agreement.

"Continuing Employee" has the meaning set forth in Section 6.11(a) of the
Agreement.

"Continuing Employee Change of Control Bonus Recipient" has the meaning set
forth in Section 1.4(c)(ii) of the Agreement.

"Contract" means any written, oral or other agreement (including a "click-
through" agreement), contract, license, sublicense, subcontract, settlement
agreement, lease, understanding, arrangement, instrument, note, purchase
order, warranty, insurance policy, benefit plan or legally binding commitment
or undertaking of any nature.

"Covered Claim" has the meaning set forth in Section 11.3(c)(vii) of the
Agreement.

"DandO Policies" has the meaning set forth in Section 6.9(b) of the Agreement.

"Data Breach" means any unauthorized Processing of or access to Personal Data,
Company Data, User Data or Company IT Systems, or any other data security
incident requiring notification to any Person or Governmental Body under
applicable Privacy Requirements.



"Damages" includes any loss, damage, injury, Liability, claim, demand, action
or cause of action, settlement, judgment, award, fine, penalty, Tax, fee
(including reasonable attorneys' fees), assessment, levy, charge, cost
(including costs of attorneys, accountants, investigators and experts, and
other costs of investigation) or expense of any nature (including reasonable
out-of-pocket attorneys', accountants', consultants' and experts' fees and
expenses), but excluding punitive or exemplary damages (except, in each case,
to the extent arising in a claim for Fraud or to the extent any such Damages
are awarded to a third-party).

"Deductible" has the meaning set forth in Section 11.3(a) of the Agreement.

"Designated Matter Damages" has the meaning set forth in Section 11.12(a) of
the Agreement.

"Designated Special Indemnification Matter" means any claim for
indemnification, compensation or reimbursement under Section 11.2(a) of the
Agreement with respect to the Designated Tax Matter.

"Designated Tax Matter" has the meaning set forth in Paragraph 2 of Schedule
11.2(a)(vi) to the Agreement.

"Determination Date" has the meaning set forth in Section 11.6 of the
Agreement. 

"Determined Amount" has the meaning set forth in Section 11.5(c), Section
11.5(d), Section 11.5(e), Section 11.5(f) or Section 11.5(g)(viii) of the
Agreement.

"Determined Order" has the meaning set forth in Section 11.5(g)(viii) of the
Agreement.

"Disclosure Schedule" means the schedule (dated as of the date of the
Agreement) delivered by the Company with respect to the representations and
warranties set forth in Section 2, by the Sellers with respect to the
representations and warranties set forth in Section 3, and by Blocker with
respect to the representations and warranties set forth in Section 4, in each
case prepared in accordance with Section 12.22 of the Agreement.

"Disposition Transaction" has the meaning set forth in Section 6.5 of the
Agreement.

"Dispute Period" has the meaning set forth in Section 11.5(b) of the
Agreement.

"Divisional Merger" means the divisional merger of PSG effectuated pursuant to
the Divisional Merger Agreement.

"Divisional Merger Agreement" has the meaning set forth in the definition of
Spin-Off Agreements.

"DMS Sales Taxes" means, in the aggregate for all Pre-Closing Tax Periods,
sales Taxes incurred by the Acquired Companies and Spin-Off Entities (a) with
respect to DMS consulting revenue, all sales Taxes in the states of
Connecticut and Hawaii, (b) with respect to educational and sponsored research
revenue, all sales Taxes in the states of Connecticut, New Jersey, New York,
Texas and Washington DC, and (c) with respect to analytics and specialty
consulting revenue, all sales Taxes in the states of New York, Ohio,
Pennsylvania, Tennessee, Texas and Washington.

"Domain Name" shall mean any or all of the following and all worldwide rights
in, arising out of or associated therewith: domain names, uniform resource
locators and other names and locators associated with the internet.

"Electronic Delivery" has the meaning set forth in Section 12.9 of the
Agreement.

"Encumbrance" means any lien, pledge, hypothecation, charge, mortgage,
easement, encroachment, security interest, encumbrance, intangible property
right, claim, infringement, option, right of first refusal, preemptive right,
license, community property interest or restriction of any nature (including
any restriction on the voting of any security, any restriction on the
transfer, use or ownership of any security or other asset, any restriction on
the receipt of any income derived from any asset, any restriction on the use
of any asset and any restriction on the possession, exercise or transfer of
any other attribute of ownership of any asset).

"Entity" means any corporation (including any non-profit corporation), general
partnership, limited partnership, limited liability partnership, joint
venture, estate, trust, company (including any limited liability company or
joint stock company), firm or other enterprise, association, organization or
entity. 

"Environment" includes: (a) any and all buildings, structures, fixtures,
fittings, appurtenances, pipes, conduits, valves, tanks, vessels and
containers whether above or below ground level; and (b) ambient air, land
surface, sub-surface strata, soil, surface water, ground water, river
sediment, marshes, wet lands, flora and fauna.

"Environmental Law" means all Legal Requirements, by-laws, Orders,
instruments, directives, decisions, injunctions and judgments of any
Governmental Body and all approved codes of practice (whether voluntary or
compulsory) relating to the protection of the Environment or of human health
or safety or welfare or to the manufacture, formulation, processing,
treatment, storage, containment, labeling, handling, transportation,
distribution, recycling, reuse, release, disposal, removal, remediation,
abatement or clean-up of any Contaminant and any amendment thereto and any and
all regulations, Orders and notices made or served thereunder or pursuant
thereto.

"Environmental License" means any Consent or Governmental Authorization
required by or pursuant to any applicable Environmental Laws.

"Environmental Release" means the spilling, leaking, pumping, pouring,
emitting, releasing, emptying, discharging, injecting, escaping, leaching,
dumping, leaving, discarding or disposing of any Contaminant into or upon the
Environment.

"ePHI" has the meaning set forth in Section 2.10(v) of the Agreement.

"Equity Plan" means Pharmaceutical Strategies Group, LLC's 2012 Long-Term
Incentive Plan.

"ERISA" means the Employee Retirement Income Security Act of 1974, as amended.

"ERISA Affiliate" means any Entity that would be considered a single employer
with any Acquired Company within the meaning of Section 414 of the Code or
Section 4001 of ERISA.

"Escrow Agent" has the meaning set forth in Section 1.2(b) of the Agreement.

"Escrow Agreement" means the escrow agreement to be entered into among
Purchaser, the Sellers' Representative and the Escrow Agent on the Closing
Date, substantially in the form of Exhibit D to the Agreement.

"Escrow Amount" means the General Indemnity Escrow Amount and the Special
Indemnity Escrow Amount, collectively.

"Escrow Funds" means the General Indemnity Escrow Funds and the Special
Indemnity Escrow Funds, collectively.

"Estimated Closing Purchase Price" has the meaning set forth in Section 1.2(a)
of the Agreement. 

"Fair Market Value Balance Sheet" has the meaning set forth in Section 1.8 of
the Agreement.

"Federal Health Care Program" has the meaning set forth in 42 U.S.C. 
1320a-7b(f) and any implementing regulations thereto and, without limiting the
foregoing, shall include any plan or program that provides health care
benefits, whether directly, through insurance, or otherwise, that is funded
directly, in whole or in part, by the government of the United States of
America (other than the Federal Employees Health Benefits Program), including
Medicare, Medicaid, the Children's Health Insurance Program, TRICARE, 340B
Federal Drug Discount Program and Veterans Health Administration programs
(described in Title XVIII of the Social Security Act ("SSA"), Title XIX of the
SSA, Title XXI of the SSA, Title 10, Chapter 55 of the U.S.C., 42 U.S.C. 
256b and 38 U.S.C.  8126, respectively), or any state health care program (as
defined in Section 1128(h) of the SSA).

"Final Release Date Special Indemnity Escrow Distribution Amount" has the
meaning set forth in Section 11.7(c)(iii) of the Agreement.

"Final Release Date Special Indemnity Escrow Retained Amount" has the meaning
set forth in Section 11.7(c)(iii) of the Agreement.

"Final Release Date Unresolved Special Indemnity Escrow Claim," has the
meaning set forth in Section 11.7(c)(iii) of the Agreement.

"Final Special Indemnity Escrow Release Date" has the meaning set forth in
Section 11.7(c)(iii) of the Agreement.

"First Release Date Special Indemnity Escrow Distributed Amounts" has the
meaning set forth in Section 11.7(c)(i) of the Agreement.

"First Release Date Special Indemnity Escrow Distribution Amount" has the
meaning set forth in Section 11.7(c)(i) of the Agreement.

"First Release Date Special Indemnity Escrow Retained Amount" has the meaning
set forth in Section 11.7(c)(i) of the Agreement.

"First Release Date Unresolved Special Indemnity Escrow Claim" has the meaning
set forth in Section 11.7(c)(i) of the Agreement.

"First Special Indemnity Escrow Release Date" has the meaning set forth in
Section 11.7(c)(i) of the Agreement.

"Form of Assignment" has the meaning set forth in Section 1.4(b)(i) of the
Agreement.

"Fraud" means actual Delaware common law fraud committed by a party to the
Agreement with an intent to deceive with respect to the representations and
warranties made in Section 2, Section 3 or Section 4 of the Agreement (in each
case as modified or supplemented by the Disclosure Schedule) or in any of the
Company Closing Certificate, the Closing 

Consideration Certificate, an Individual Seller Closing Certificate or the
Blocker Closing Certificate.

"Fundamental Cap" has the meaning set forth in Section 11.3(d)(ii) of the
Agreement.

"Fundamental Representations" means: (a) the representations and warranties
set forth in Sections 2.1 (Due Organization; Subsidiaries; Etc.), 2.2 (Charter
Documents; Records), 2.3(a), (b), (d), (e), (f), (h), (i) and (j)
(Capitalization), 2.14 (Tax Matters), 2.20 (Authority; Binding Nature of
Agreement; Inapplicability of Anti-Takeover Statues), 2.21(a), (b), (c) and
(e) (Non-Contravention; Consents) and 2.25 (Brokers) of the Agreement; (b)
Section 3 (Representations and Warranties of Each Seller) of the Agreement;
(c) Section 4 (Representations and Warranties of Blocker) of the Agreement;
and (d) the representations, warranties, certifications and other statements
and information set forth in the Company Closing Certificate, the Individual
Seller Closing Certificates and the Blocker Closing Certificate with respect
to such Sections specified in the foregoing clauses "(a)" through "(c)" of
this sentence.

"GAAP" means United States generally accepted accounting principles,
consistently applied.

"General Indemnification Matter" means any claim for indemnification,
compensation or reimbursement under Section 11.2(a) of the Agreement.

"General Indemnity Escrow Account" means the account established by the Escrow
Agent for the General Indemnity Escrow Amount pursuant to the terms of the
Escrow Agreement.

"General Indemnity Escrow Amount" means $843,750.

"General Indemnity Escrow Funds" means as of any date of determination, the
excess (if any) of the General Indemnity Escrow Amount (plus any dividends,
interest, distributions and other income received in respect thereof) minus
the sum of all distributions and other payments to any Person on or prior to
such date of determination from the General Indemnity Escrow Account.

"General Indemnity Escrow Release Date" has the meaning set forth in Section
11.7(b) of the Agreement.

"General Representations" means: (a) the representations and warranties set
forth in Section 2 of the Agreement, other than any Fundamental
Representations; and (b) the representations, warranties, certifications and
other statements and information set forth in the Company Closing Certificate
with respect to such Sections specified in the foregoing clause "(a)" of this
sentence.

"General Survival Expiration Date" has the meaning set forth in Section
11.1(a) of the Agreement. 

"Governmental Authorization" means any: (a) permit, license, approval,
certificate, right, exemption, waiver, franchise, permission, clearance,
registration, qualification, authorization or similar rights to operate or
conduct any business issued, granted, given or otherwise made available by or
under the authority of any Governmental Body or pursuant to any Legal
Requirement; or (b) right under any Contract with any Governmental Body.

"Governmental Body" means any: (a) multinational or supranational body
exercising legislative, judicial or regulatory powers; (b) nation, state,
commonwealth, province, territory, county, municipality, district or other
jurisdiction of any nature; (c) federal, state, local, municipal, foreign or
other government; (d) governmental or quasi-governmental authority of any
nature (including any governmental division, department, agency, commission,
instrumentality, official, organization, unit, body or Entity and any court or
other tribunal); (e) Entity that registers, provides or allocates domain names
and top level domains; or (f) any security force, security agency or other
defense related entity. For the avoidance of doubt, "Governmental Body" shall
include HHS (including all agencies and subdivisions thereof, such as the
Health Resources and Services Administration) and the U.S. Department of
Justice.

"Government Official" means any director, manager, officer, official,
employee, agent or other person acting on behalf of a Governmental Body
(including candidates for political office).

"Health Care Laws" means, collectively, any and all Legal Requirements
relating to the manufacture, marketing, sale, promotion, use, advertising,
offering, licensure, operation, management, registration or certification of,
qualification or authority to transact or operate business in connection with,
the provision, coverage of, arranging for or administration of, or pricing or
payment for the provision, arranging for or administration of, any Acquired
Company or Company Products and/or other healthcare products and services,
including, without limitation: (i) fraud and abuse Legal Requirements,
including the federal Anti-Kickback Statute (42 U.S.C.  1320a-7b(b)), state
anti-kickback and all-payer Legal Requirements, the federal criminal False
Claims Statutes (18 U.S.C.  286, 287 and 1001), the False Statements
Relating to Health Care Matters Law (18 U.S.C.  1035), the HIPAA All-Payor
Fraud Statute (18 U.S.C.  1347), the federal criminal False Statements and
Representations Law (42 U.S.C.  1320a-7b(a)), the federal Physician Self-
Referral ("Stark") Law (42 U.S.C.  1395nn and 1396b(s)), the federal False
Claims Act (31 U.S.C.  3729 et seq.), the federal Civil Monetary Penalties
Law (42 U.S.C.  1320a7a and 1320a-8), the federal exclusion laws (42 U.S.C.
 1320a-7) and the federal Beneficiary Anti-Inducement Statute (42 U.S.C. 
1320a-7a(a)(5)); (ii) the Medicare Statute (Title XVIII of the SSA) and the
regulations promulgated thereunder; (iii) the Medicaid Statute (Title XIX of
the SSA) and the regulations promulgated thereunder; (iv) the Children's
Health Insurance Program Statute (Title XXI of the SSA) and the regulations
promulgated thereunder; (v) Legal Requirements implementing the TRICARE
program (10 U.S.C.  1071 et seq.) and the regulations promulgated thereunder;
(vi) Legal Requirements implementing Veterans Health Administration programs
(including 38 U.S.C. Chapter 17) and the regulations promulgated thereunder;
(vii) the Public Health Service Act (42 U.S.C.  201 et seq.); (viii) the
Patient Protection and Affordable Care Act (Pub. L. No. 111148) as amended by
the Health Care and Education Reconciliation Act of 2010 (Pub. L. No. 111152)
and the regulations adopted thereunder; (ix) the 340B Drug Discount Program
Law (42 U.S.C.  256b); 

(x) any regulations or guidance promulgated pursuant to each of the foregoing,
and similar state or local statutes or regulations; (xi) Legal Requirements,
policies and guidelines relating to coding, coverage, reimbursement, claims
submission, billing and collections; (xii) the Health Insurance Portability
and Accountability Act of 1996 (Pub L. No. 104-191) ("HIPAA"), as amended by
the Health Information Technology for Economic and Clinical Health Act of 2009
(Pub. L. No. 111-5) ("HITECH") and their implementing regulations, including
45 C.F.R. Parts 160, 162 and 164 (the "HIPAA Rules") and any similar state or
local health care privacy, security or confidentiality Legal Requirements;
(xiii) Legal Requirements regulating the interactions with health care
professionals (including, but not limited to, pharmacists and pharmacy
technicians) and reporting thereof; (xiv) Legal Requirements relevant to false
statements or claims and all similar state, local and foreign Legal
Requirements of any jurisdiction applicable to the operations of any Acquired
Company; (xv) Legal Requirements relating to the administration of healthcare
claims for, or processing or payment for healthcare services, treatment or
supplies furnished by providers; (xvi) Legal Requirements relating to or
governing the contracting and administration of provider networks (including
pharmacy networks); (xvii) state or local Legal Requirements relating to
Medicaid or any other state health care or health insurance programs and Legal
Requirements related to any other government or quasi-government health care
or health insurance program; and (xviii) Legal Requirements applicable to the
developing, provision, offering, contracting, marketing, advertising,
administering and claims processing in connection with discount prescription
programs and related services.

"HHS" has the meaning set forth in Section 2.22(b) of the Agreement.

"Historic Treatment" has the meaning set forth in Paragraph 2 of Schedule
11.2(a)(vi) to the Agreement.

"Holland and Knight" has the meaning set forth in Section 12.20 of the
Agreement.

"HSR Act" means the Hart Scott Rodino Antitrust Improvements Act of 1976, as
amended, and the rules and regulations promulgated thereunder, or any
successor Legal Requirement thereto.

"Inbound Licenses" has the meaning set forth in Section 2.10(c) of the
Agreement.

"Indebtedness" means, with respect to any Person, without duplication, as of
the date of determination: (a) all obligations (including the principal amount
thereof or, if applicable, the accreted amount thereof and the amount of
accrued and unpaid interest thereon) of such Person whether or not represented
by bonds, debentures, notes or other securities (whether or not convertible
into any other security) for (i) the repayment of money borrowed, whether
owing to banks, financial institutions, on equipment capital leases or
otherwise or (ii) the payment in full of all amounts payable or outstanding
under notes issued by any Acquired Company or Spin-Off Entity in connection
with repurchase of units or other equities issued by any Acquired Company or
Spin-Off Entity; (b) all obligations of such Person issued or assumed as the
deferred purchase price of assets, or securities, contingent or otherwise
(including "earn-outs" and "seller notes" payable); (c) all lease obligations
of such Person for real or personal property required under 

GAAP to be capitalized on the books and records of such Person; (d) all
outstanding obligations of such Person with respect to letters of credit,
bankers' acceptances or similar facilities issued for the account of such
Person; (e) all obligations of such Person under interest rate, currency or
commodity derivatives or hedging transactions or similar arrangements (valued
at the termination value thereof); (f) all obligations secured by any security
interest, lien or UCC financing statement existing on property owned by such
Person, whether or not indebtedness secured thereby will have been assumed;
(g) all guaranties, endorsements, assumptions and other contingent obligations
of such Person in respect of, or to purchase or to otherwise acquire,
Indebtedness of others; (h) all unpaid amounts due pursuant to any settlement,
adjustment or compromise of any claim or Legal Proceeding made prior to the
Closing; (i) all obligations of such Person, whether interest bearing or
otherwise, owed to any securityholder of such Person or any Affiliate of any
securityholder of such Person, except for compensation to securityholders or
Affiliates who are employed by such Person and with respect to the proceeds
hereunder; (j) all unsatisfied severance obligations of such Person in respect
of any termination of employment occurring prior to the Closing (other than as
included in the definition of Transaction Expenses hereunder) and all accrued
bonuses, deferred compensation, retirement benefits or pension obligations of
such Person or any other contingent compensation (including such Person's
portion of any related Taxes) or unfunded benefits liabilities of such Person,
in each case to the extent not constituting Spin-Off Liabilities and to the
extent relating to the period prior to the Closing; (k) long-term deferred
revenue; (l) any accrued unpaid Pre-Closing Taxes, including, for the
avoidance of doubt, any Taxes attributable to the deferral of payroll Taxes
pursuant to the CARES Act or other pandemic relief legislation (other than any
Taxes included in Transaction Expenses or in the Net Working Capital Amount,
in each case only to the extent that such inclusion results in a reduction of
the Closing Purchase Price); and (m) all premiums, penalties, fees, expenses,
breakage costs and change of control payments required to be paid prior to or
in connection with the Closing or offered in respect of any of the foregoing
(regardless if any of such are actually paid), as a result of the consummation
of the transactions contemplated by the Agreement or in connection with any
lender Consent For purposes of this Agreement, "Indebtedness" specifically
excludes: (i) trade payables (to the extent included in the Net Working
Capital Amount); (ii) credit card debt incurred in the Ordinary Course of
Business (to the extent included in Net Working Capital Amount); and/or (iii)
liabilities included in Transaction Expenses.

"Indemnification Matter" means any General Indemnification Matter, any
Individual Seller Indemnification Matter or any Blocker Indemnification
Matter.

"Indemnitees" means the following Persons: (a) Purchaser; (b) Purchaser's
current and future Affiliates (including, following the Closing, the Acquired
Companies and the Blocker Entities); (c) the respective securityholders and
Representatives of the Persons referred to in clauses "(a)" and "(b)" of this
sentence; and (d) the respective successors and assigns of the Persons
referred to in clauses "(a)," "(b)" and "(c)" of this sentence; provided, that
(x) with respect to the Designated Tax Matter, each Person who was classified
as an employee of any Acquired Company or Spin-Off Entity pursuant to the
Historic Treatment shall also be deemed to be an Indemnitee and (y) the
Sellers shall not be deemed to be "Indemnitees" except to the extent provided
in clause "(x)" of this sentence. 

"Indemnity Agreement" has the meaning set forth in the definition of Spin-Off
Agreements.

"Individual Seller Closing Certificate" has the meaning set forth in Section
1.4(b)(x) of the Agreement.

"Individual Seller Indemnification Matter" means, with respect to any Seller,
(i) any claim for indemnification, compensation or reimbursement under Section
11.2(b)(i) or Section 11.2(b)(ii) of the Agreement or (ii) any claim for
indemnification, compensation or reimbursement under Section 11.2(b)(iii) of
the Agreement.

"Information Security Program" has the meaning set forth in Section 2.10(v) of
the Agreement.

"Insider Payables" has the meaning set forth in Section 2.4(e) of the
Agreement.

"Insider Receivables" has the meaning set forth in Section 2.4(e) of the
Agreement.

"Insurance Costs" has the meaning set forth in Section 11.3(f) of the
Agreement.

"Intellectual Property" means algorithms, application programming interfaces
("APIs"), apparatus, circuit designs and assemblies, gate arrays, net lists,
test vectors, data, data collections and databases, diagrams, formulae,
inventions (whether or not patentable), logos, marks (including brand names,
product names, logos and slogans), methods, network configurations and
architectures, processes, proprietary information, protocols, schematics,
specifications, software, software code (in any form, including source code
and executable or object code), subroutines, techniques, Trade Secrets, user
interfaces, uniform resource locators, web sites, Domain Names, works of
authorship and other forms of technology (whether or not embodied in any
tangible form and including all tangible embodiments of the foregoing, such as
instruction manuals, laboratory notebooks, prototypes, samples, studies and
summaries).

"Intellectual Property Rights" means all rights of the following types, which
may exist or be created under the laws of any jurisdiction in the world: (a)
rights associated with works of authorship, including exclusive exploitation
rights, copyrights and moral rights; (b) Trademark and trade name rights and
similar rights and the goodwill associated with any of the foregoing; (c)
Trade Secret rights; (d) Patent and industrial property rights; (e) other
proprietary rights in Intellectual Property, including rights to control
commercial exploitation of a person's name, image and likeness; (f) rights in
or relating to registrations, renewals, extensions, combinations, divisions
and reissues of, and applications for, any of the rights referred to in
clauses "(a)" through "(e)" above; and (g) together with, in each of clauses
"(a)" through "(f)" above, all claims for Damages by reason of past
infringement thereof, with the right to sue for, and collect the same.

An individual shall be deemed to have "Knowledge" of a particular fact or
other matter if: (a) such individual is actually aware of such fact or other
matter; or (b) such individual would have known such fact or other matter had
such individual made reasonable inquiry of the Persons 

who would reasonably be expected to have actual knowledge of such fact or
other matter. The Company shall be deemed to have "Knowledge" of a particular
fact or other matter if any officer or manager of any Acquired Company or any
other Person identified on Exhibit E-1 (each a "Knowledge Person") has
Knowledge of such fact or other matter. Blocker shall be deemed to have
"Knowledge" of a particular fact or other matter if any officer, manager or
director of any Blocker Entity or any Person identified on Exhibit E-2 has
Knowledge of such fact or other matter. A Seller that is not an individual
shall be deemed to have "Knowledge" of a particular fact or other matter if
any officer, manager, director or individual holding comparable positions of
any Seller has Knowledge of such fact or other matter.

"Knowledge Person" has the meaning set forth in the definition of "Knowledge".

"Landlord" means Whetstone Legacy Campus L.P. (f/k/a Legacy Campus, L.P.), the
landlord under the Lease Agreements.

"Lease Agreements" has the meaning set forth in Section 2.9(b) of the
Agreement.

"Leased Real Property" has the meaning set forth in Section 2.9(b) of the
Agreement.

"Legal Proceeding" means any claim, action, suit, litigation, arbitration,
proceeding (including any civil, criminal, administrative, investigative or
appellate proceeding), hearing, inquiry, audit, examination, investigation,
charge, demand (including a civil investigative demand), complaint, subpoena,
qui tam complaint, assessment with respect to fines or penalties or Order
commenced, brought, conducted or heard by or before, or otherwise involving,
any court or other Governmental Body or any arbitrator or arbitration panel.

"Legal Requirement" means any federal, state, local, municipal, foreign,
supranational or other law, statute, constitution, treaty, principle of common
law, directive, resolution, ordinance, code, edict, writ, decree, rule,
regulation, judgment, ruling, injunction, published guideline (including sub-
regulatory guidance) or requirement issued, enacted, adopted, promulgated,
implemented or otherwise put into effect by or under the authority of any
Governmental Body.

"Liability" means any debt, obligation or liability of any nature (including
any unknown, undisclosed, unmatured, unaccrued, unasserted, contingent,
conditional, implied, vicarious, derivative, joint, several or secondary
liability), regardless of whether such debt, obligation or liability would be
required to be disclosed on a balance sheet prepared in accordance with GAAP
and regardless of whether such debt, obligation or liability is immediately
due and payable.

"Malicious Code" means any "back door," "drop dead device," "time bomb,"
"Trojan horse," "virus," "ransomware" or "worm" (as such terms are commonly
understood in the software industry) or any other code designed or intended to
have, or capable of performing, any of the following functions: (A)
disrupting, disabling, harming, interfering with or otherwise impeding in any
manner the operation of, or providing unauthorized access to, a computer
system or network or other device on which such code is stored or installed;
or (B) damaging or destroying any data or file without the user's consent.



"Made Available" A document or other item of information shall be deemed to
have been "Made Available" only if (a) such document or other item of
information was included in the Smart Room virtual data room prepared by the
Company and hosted on behalf of the Company by BMC Group in the online
workspace captioned "Project Phoenix" in connection with the transactions
contemplated by this Agreement as of August 10, 2020 and (b) Purchaser's
Representatives had full access to such document or other item after such
document or other item was included in such virtual data room.

"Material Adverse Effect" means any occurrence, fact, change, event, effect,
claim, circumstance or matter (each, an "Effect") that, individually or
considered together with all other Effects, is, or would reasonably be
expected to be or to become, materially adverse to: (a) the business,
condition, assets, Liabilities, operations, results of operations or financial
performance of the Acquired Companies, taken as a whole; or (b) the ability of
any of the Sellers, Blocker or the Company to consummate the transactions
contemplated by this Agreement; provided, however, that no Effect resulting
from any of the following, either alone or in combination, shall constitute,
or will be considered in determining whether there has occurred, a Material
Adverse Effect: (i) any occurrence, change or event in (A) any one or more of
the industries or markets in which the Acquired Companies operate generally or
(B) the United States or global economy generally or capital, commodity or
financial markets generally, including changes in interest or exchange rates,
or political conditions generally of the United States or any other country or
jurisdiction in which the Acquired Companies operate; (ii) the announcement or
consummation of the transactions contemplated by this Agreement, including the
impact thereof on relationships, contractual or otherwise, with customers,
suppliers, licensors, distributors, partners, providers, employees or
regulators; (iii) the identity of, or the effects of any facts or
circumstances to the extent relating to, Purchaser or any of its Affiliates,
including any communication by Purchaser or any of its Affiliates regarding
the plans or intentions of any such Person with respect to the conduct of the
business of Purchaser or any such Affiliates; (iv) any changes or prospective
changes in GAAP or in any Legal Requirements or other requirements of any
Governmental Body generally applicable to the industry or market in which the
Acquired Companies operate or in the interpretation thereof; (v) any actions
taken or omitted to be taken by the Company in the course of complying with
its obligations under this Agreement or which are taken with Purchaser's
written consent; (vi) the effect of any action taken by Purchaser or any of
its Affiliates with respect to the transactions contemplated hereby; (vii) any
acts of God, natural disasters, hostilities, act of war, sabotage, terrorism
or military actions, or any escalation or worsening of any such hostilities,
act of war, sabotage, terrorism or military actions; (viii) any actual or
perceived threats associated with pandemics, epidemics or other public health
crises, including, but not limited to, the COVID-19 outbreak; or (ix) any
failure by the Acquired Companies to achieve any earnings or other financial
projections or forecasts (provided, that the underlying cause of such failure,
to the extent not otherwise excluded herein, may be taken into account in
making a determination as to whether a Material Adverse Effect has occurred or
would reasonably be expected to occur); provided, however, that Effects set
forth in the foregoing clauses "(i)", "(iv)", "(vii)" and "(viii)" of this
sentence shall be taken into account in determining whether a Material Adverse
Effect has occurred or would reasonably be expected to occur to the extent
that any such Effect has a disproportionate effect on the Acquired Companies 

or their business relative to other Persons operating in the same industries
or markets in which the Acquired Companies operates their businesses.

"Material Contracts" has the meaning set forth in Section 2.11(a) of the
Agreement.

"Net Working Capital Amount" means (a) the aggregate current assets of the
Retained Business, consisting of the general ledger account balances under the
heading "Current Assets" in Exhibit F, as of the close of business on the day
immediately prior to the Closing Date less (b) the aggregate current
liabilities of the Retained Business, consisting of the general ledger account
balances under the heading "Current Liabilities" in Exhibit F (excluding the
liabilities owed by any of the Company, 340B OpCo or PHSS to each other), as
of the close of business on the day immediately prior to the Closing Date plus
(c) the adjustments consisting of the general ledger account balances under
the heading "Adjustments" in Exhibit F, as of the close of business on the day
immediately prior to the Closing Date, each determined in accordance with GAAP
applied on a basis consistent with the Acquired Companies' past practices. For
purposes of calculating Net Working Capital Amount: (i) the current assets
shall exclude (A) the Closing Cash Amount, (B) the portion of any prepaid
expense of which Purchaser cannot receive the benefit, directly or indirectly,
following the Closing and (C) deferred Tax assets and (ii) the current
liabilities shall exclude (A) the Transaction Expenses, (B) the Closing
Indebtedness and (C) the deferred Tax liabilities. An illustration of the
calculation of Net Working Capital Amount is attached to this Agreement as
Exhibit F, which illustration includes the individual components, line items
and general ledger account numbers (as established in the Acquired Companies'
accounting system) used in such sample calculation. For purposes of clarity,
"Net Working Capital Amount" shall be calculated prior to giving effect to any
payment of any amounts by or on behalf of Purchaser in connection with or
following the Closing.

"Net Working Capital Shortfall Amount" means the amount, if any, by which the
Net Working Capital Amount is less than the Target Net Working Capital
Minimum.

"Net Working Capital Surplus Amount" means the amount, if any, by which the
Net Working Capital Amount is more than the Target Net Working Capital
Maximum.

"Net Working Capital Target" means $8,845,658.

"Non-Blocker Seller" means a Seller that is not Blocker Seller.

"Noncompetition Agreement" has the meaning set forth in the recitals of the
Agreement.

"Norton Rose Fulbright" has the meaning set forth in Section 12.20 of the
Agreement.

"Notice of Disagreement" has the meaning set forth in Section 1.3(b) of the
Agreement.

"Offered Employees" means the employees of the Acquired Companies and the
Spin-Off Entities set forth on Exhibit L to the Agreement and any employees
hired by any Acquired Company or Spin-Off Entity after the date of this
Agreement and before the Closing Date to perform services primarily for the
Retained Business. 

"Open Source Code" means any Computer Software that is distributed under "open
source" (as that term is defined by the Open Source Initiative) or "free
software" (as that term is defined by the Free Software Foundation) terms,
including any Computer Software distributed under the GPL, LGPL, AGPL, Mozilla
License, Apache License, Common Public License, MIT license, BSD license or
similar terms and including any Computer Software distributed with any license
term or condition that: (a) requires or could require, or conditions or could
condition, the use or distribution of such Computer Software on the
disclosure, licensing or distribution of any source code for any portion of
such Computer Software or any derivative work of such Computer Software; (b)
requires or could require, or conditions or could condition, that any portion
of such Computer Software or any derivative work of such Computer Software be
licensed for the purpose of making modifications or derivative works or be
redistributable at no charge; or (c) otherwise imposes or could impose any
limitation, restriction or condition on the right or ability of the licensee
of such software to use or distribute such Computer Software or any derivative
work of such Computer Software.

"Order" means any order, writ, injunction, judgment, decree, settlement
agreement, ruling or award of, with or imposed by any arbitrator or any court
or other Governmental Body, including any corporate integrity agreement,
monitoring agreement, deferred or no prosecution agreement or other similar
agreement.

"Ordinary Course of Business" means, in respect of any Person, the ordinary
course of business of such Person consistent with past practices.

"Outbound Licenses" has the meaning set forth in Section 2.10(d) of the
Agreement.

"Outside Date" has the meaning set forth in Section 10.1(b) of the Agreement.

"Party" or "Parties" has the meaning set forth in the preamble to the
Agreement.

"Patents" means patents (including utility, utility model, plant and design
patents, and certificates of invention), patent applications (including
additions, provisional, national, regional and international applications, as
well as original, continuation, continuation-in-part, divisional and continued
prosecution applications, reissues and re-examination applications), patent or
invention disclosures, registrations, applications for registrations and any
term extension or other governmental action which provides rights beyond the
original expiration date of any of the foregoing.

"Paying Agent" means Citizens Bank, N.A. or another Person selected by
Purchaser.

"Permitted Encumbrance" means (a) liens in respect of Taxes which are not yet
due and payable and for which adequate reserves have been established in
accordance with GAAP, if applicable (b) carriers', warehousemens', mechanics',
materialmens', repairmens', landlords' or other similar liens arising in the
Ordinary Course of Business which are not yet due and payable and which are
not, individually or in the aggregate, material to the business, operations,
financial condition or the assets of any Acquired Company, (c) liens
consisting of pledges or deposits required in the Ordinary Course of Business
in connection with workers' compensation, 

unemployment insurance and other similar programs mandated by applicable Legal
Requirements, and (d) minor liens that have arisen in the Ordinary Course of
Business and that do not (individually or in the aggregate) materially detract
from the value of the assets subject thereto or materially impair the
operations of any Acquired Company.

"Person" means any individual, Entity or Governmental Body.

"Personal Data" means information relating to an identified or identifiable
person, device or household including: (i) a natural person's name, street
address or specific geolocation information, date of birth, telephone number,
email address, online contact information, photograph, biometric data, Social
Security number, driver's license number, passport number, tax identification
number, any government-issued identification number, financial account number,
credit card number, any information that would permit access to a financial
account, a user name and password that would permit access to an online
account, health information, insurance account information, any persistent
identifier such as customer number held in a cookie, an Internet Protocol
address, a processor or device serial number or a unique device identifier;
(ii) "personal data," "personal information," protected health information,"
"nonpublic personal information" or other similar terms as defined by Privacy
Requirements; or (iii) any other information that allows the identification of
a natural person.

"PHSS" means PSG Health Systems Solutions, LLC, a Texas limited liability
company and a wholly-owned subsidiary of PSG as of the date of the Agreement
and until the completion of the Divisional Merger.

"Post-DM Spin-Off" means all transactions contemplated by the Spin-Off
Agreements other than the Divisional Merger, including (a) the determination
of the PSG Units FMV, (b) the PSG Distribution, (c) the BWAH Pay-Down, (d) the
termination and satisfaction of the Blocker Note, (e) the DAB Sale and (f) the
PSG Purchase Price Distribution (each capitalized term used in this definition
of "Post-DM Spin-Off" (other than the term "Blocker Note") has the meaning
ascribed to it in the Reorganization Agreement).

"Pre-Closing Period" has the meaning set forth in Section 6.1 of the
Agreement.

"Pre-Closing Tax Period" means any tax period (or portion of any Straddle
Period) ending on or before the Closing Date.

"Pre-Closing Taxes" means the Acquired Company Pre-Closing Taxes and the
Blocker Entity Pre-Closing Taxes, collectively.

"Privacy Requirements" means any and all applicable Legal Requirements and
industry requirements relating to the Processing of Personal Data, including:
(i) each Legal Requirement relating to the protection or Processing of
Personal Data to the extent applicable to the Acquired Companies, including,
as applicable, but not limited to, the Federal Trade Commission Act, 15 U.S.C.
 45; the CAN-SPAM Act of 2003, 15 U.S.C.  7701 et seq.; the Telephone
Consumer Protection Act, 47 U.S.C.  227; HIPAA and the HIPAA Rules; HITECH;
the Fair Credit Reporting Act, 15 U.S.C. 1681; the Gramm-Leach-Bliley Act, 15
U.S.C.  6801, et seq.; the 

Electronic Communications Privacy Act, 18 U.S.C.  2510-22; the Stored
Communications Act, 18 U.S.C.  2701-12; the California Consumer Privacy Act,
Cal. Civ. Code  1798.100, et seq.; the California Online Privacy Protection
Act, Cal. Bus. and Prof. Code  22575, et seq.; the New York Department of
Financial Services Cybersecurity Regulation, 23 NYCRR 500; the South Carolina
Privacy of Consumer Financial and Health Information Regulation, South
Carolina Code  69-58; Massachusetts Gen. Law Ch. 93H, 201 C.M.R. 17.00; Nev.
Rev. Stat. 603A; Cal. Civ. Code  1798.82; N.Y. Gen. Bus. Law  899-aa; the
European Union's Directive on Privacy and Electronic Communications
(2002/58/EC); the General Data Protection Regulation (2016/679); and all
implementing regulations and requirements, and other similar Legal
Requirements; (ii) each obligation of any Contract relating to the Processing
of Personal Data applicable to the Acquired Companies, including any third
party privacy policy to which any Acquired Company is contractually bound; and
(iii) each applicable rule, codes of conduct or other requirement of self-
regulatory bodies and applicable industry standards, including, but not
limited to, and, to the extent applicable, the Payment Card Industry Data
Security Standard.



"Privileged Communications" has the meaning set forth in Section 12.20 of the
Agreement.



"Pro Rata Portion" of a particular Seller means the percentage set forth
adjacent to such Seller's name under the heading "Pro Rata Portion" on
Schedule 1.2 to the Agreement.

"Processing", "Process" or "Processed", with respect to data, including, but
not limited to, Company Data, Personal Data and User Data, or Company IT
Systems, means any collection, access, acquisition, storage, protection, use,
re-use, disposal, disclosure, re-disclosure, destruction, transfer,
modification, maintenance or any other processing (as defined by any
applicable Privacy Requirement) of such data or Company IT Systems.



"Provided 340B Link Financial Statements" has the meaning set forth in Section
2.4(a)(ii) of the Agreement.

"Provided Company Financial Statements" has the meaning set forth in Section
2.4(a)(i) of the Agreement.

"PSG" means Pharmaceutical Strategies Group, LLC, a Texas limited liability
company and a wholly-owned Subsidiary of the Company as of the date of the
Agreement and until the completion of the PSG Distribution.



"PSG Distribution" has the meaning as set forth in the Reorganization
Agreement.



"PSG Distribution Damages" has the meaning set forth in Paragraph 1 of
Schedule 11.3(c)(v) to the Agreement.



"PSG Transition Services Agreement" means the Transition Services Agreement,
dated as of the Closing Date, by and between SpinCo and 340B OpCo in the form
of Exhibit H-2 to the Agreement. 

"PSGSS" means PSG Support Services, LLC, a Texas limited liability company and
an indirect wholly-owned Subsidiary of the Company as of the date of the
Agreement and until the completion of the PSG Distribution.

"Purchase Price" has the meaning set forth in Section 1.2(a) of the Agreement.

"Purchased Securities" has the meaning set forth in Section 1.1 of the
Agreement.

"Purchaser" has the meaning set forth in the preamble to the Agreement.

"Purchaser Authorized Persons" has the meaning set forth in Section 6.2 of the
Agreement.

"Purchaser Cure Period" has the meaning set forth in Section 10.1(f) of the
Agreement.

"RandW Insurer" means BlueChip Underwriting Services LLC on behalf of the
applicable underlying insurers.

"RandW Policy" means that certain representation and warranties insurance policy
underwritten by the RandW Insurer in connection with the transactions
contemplated by this Agreement.

"Registered IP" means all Intellectual Property Rights that are registered,
filed, issued or granted under the authority of, with or by, any Governmental
Body, including all Patents, registered copyrights, registered Trademarks,
Domain Names and all applications for any of the foregoing.

"Related Party" means: (a) each of the Sellers; (b) each individual who is, or
who has at any time since inception been, an officer or manager of any
Acquired Company; (c) each member of the immediate family of each of the
individuals referred to in clauses "(a)," and "(b)" above; and (d) any trust
or other Entity (other than any Acquired Company) in which any one of the
Persons referred to in clauses "(a)," "(b)" and "(c)" above holds (or in which
more than one of such Persons collectively hold), beneficially or otherwise, a
voting, proprietary, equity or economic interest.

"Release" means the release to be executed by each of the Persons identified
in Schedule 1.4(b)(iv) substantially in the form of Exhibit C to the
Agreement.

"Release Date" or "Release Dates" has the meaning set forth in Section
11.7(c)(iii) of the Agreement.

"Release Date General Indemnity Escrow Retained Amount" has the meaning set
forth in Section 11.7(b) of the Agreement.

"Unresolved General Indemnity Escrow Claim" has the meaning set forth in
Section 11.7(b) of the Agreement. 

"Reorganization Agreement" has the meaning set forth in the definition of
Spin-Off Agreements.

"Reply" has the meaning set forth in Section 1.3(c) of the Agreement.

"Representatives" means officers, directors, managers, employees, independent
contractors and consultants, agents, attorneys, accountants, advisors and
representatives.

"Required 340B Link Financial Statements" has the meaning set forth in Section
6.15(b) of the Agreement.

"Required 340B Link Historical Financial Statements" has the meaning set forth
in Section 6.15(b) of the Agreement.

"Required 340B Link Interim Financial Statements" has the meaning set forth in
Section 6.15(a) of the Agreement.

"Required Employees" has the meaning set forth in Section 1.4(b)(xx) of the
Agreement.

"Required Company Financial Statements" has the meaning set forth in Section
6.15(a) of the Agreement.

"Required Financial Statements" means, collectively, the Required Company
Financial Statements and the Required 340B Link Financial Statements.

"Response Notice" has the meaning set forth in Section 11.5(b) of the
Agreement.

"Restricted Cash" means cash deposits, cash in reserve or escrow accounts,
custodial cash and cash subject to a lockbox, dominion, control or similar
agreement or otherwise subject to any legal or contractual restriction on the
ability to freely transfer or use such cash for any lawful purpose.

"Retained Business" means the 340B Business, as such term is defined in the
Divisional Merger Agreement.

"Retained Business IT Systems" has the meaning set forth in Section 2.10(o) of
the Agreement.

"Second Release Date Special Indemnity Escrow Distributed Amounts" has the
meaning set forth in Section 11.7(c)(ii) of the Agreement.

"Second Release Date Special Indemnity Escrow Distribution Amount" has the
meaning set forth in Section 11.7(c)(ii) of the Agreement.

"Second Release Date Special Indemnity Escrow Excess Amount" has the meaning
set forth in Section 11.7(c)(ii) of the Agreement. 

"Second Release Date Special Indemnity Escrow Retained Amount" has the meaning
set forth in Section 11.7(c)(ii) of the Agreement.

"Second Release Date Unresolved Special Indemnity Escrow Claim" has the
meaning set forth in Section 11.7(c)(ii) of the Agreement.

"Second Special Indemnity Escrow Release Date" has the meaning set forth in
Section 11.7(c)(ii) of the Agreement.

"Seller" or "Sellers" each have the meaning set forth in the preamble to the
Agreement.

"Sellers Cure Period" has the meaning set forth in Section 10.1(e) of the
Agreement.

"Seller Representations" means (a) the representations and warranties made by
each Seller set forth in Section 3 (Representations and Warranties of Each
Seller) of the Agreement and (b) the representations, warranties,
certifications and other statements and information set forth in such Seller's
Individual Seller Closing Certificate with respect to such Section specified
in the foregoing clause "(a)".

"Sellers' Representative" has the meaning set forth in the preamble to the
Agreement.

"Sellers' Representative Amount" has the meaning set forth in Section
12.1(b)(iv) of the Agreement.

"Sellers' Representative Fund" has the meaning set forth in Section
12.1(b)(iv) of the Agreement.

"Signing Date Offer Letters" has the meaning set forth in the recitals of the
Agreement.

"Solvent" has the meaning set forth in Section 2.1(e) of the Agreement.

"Special Distribution" means a distribution of cash by the Company pursuant to
Part 6.2(b)(ii) of the Disclosure Schedule to BWA Feeder in excess of the
amount that it would otherwise be entitled to receive under the Company
Operating Agreement, which Special Distribution shall be treated under the
Company Operating Agreement as an advance distribution under Section 5.2 of
the Company Operating Agreement and is and shall only be made by the Company
to BWA Feeder prior to the Company's delivery of the draft of Updated Pro Rata
Portion Schedule pursuant to Section 6.10(b) for the sole purpose of funding
BWA Feeder's satisfaction of the Blocker Note prior to the Closing.

"Special Indemnity Escrow Account" means the account established by the Escrow
Agent for the Special Indemnity Escrow Amount pursuant to the terms of the
Escrow Agreement.

"Special Indemnity Escrow Amount" means $3,000,000. 

"Special Indemnity Escrow Funds" means as of any date of determination, the
excess (if any) of the Special Indemnity Escrow Amount (plus any dividends,
interest, distributions and other income received in respect thereof) minus
the sum of all distributions and other payments to any Person on or prior to
such date of determination from the Special Indemnity Escrow Account.

"Special Pro Rata Portion" of a particular Seller means the percentage set
forth adjacent to such Seller's name under the heading "Special Pro Rata
Portion" set forth on Schedule 1.2 to the Agreement.

"Special Tax Indemnity Matters" means the tax indemnities described in
Paragraphs 1, 2 and 3 of Schedule 11.2(a)(vi) to the Agreement.

"Spin-Off" means all the transactions contemplated by the Spin-Off Agreements.

"Spin-Off Agreements" means the following agreements that are related to the
Spin-Off: (a) the Reorganization Agreement in substantially the form attached
hereto as Exhibit G-1 (the "Reorganization Agreement"), (b) the Agreement and
Plan of Merger (Divisional Merger), in substantially the form attached hereto
as Exhibit G-2 (the "Divisional Merger Agreement"), (c) the Indemnity
Agreement, in substantially the form attached hereto as Exhibit G-3 (the
"Indemnity Agreement") and (d) all schedules and exhibits to, and all
agreements, documents and instruments referred to in or contemplated by, the
agreements set forth in the foregoing clauses "(a)" through "(c)" and any
other agreements relating to the Spin-Off, to be executed and performed, as
applicable, by the Company, PSG, SpinCo, 340B OpCo, Blocker, Blocker Seller,
the BWA Entities and the Class A Holder.

"Spin-Off Assets" means the DMS Assets, as such term is defined in the
Divisional Merger Agreement.

"Spin-Off Employees" has the meaning set forth in Section 7.5 of the
Agreement.

"Spin-Off Entities" means each of the following Subsidiaries of the Company:
SpinCo (following the completion of the Divisional Merger), PBMI, LLC, a Texas
limited liability company, Pharmacy Benefit Management Institute, LP, a Texas
limited partnership, PSG Support Services, LLC, a Texas limited liability
company, PSG Consulting, LLC, a Texas limited liability company, Intelligent
Compliance Solutions, LLC, a Texas limited liability company, Artemetrx, LLC,
a Texas limited liability company, Artemetrx Specialty Drug Solutions, LLC, a
Texas limited liability company and Cogneta LLC, a Texas limited liability
company.

"Spin-Off Liabilities" means the DMS Obligations, as such term is defined in
the Divisional Merger Agreement.

"SpinCo" has the meaning set forth in Section 6.14 of the Agreement.

"SpinCo Policies" has the meaning set forth in Section 6.17 of the Agreement. 

"Statement" has the meaning set forth in Section 1.3(a) of the Agreement.

"Stipulated Amount" has the meaning set forth in Section 11.5(f) of the
Agreement.

"Straddle Period" means any taxable year or period beginning on or before and
ending after the Closing Date.

"Sublease Agreement" has the meaning set forth in Section 6.18 of the
Agreement.

"Subleasing Expenses" has the meaning set forth in the in the Sublease Term
Sheet attached to the Agreement as Exhibit M.

An Entity shall be deemed to be a "Subsidiary" of another Person if such
Person directly or indirectly owns or purports to own, beneficially or of
record: (a) an amount of voting securities or other interests in such Entity
that is sufficient to enable such Person to elect at least a majority of the
members of such Entity's board of directors or other governing body; or (b) at
least 50% of the outstanding equity or financial interests of such Entity.

"Target Net Working Capital Maximum" means an amount equal to the Net Working
Capital Target plus $100,000.

"Target Net Working Capital Minimum" means an amount equal to the Net Working
Capital Target minus $100,000.

"Tax", "Taxation", "tax" and "taxation" includes all forms of taxation and
statutory, governmental, supra-governmental, federal, state, principal, local
government or municipal impositions, duties, contributions, deductions,
charges and levies, including any net income, gross income, gross receipts,
windfall profit, severance, property, production, sales, use, license, excise,
value-added, franchise, employment, payroll, withholding, alternative or add-
on minimum, ad valorem, transfer, stamp, escheat payment, environmental or
similar taxes, in each case whether of the United States or elsewhere and
whenever imposed, and all penalties, charges, surcharges, costs, expenses,
interest and inflation indexation relating thereto regardless of whether any
such taxes, impositions, duties, contributions, deductions, charges and levies
are chargeable directly or primarily against or attributable directly or
primarily to any Acquired Company or any other Person (including any Liability
for the payment of such amounts as a result of being or having been a member
of an Affiliated Group, as a result of any obligation under any agreement or
arrangement, as a result of being a transferee or successor or by contract or
otherwise) and of whether any amount in respect of any of them is recoverable
from any other Person.

"Tax Basis Balance Sheet" has the meaning set forth in Section 1.8 of the
Agreement.

"Tax Proceeding" has the meaning set forth in Section 12.4(b) of this
Agreement.

"Tax Return" means any return (including any information, tax credit,
incentive or benefit return, amended return or claim for refund), report,
statement, declaration, estimate, schedule, notice, notification, form,
election, certificate or other document or information filed 

with or submitted to, or required to be filed with or submitted to, any
Governmental Body in connection with the determination, assessment, collection
or payment of any Tax or in connection with the administration, implementation
or enforcement of or compliance with any applicable Legal Requirement relating
to any Tax (including any attached schedule).

"Texas 2020 Return" has the meaning set forth in Section 12.4(a)(i)(C) of the
Agreement.

"Top Customer" has the meaning set forth in Section 2.23(a) of the Agreement.

"Top Supplier" has the meaning set forth in Section 2.23(b) of the Agreement.

"Trade Secrets" means trade secrets (including, but not limited to, those
trade secrets defined in the Uniform Trade Secrets Act and under corresponding
foreign statutory and common law) and confidential information, including all
source code, documentation, know how, processes, protocols, algorithms,
schematics, specifications, diagrams, methods, techniques, technology,
formulae, customer lists or data, data collections and databases, business and
marketing plans, inventions (whether or not patentable) and marketing
information.

"Trademarks" shall mean trademarks, service marks, trade names, trade dress,
logos, corporate names and other source or business identifiers (in each case
whether or not registered), and, for any of the foregoing, any registrations,
applications for registration, renewals of registration and extensions of
registration, and all goodwill associated with any of the foregoing.

"Transaction Expenses" means, without duplication, all fees, costs, expenses,
payments, expenditures or liabilities (collectively, "Expenses"), whether
incurred prior to the date of the Agreement, during the Pre-Closing Period or
at or after the Closing, and whether or not invoiced prior to the Closing,
incurred by or on behalf of any Acquired Company, Spin-Off Entity or Blocker
Entity, or to or for which any Acquired Company, Spin-Off Entity or Blocker
Entity is or becomes subject or liable, in each case, in connection with the
Company's, Blocker's, and the Sellers' negotiation or consummation of any of
the transactions contemplated by the Agreement, in each case, to the extent
unpaid as of immediately prior to the Closing, including: (a) Expenses
described in Section 12.3 of the Agreement; (b) Expenses payable to legal
counsel or to any financial advisor, broker, accountant or other Person who
performed services for or on behalf of, or provided advice to any Acquired
Company, Spin-Off Entity or Blocker Entity, in connection with or relating to
the Agreement, any of the transactions contemplated by the Agreement or the
process resulting in such transactions, including all fees, costs and expenses
payable by the Acquired Companies and the Spin-Off Entities under the BW
Management Agreement and the Due Diligence Fees (as defined in the Disclosure
Schedule); (c) Expenses or compensation that arise or are expected to arise,
or are triggered or become due or payable, as a direct or indirect result of
the consummation (whether alone or in combination with any other event or
circumstance) of the transactions contemplated by the Agreement, including any
fees and expenses related to the DandO Policies, the SpinCo Policies, any
obligation or Liability set forth in Part 2.15(k) of the Disclosure Schedule,
any other bonus, stay, retention, severance, profit sharing or change of
control payment or benefit (or similar payment obligation), made or provided,
or required to be made or provided, by any Acquired Company as a result of or
in connection with any of the transactions contemplated by the Agreement and
the Change of 

Control Bonuses, and the employer portion of any payroll or similar Taxes
attributable to any of the foregoing; (d) Transfer Taxes; (e) any social
security, Medicare, unemployment or other employment, withholding or payroll
Tax or similar amount owed by any Acquired Company or Blocker Entity with
respect to any of the transactions contemplated by this Agreement; (f)
Expenses incurred by or on behalf of any Seller or any Company Service
Provider in connection with the transactions contemplated by the Agreement
that any Acquired Company or Blocker Entity is or will be obligated to pay or
reimburse after the Closing (including the Change of Control Bonuses to be
paid in connection with the consummation of the transactions contemplated
herein); (g) any forgiveness by any Acquired Company or Blocker Entity of any
Indebtedness; (h) any Expenses incurred before Closing to terminate or amend
or obtain any consents, waivers or approvals under any Company Contract as a
result of or in connection with the transactions contemplated by the
Agreement, including the Subleasing Expenses; (h) one-half of the portion of
the premium of the RandW Policy specifically attributable to the excess coverage
pertaining to the Fundamental Representations and the Pre-Closing Taxes and
(i) the Accrued Employee Amounts; provided, however, that Transaction Expenses
shall not include any amount included in the Closing Indebtedness Amount.



"Transaction Tax Deductions" means, to the extent at least more likely than
not deductible for income Tax purposes, any tax deduction attributable to the
payment of the Transaction Expenses, any deduction for unamortized financing
costs of the Acquired Companies' premium deductions arising from the repayment
of indebtedness, and any other costs, expenses or other Liabilities relating
to, arising from, incurred in connection with or incident to the transactions
contemplated by this Agreement that are paid on or prior to the Closing Date
or that are included in the calculation of Net Working Capital Amount or
Closing Indebtedness Amount; provided, that, the Parties shall make any
available elections under Revenue Procedure 2011-29, 2011-18 IRB to treat 70%
of any success-based fees that were paid as an amount that did not facilitate
the transactions contemplated by this Agreement, and therefore treat 70% of
such costs as at least more likely than not deductible in the Pre-Closing Tax
Period for U.S. federal income (and applicable state and local income) tax
purposes.

"Transfer Taxes" means any real property transfer or gains Tax, conveyance
Tax, controlling interest transfer Tax, sales Tax, use Tax, stamp Tax, stock
transfer Tax, value added Tax, registration Tax, documentary Tax, excise Tax
or other similar Tax imposed on the transactions contemplated by this
Agreement.

"Transition Services Agreements" means, collectively, the 340B Transition
Services Agreement and the PSG Transition Services Agreement.

"United States" means any State of the United States and the District of
Columbia.

"Units" has the meaning set forth in the recitals of the Agreement.

"Unregistered IP" has the meaning set forth in Section 2.10(b) of the
Agreement.

"Updated DMA Schedules/Annexes" has the meaning set forth in Section 6.10(c). 

"Updated Pro Rata Portion Schedule" has the meaning set forth in Section
1.2(a) of the Agreement.

"Unresolved Claim" or "Unresolved Claims" has the meaning set forth in Section
11.7(c)(iii) of the Agreement.

"User Data" means any Personal Data or other data or information collected by
or on behalf of any Acquired Company from users of any Company Web Site or any
Company Software or in connection with any Company Product.





A-30



   '

